Publications

View a complete and updated list of publications.

1. Thakar,M.S., Bonfim,C., Sandmaier,B.M., O’Donnell,P., Ribeiro,L., Gooley,T., Deeg,H.J., Flowers,M.E., Pasquini,R., Storb,R., Woolrey,A.E., Kiem,H.P. Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi Anemia. Ped. Hematol. Oncol. (in press)
2. Graves,S.S., Mathes,D.W., Georges,G.E., Kuhr,C.S., Chang,J., Butts,T.M., Storb,R. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model. Transplantation (in press).
3. Wang,Z., Storb,R., Halbert,C.L., Banks,G.B., Butts,T.M., Finn,E.E., Allen,J.M., Miller,A.D., Chamberlain,J.S., Tapscott,S.J. Successful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies. Mol Ther. (in press)
4. Burroughs,L.M., Woolfrey,A.E., Storer,B.E., Deeg,H.J., Flowers,M.E.D., Martin,P.J., Carpenter,P.A., Doney,K., Appelbaum,F.R., Sanders,J.E., Storb,R. Success of allogeneic marrow transplantation for children with severe aplastic anemia. Br. J. Haematol. 158: 120-128, 2012.
5. Parker,M.H., Loretz,C., Tyler,A., Snider,L., Storb,R., Tapscott,S.J. Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation. Skeletal Muscle (in press)
6. Mielcarek,M., Storer,B., Martin,P.J., Forman,S.J., Negrin,R.S., Flowers,M.E., Inamoto,Y., Chauncey,T.R., Storb,R., Appelbaum,F.R., Bensinger,W.I. Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow. Blood 119: 2675-2678, 2012.
7. Wang,Z., Tapscott,S.J., Chamberlain,J.S., Storb,R. Immunity and AAV-mediated gene therapy for muscular dystrophies in large animal models and human trials. Frontiers in Microbiology 2: 201, 2011.
8. Wang,Z., Storb,R., Tapscott,S.J., Riddell,S. Analyzing cellular immunity to AAV in a canine model using ELISPOT assay. In: Handbook of ELISPOT: Methods and Protocols, Kalyuzhny,A.E. (ed.). Clifton, NJ: Springer, Chapter 5: 65-74, 2012.
9. Scott,B.L., Gooley,T.A., Sorror,M.L., Rezvani,A.R., Linenberger,M.L., Grim,J., Sandmaier,B.M., Myerson,D., Chauncey,T.R., Storb,R., Buxhofer-Ausch,V., Radich,J.P., Appelbaum,F.R., Deeg,H.J. The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietiic cell transplantation. Blood 119: 2657-2664, 2012.
10. Chen,Y., Kornblit,B., Hamlin,D.K., Sale,G.E., Santos,E.B., Wilbur,D.S., Storer,B.E., Storb,R., Sandmaier,B.M. Durable donor engraftment after radioimmunotherapy using -emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoeitic cell transplantation. Blood 119: 1130-1138, 2012.
11. Bowen,J.D., Kraft,G.H., Wundes,A., Guan,Q., Maravilla,K.R., Gooley,T.A., McSweeney,P.A., Pavletic,S.Z., Openshaw,H., Storb,R., Wener,M., McLaughlin,B.A., Henstorf,G.R., Nash,R.A. Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results. Bone Marrow Transplant. 47: 946-951, 2012.
12. Bensinger,W., Rotta,M., Storer,B., Chauncey,T., Holmberg,L., Becker,P., Sandmaier,B.M., Storb,R., Maloney,D. Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center. Bone Marrow Transplant. [Advance online publication, 13 February 2012]; doi:10.1038/bmt/2012.1.
13. Sorror,M.L., Sandmaier,B.M., Storer,B.E., Franke,G.N., Laport,G.G., Chauncey,T.R., Agura,E., Maziarz,R.T., Langston,A., Hari,P., Pulsipher,M.A., Bethge,W., Sahebi,F., Bruno,B., Maris,M.B., Yeager,A., Petersen,F.B., Vindeløv,L., McSweeney,P.A., Hübel,K., Mielcarek,M., Georges,G.E., Niederwieser,D., Blume,K.G., Maloney,D.G., Storb,R. Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies. JAMA 306: 1874-1883, 2011.
14. Mathes,D.W., Hwang,B., Graves,S.S., Edwards,J., Chang,J., Storer,B.E., Butts-Miwongtum,T., Sale,G.E., Nash,R.A., Storb,R. Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras. Transplantation 92: 1301-1308, 2011.
15. Baron,F., Storb,R. Mesenchymal stromal cells: a new tool against graft-versus-host disease? Biol Blood Marrow Transplant 18: 822-840, 2012.
16. Nakamae,H., Storer,B., Sandmaier,B.M., Maloney,D.G., Davis,C., Corey,L., Storb,R., Boeckh,M. Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs. Haematologica 96: 1838-1846, 2011.
17. Ram,R., Storer,B., Mielcarek,M., Sandmaier,B.M., Maloney,D.G., Martin,P.J., Flowers,M.E.D., Chua,B.K., Rotta,M., Storb,R. Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 18: 414-422, 2012.
18. Rezvani,A.R., Storer,B.E., Storb,R.F., Mielcarek,M., Maloney,D.G., Sandmaier,B.M., Martin,P.J., McDonald,G.B. Decreased serum albumin as a biomarker for severe acute graft-vs-host disease after reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 17: 1594-1601, 2011.
19. Kennedy,L.J., Ollier,E.R., Marti,E., Wagner,J.L., Storb,R. Canine immunogenetics. In: The Genetics of the Dog, Second Edition, Ostrander,E.A. and Ruvinsky,A. (eds.). Oxfordshire, UK: CAB International, Chapter 6: 91-135, 2012.
20. Chen,Y., Fukuda,T., Thakar,M.S., Kornblit,B.T., Storer,B.E., Santos,E.B., Storb,R., Sandmaier,B.M. Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation. Cytotherapy 13: 1269-1280, 2011.
21. Sanders,J.E., Woolfrey,A.E., Carpenter,P.A., Storer,B.E., Hoffmeister,P.A., Deeg,H.J., Flowers,M.E.D., Storb,R.F. Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia. Blood 118: 1421-1428, 2011.
22. Inamoto,Y., Flowers,M.E.D., Lee,S.J., Carpenter,P.A., Warren,E.H., Deeg,H.J., Storb,R.F., Appelbaum,F.R., Storer,B.E., Martin,P.J. Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation. Blood 118: 456-463, 2011.
23. Ram,R., Storb,R., Sandmaier,B.M., Maloney,D.G., Woolfrey,A., Flowers,M.E.D., Maris,M.B., Laport,G.G., Chauncey,T.R., Lange,T., Langston,A.A., Storer,B., Georges,G.E. Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia. Haematologica 96: 1113-1120, 2011.
24. Gopal,A.K., Guthrie,K.A., Rajendran,J., Pagel,J.M., Olivieri,A., Maloney,D.G., Matesan,M.C., Storb,R.F., Press,O.W. 90Y-ibritumomab tiuxetan, fludarabine, and TBI based non-myeloablative allogeneic tranplant conditioning for patients with persistent high-risk B-cell lymphoma. Blood 118: 1132-1139, 2011.
25. Ram,R., Gooley,T.A., Maloney,D.G., Press,O.W., Pagel,J.M., Petersdorf,S.H., Shustov,A., Flowers,M.E.D., O’Donnell,P., Sandmaier,B.M., Storb,R.F., Gopal,A.K. Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 17: 1537-1545, 2011.
26. Inamoto,Y., Yannucci,J., Storb,R.F., Flowers,M.E.D. Recurrence of β-thalassemia major more than 20 years after HLA-identical sibling BMT treated successfully with donor lymphocyte infusion (Letter to the Editor). Bone Marrow Transplant. 46: 1037-1038, 2011.
27. Giaccone,L., Storer,B., Patriarca,F., Rotta,M., Sorasio,R., Allione,B., Carnevale-Schianca,F., Festuccia,M., Brunello,L., Omede,P., Bringhen,S., Aglietta,M., Levis,A., Mordini,N., Gallamini,A., Fanin,R., Massaia,M., Palumbo,A., Ciccone,G., Storb,R., Gooley,T.A., Boccadoro,M., Bruno,B. Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma. Blood 117: 6721-6727, 2011.
28. Samuelson,S., Sandmaier,B.M., Heslop,H.E., Popat,U., Carrum,G., Champlin,R.E., Storb,R., Prchal,J.T., Gooley,T.A., Deeg,H.J. Allogeneic haematopoeietic cell transplantation for myelofibrosis in 30 patients 60 – 78 years of age. Br. J. Haematol. 153: 76-82, 2011.
29. Graves,S.S., Stone,D.M., Loretz,C., Peterson,L.J., Lesnikova,M., Hwang,B., Georges,G.E., Nash,R., Storb,R. Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation. Transplantation 91: 833-840, 2011.
30. Mielcarek,M., Torok-Storb,B., Storb,R. Pharmacological immunosuppression reduces but does not eliminate the need for total-body irradiation in nonmyeloablative conditioning regimens for hematopoietic cell transplantation. Biol Blood Marrow Transplant 17: 1255-1260, 2011.
31. Inamoto,Y., Flowers,M.E.D., Appelbaum,F.R., Carpenter,P.A., Deeg,H.J., Furlong,T., Kiem,H.-P., Mielcarek,M., Nash,R.A., Storb,R.F., Witherspoon,R.P., Storer,B.E., Martin,P.J. A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells. Biol Blood Marrow Transplant 17: 1088-1092, 2011.
32. Flowers,M.E.D., Inamoto,Y., Carpenter,P.A., Lee,S.J., Kiem,H.-P., Petersdorf,E.W., Pereira,S.E., Nash,R.A., Mielcarek,M., Fero,M.L., Warren,E.H., Sanders,J.E., Storb,R.F., Appelbaum,F.R., Storer,B.E., Martin,P.J. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 117: 3214-3219, 2011.
33. Inamoto,Y., Fefer,A., Sandmaier,B.M., Gooley,T.A., Warren,E.H., Petersdorf,S.H., Sanders,J.E., Storb,R.F., Appelbaum,F.R., Martin,P.J., Flowers,M.E.D. A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 17: 1308-1315, 2011.
34. Doney,K., Gooley,T.A., Deeg,H.J., Flowers,M.E.D., Storb,R., Appelbaum,F.R. Allogeneic hematopoietic cell transplantation with full-intensity conditioning for adult acute lymphoblastic leukemia: results from a single center 1998-2006. Biol Blood Marrow Transplant 17: 1187-1195, 2011.
35. Bethge,W.A., Kerbauy,F.R., Santos,E., Gooley,T.A., Storb,R., Sandmaier,B.M. Extracorporeal photopheresis in addition to pentostatin in conditioning for canine hematopoietic cell transplantation: role in engraftment. Bone Marrow Transplant. 46: 1382-1388, 2011.
36. Castermans,E., Hannon,M., Dutrieux,J., Humblet-Baron,S., Seidel,L., Cheynier,R., Willems,E., Gothot,A., Vanbellinghen,J.-F., Geenen,V., Sandmaier,B.M., Storb,R., Beguin,Y., Baron,F. Thymic recovery after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning is limited to patients younger then 60 years of age. Haematologica 96: 298-306, 2011.
37. Eissa,H., Gooley,T.A., Sorror,M.L., Nguyen,F., Scott,B.L., Doney,K., Loeb,K.R., Martin,P.J., Pagel,J.M., Radich,J.P., Sandmaier,B.M., Warren,E.H., Storb,R., Appelbaum,F.R., Deeg,H.J. Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities. Biol Blood Marrow Transplant 17: 908-915, 2011.
38. Mielcarek,M., Storb,R., Georges,G.E., Golubev,L., Nikitine,A., Hwang,B., Nash,R.A., Torok-Storb,B. Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation. Biol Blood Marrow Transplant 17: 214-225, 2011.
39. O’Donnell,P.V., Harrington,E., Gooley,T.A., Pagel,J.M., Pereira,S.E., Flowers,M.E., Hansen,J.A., Burroughs,L.M., Sandmaier,B.M., Storb,R.F., Luznik,L., Jones,R.J., Symons,H.J., Kasamon,Y.L., Fuchs,E.J. Cyclophosphamide-induced tolerance following bone marrow transplantation from haploidentical donors. Haematologica Edición Española 95 (Extra 1): 266-271, 2010.
40. Gooley,T.A., Chien,J.W., Pergam,S.A., Hingorani,S., Sorror,M.L., Boeckh,M., Martin,P.J., Sandmaier,B.M., Marr,K.A., Appelbaum,F.R., Storb,R., McDonald,G.B. Reduced mortality after allogeneic hematopoietic-cell transplantation. N. Engl. J. Med. 363 : 2091-2101, 2010.
41. Gyurkocza,B., Rezvani,A., Storb,R. Allogeneic hematopoietic cell transplantation: the state of the art. Expert Review of Hematology 3: 285-299, 2010.
42. Thakar,M.S., Santos,E.B., Gooley,T.A., Sale,G., Storb,R., Kiem,H.-P., Sandmaier,B.M. Evaluation of posttransplant methotrexate to facilitate engraftment in the canine major histocompatibility complex-haploidentical nonmyeloablative transplant model. Transplantation 90: 14-22, 2010.
43. Sorror,M.L., Storer,B., Storb,R. Assignment of scores for the Hematopoietic Cell Transplantation-Comorbidity Index: integer vs exact weights (Letter to the Editor). Bone Marrow Transplant. 46: 464-466, 2011.
44. Thakar,M.S., Kurre,P., Storb,R., Kletzel,M., Frangoul,H., Pulsipher,M.A., Leisenring,W., Flowers,M.E.D., Sandmaier,B.M., Woolfrey,A., Kiem,H.-P. Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation. Bone Marrow Transplant. 46: 539-544, 2011.
45. Rotta,M., Storer,B.E., Storb,R., Martin,P.J., Flowers,M.E.D., Vernon,M.S., Peffer,A., Maloney,D.G., Deeg,H.J., Sandmaier,B.M., Appelbaum,F.R., Mielcarek,M. Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 16: 1463-1466, 2010.
46. Lee,W.S., Suzuki,Y., Graves,S.S., Iwata,M., Venkataraman,G.M., Mielcarek,M., Peterson,L.J., Ikehara,S., Torok-Storb,B., Storb,R. Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation. Biol Blood Marrow Transplant 17: 465-475, 2011.
47. Sorror,M.L., Storb,R.F. Role of comorbidities in optimizing decision-making for allogeneic hematopoietic cell transplantation. Mediterranean Journal of Hematology and Infectious Diseases 2: e2010015; DOI:10.4084/MJHID.2010.015, 2010.
48. Shustov,A.R., Gooley,T.A., Sandmaier,B.M., Shizuru,J., Sorror,M.L., Sahebi,F., McSweeney,P., Niederwieser,D., Bruno,B., Storb,R., Maloney,D.G. Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas. Br. J. Haematol. 150: 170-178, 2010.
49. Sangiolo,D., Storb,R., Deeg,H.J., Flowers,M.E.D., Martin,P.J., Sandmaier,B.M., Kiem,H.-P., Nash,R.A., Doney,K., Leisenring,W.M., Georges,G.E. Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age. Biol Blood Marrow Transplant 16: 1411-1418, 2010.
50. Georges,G.E., Lesnikov,V., Baran,S.W., Aragon,A., Lesnikova,M., Jordan,R., Yang,Y.-J.L., Yunusov,M.Y., Zellmer,E., Heimfeld,S., Venkataraman,G.M., Harkey,M.A., Graves,S.S., Storb,R., Storer,B., Nash,R.A. A preclincal model of double- versus single-unit unrelated cord blood transplantation. Biol Blood Marrow Transplant 16: 1090-1098, 2010.
51. Burroughs,L.M., Torgerson,T.R., Storb,R., Carpenter,P.A., Rawlings,D.J., Sanders,J., Scharenberg,A.M., Skoda-Smith,S., Englund,J., Ochs,H.D., Woolfrey,A.E. Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. J. Allergy Clin. Immunol. 126: 1000-1005, 2010.
52. Rosinski,S.L., Deeg,H.J., Storb,R.F., Levis,M., Estey,E.H. Sorafenib in relapse of FLT3-ITD-positive acute myeloid leukemia (e-Letter). Blood e-Letter response to Metzelder, et al, Blood 2009;113:6567-6571, 2010.
53. Nakamae,H., Kerbauy,F.R., Wilbur,D.S., Bethge,W., Hamlin,D.K., Santos,E.B., Storb,R., Sandmaier,B.M. Pilot study of a 213bismuth-labeled anti-CD45 mAb as a novel nonmyeloablative conditioning for DLA-haploidentical littermate hematopoietic transplantation. Transplantation 89: 1336-1340, 2010.
54. Halbert,C.L., Madtes,D.K., Vaughan,A.E., Wang,Z., Storb,R., Tapscott,S.J., Miller,A.D. Expression of human α1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs. Molecular Therapy 18: 1165-1172, 2010.
55. Mayadev,J.S., Douglas,J.G., Storer,B.E., Appelbaum,F.R., Storb,R. Impact of cranial irradiation added to the intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement. Int. J. Radiat. Oncol. Biol. Phys. 80: 193-198, 2011.
56. Gyurkocza,B., Storb,R., Storer,B.E., Chauncey,T.R., Lange,T., Shizuru,J.A., Langston,A.A., Pulsipher,M.A., Bredeson,C.N., Maziarz,R.T., Bruno,B., Petersen,F.B., Maris,M.B., Agura,E., Yeager,A., Bethge,W., Sahebi,F., Appelbaum,F.R., Maloney,D.G., Sandmaier,B.M. Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. J. Clin. Oncol. 28: 2859-2867, 2010.
57. Wang,Z., Sorror,M.L., Leisenring,W., Schoch,G., Maloney,D.G., Sandmaier,B.M., Storb,R. The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative hematopoietic cell transplantation. Br. J. Haematol. 149: 101-110, 2010.
58. Mathes,D.W., Noland,M., Graves,S., Schlenker,R., Miwongtum,T., Storb,R. A preclinical canine model for composite tissue transplantation. Journal of Reconstructive Microsurgery 26: 201-207, 2010.
59. Wang,Z., Storb,R., Lee,D., Kushmerick,M.J., Chu,B., Berger,C., Arnett,A., Allen,J., Chamberlain,J.S., Riddell,S.R., Tapscott,S.J. Immune responses to AAV in canine muscle monitored by cellular assays and non-invasive imaging. Molecular Therapy 18: 617-624, 2010.
60. Storb,R., Antin,J.H., Cutler,C. Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease? Biol Blood Marrow Transplant 16: S18-S27, 2010.
61. Palmer,L.A., Sale,G.E., Balogun,J.I., Li,D., Jones,D., Molldrem,J.J., Storb,R.F., Ma,Q. Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease. Biol Blood Marrow Transplant 16: 311-319, 2010.
62. Thakar,M.S., Santos,E.B., Fricker,S., Bridger,G., Storb,R., Sandmaier,B.M. Plerixafor-mobilized stem cells alone are capable of inducing early engraftment across the MHC-haploidentical canine barrier (Letter to the Editor). Blood 115: 916-917, 2010.
63. Rotta,M., Storer,B.E., Storb,R.F., Martin,P.J., Heimfeld,S., Peffer,A., Maloney,D.G., Deeg,H.J., Sandmaier,B.M., Appelbaum,F.R., Mielcarek,M. Donor-statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation. Blood 115: 1288-1295, 2010.
64. Nakamae,H., Storer,B.E., Storb,R., Storek,J., Chauncey,T.R., Pulsipher,M.A., Petersen,F.B., Wade,J.C., Maris,M.B., Bruno,B., Panse,J., Petersdorf,E., Woolfrey,A., Maloney,D.G., Sandmaier,B.M. Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial. Biol Blood Marrow Transplant 16: 384-394, 2010.
65. Wang,Z., Chamberlain,J.S., Tapscott,S.J., Storb,R. Gene therapy in large animal models of muscular dystrophy. Institute of Laboratory Animal Resources Journal 50: 187-198, 2009.
66. Shimabukuro-Vornhagen,A., Hallek,M.J., Storb,R.F., von Bergwelt-Baildon,M.S. The role of B cells in the pathogenesis of graft-versus-host disease. Blood 114: 4919-4927, 2009.
67. Martin,P.J., Counts,G.W., Jr., Appelbaum,F.R., Lee,S.J., Sanders,J.E., Deeg,H.J., Flowers,M.E.D., Syrjala,K.L., Hansen,J.A., Storb,R.F., Storer,B.E. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J. Clin. Oncol. 28: 1011-1016, 2010.
68. Pagel,J.M., Gooley,T.A., Rajendran,J., Fisher,D.R., Wilson,W.A., Sandmaier,B.M., Matthews,D.C., Deeg,H.J., Gopal,A.K., Martin,P.J., Storb,R., Press,O.W., Appelbaum,F.R. Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome. Blood 114: 5444-5453, 2009.
69. Wang,Z., Tapscott,S.J., Storb,R. Local gene delivery and methods to control immune responses in muscles of normal and dystrophic dogs. In: Methods in Molecular Biology: Muscle Gene Therapy: Methods and Protocols, Duan,D. (ed.). Humana Press, Inc., Chapter 17: 265-275, 2011.
70. Sanders,J.E., Hoffmeister,P.A., Storer,B.E., Appelbaum,F.R., Storb,R.F., Syrjala,K.L. The quality of life of adult survivors of childhood hematopoietic cell transplant. Bone Marrow Transplant. 45: 746-754, 2010.
71. Gyurkocza,B., Cao,T.M., Storb,R.F., Lange,T., Leisenring,W., Franke,G.N., Sorror,M., Hoppe,R., Maloney,D.G., Negrin,R.S., Shizuru,J.A., Sandmaier,B.M. Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts. Biol Blood Marrow Transplant 15: 1314-1322, 2009.
72. Storb,R. Reduced-intensity conditioning transplantation in myeloid malignancies. Curr. Opin. Oncol. 21 (Suppl. 1): S3-S5, 2009.
73. Nishida,T., Hudecek,M., Kostic,A., Bleakley,M., Warren,E.H., Maloney,D., Storb,R., Riddell,S.R. Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia. Clin. Cancer Res. 15: 4759-4768, 2009.
74. Graves,S.S., Stone,D., Loretz,C., Peterson,L., McCune,J.S., Mielcarek,M., Storb,R. Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig. Transplantation 88: 317-322, 2009.
75. Ding,Y., Rotta,M., Graves,S.S., Storer,B.E., Peterson,L.J., Sale,G.E., Forough,R., Zellmer,E., Georges,G.E., Sandmaier,B.M., Kuhr,C.S., Storb,R. Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation. Biol Blood Marrow Transplant 15: 1244-1250, 2009.
76. Ma,Q., Gooley,T.A., Storb,R.F. CCR5 expression on cells from HLA-matched unrelated marrow donors and graft-versus-host disease (Letter to the Editor). Biol Blood Marrow Transplant 16: 132-133, 2010.
77. Schiffer,J.T., Kirby,K., Sandmaier,B., Storb,R., Corey,L., Boeckh,M. Timing and severity of community acquired respiratory virus infections after myeloablative verus non-myeloablative hematopoietic stem cell transplantation. Haematologica 94: 1101-1108, 2009.
78. Furlong,T., Martin,P., Flowers,M.E.D., Carnevale-Schianca,F., Yatscoff,R., Chauncey,T., Appelbaum,F.R., Deeg,H.J., Doney,K., Witherspoon,R., Storer,B., Sullivan,K.M., Storb,R., Nash,R.A. Therapy with mycophenolate mofetil for refractory acute and chronic graft-versus-host disease. Bone Marrow Transplant. 44: 739-748, 2009.
79. Carnevale-Schianca,F., Leisenring,W., Martin,P.J., Furlong,T., Schoch,G., Anasetti,C., Appelbaum,F.R., Carpenter,P.A., Deeg,H.J., Kiem,H.-P., Storb,R., McDonald,G.B., Nash,R.A. Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study. Biol Blood Marrow Transplant 15: 749-756, 2009.
80. Nakamae,H., Kirby,K.A., Sandmaier,B.M., Norasetthada,L., Maloney,D.G., Maris,M.B., Davis,C., Corey,L., Storb,R., Boeckh,M. Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 15: 694-703, 2009.
81. Sorror,M.L., Storer,B., Storb,R.F. Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) in single and multiple institutions: limitations and inferences (Letter to the Editor). Biol Blood Marrow Transplant 15: 757-758, 2009.
82. Nash,R.A., Yunusov,M., Abrams,K., Hwang,B., Castilla-Llorente,C., Chen,P., Farivar,A.S., Georges,G.E., Hackman,R.C., Lamm,W.J.E., Lesnikova,M., Ochs,H.D., Randolph-Habecker,J., Ziegler,S.F., Storb,R., Storer,B., Madtes,D.K., Glenny,R., Mulligan,M.S. Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantation. Am J Transplant 9: 1037-1047, 2009.
83. Nakamae,H., Wilbur,D.S., Hamlin,D.K., Thakar,M.S., Santos,E.B., Fisher,D.R., Kenoyer,A.L., Pagel,J.M., Press,O.W., Storb,R., Sandmaier,B.M. Biodistribution, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the α-emitting radionuclides bismuth-213 or astatine-211. Cancer Res. 69: 2408-2415, 2009.
84. Bruno,B., Rotta,M., Patriarca,F., Mattei,D., Allione,B., Carnevale-Schianca,F., Sorasio,R., Rambaldi,A., Casini,M., Parma,M., Bavaro,P., Onida,F., Busca,A., Castagna,L., Benedetti,E., Iori,A.P., Giaccone,L., Palumbo,A., Corradini,P., Fanin,R., Maloney,D., Storb,R., Baldi,I., Ricardi,U., Boccadoro,M. Non-myeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo. Blood 113: 3375-3382, 2009.
85. Baron,F., Petersdorf,E.W., Gooley,T., Sandmaier,B.M., Malkki,M., Chauncey,T.R., Maloney,D.G., Storb,R. What is the role for donor NK cells after nonmyeolablative conditioning? Biol Blood Marrow Transplant 15: 580-588, 2009.
86. Rotta,M., Storer,B.E., Sahebi,F., Shizuru,J.A., Bruno,B., Lange,T., Agura,E.D., McSweeney,P.A., Pulsipher,M.A., Hari,P., Maziarz,R.T., Chauncey,T.R., Appelbaum,F.R., Sorror,M.L., Bensinger,W., Sandmaier,B.M., Storb,R.F., Maloney,D.G. Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting. Blood 113: 3383-3391, 2009.
87. Mielcarek,M., Storer,B.E., Boeckh,M., Carpenter,P.A., McDonald,G.B., Deeg,H.J., Nash,R.A., Flowers,M.E.D., Doney,K., Lee,S., Marr,K.A., Furlong,T., Storb,R., Appelbaum,F.R., Martin,P.J. Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. Blood 113: 2888-2894, 2009.
88. Storb,R. In memory of Reginald Clift, 1929-2008. Bone Marrow Transplant. 43: 89-90, 2009.
89. Sanders,J.E., Hoffmeister,P.A., Woolfrey,A.E., Carpenter,P.A., Storer,B.E., Storb,R.F., Appelbaum,F.R. Thyroid function following hematopoeitic cell transplantation in children: 30 years experience. Blood 113: 306-308, 2009.
90. Lange,S., Altmann,S., Brandt,B., Adam,C., Riebau,F., Vogel,H., Weirich,V., Hilgendorf,I., Storb,R., Freund,M., Junghanss,C. Investigation of immunological approaches to enhance engraftment in a 1-Gy TBI canine hematopoietic stem cell transplantation model. Exp. Hematol. 37: 143-150, 2009.
91. Baron,F., Storb,R. Stem cell therapy: past, present, and future. In: Advances in Tissue Engineering, Polak,J. (ed.). London, UK: Imperial College Press, Chapter 27: 561-591, 2008.
92. Storb,R. B cells versus T cells as primary barrier to hematopoietic engraftment in allosensitized recipients (Letter to the Editor). Blood 113: 1205, 2009.
93. Rezvani,A.R., Norasetthada,L., Gooley,T., Sorror,M., Bouvier,M.E., Sahebi,F., Agura,E., Chauncey,T., Maziarz,R.T., Maris,M., Shizuru,J., Bruno,B., Bredeson,C., Lange,T., Yeager,A., Sandmaier,B.M., Storb,R.F., Maloney,D.G. Non-myeloablative allogeneic haematopoietic cell transplantation of relapsed diffuse large B-cell lymphoma: a multicentre experience. Br. J. Haematol. 143: 395-403, 2008.
94. Burroughs,L.M., O’Donnell,P.V., Sandmaier,B.M., Storer,B.E., Luznik,L., Symons,H.J., Jones,R.J., Ambinder,R.F., Maris,M.B., Blume,K.G., Niederwieser,D.W., Bruno,B., Maziarz,R.T., Pulsipher,M.A., Petersen,F.B., Storb,R., Fuchs,E.J., Maloney,D.G. Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablatvie conditioning for relapsed or refractory Hodgkin lymphoma. Biol Blood Marrow Transplant 14: 1279-1287, 2008.
95. Graves,S.S., Hogan,W.J., Kuhr,C., Diaconescu,R., Harkey,M., Sale,G.E., Stone,B., Georges,G.E., Storb,R. Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism. Biol Blood Marrow Transplant 14: 1201-1208, 2008.
96. Woolfrey,A.E., Malhotra,U., Harrington,R.D., McNevin,J., Manley,T.J., Riddell,S.R., Coombs,R.W., Appelbaum,F.R., Corey,L., Storb,R. Generation of HIV-1 specific CD8+ cell responses following allogeneic hematopoietic cell transplantation. Blood 112 : 3484-3487, 2008.
97. Scott,B.L., Park,J.Y., Deeg,H.J., Marr,K.A., Boeckh,M., Chauncey,T.R., Appelbaum,F.R., Storb,R., Storer,B.E. Pre-transplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes. Biol Blood Marrow Transplant 14: 799-806, 2008.
98. Sorror,M.L., Storer,B.E., Sandmaier,B.M., Maris,M., Shizuru,J., Maziarz,R., Agura,E., Chauncey,T.R., Pulsipher,M.A., McSweeney,P.A., Wade,J.C., Bruno,B., Langston,A., Radich,J., Niederwieser,D., Blume,K.G., Storb,R., Maloney,D.G. Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. J. Clin. Oncol. 26: 4912-4920, 2008.
99. Parker,M.H., Kuhr,C., Tapscott,S.J., Storb,R. Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs. Molecular Therapy 16: 1340-1346, 2008.
100. Furlong,T., Kiem,H.-P., Appelbaum,F.R., Carpenter,P.A., Deeg,H.J., Doney,K., Flowers,M.E.D., Mielcarek,M., Nash,R.A., Storb,R., Martin,P.J. Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors. Biol Blood Marrow Transplant 14: 531-537, 2008.
101. Storb,R. Using graft-vs-tumor effects to cure acute leukemias. Ann. Hematol. 87 (Suppl. 1): S89-S92, 2008.
102. Sorror,M.L., Leisenring,W., Mielcarek,M., Baron,F., Diaconescu,R., Hogan,W.J., Graves,S.S., Storb,R. Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation. Transplantation 85: 1023-1029, 2008.
103. Sorror,M., Storer,B., Sandmaier,B.M., Maloney,D.G., Chauncey,T.R., Langston,A., Maziarz,R.T., Pulsipher,M., McSweeney,P.A., Storb,R. Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation. Cancer 112: 1992-2001, 2008.
104. Sandmaier,B.M., Storb,R. Reduced-intensity conditioning followed by hematopoietic cell transplantation for hematologic malignancies. In: Thomas’ Hematopoietic Cell Transplantation, Fourth Edition, Appelbaum,F.R., Forman,S.J., Negrin,R.S., and Blume,K.G. (eds.). Oxford, UK: Wiley-Blackwell, Chapter 71: 1043-1058, 2009.
105. Sala-Torra,O., Martin,P.J., Storer,B., Traina,F., Sorror,M.L., Storb,R., Sandmaier,B.M., Flowers,M.E.D. Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and non-myeloablative conditioning regimens. Bone Marrow Transplant. 41: 887-893, 2008.
106. Rezvani,A.R., Storb,R.F. Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. J. Autoimmun. 30: 172-179, 2008.
107. Mattsson,J., Ringdén,O., Storb,R. Graft failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 14: 165-170, 2008.
108. Luznik,L., O’Donnell,P.V., Symons,H.J., Chen,A.R., Leffell,M.S., Zahurak,M., Gooley,T.A., Piantadosi,S., Kaup,M., Ambinder,R.F., Huff,C.A., Matsui,W., Bolaños-Meade,J., Borrello,I., Powell,J.D., Harrington,E., Warnock,S., Flowers,M., Brodsky,R.A., Sandmaier,B.M., Storb,R.F., Jones,R.J., Fuchs,E.J. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, post-transplantation cyclophosphamide. Biol Blood Marrow Transplant 14: 641-650, 2008.
109. Jochum,C., Beste,M., Stone,D., Graves,S.S., Storb,R. Development and in vitro characterization of canine CD40-Ig. Vet. Immunol. Immunopathol. 123: 260-265, 2008.
110. Georges,G.E., Storb,R. Hematopoeitic cell transplantation for aplastic anemia. In: Thomas’ Hematopoietic Cell Transplantation, Fourth Edition, Appelbaum,F.R., Forman,S.J., Negrin,R.S., and Blume,K.G. (eds.). Oxford, UK: Wiley-Blackwell, Chapter 49: 707-726, 2009.
111. Rezvani,A.R., Storb,R. Using allogeneic stem cell/T-cell grafts to cure hematological malignancies (Review). Expert Opinion On Biological Therapy 8: 161-179, 2008.
112. Parikh,C.R., Yarlagadda,S.G., Storer,B., Sorror,M., Storb,R., Sandmaier,B. Impact of acute kidney injury on long-term mortality after nonmyeloablative hematopoietic cell transplantation. Biol Blood Marrow Transplant 14: 309-315, 2008.
113. Laport,G.G., Sandmaier,B.M., Storer,B.E., Scott,B.L., Stuart,M.J., Lange,T., Maris,M.B., Agura,E.D., Chauncey,T.R., Wong,R.M., Forman,S.J., Petersen,F.B., Wade,J.C., Epner,E., Bruno,B., Bethge,W.A., Curtin,P.T., Maloney,D.G., Blume,K.G., Storb,R.F. Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders. Biol Blood Marrow Transplant 14: 246-255, 2008.
114. Bonfim,C.M., de Medeiros,C.R., Bitencourt,M.A., Zanis-Neto,J., Funke,V.A., Setubal,D.C., Ruiz,J., Sanders,J.E., Flowers,M.E.D., Kiem,H.-P., Storb,R., Pasquini,R. HLA-matched related donor hematopoietic cell transplantation in 43 patients with fanconi anemia conditioned with 60 mg/kg of cyclophosphamide. Biol Blood Marrow Transplant 13: 1455-1460, 2007.
115. Sorror,M.L., Storer,B.E., Maloney,D.G., Sandmaier,B.M., Martin,P.J., Storb,R. Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative regimens for treatment of lymphoma and chronic lymphocytic leukemia. Blood 111: 446-452, 2008.
116. Sorror,M.L., Giralt,S., Sandmaier,B.M., de Lima,M., Shahjahan,M., Maloney,D.G., Deeg,H.J., Appelbaum,F.R., Storer,B., Storb,R. Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: Combined FHCRC and MDACC experiences. Blood 110: 4608-4613, 2007.
117. Rezvani,A.R., Storer,B., Maris,M., Sorror,M.L., Agura,E., Maziarz,R.T., Wade,J.C., Chauncey,T., Forman,S.J., Lange,T., Shizuru,J., Langston,A., Pulsipher,M.A., Sandmaier,B.M., Storb,R., Maloney,D.G. Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin lymphoma. J. Clin. Oncol. 28: 211-217, 2008.
118. Mielcarek,M., Storer,B.E., Flowers,M.E.D., Storb,R., Sandmaier,B.M., Martin,P.J. Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 13: 1160-1168, 2007.
119. Mielcarek,M., Storer,B.E., Sandmaier,B.M., Sorror,M.L., Maloney,D.G., Petersdorf,E., Martin,P.J., Storb,R. Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors. Biol Blood Marrow Transplant 13: 1499-1507, 2007.
120. Lupu,M., Gooley,T., Zellmer,E., Graves,S.S., Storb,R. Principles of peripheral blood mononuclear cell apheresis in a preclinical canine model of hematopoietic cell transplantation. J. Vet. Med. Sci. 22: 74-82, 2008.
121. Kahl,C., Storer,B.E., Sandmaier,B.M., Mielcarek,M., Maris,M.B., Blume,K.G., Niederwieser,D., Chauncey,T.R., Forman,S.J., Agura,E., Leis,J.F., Bruno,B., Langston,A., Pulsipher,M.A., McSweeney,P.A., Wade,J.C., Epner,E., Petersen,F.B., Bethge,W.A., Maloney,D.G., Storb,R. Relapse risk among patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 110: 2744-2748, 2007.
122. Sorror,M.L., Sandmaier,B.M., Storer,B.E., Maris,M.B., Baron,F., Maloney,D.G., Scott,B.L., Deeg,H.J., Appelbaum,F.R., Storb,R. Comorbidity and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. J. Clin. Oncol. 25: 4246-4254, 2007.
123. Burroughs,L.M., Storb,R., Leisenring,W.M., Pulsipher,M.A., Loken,M.R., Torgerson,T.R., Ochs,H.D., Woolfrey,A.E. Intensive postgrafting immune suppression combined with nonmyeolablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders. Bone Marrow Transplant. 40: 633-642, 2007.
124. Kuhr,C.S., Yunusov,M., Sale,G., Loretz,C., Storb,R. Long-term tolerance to kidney allografts in a preclinical canine model. Transplantation 84: 545-547, 2007.
125. Kuhr,C.S., Lupu,M., Storb,R. Hematopoietic cell transplantation directly into dystrophic muscle fails to reconstitute satellite cells and myofibers. Biol Blood Marrow Transplant 13: 886-888, 2007.
126. Baron,F., Sandmaier,B.M., Storer,B.E., Maris,M.B., Langston,A.A., Lange,T., Petersdorf,E., Bethge,W., Maziarz,R.T., McSweeney,P.A., Pulsipher,M.A., Wade,J.C., Chauncey,T.R., Shizuru,J.A., Sorror,M.L., Woolfrey,A.E., Maloney,D.G., Storb,R. Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning. Biol Blood Marrow Transplant 13: 1041-1048, 2007.
127. Chang,C.K., Storer,B.E., Scott,B.L., Bryant,E.M., Shulman,H.M., Flowers,M.E., Sandmaier,B.M., Witherspoon,R.P., Nash,R.A., Sanders,J.E., Bedalov,A., Hansen,J.A., Clurman,B.E., Storb,R., Appelbaum,F.R., Deeg,H.J. Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders. Blood 110: 1379-1387, 2007.
128. Nash,R.A., McSweeney,P.A., Crofford,L.J., Abidi,M., Chen,C.-S., Godwin,J.D., Gooley,T.A., Holmberg,L., Henstorf,G., LeMaistre,C.F., Mayes,M.D., McDonagh,K.T., McLaughlin,B., Molitor,J.A., Nelson,J.L., Shulman,H., Storb,R., Viganego,F., Wener,M.H., Seibold,J.R., Sullivan,K.M., Furst,D.E. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the U.S. multicenter pilot study. Blood 110: 1388-1396, 2007.
129. Venkataraman,G.M., Stroup,P., Graves,S.S., Storb,R. An improved method for dog leukocyte antigen 88 typing and two new major histocompatibility complex cass I alleles, DLA-88*01101 and DLA-88*01201. Tissue Antigens 70: 53-57, 2007.
130. Graves,S.S., Hogan,W., Kuhr,C.S., Diaconescu,R., Harkey,M.A., Georges,G.E., Sale,G.E., Zellmer,E., Baran,S., Jochum,C., Stone,B., Storb,R. Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning. Blood 110: 418-423, 2007.
131. Storb,R. Can reduced-intensity allogeneic transplantation cure older adults with AML? Best Practice & Research Clinical Haematology 20: 85-90, 2007.
132. Wang,Z., Kuhr,C.S., Allen,J.M., Blankinship,M., Gregorevic,P., Chamberlain,J.S., Tapscott,S.J., Storb,R. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Molecular Therapy 15: 1160-1166, 2007.
133. Bruno,B., Rotta,M., Patriarca,F., Mordini,N., Allione,B., Carnevale-Schianca,F., Giaccone,L., Sorasio,R., Omedè,P., Baldi,I., Bringhen,S., Massaia,M., Aglietta,M., Levis,A., Gallamini,A., Fanin,R., Palumbo,A., Storb,R., Ciccone,G., Boccadoro,M. A comparison of allografting with autografting for newly diagnosed myeloma. N. Engl. J. Med. 356: 1110-1120, 2007.
134. Lupu,M., Storb,R. Five decades of progress in haematopoietic cell transplantation based on preclinical canine model (Review). Veterinary and Comparative Oncology 5: 14-30, 2007.
135. Yunusov,M.Y., Kerbauy,F., Abrams,K., Zellmer,E., Spector,M., Kuhr,C.S., Hwang,B., Storer,B., Georges,G.E., Weigler,B.J., Storb,R., Nash,R.A. Intussusception in canine recipients of hematopoietic cell grafts and surgical correction. Comparative Medicine 57: 287-291, 2007.
136. Wang,Z., Allen,J.M., Riddell,S.R., Gregorevic,P., Storb,R., Tapscott,S.J., Chamberlain,J.S., Kuhr,C.S. Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy. Hum. Gene Ther. 18: 18-26, 2007.
137. Kerbauy,D.M.B., Gooley,T.A., Sale,G.E., Flowers,M.E.D., Doney,K.C., Georges,G.E., Greene,J.E., Linenberger,M., Petersdorf,E., Sandmaier,B.M., Scott,B.L., Sorror,M., Stirewalt,D.L., Stewart,M., Witherspoon,R.P., Storb,R., Appelbaum,F.R., Deeg,H.J. Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia. Biol Blood Marrow Transplant 13: 355-365, 2007.
138. Jochum,C., Beste,M., Zellmer,E., Graves,S.S., Storb,R. CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation. Biol Blood Marrow Transplant 13: 164-171, 2007.
139. Georges,G.E., Maris,M.B., Maloney,D.G., Sandmaier,B.M., Sorror,M.L., Shizuru,J.A., Lange,T., Agura,E.D., Bruno,B., McSweeney,P.A., Pulsipher,M.A., Chauncey,T.R., Mielcarek,M., Storer,B.E., Storb,R. Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma. Biol Blood Marrow Transplant 13: 423-432, 2007.
140. Baron,F., Storb,R. Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission. Curr. Opin. Hematol. 14: 145-151, 2007.
141. Yunusov,M.Y., Kuhr,C.S., Georges,G.E., Hogan,W.J., Taranova,A.G., Lesnikova,M., Kim,Y.S., Abrams,K., Hwang,B., Sale,G.E., Storer,B., Storb,R., Nash,R.A. Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graft. Transplantation 82: 629-637, 2006.
142. Robien,K., Bigler,J., Yasui,Y., Potter,J.D., Martin,P., Storb,R., Ulrich,C.M. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-vs-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant 12: 973-980, 2006.
143. Robien,K., Schubert,M.M., Yasui,Y., Martin,P., Storb,R., Potter,J.D., Ulrich,C.M. Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation. Bone Marrow Transplant. 37: 687-692, 2006.
144. Nash,R.A., McSweeney,P.A., Nelson,J.L., Wener,M., Georges,G.E., Langston,A.A., Shulman,H., Sullivan,K.M., Lee,J., Henstorf,G., Storb,R., Furst,D.E. Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis. Arthritis Rheum. 54: 1982-1986, 2006.
145. Mielcarek,M., Georges,G.E., Storb,R. Denileukin difitoxin as prophylaxis against graft-versus-host disease in the canine hematopoietic cell transplantation model. Biol Blood Marrow Transplant 12: 899-904, 2006.
146. Lupu,M., McCune,J.S., Kuhr,C.S., Gooley,T., Storb,R. Pharmacokinetics of oral mycophenolate mofetil in dog: bioavailability studies and the impact of antibiotic therapy (Letter to the Editor). Biol Blood Marrow Transplant 12: 1352-1354, 2006.
147. Kuhr,C.S., Lupu,M., Little,M.-T., Zellmer,E., Sale,G.E., Storb,R. RDP58 does not prevent graft-versus-host disease after dog leukocyte antigen-nonidentical canine hematopoietic cell transplantation. Transplantation 81: 1460-1462, 2006.
148. Jochum,C., Beste,M., Zellmer,E., Graves,S.G., Storb,R. Donor-specific mononuclear cell transfusion and methotrexate as pretransplant treatment in dogs given DLA-identical marrow grafts after nonmyeloablative conditioning (Letter to the Editor). Biol Blood Marrow Transplant 12: 885-886, 2006.
149. Graves,S.S., Ryoo,H.-M., Sale,G., Storb,R., Cowan,L.A., Matsuda,K. Pegylated TNF-α receptor does not prevent acute graft-versus-host disease in the dog leukocyte antigen-nonidentical unrelated canine model (Letter to the Editor). Biol Blood Marrow Transplant 12: 1198-1200, 2006.
150. Gopal,A.K., Pagel,J.M., Rajendran,J.G., Maloney,D.G., Appelbaum,F.R., Sorror,M.L., Sandmaier,B.M., Storb,R., Press,O.W. Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy. Biol Blood Marrow Transplant 12: 697-702, 2006.
151. Fukuda,T., Kerbauy,F.R., Gooley,T., Santos,E.B., Storb,R., Sandmaier,B.M. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model. Transplantation 82: 332-339, 2006.
152. Baron,F., Sandmaier,B.M., Zellmer,E., Sorror,M., Storer,B., Storb,R. Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy total body irradiation. Biol Blood Marrow Transplant 12: 813-817, 2006.
153. Baron,F., Storb,R. The immune system as a foundation for immunologic therapy and hematologic malignancies: a historical perspective. Best Practice & Research Clinical Haematology 19: 637-653, 2006.
154. Baron,F., Storer,B., Maris,M.B., Storek,J., Piette,F., Metcalf,M., White,K., Sandmaier,B.M., Maloney,D.G., Storb,R., Boeckh,M. Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning. Biol Blood Marrow Transplant 12: 1176-1187, 2006.
155. Baron,F., Storb,R., Storer,B.E., Maris,M.B., Niederwieser,D., Shizuru,J.A., Chauncey,T.R., Bruno,B., Forman,S.J., McSweeney,P.A., Maziarz,R.T., Pulsipher,M.A., Agura,E.D., Wade,J., Sorror,M., Maloney,D.G., Sandmaier,B.M. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopietic cell transplantation. J. Clin. Oncol. 24: 4150-4157, 2006.
156. Storb,R. In response to transplantation 80: 1145-1152, Kuwatani, et al (Letter to the Editor). Transplantation 81: 1357, 2006.
157. Robien,K., Schubert,M.M., Chay,T., Bigler,J., Storb,R., Yasui,Y., Potter,J.D., Ulrich,C.M. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation. Bone Marrow Transplant. 37: 799-800, 2006.
158. Maris,M.B., Sandmaier,B.M., Storer,B.E., Maloney,D.G., Shizuru,J.A., Agura,E., Kliem,C., Pulsipher,M., Maziarz,R.T., McSweeney,P.A., Wade,J., Langston,A.A., Chauncey,T.R., Bruno,B., Blume,K.G., Storb,R. Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing. Biol Blood Marrow Transplant 12: 454-465, 2006.
159. Deeg,H.J., Storer,B.E., Boeckh,M., Martin,P.J., McCune,J.S., Myerson,D., Heimfeld,S., Flowers,M.E., Anasetti,C., Doney,K.C., Hansen,J.A., Kiem,H.-P., Nash,R.A., O’Donnell,P.V., Radich,J.P., Sandmaier,B.M., Scott,B.L., Sorror,M.L., Warren,E.H., Witherspoon,R.P., Woolfrey,A., Appelbaum,F.R., Storb,R. Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen. Biol Blood Marrow Transplant 12: 573-584, 2006.
160. Burroughs,L., Mielcarek,M., Leisenring,W., Sandmaier,B.M., Maloney,D.G., Baron,F., Martin,P.J., Flowers,M.E.D., Forman,S.J., Chauncey,T.R., Bruno,B., Storb,R. Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation. Transplantation 81: 818-825, 2006.
161. Baron,F., Storb,R. Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders (Review). Molecular Therapy 13: 26-41, 2006.
162. Weiss,A.S., Sandmaier,B.M., Storer,B., Storb,R., McSweeney,P.A., Parikh,C.R. Chronic kidney disease following nonmyeloablative hematopoietic cell transplantation. Am J Transplant 6: 89-94, 2006.
163. Scott,B.L., Sandmaier,B.M., Storer,B., Maris,M.B., Sorror,M.L., Maloney,D.G., Chauncey,T.R., Storb,R., Deeg,H.J. Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis. Leukemia 20: 128-135, 2006.
164. Mielcarek,M., Bryant,E., Loken,M., Zaucha,J.M., Torok-Storb,B., Storb,R. Long-term engraftment and clonal dominance of donor-derived del(20q) hematopoietic cells after allogeneic stem cell transplantation (Letter to the Editor). Blood 107: 1732-1733, 2006.
165. Lupu,M., Sullivan,E.W., Westfall,T.E., Little,M.-T., Weigler,B.J., Moore,P.F., Stroup,P.A., Zellmer,E., Kuhr,C., Storb,R. Use of multigeneration-family molecular dog leukocyte antigen typing to select a hematopoietic cell transplant donor for a dog with T-cell lymphoma. J. Am. Vet. Med. Assoc. 228: 728-732, 2006.
166. Hegenbart,U., Niederwieser,D., Sandmaier,B.M., Maris,M.B., Shizuru,J.A., Greinix,H., Cordonnier,C., Rio,B., Gratwohl,A., Lange,T., Al-Ali,H., Storer,B., Maloney,D., McSweeney,P., Chauncey,T., Agura,E., Bruno,B., Maziarz,R.T., Petersen,F., Storb,R. Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors. J. Clin. Oncol. 24: 444-453, 2006.
167. Giaccone,L., McCune,J.S., Maris,M.B., Gooley,T.A., Sandmaier,B.M., Slattery,J.T., Cole,S., Nash,R.A., Storb,R., Georges,G.E. Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation. Blood 106: 4381-4388, 2005.
168. Burroughs,L., Mielcarek,M., Little,M.-T., Bridger,G., MacFarland,R., Fricker,S., LaBrecque,J., Sandmaier,B.M., Storb,R. Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral blood mononuclear cells in a canine transplantation model. Blood 106: 4002-4008, 2005.
169. Sorror,M.L., Maris,M.B., Storb,R., Baron,F., Sandmaier,B.M., Maloney,D.G., Storer,B. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106: 2912-2919, 2005.
170. Panse,J.P., Storb,R., Storer,B., Santos,E.B., Wentzel,C., Sandmaier,B.M. Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100 cGy total body irradiation and pentostatin before and pharmocological immunosuppression after transplantation. Transplantation 80: 1518-1521, 2005.
171. Zanis-Neto, J., Flowers, M.E.D., Medeiros, C.R., Bitencourt, M.A., Bonfim, C.M., Setúbal, D.C., Funke, V., Sanders, J., Deeg, H.J., Kiem, H.P., Martin, P., Leisenring, W., Storb, R., Pasquini, R. Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anemia. Br. J. Haematol. 130: 99-106, 2005.
172. Wagner,J.L., Storb,R.F. The canine major histocompatibility complex. In: The Dog and Its Genome, Ostrander,E.A., Giger,U., and Lindblad-Toh,K. (eds.). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, Chapter 14: 233-247, 2006.
173. Sorror, M.L., Leisenring, W., Deeg, H.J., Martin, P.J., Storb, R. Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease (Letter to the Editor). Biol Blood Marrow Transplant 11: 567-568, 2005.
174. Sorror,M.L., Leisenring,W., Deeg,H.J., Martin,P.J., Storb,R. Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia (Letter to the Editor). Biol Blood Marrow Transplant 11: 814-815, 2005.
175. Nash, R.A., Johnston, L., Parker, P., McCune, J.S., Storer, B., Slattery, J.T., Furlong, T., Anasetti, C., Appelbaum, F.R., Lloid, M.E., Deeg, H.J., Kiem, H.-P., Martin, P.J., Schubert, M.M., Witherspoon, R.P., Forman, S.J., Blume, K.G., Storb, R. A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 11: 495-505, 2005.
176. Mielcarek,M., Storb,R. Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation. Leuk. Lymphoma 46: 1251-1260, 2005.
177. Kerbauy,D.M.B., Chyou,F., Gooley,T., Sorror,M.L., Scott,B., Pagel,J.M., Myerson,D., Appelbaum,F.R., Storb,R., Deeg,H.J. Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia. Biol Blood Marrow Transplant 11: 713-720, 2005.
178. Kahl,C., Leisenring,W., Deeg,H.J., Chauncey,T.R., Flowers,M.E.D., Martin,P.J., Sanders,J.E., Storb,R. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. Br. J. Haematol. 130: 747-751, 2005.
179. Giaccone,L., Martin,P., Carpenter,P., Moravec,C., Hooper,H., Funke,V.A.M., Storb,R., Flowers,M.E.D. Safety and potential efficacy of low dose methotrexate for treatment of chronic graft-versus-host disease. Bone Marrow Transplant. 36: 337-341, 2005.
180. Bensinger, W.I., Buckner, C.D., Lilleby, K., Holmberg, L., Storb, R., Slattery, J.T. Dose escalation of busulfan with pentoxifylline and ciprofloxacin in patients with breast cancer undergoing autologous transplants. Oncology 67: 368-375, 2004.
181. Wallen, H., Gooley, T.A., Deeg, H.J., Pagel, J.M., Press, O.W., Appelbaum, F.R., Storb, R., Gopal, A.K. Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older. J. Clin. Oncol. 23: 3439-3446, 2005.
182. Sorror, M.L., Maris, M.B., Sandmaier, B.M., Storer, B.E., Stuart, M.J., Hegenbart, U., Agura, E., Chauncey, T.R., Leis, J., Pulsipher, M., McSweeney, P., Radich, J.P., Bredeson, C., Bruno, B., Langston, A., Loken, M.R., Al-Ali, H., Blume, K.G., Storb, R., Maloney, D.G. Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia. J. Clin. Oncol. 13: 3819-3829, 2005.
183. Mielcarek, M., Burroughs, L., Leisenring, W., Diaconescu, R., Martin, P.J., Sandmaier, B.M., Maloney, D.G., Maris, M.B., Chauncey, T.R., Shizuru, J.A., Blume, K.G., Hegenbart, U., Niederwieser, D., Forman, S., Bruno, B., Woolfrey, A., Storb, R. Prognostic relevance of “early-onset” graft-versus-host disease following nonmyeloablative hematopoietic cell transplantation. Br. J. Haematol. 129: 381-391, 2005.
184. Maris,M.B., Storb,R. Allogeneic hematopoietic cell transplantation as consolidation immunotherapy of cancer after autologous transplantation. Acta Haematol. 114: 221-229, 2005.
185. Kerbauy, F.R., Storb, R., Hegenbart, U., Gooley, T., Shizuru, J., Al-Ali, H.K., Radich, J.P., Maloney, D.G., Agura, E., Bruno, B., Epner, E.M., Chauncey, T.R., Blume, K.G., Niederwieser, D., Sandmaier, B.M. Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML. Leukemia 19: 990-997, 2005.
186. Diaconescu, R., Little, M.-T., Leisenring, W., Yunusov, M., Hogan, W.J., Sorror, M.L., Baron, F., Storb, R. What role is there for antithymocyte globulin in allogeneic nonmyeloablative canine hematopoietic cell transplantation? Biol Blood Marrow Transplant 11: 335-344, 2005.
187. Chien, J.W., Maris, M.B., Sandmaier, B.M., Maloney, D.G., Storb, R.F., Clark, J.G. Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11: 288-296, 2005.
188. Baron, F., Maris, M.B., Storer, B.E., Sandmaier, B.M., Panse, J.P., Chauncey, T.R., Sorror, M., Little, M.-T., Maloney, D.G., Storb, R., Heimfeld, S. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation. Leukemia 19: 822-828, 2005.
189. Baron, F., Maris, M.B., Sandmaier, B.M., Storer, B.E., Sorror, M., Diaconescu, R., Woolfrey, A.E., Chauncey, T.R., Flowers, M.E.D., Mielcarek, M., Maloney, D.G., Storb, R. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J. Clin. Oncol. 23: 1993-2003, 2005.
190. Baron, F., Maris, M.B., Storer, B.E., Sandmaier, B.M., Stuart, M.J., McSweeney, P.A., Radich, J.P., Pulsipher, M.A., Agura, E.D., Chauncey, T.R., Maloney, D.G., Shizuru, J.A., Storb, R. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia. Biol Blood Marrow Transplant 11: 272-279, 2005.
191. Mielcarek, M., Gooley, T., Martin, P.J., Chauncey, T.R., Young, B.A., Storb, R., Torok-Storb, B. Effects of race on survival after stem cell transplantation. Biol Blood Marrow Transplant 11: 231-239, 2005.
192. Panse, J.P., Heimfeld, S., Guthrie, K.A., Maris, M.B., Maloney, D.G., Baril, B.B., Little, M.-T., Chauncey, T.R., Storer, B.E., Storb, R., Sandmaier, B.M. Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after nonmyeloablative conditioning. Br. J. Haematol. 128: 659-667, 2005.
193. Parikh, C.R., Schrier, R.W., Storer, B., Diaconescu, R., Sorror, M.L., Maris, M.B., Maloney, D.G., McSweeney, P., Storb, R., Sandmaier, B.M. Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. American Journal of Kidney Diseases 45: 502-509, 2005.
194. Sorror, M., Maris, M., Diaconescu, R., Storb, R. Lessened severe graft-versus-host after “minitransplantations” (Letter to the Editor). Blood 105: 2614, 2005.
195. Scott, B.L., Storer, B., Loken, M., Storb, R., Appelbaum, F.R., Deeg, H.J. Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome. Biol Blood Marrow Transplant 11: 65-73, 2005.
196. Flowers, M.E.D., Traina, F., Storer, B., Maris, M., Bethge, W.A., Carpenter, P., Appelbaum, F.R., Storb, R., Sandmaier, B.M., Martin, P.J. Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning [erratum appears in BMT 2005;35:535]. Bone Marrow Transplant. 35: 277-282, 2005.
197. Burroughs, L., Storb, R. Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host disease. Curr. Opin. Hematol. 12: 45-54, 2005.
198. Tykodi, S.S., Warren, E.H., Thompson, J.A., Riddell, S.R., Childs, R.W., Otterud, B.E., Leppert, M.F., Storb, R., Sandmaier, B.M. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response and immunological response to minor histocompatibility antigens. Clin. Cancer Res. 10: 7799-7811, 2004.
199. Storek, J., Zhao, Z., Lin, E., Berger, T., McSweeney, P.A., Nash, R.A., Akatsuka, Y., Metcalf, M.D., Lu, H., Kalina, T., Reindl, M., Storb, R., Hansen, J.A., Sullivan, K.M., Kraft, G.H., Furst, D.E., Maloney, D.G. Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases). Clinical Immunology 113: 285-298, 2004.
200. Stewart, B.L., Storer, B., Storek, J., Deeg, H.J., Storb, R., Hansen, J.A., Appelbaum, F.R., Carpenter, P.A., Sanders, J.E., Kiem, H.-P., Nash, R.A., Petersdorf, E.W., Moravec, C., Morton, A.J., Anasetti, C., Flowers, M.E.D., Martin, P.J. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 104: 3501-3506, 2004.
201. Maris, M.B., Sandmaier, B.M., Storer, B.E., Chauncey, T., Stuart, M.J., Maziarz, R.T., Agura, E., Langston, A.A., Pulsipher, M., Storb, R., Maloney, D.G. Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. Blood 104: 3535-3542, 2004.
202. Lee, J.-H., Joo, Y.-D., Yim, D., Lee, R., Ostrander, E.A., Loretz, C., Little, M.-T., Storb, R., Kuhr, C.S. Molecular cloning and characterization of canine ICOS. Genomics 84: 730-736, 2004.
203. Diaconescu, R., Storb, R. Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care. J. Cancer Res. Clin. Oncol. 131: 1-13, 2005.
204. Dell’Agnola, C., Wang, Z., Storb, R., Tapscott, S.J., Kuhr, C.S., Hauschka, S.D., Lee, R.S., Sale, G.E., Zellmer, E., Gisburne, S., Bogan, J., Kornegay, J.N., Cooper, B.J., Gooley, T.A., Little, M.-T. Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs. Blood 104: 4311-4318, 2004.
205. Baron, F., Baker, J.E., Storb, R., Gooley, T.A., Sandmaier, B.M., Maris, M.B., Maloney, D.G., Heimfeld, S., Oparin, D., Zellmer, E., Radich, J.P., Grumet, F.C., Blume, K.G., Chauncey, T.R., Little, M.-T. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 104: 2254-2262, 2004.
206. Baron, F., Little, M.T., Storb, R. Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning. Blood Rev. 19: 153-164, 2005.
207. Diaconescu, R., Flowers, C.R., Storer, B., Sorror, M.L., Maris, M.B., Maloney, D.G., Sandmaier, B.M., Storb, R. Morbidity and mortality with nonmyeloablative compared to myeloablative conditioning before hematopoietic cell transplantation from HLA matched related donors. Blood 104: 1550-1558, 2004.
208. Sorror, M.L., Maris, M.B., Storer, B., Sandmaier, B.M., Diaconescu, R., Flowers, C., Maloney, D.G., Storb, R. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplant comorbidities. Blood 104: 961-968, 2004.
209. Parikh, C.R., Sandmaier, B.M., Storb, R.F., Blume, K.G., Sahebi, F., Maloney, D.G., Maris, M.B., Nieto, Y., Edelstein, C.L., Schrier, R.W., McSweeney, P. Acute renal failure after nonmyeloablative hematopoietic cell transplantation. Journal of the American Society of Nephrology 15: 1868-1876, 2004.
210. Martin, P.J., Pei, J., Gooley, T., Anasetti, C., Appelbaum, F.R., Deeg, J., Hansen, J.A., Nash, R.A., Petersdorf, E.W., Storb, R., Ghetie, V., Schindler, J., Vitetta, E.S. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation. Biol Blood Marrow Transplant 10: 552-560, 2004.
211. Lange, T., Deininger, M., Brand, R., Hegenbart, U., Al-Ali, H., Krahl, R., Poenisch, W., Uharek, L., Leiblein, S., Gentilini, C., Petersdorf, E., Storb, R.F., Niederwieser, D. BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning. Leukemia 18: 1468-1475, 2004.
212. Fukuda, T., Boeckh, M., Guthrie, K.A., Mattson, D.K., Owens, S., Wald, A., Sandmaier, B.M., Corey, L., Storb, R.F., Marr, K.A. Invasive aspergillosis prior to allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biol Blood Marrow Transplant 10: 494-503, 2004.
213. Bethge, W.A., Wilbur, D.S., Storb, R., Hamlin, D.K., Santos, E.B., Brechbiel, M.W., Sandmaier, B.M. Radioimmunotherapy with Bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study. Transplantation 78: 352-359, 2004.
214. Baron, F., Storb, R. Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review. Seminars in Immunopathology 26: 71-94, 2004.
215. Yusuf, U., Frangoul, H.A., Gooley, T.A., Woolfrey, A.E., Carpenter, P.A., Andrews, R.G., Deeg, H.J., Appelbaum, F.R., Anasetti, C., Storb, R., Sanders, J.E. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transplant. 33: 805-814, 2004.
216. Storb, R. Allogeneic hematopoietic cell transplantation: a historical perspective. Transfusion Medicine and Hemotherapy 31: 21-32, 2004.
217. Martin, P.J., McDonald, G.B., Sanders, J.E., Anasetti, C., Appelbaum, F.R., Deeg, H.J., Nash, R.A., Petersdorf, E.W., Hansen, J.A., Storb, R. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 10: 320-327, 2004.
218. Hogan, W.J., Storb, R. Use of cyclosporine in hematopoietic cell transplantation. Transplant. Proc. 36 (Suppl. 2S): 367S-371S, 2004.
219. Baron,F., Little,M.-T., Storb,R. Non-myeloablative conditioning regimen for allogeneic hematopoietic cell transplantation. In: Clinical Malignant Hematology, Sekeres,M.A., Kalaycio,M.E., and Bolwell,B.J. (eds.). New York, NY: McGraw-Hill Companies, Chapter 96: 1025-1038, 2007.
220. Baron, F., Storb, R., Little, M.-T. Hematopoietic cell transplantation: five decades of progress (Review). Archives of Medical Research 34: 528-544, 2003.
221. Takatu, A., Nash, R.A., Zaucha, J.M., Little, M.-T., Georges, G.E., Sale, G.E., Zellmer, E., Kuhr, C.S., Lothrop, C.D., Jr., Storb, R. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia. Biol Blood Marrow Transplant 9: 674-682, 2003.
222. Storb, R., Sandmaier, B.M., Forman, S., Maris, M., Chauncey, T., Maloney, D.G., McSweeney, P.A., Blume, K.G., Stuart, M.J., Hegenbart, U., Sahebi, F., Bruno, B., Agura, E., Little, M.-T., Niederwieser, D. What role for nonmyeloablative conditioning in allogeneic hematopoietic cell transplantation? Acta Haematologica Polonica 34 (Suppl. 1): 17-20, 2003.
223. Storb, R., Lucarelli, G., McSweeney, P.A., Childs, R.W. Hematopoietic cell transplantation for benign hematological disorders and solid tumors. In: Hematology 2003: American Society of Hematology Education Program Book, Broudy, V.C., Prchal, J.T., and Tricot, G.J. (eds.). Washington, DC: American Society of Hematology, 372-397, 2003.
224. Baron,F., Storb,R. Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioning. Clinical Advances in Hematology & Oncology 3: 799-813, 2005.
225. Storb, R. Non-myeloablative allogeneic transplantation – state-of-the-art. Pediatr Transplant 8 (Suppl. 5): 12-18, 2004.
226. Storb, R. History of pediatric stem cell transplantation. Pediatr Transplant 8 (Suppl. 5): 5-11, 2004.
227. Sorror, M.L., Storb, R. Hematopoietic cell transplantation after nonmyeloablative conditioning. In: Regenerative and Cell Therapy: Clinical Advances, Ernst Schering Research Foundation Workshop, Supplement 11. Keating, A., Dicke, K., Gorin, N., Weber, R., and Graf, H. (eds.). Berlin, Germany: Springer, Chapter 10: 145-175, 2005.
228. Nash, R.A., Bowen, J.D., McSweeney, P.A., Pavletic, S.Z., Maravilla, K.R., Park, M.-S., Storek, J., Sullivan, K.M., Al-Omaishi, J., Corboy, J.R., DiPersio, J., Georges, G.E., Gooley, T.A., Holmberg, L.A., LeMaistre, C.F., Ryan, K., Openshaw, H., Sunderhaus, J., Storb, R., Zunt, J., Kraft, G.H. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood 102: 2364-2372, 2003.
229. Mielcarek, M., Martin, P.J., Heimfeld, S., Storb, R., Torok-Storb, B. CD34 cell dose and chronic graft-versus-host disease after human leukocyte antigen-matched sibling hematopoietic stem cell transplantation. Leuk. Lymphoma 45: 27-34, 2004.
230. Maris, M., Boeckh, M., Storer, B., Dawson, M., White, K., Keng, M., Sandmaier, B., Maloney, D., Storb, R., Storek, J. Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. Exp. Hematol. 31: 941-952, 2003.
231. Maloney, D.G., Molina, A.J., Sahebi, F., Stockerl-Goldstein, K.E., Sandmaier, B.M., Bensinger, W., Storer, B., Hegenbart, U., Somlo, G., Chauncey, T., Bruno, B., Appelbaum, F.R., Blume, K.G., Forman, S.J., McSweeney, P., Storb, R. Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood 102: 3447-3454, 2003.
232. Lee, R.S., Kuhr, C.S., Sale, G.E., Zellmer, E., Hogan, W.J., Storb, R., Little, M.-T. FTY720 does not abrogate acute graft-versus-host disease in the DLA-nonidentical unrelated canine model. Transplantation 76: 1155-1158, 2003.
233. Junghanss, C., Storb, R., Maris, M.B., Carter, R.A., Sandmaier, B.M., Maloney, D.G., McSweeney, P.A., Corey, L., Boeckh, M. Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation. Br. J. Haematol. 123: 662-670, 2003.
234. Hogan, W.J., Maris, M., Storer, B., Sandmaier, B.M., Maloney, D.G., Schoch, H.G., Woolfrey, A.E., Shulman, H.M., Storb, R., McDonald, G.B. Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients. Blood 103: 78-84, 2004.
235. Hegenbart, U., Niederwieser, D., Forman, S., Holler, E., Leiblein, S., Johnston, L., Pönisch, W., Epner, E., Witherspoon, R., Blume, K., Storb, R. Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant 9: 689-697, 2003.
236. Fukuda, T., Hackman, R.C., Guthrie, K.A., Sandmaier, B.M., Boeckh, M., Maris, M.B., Maloney, D.G., Deeg, H.J., Martin, P.J., Storb, R.F., Madtes, D.K. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 102: 2777-2785, 2003.
237. Deeg, H.J., Gooley, T.A., Flowers, M.E.D., Sale, G.E., Slattery, J.T., Anasetti, C., Chauncey, T.R., Doney, K., Georges, G.E., Kiem, H.-P., Martin, P.J., Petersdorf, E.W., Radich, J., Sanders, J.E., Sandmaier, B.M., Warren, E.H., Witherspoon, R.P., Storb, R., Appelbaum, F.R. Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Blood 102: 3912-3918, 2003.
238. Bethge, W.A., Storer, B.E., Maris, M.B., Flowers, M.E.D., Maloney, D.G., Chauncey, T.R., Woolfrey, A.E., Storb, R., Sandmaier, B.M. Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome. Exp. Hematol. 31: 974-980, 2003.
239. Bethge, W.A., Hegenbart, U., Stuart, M.J., Storer, B.E., Maris, M.B., Flowers, M.E.D., Maloney, D.G., Chauncey, T., Bruno, B., Agura, E., Forman, S.J., Blume, K.G., Niederwieser, D., Storb, R., Sandmaier, B.M. Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning. Blood 103: 790-795, 2004.
240. Maris, M.B., Niederwieser, D., Sandmaier, B.M., Storer, B., Stuart, M., Maloney, D., Petersdorf, E., McSweeney, P., Pulsipher, M., Woolfrey, A., Chauncey, T., Agura, E., Heimfeld, S., Slattery, J., Hegenbart, U., Anasetti, C., Blume, K., Storb, R. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 102: 2021-2030, 2003.
241. Iannone, R., Casella, J.F., Fuchs, E.J., Chen, A.R., Jones, R.J., Woolfrey, A., Amylon, M., Sullivan, K.M., Storb, R.F., Walters, M.C. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia. Biol Blood Marrow Transplant 9: 519-528, 2003.
242. Hogan, W.J., Little, M.-T., Zellmer, E., Friedetzky, A., Diaconescu, R., Gisburne, S., Lee, R., Kuhr, C., Storb, R. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates. Biol Blood Marrow Transplant 9: 489-495, 2003.
243. Guardiola, P., Kurre, P., Vlad, A., Cayuela, J.-M., Espérou, H., Devergie, A., Ribaud, P., Socié, G., Richard, P., Traineau, R., Storb, R., Gluckman, E. Effective graft-versus-leukaemia effect after allogeneic stem cell transplantation using reduced-intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemia. Br. J. Haematol. 122: 806-809, 2003.
244. Doney, K., Hägglund, H., Leisenring, W., Chauncey, T., Appelbaum, F.R., Storb, R. Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia. Biol Blood Marrow Transplant 9: 472-481, 2003.
245. Storb, R. What role for mycophenolate mofetil in allogeneic hematopoietic cell transplantation? (Letter to Editor). Transplantation 76: 747, 2003.
246. Mielcarek, M., Martin, P.J., Leisenring, W., Flowers, M.E.D., Maloney, D.G., Sandmaier, B.M., Maris, M.B., Storb, R. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 102: 756-762, 2003.
247. Fukuda, T., Boeckh, M., Carter, R.A., Sandmaier, B.M., Maris, M.B., Maloney, D.G., Martin, P.J., Storb, R.F., Marr, K.A. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 102: 827-833, 2003.
248. Güngör, T., Corbacioglu, S., Storb, R., Seger, R.A. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of dyskeratosis congenita. Bone Marrow Transplant. 31: 407-410, 2003.
249. Sandmaier, B.M., Storb, R. Nonmyeloablative therapy and hematopoietic cell transplantation for hematologic disorders. In: Thomas’ Hematopoietic Cell Transplantation, Third Edition, Blume, K.G., Forman, S.J., and Appelbaum, F.R. (eds.). Oxford, UK: Blackwell Publishing Ltd., Chapter 85: 1164-1176, 2004.
250. Georges, G.E., Lesnikova, M., Storb, R., Yunusov, M., Little, M.-T., Nash, R.A. Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermates. Biol Blood Marrow Transplant 9: 234-242, 2003.
251. Georges, G.E., Storb, R., Zaucha, J.M., Taranova, A.G., Gooley, T., Nash, R.A. IL-2 does not enhance the conversion to complete donor chimerism following nonmyeloablative hematopoietic cell transplantation in dogs. Bone Marrow Transplant. 31 : 1027-1031, 2003.
252. Georges, G., Storb, R. Failure of sustained engraftment: clinical manifestations and treatment. In: Clinical Bone Marrow and Blood Stem Cell Transplantation, Third Edition, Atkinson, K., Champlin, R., Ritz, J., Fibbe, W.E., Ljungman, P., and Brenner, M.K. (eds.). Cambridge, UK: Cambridge University Press, Chapter 70: 1088-1108, 2004.
253. Feinstein, L.C., Sandmaier, B.M., Maloney, D.G., Maris, M.B., Gooley, T.A., Chauncey, T.R., Hegenbart, U., McSweeney, P.A., Stuart, M.J., Forman, S.J., Agura, E.A., Pulsipher, M.A., Blume, K.G., Niederwieser, D.W., Storb, R.F. Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant. Biol Blood Marrow Transplant 9: 266-272, 2003.
254. Bethge, W.A., Wilbur, D.S., Storb, R., Hamlin, D.K., Santos, E.B., Brechbiel, M.W., Fisher, D.R., Sandmaier, B.M. Selective T-cell ablation with bismuth-213-labeled anti-TCRαβ as nonmyeloablative conditioning for allogeneic canine marrow transplantation. Blood 101: 5068-5075, 2003.
255. Mielcarek, M., Torok-Storb, B., Storb, R. Is alloantigen expression by host epithelium required for acute graft-versus-host disease? (Letter to the Editor). Nat. Med. 9: 150-151, 2003.
256. Warren, E.H., Tykodi, S.S., Murata, M., Sandmaier, B.M., Storb, R., Jaffee, E., Childs, R., Thompson, J.A., Greenberg, P.D., Riddell, S.R. T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma. Cytotherapy 4: 441, 2002.
257. Zaucha, J.M., Mielcarek, M., Takatu, A., Little, M.-T., Gooley, T., Baker, J., Maloney, D.G., Sandmaier, B.M., Maris, M., Chauncey, T., Storb, R., Torok-Storb, B. Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation. Br. J. Haematol. 119: 740-750, 2002.
258. Yunusov, M.Y., Georges, G.E., Storb, R., Moore, P., Hagglund, H., Affolter, V., Lesnikova, M., Gass, M.J., Little, M.-T., Loken, M., McKenna, H., Storer, B., Nash, R.A. FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease. Transplantation 75: 933-940, 2003.
259. Yunusov, M.Y., Kuhr, C., Georges, G.E., Sale, G.E., Spector, M., Lesnikova, M., Lee, R., Little, M.-T., Gass, M.J., Weber, K., Joslyn, A., Storb, R., Nash, R.A. Survival of small bowel transplants in canine mixed hematopoietic chimeras: preliminary results. Transplant. Proc. 34: 3366-3367, 2002.
260. Storb, R. Allogeneic hematopoietic stem cell transplantation – yesterday, today, and tomorrow. Exp. Hematol. 31: 1-10, 2003.
261. Sandmaier, B.M., Fukuda, T., Gooley, T., Yu, C., Santos, E.B., Storb, R. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model. Exp. Hematol. 31: 168-175, 2003.
262. Panse, J.P., Bastianelli, C., Santos, E.B., Schwarzinger, I., Raff, R.F., Storb, R., Sandmaier, B.M. Dog leukocyte antigen nonidentical unrelated canine marrow grafts: enhancement of engraftment by both CD4 and CD8 T cells. Transplantation 76: 474-480, 2003.
263. Niederwieser, D., Maris, M., Shizuru, J.A., Petersdorf, E., Hegenbart, U., Sandmaier, B.M., Maloney, D.G., Storer, B., Lange, T., Chauncey, T., Deininger, M., Pönisch, W., Anasetti, C., Woolfrey, A., Little, M.-T., Blume, K.G., McSweeney, P.A., Storb, R.F. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 101: 1620-1629, 2003.
264. Mielcarek, M., Storb, R. Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematologic malignancies. Cancer Treat. Rev. 29: 283-290, 2003.
265. Maris, M., Storb, R. The transplantation of hematopoietic stem cells after non-myeloablative conditioning: A cellular therapeutic approach to hematologic and genetic diseases. Immunologic Research 28: 13-24, 2003.
266. Lee, R., Storb, R., Little, M.-T., Joslyn, A., Spector, M., Kuhr, C.S. Percutaneous central dual-lumen catheter for apheresis in the canine. J. Invest. Surg. 15: 337-341, 2002.
267. Kurre, P., Pulsipher, M., Woolfrey, A., Maris, M., Sandmaier, B., Kiem, H.-P., Storb, R. Reduced toxicity and prompt engraftment after minimal conditioning of a patient with fanconi anemia undergoing hematopoietic stem cell transplantation from an HLA-matched unrelated donor. J. Pediatr. Hematol. Oncol. 25: 581-583, 2003.
268. Junghanss, C., Takatu, A., Little, M.-T., Zaucha, J.M., Zellmer, E., Yunusov, M., Sale, G., Georges, G.E., Storb, R. Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras. Transplantation 75: 268-274, 2003.
269. Georges, G.E., Maris, M., Sandmaier, B.M., Maloney, D.G., Feinstein, L., Niederwieser, D., Shizuru, J.A., McSweeney, P.A., Chauncey, T.R., Agura, E., Little, M.-T., Sahebi, F., Hegenbart, U., Pulsipher, M.A., Bruno, B., Forman, S., Woolfrey, A.E., Radich, J.P., Blume, K.G., Storb, R. Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases. Int. J. Hematol. 76 (Suppl. I): 184-189, 2002.
270. Georges, G.E., Storb, R. Allogeneic hematopoietic cell transplantation for aplastic anemia. In: Thomas’ Hematopoietic Cell Transplantation, 3rd Edition, Blume, K.G., Forman, S.J., and Appelbaum, F.R. (eds.). Oxford, UK: Blackwell Publishing Ltd., Chapter 71: 981-1001, 2004.
271. Georges, G.E., Storb, R. Review of “minitransplantation”: nonmyeloablative allogeneic hematopoietic stem cell transplantation. Int. J. Hematol. 77: 3-14, 2003.
272. Georges, G., Storb, R. Allogeneic hematopoietic stem cell transplantation for severe aplastic anemia. In: Clinical Bone Marrow and Blood Stem Cell Transplantation , Third Edition, Atkinson, K., Champlin, R., Ritz, J., Fibbe, W.E., Ljungman, P., and Brenner, M.K. (eds.). Cambridge, UK: Cambridge University Press, Chapter 58: 901-920, 2004.
273. Feinstein, L.C., Sandmaier, B.M., Hegenbart, U., McSweeney, P.A., Maloney, D.G., Gooley, T.A., Maris, M.B., Chauncey, T.R., Bruno, B., Appelbaum, F.R., Niederwieser, D.W., Storb, R.F. Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission. Br. J. Haematol. 120: 281-288, 2003.
274. Chen, C.-S., Boeckh, M., Seidel, K., Clark, J.G., Kansu, E., Madtes, D.K., Wagner, J.L., Witherspoon, R.P., Anasetti, C., Appelbaum, F.R., Bensinger, W.I., Deeg, H.J., Martin, P.J., Sanders, J.E., Storb, R., Storek, J., Wade, J., Siadak, M., Flowers, M.E.D., Sullivan, K.M. Incidence, risk factors and mortality from pneumonia developing late after hematopoietic stem cell transplantation. Bone Marrow Transplant. 32: 515-522, 2003.
275. Abrams, K., Yunusov, M.Y., Slichter, S., Moore, P., Nelp, W.B., Burstein, S.A., McDonough, S., Durack, L., Storer, B., Storb, R., Gass, M.J., Georges, G., Nash, R.A. Recombinant human macrophage colony-stimulating factor-induced thrombocytopenia in dogs. Br. J. Haematol. 121: 614-622, 2003.
276. Woolfrey, A.E., Pulsipher, M.A., Storb, R. Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children. Int. J. Hematol. 76 (Suppl. II): 271-277, 2002.
277. Mielcarek, M., Torok-Storb, B., Storb, R. ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia (Letter to the Editor). Bone Marrow Transplant. 30: 547-548, 2002.
278. Kobbe, G., Germing, U., Aivado, M., Zohren, F., Schubert, D., Strupp, C., Pape, H., Tenderich, G., Körfer, R., Storb, R., Haas, R., Schneider, P. Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantation. Transplantation 74: 1198-1200, 2002.
279. Junghanss, C., Storb, R., Boeckh, M. Risk of cytomegalovirus infection after transplantation with nonmyeloablative and reduced-intensity conditioning regimens. Blood 100: 2675-2676, 2002.
280. Anderson, J.E., Appelbaum, F.R., Schoch, G., Gooley, T., Anasetti, C., Bensinger, W.I., Bryant, E., Buckner, C.D., Chauncey, T., Clift, R.A., Deeg, H.J., Doney, K., Flowers, M., Hansen, J.A., Martin, P.J., Matthews, D.C., Nash, R.A., Sanders, J.E., Shulman, H., Sullivan, K.M., Witherspoon, R.P., Storb, R. Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors (JCO 1996 14: 220-226) [Author Update]. Classic Papers and Current Comments 7: 237-244, 2002.
281. Wagner, J.L., Sarmiento, U.M., Storb, R. Cellular, serological, and molecular polymorphism of the class I and class II loci of the canine major histocompatibility complex. Tissue Antigens 59: 205-210, 2002.
282. Junghanss, C., Marr, K.A., Carter, R.A., Sandmaier, B.M., Maris, M.B., Maloney, D.G., Chauncey, T., McSweeney, P.A., Storb, R. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol. Blood. Marrow. Transplant. 8: 512-520, 2002.
283. Nash, R.A., Takatu, A., Feng, Z., Slichter, S., Abrams, K., Espino, G., Gass, M.J., Georges, G.E., McSweeney, P.A., Shulman, H.M., Storb, R. Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization. Biol Blood Marrow Transplant 8: 360-367, 2002.
284. Hogan, W.J., Storb, R. Clinical developments in reduced intensity haematopoietic stem cell transplantation (Review). Expert Opinion On Biological Therapy 2: 703-714, 2002.
285. Deeg, H.J., Storer, B., Slattery, J.T., Anasetti, C., Doney, K.C., Hansen, J.A., Kiem, H.-P., Martin, P.J., Petersdorf, E., Radich, J.P., Sanders, J.E., Shulman, H.M., Warren, E.H., Witherspoon, R.P., Bryant, E.M., Chauncey, T.R., Getzendaner, L., Storb, R., Appelbaum, F.R. Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood 100: 1201-1207, 2002.
286. Flowers, M.E.D., Parker, P.M., Johnston, L.J., Matos, A.V.B., Storer, B., Bensinger, W.I., Storb, R., Appelbaum, F.R., Forman, S.J., Blume, K.G., Martin, P.J. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 100: 415-419, 2002.
287. Koc, S., Leisenring, W., Flowers, M.E.D., Anasetti, C., Deeg, H.J., Nash, R.A., Sanders, J.E., Witherspoon, R.P., Storb, R., Appelbaum, F.R., Martin, P.J. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 100: 48-51, 2002.
288. Storb, R., Martin, P.J., Zaucha, J.M., Bensinger, W.I., Flowers, M.E.D., Georges, G., Gooley, T., Chauncey, T.R., Storek, J., Torok-Storb, B. Association of CD34 cell number with chronic graft-versus-host disease in adults (Response to Letter to Editor). Blood 99: 3876-3877, 2002.
289. Little, M.-T., Storb, R. History of haematopoietic stem-cell transplantation. Nature Reviews Cancer 2: 231-238, 2002.
290. Hogan, W.J., Storb, R. Therapeutic applications of non-myeloablative hematopoietic stem cell transplantation in malignant disease. Immunologic Research 28: 1-11, 2003.
291. Furlong, T., Leisenring, W., Storb, R., Anasetti, C., Appelbaum, F.R., Carpenter, P.A., Deeg, H.J., Doney, K., Kiem, H.-P., Nash, R.A., Sanders, J.E., Witherspoon, R., Thompson, D., Martin, P.J. Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease. Biol. Blood and Marrow Transplantation 8: 206-212, 2002.
292. Storb, R. Hematopoietic cell transplantation as immunotherapy for hematologic malignancy. In: American Society of Clinical Oncology 2002 Educational Book, Perry, M.C. (ed.). Alexandria, VA: American Society of Clinical Oncology, 77-83, 2002.
293. McSweeney,P.A., Nash,R.A., Sullivan,K.M., Storek,J., Crofford,L.J., Dansey,R., Mayes,M.D., McDonagh,K.T., Nelson,J.L., Gooley,T.A., Holmberg,L.A., Chen,C.S., Wener,M.H., Ryan,K., Sunderhaus,J., Russell,K., Rambharose,J., Storb,R., Furst,D.E. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood 100: 1602-1610, 2002.
294. Sandmaier, B.M., Bethge, W.A., Wilbur, D.S., Hamlin, D.K., Santos, E.B., Brechbiel, M.W., Fisher, D.R., Storb, R. Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts. Blood 100: 318-326, 2002.
295. Jurado, M., Deeg, H.J., Storer, B., Anasetti, C., Anderson, J.E., Bryant, E., Chauncey, T., Doney, K., Flowers, M.E.D., Hansen, J., Martin, P.J., Nash, R.A., Petersdorf, E., Radich, J., Sale, G., Sandmaier, B.M., Storb, R., Wade, J., Witherspoon, R., Appelbaum, F.R. Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality. Biology of Blood and Marrow Transplantation 8: 161-169, 2002.
296. Platzbecker, U., Gooley, T., Anasetti, C., Appelbaum, F.R., Clurman, B., Doney, K., Chauncey, T., Flowers, M.E.D., Myerson, D., Radich, J.P., Storb, R., Witherspoon, R.P., Deeg, H.J. Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation. Leuk. Lymphoma 43: 1409-1414, 2002.
297. Carpenter, P.A., Appelbaum, F.R., Corey, L., Deeg, H.J., Doney, K., Gooley, T., Krueger, J., Martin, P., Pavlovic, S., Sanders, J., Slattery, J., Levitt, D., Storb, R., Woolfrey, A., Anasetti, C. A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease. Blood 99: 2712-2719, 2002.
298. Georges, G.E., Storb, R. Stem cell transplantation for aplastic anemia. International Journal of Hematology 75: 141-146, 2002.
299. Junghanss, C., Boeckh, M., Carter, R.A., Sandmaier, B.M., Maris, M.B., Maloney, D.G., Chauncey, T., McSweeney, P.A., Little, M.-T., Corey, L., Storb, R. Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood 99: 1978-1985, 2002.
300. Goerner, M., Gooley, T., Flowers, M.E.D., Sullivan, K.M., Kiem, H.-P., Sanders, J.E., Martin, P.J., Storb, R. Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biology of Blood and Marrow Transplantation 8: 47-56, 2002.
301. Mielcarek, M., Sandmaier, B.M., Maloney, D.G., Maris, M., McSweeney, P.A., Woolfrey, A., Chauncey, T., Feinstein, L., Niederwieser, D., Blume, K.G., Forman, S., Torok-Storb, B., Storb, R. Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives. Journal of Clinical Immunology 22: 70-74, 2002.
302. Kuhr, C.S., Allen, M.D., Junghanss, C., Zaucha, J.M., Marsh, C.L., Yunusov, M., Zellmer, E., Little, M.-T., Torok-Storb, B., Storb, R. Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras. Transplantation 73: 1487-1493, 2002.
303. Zaucha, J.M., Zellmer, E., Georges, G., Little, M.-T., Storb, R., Storer, B., Torok-Storb, B. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required. Biol. Blood and Marrow Transplantation 7: 613-619, 2001.
304. Woolfrey, A., Pulsipher, M.A., Storb, R. Nonmyeloablative hematopoietic cell transplant for treatment of immune deficiency. Curr. Opin. Pediatr. 13: 539-545, 2001.
305. Weissinger, F., Sandmaier, B.M., Maloney, D.G., Bensinger, W.I., Gooley, T., Storb, R. Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings. Blood 98: 3584-3588, 2001.
306. Walters, M.C., Patience, M., Leisenring, W., Rogers, Z.R., Aquino, V.M., Buchanan, G.R., Roberts, I.A.G., Yeager, A.M., Hsu, L., Adamkiewicz, T., Kurtzberg, J., Vichinsky, E., Storer, B., Storb, R., Sullivan, K.M. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biology of Blood and Marrow Transplantation 7: 665-673, 2001.
307. Storek, J., Joseph, A., Espino, G., Dawson, M.A., Douek, D.C., Sullivan, K.M., Flowers, M.E.D., Martin, P., Mathioudakis, G., Nash, R.A., Storb, R., Appelbaum, F.R., Maloney, D.G. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation (Plenary Paper). Blood 98: 3505-3512, 2001.
308. Storb, R. Mixed allogeneic chimerism and graft-versus-leukemia effects in acute myeloid leukemia (Keynote Address). Leukemia 16: 753-754, 2002.
309. Nash, R.A., Niederwieser, D., McSweeney, P.A., Sandmaier, B.M., Georges, G., Maloney, D.G., Feinstein, L., Maris, M., Woolfrey, A., Chauncey, T., Zaucha, J.M., Blume, K.G., Shizuru, J., Storb, R. Allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. In: Acute Leukemias IX: Basic Research, Experimental Approaches and Novel Therapies, Haematology and Blood Transfusion: 41. Hiddemann, W., Büchner, T., Ritter, J., Unterhalt, M., and Haferlach, T. (eds.). Heidelberg, Germany: Springer-Verlag, 479-482, 2003.
310. Mielcarek, M., Zaucha, J.M., Sandmaier, B., Maloney, D., Butrynski, J., Maris, M., Feinstein, L., Torok-Storb, B., Storb, R. Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO-incompatibility (Letter to the Editor). British Journal of Haematology 116: 500-501, 2002.
311. Kansu, E., Gooley, T., Flowers, M.E.D., Anasetti, C., Deeg, H.J., Nash, R.A., Sanders, J.E., Witherspoon, R.P., Appelbaum, F.R., Storb, R., Martin, P.J. Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial (Brief Report). Blood 98: 3868-3870, 2001.
312. Bruno, B., Goerner, M., Nash, R.A., Storb, R., Kiem, H.P., McSweeney, P.A. Purified canine CD34+Lin- marrow cells transduced with retroviral vectors give rise to long-term multi-lineage hematopoiesis. Biol. Blood. Marrow. Transplant. 7: 543-551, 2001.
313. Bensinger, W.I., Maloney, D., Storb, R. Allogeneic hematopoietic cell transplantation for multiple myeloma. Semin. Hematol. 38: 243-249, 2001.
314. Zaucha, J.M., Gooley, T., Bensinger, W.I., Heimfeld, S., Chauncey, T.R., Zaucha, R., Martin, P.J., Flowers, M.E.D., Storek, J., Georges, G., Storb, R., Torok-Storb, B. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 98: 3221-3227, 2001.
315. Zaucha, J.M., Yu, C., Zellmer, E., Takatu, A., Junghanss, C., Little, M.-T., Storb, R. Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model. Biol. Blood. Marrow. Transplant. 7: 513-516, 2001.
316. Xun, C.-Q., Little, M.-T., Zellmer, E., Yu, C., Zaucha, J.M., Sale, G.E., Storer, B., Storb, R. What role for FTY720, a novel immunosuppressive agent, in canine nonmyeloablative hematopoietic stem cell transplantation? Transplantation 73: 310-313, 2002.
317. Ulrich, C.M., Storb, R., Schubert, M.M., Potter, J.D. MTHFR polymorphism, DNA repair capacity, and methotrexate toxicity (Letter). Blood 98: 2284, 2001.
318. Torok-Storb, B., Bolles, L., Iwata, M., Doney, K., Sale, G.E., Gooley, T.A., Storb, R. Increased prevalence of CMV gB3 in marrow of patients with aplastic anemia (Letter to the Editor). Blood 98: 891-892, 2001.
319. Storb, R. Perspective: haematopoietic stem cell rescue enabling high-dose chemotherapy, tool for immunotherapy. Advances in Transfusion Safety 108: 123-126, 2002.
320. Storb, R., Sandmaier, B.M., Forman, S., Maris, M., Feinstein, L., Chauncey, T., Maloney, D.G., McSweeney, P.A., Blume, K.G., Shizuru, J., Hegenbart, U., Little, M.-T., Niederwieser, D. Haematopoietic cell transplantation from siblings in older patients with haematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumour effects. In: Proceedings of the 5th International Stem Cell Workshop: High-Dose Therapy and Transplantation of Haematopoietic Stem Cells (2001), Schultze, W. (ed.). Berlin, Germany: Blackwell Publishing Ltd, Chapter 1.1: 3-6, 2002.
321. Storb, R.F., Champlin, R., Riddell, S.R., Murata, M., Bryant, S., Warren, E.H. Non-myeloablative transplants for malignant disease. In: Hematology 2001: American Society of Hematology Education Program Book, Schechter, G.P., Broudy, V.C., and Williams, M.E. (eds.). Washington, DC: The American Society of Hematology, 375-391, 2001.
322. Maris, M., Sandmaier, B.M., Maloney, D.G., McSweeney, P.A., Woolfrey, A., Chauncey, T., Shizuru, J., Niederwieser, D., Blume, K.G., Forman, S., Storb, R. Non-myeloablative hematopoietic stem cell transplantation. Transfusion Clinique et Biologique 8: 231-234, 2001.
323. Goerner, M., Horn, P.A., Peterson, L., Kurre, P., Storb, R., Rasko, J.E.J., Kiem, H.-P. Sustained multilineage gene persistence and expression in dogs transplanted with CD34+ marrow cells transduced by RD114-pseudotype oncoretrovirus vectors. Blood 98: 2065-2070, 2001.
324. Georges, G.E., Storb, R.F. Experimental and clinical experience with hematopoietic stem cell transplants. In: The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims, Ricks, R.C., Berger, M.E., and O’Hara, F.M., Jr. (eds.). New York: The Parthenon Publishing Group, 73-93, 2002.
325. Georges, G.E., Storb, R., Bruno, B., Brodie, S.J., Thompson, J.D., Taranova, A.G., Zaucha, J.M., Little, M.-T., Zellmer, E., Moore, P.F., Gooley, T., Sale, G., Kiem, H.-P., Sandmaier, B.M., Lyons, R.M., Nash, R.A. Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes. Blood 98: 3447-3455, 2001.
326. Feinstein, L., Storb, R. Reducing transplant toxicity. Curr. Opin. Hematol. 8: 342-348, 2001.
327. Benito, A.I., Furlong, T., Martin, P.J., Anasetti, C., Appelbaum, F.R., Doney, K., Nash, R.A., Papayannopoulou, T., Storb, R., Sullivan, K.M., Witherspoon, R., Deeg, H.J. Sirolimus (Rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease. Transplantation 72: 1924-1929, 2001.
328. Wagner, J.L., Flowers, M.E.D., Longton, G., Storb, R., Martin, P. Use of screening studies to predict survival among patients who do not have chronic graft-versus-host disease at day 100 after bone marrow transplantation (Letter to the Editor). Biol. Blood and Marrow Transplantation 7: 239-240, 2001.
329. Bensinger, W.I., Maloney, D., Sandmaier, B.M., Molina, A., Sahebi, F., Forman, S.J., Storb, R. Non-ablative allogeneic transplants for multiple myeloma. VIII International Myeloma Workshop, Banff, Alberta, Canada, May 4-8, 2001 36-37, 2001.
330. Ulrich, C.M., Yasui, Y., Storb, R., Schubert, M.M., Wagner, J.L., Bigler, J., Ariail, K.S., Keener, C.L., Li, S., Liu, H., Farin, F.M., Potter, J.D. Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood 98: 231-234, 2001.
331. Zaucha, J.M., Yu, C., Mathioudakis, G., Seidel, K., Georges, G., Sale, G., Little, M.-T., Torok-Storb, B., Storb, R. Hematopoietic responses to stress conditions in young dogs compared with elderly dogs. Blood 98: 322-327, 2001.
332. Storb, R., Sale, G., Barnett, T., Yu, C., Zellmer, E., Little, M.-T. Transient mixed hematopoietic chimerism in dogs given thymic irradiation before and pharmacologic immunosuppression after marrow transplantation. Blood 97: 2915-2916, 2001.
333. Bensinger, W.I., Storb, R. Allogeneic peripheral blood stem cell transplantation. Reviews in Clinical and Experimental Hematology 5: 67-86, 2001.
334. McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., Chauncey, T.R., Gooley, T.A., Hegenbart, U., Nash, R.A., Radich, J., Wagner, J.L., Minor, S., Appelbaum, F.R., Bensinger, W.I., Bryant, E., Flowers, M.E.D., Georges, G.E., Grumet, F.C., Kiem, H.-P., Torok-Storb, B., Yu, C., Blume, K.G., Storb, R.F. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97: 3390-3400, 2001.
335. Storek, J., Dawson, M.A., Storer, B., Stevens-Ayers, T., Maloney, D.G., Marr, K.A., Witherspoon, R.P., Bensinger, W., Flowers, M.E.D., Martin, P., Storb, R., Appelbaum, F.R., Boeckh, M. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97: 3380-3389, 2001.
336. Witherspoon, R.P., Deeg, H.J., Storer, B., Anasetti, C., Storb, R., Appelbaum, F.R. Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia. J. Clin. Oncol. 19: 2134-2141, 2001.
337. Al-Ghamdi, H., Leisenring, W., Bensinger, W.I., Nash, R.A., Storb, R., Appelbaum, F.R., Martin, P.J. A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest. Br. J. Haematol. 113: 461-469, 2001.
338. Anderson, J.E., Appelbaum, F.R., Schoch, G., Barnett, T., Chauncey, T.R., Flowers, M.E.D., Storb, R. Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation. Biol. Blood. Marrow. Transplant. 7: 163-170, 2001.
339. Feinstein, L., Sandmaier, B., Maloney, D., McSweeney, P.A., Maris, M., Flowers, C., Radich, J., Little, M.-T., Nash, R.A., Chauncey, T., Woolfrey, A., Georges, G., Kiem, H.-P., Zaucha, J.M., Blume, K.G., Shizuru, J., Niederwieser, D., Storb, R. Nonmyeloablative hematopoietic cell transplantation: replacing high-dose cytotoxic therapy by the graft-versus-tumor effect. Ann. NY Acad. Sci. 938: 328-339, 2001.
340. Bruno, B., Gooley, T., Sullivan, K.M., Davis, C., Bensinger, W.I., Storb, R., Nash, R.A. Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Biol. Blood and Marrow Transplantation 7: 154-162, 2001.
341. Jurado, M., Deeg, H.J., Gooley, T., Anasetti, C., Chauncey, T., Flowers, M.E.D., Myerson, D., Storb, R., Appelbaum, F.R. Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia. Br. J. Haematol. 112: 392-396, 2001.
342. Storb, R., Blume, K.G., O’Donnell, M.R., Chauncey, T., Forman, S.J., Deeg, H.J., Hu, W.W., Appelbaum, F.R., Doney, K., Flowers, M.E.D., Sanders, J., Leisenring, W. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol. Blood and Marrow Transplantation 7: 39-44, 2001.
343. Bensinger, W.I., Martin, P.J., Storer, B., Clift, R., Forman, S.J., Negrin, R., Kashyap, A., Flowers, M.E.D., Lilleby, K., Chauncey, T.R., Storb, R., Appelbaum, F.R. Tranplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N. Engl. J. Med. 344: 175-181, 2001.
344. Zaucha, J.M., Yu, C., Lothrop, C.D., Jr., Nash, R.A., Sale, G., Georges, G., Kiem, H.-P., Niemeyer, G.P., Dufresne, M., Cao, Q., Storb, R. Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation. Biol. Blood and Marrow Transplantation 7: 14-24, 2001.
345. Storb, R. Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia? (Editorial). Leukemia 15: 662-663, 2001.
346. Koc, S., Leisenring, W., Flowers, M.E.D., Anasetti, C., Deeg, H.J., Nash, R.A., Sanders, J.E., Witherspoon, R.P., Appelbaum, F.R., Storb, R., Martin, P.J. Thalidomide for treatment of patients with chronic graft-versus-host disease. Blood 96: 3995-3996, 2000.
347. Wagner, J.L., Seidel, K., Boeckh, M., Storb, R. De novo chronic graft-versus-host disease in marrow graft recipients given methotrexate and cyclosporine: risk factors and survival. Biol. Blood and Marrow Transplantation 6: 633-639, 2000.
348. Storb, R., McSweeney, P.A., Sandmaier, B.M., Nash, R.A., Georges, G., Maloney, D.G., Molina, A., Maris, M., Woolfrey, A., Chauncey, T., Zaucha, J.M., Blume, K.G., Shizuru, J., Niederwieser, D. Nonmyeloablative allografts: from the laboratory to the clinic. In: Autologous Blood and Marrow Transplantation: Proceedings of the Tenth International Symposium, Dallas, Texas , Dicke, K.A. and Keating, A. (eds.). Charlottesville, VA: Carden Jennings Publishing, Chapter 7: 315-320, 2001.
349. Mosca, J.D., Hendricks, J.K., Buyaner, D., Davis-Sproul, J., Chuang, L.-C., Majumdar, M.K., Chopra, R., Barry, F., Murphy, M., Thiede, M.A., Junker, U., Rigg, R.J., Forestell, S.P., Böhnlein, E., Storb, R., Sandmaier, B.M. Mesenchymal stem cells as vehicles for gene delivery. Clinical Orthopaedics and Related Research 379S: S71-S90, 2000.
350. Mathioudakis, G., Storb, R., McSweeney, P.A., Torok-Storb, B., Lansdorp, P.M., Brümmendorf, T.H., Gass M.J., Bryant, E.M., Storek, J., Flowers, M.E.D., Gooley, T., Nash, R.A. Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients (Brief Report). Blood 96: 3991-3994, 2000.
351. Furlong, T., Storb, R., Anasetti, C., Appelbaum, F.R., Deeg, H.J., Doney, K., Martin, P., Sullivan, K., Witherspoon, R., Nash, R.A. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities. Bone Marrow Transplant. 26: 985-991, 2000.
352. Feinstein, L., Storb, R. Nonmyeloablative hematopoietic cell transplantation. Curr. Opin. Oncol. 13: 95-100, 2001.
353. Carnevale-Schianca, F., Martin, P., Sullivan, K., Flowers, M., Gooley, T., Anasetti, C., Deeg, J., Furlong, T., McSweeney, P., Storb, R., Nash, R.A. Changing cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease. Biol. Blood. Marrow. Transplant. 6: 613-620, 2000.
354. Sierra, J., Storer, B., Hansen, J.A., Martin, P.J., Petersdorf, E.W., Woolfrey, A., Matthews, D., Sanders, J.E., Storb, R., Appelbaum, F.R., Anasetti, C. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience. Bone Marrow Transplant. 26: 397-404, 2000.
355. Maris, M., Woolfrey, A., McSweeney, P.A., Sandmaier, B.M., Nash, R.A., Georges, G., Maloney, D.G., Molina, A., Chauncey, T., Yu, C., Zaucha, J.M., Blume, K.G., Shizuru, J., Niederwieser, D., Storb, R. Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st century. Frontiers in Bioscience 6 : g13-16 (http://www.bioscience.org/2001/v6/g/maris/fulltext.htm), 2001.
356. Sandmaier, B.M., McSweeney, P.A., Niederwieser, D., Maloney, D.G., Blume, K.G., Molina, A., Shizuru, J., Chauncey, T., Georges, G., Zaucha, J.M., Maris, M., Woolfrey, A., Storb, R. Post-transplant immunosuppression – canine models and clinical application. In: New Frontiers in Cancer Therapy: Non-myeloablative Stem Cell Transplantation (NST), First Edition, Giralt, S. and Slavin, S. (eds.). Oxfordshire, UK: Darwin Scientific Publishing Limited, 37-43, 2000.
357. Flowers, M.E.D., Leisenring, W., Beach, K., Riddell, S., Radich, J.P., Higano, C., Rowley, S.D., Chauncey, T.R., Bensinger, W.I., Sanders, J.E., Anasetti, C., Storb, R., Wade, J., Appelbaum, F.R., Martin, P.J. Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation. Biol. Blood and Marrow Transplantation 6: 321-326, 2000.
358. Niederwieser, D., McSweeney, P., Hegenbart, U., Pönisch, W., Lange, T., Deininger, M., Uharek, L., Storb, R. Haematopoietic stem cell transplantation with reduced conditioning: a new treatment modality for patients at high risk of transplant-related mortality. In: European Haematology Association Educational Book, Fifth Congress of the European Haematolgy Association Birmingham, UK, 25-28 June 2000, 59-60, 2000.
359. Wagner, J.L., Storb, R., Storer, B., Mignot, E. DLA-DQB1 alleles and bone marrow transplantation experiments in narcoleptic dogs. Tissue Antigens 56: 223-231, 2000.
360. Hägglund, H.G., McSweeney, P.A., Mathioudakis, G., Bruno, B., Georges, G.E., Gass, M.J., Moore, P., Sale, G.E., Storb, R., Nash, R.A. Ex vivo expansion of canine dendritic cells from CD34+ bone marrow progenitor cells. Transplantation 70: 1437-1442, 2000.
361. McSweeney, P., Storb, R. Hematopoietic stem cell transplantation for malignant disease. In: Clinical Immunology: Principles and Practice, Second Edition, Volume Two, Rich, R.R., Fleisher, T.A., Shearer, W.T., Kotzin, B.L., and Schroeder, H.W., Jr. (eds.). London, UK: Harcourt Publishers Limited, Chapter 102: 102.1-102.17, 2001.
362. Nash, R.A., Antin, J.H., Karanes, C., Fay, J.W., Avalos, B.R., Yeager, A.M., Przepiorka, D., Davies, S., Petersen, F.B., Bartels, P., Buell, D., Fitzsimmons, W., Anasetti, C., Storb, R., Ratanatharathorn, V. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 96 : 2062-2068, 2000.
363. Maris, M., Storb, R. Outpatient allografting in hematologic malignancies and nonmalignant disorders-applying lessons learned in the canine model to humans. In: Non-Myeloablative Allogeneic Transplantation, Bashey, A. and Ball, E.D. (eds.). Boston: Kluwer Academic Publishers, Chapter 8: 149-175, 2002.
364. Storb, R., McSweeney, P.A., Sandmaier, B.M., Nash, R.A., Georges, G., Maloney, D.G., Molina, A., Maris, M., Woolfrey, A., Chauncey, T., Zaucha, M., Blume, K.G., Shizuru, J., Niederwieser, D. Nonmyeloablative allogeneic hematopoietic stem cell transplantation. Hematologica 85 (Suppl. 2): 85-87, 2000.
365. Deeg, H.J., Flowers, M.E.D., Leisenring, W., Appelbaum, F.R., Martin, P.J., Storb, R.F. Cyclosporine (CSP) or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial (Letter to Editor). Blood 96: 1194-1195, 2000.
366. Maris, M.B., Storb, R. Hematopoietic stem cell transplantation. In: Samter’s Immunologic Diseases, Sixth Edition, Volume II, Austen, K.F., Frank, M.M., Atkinson, J.P., and Cantor, H. (eds.). Philadelphia, PA: Lippincott Williams & Wilkins, Chapter 83: 1095-1121, 2001.
367. Wagner, J.L., Storb, R., Marti, E. Immunogenetics. In: The Genetics of the Dog, Ruvinsky, A. and Sampson, J. (eds.). Wallingford, Oxon, UK: CAB International, Chapter 8: 159-189, 2001.
368. Little, M.-T., Storb, R. The future of allogeneic hematopoietic stem cell transplantation: minimizing pain, maximizing gain (Commentary). J. Clin. Invest. 105: 1679-1681, 2000.
369. Wagner, J.L., Creer, S.A., Storb, R. Dog class I gene DLA-88 histocompatibility typing by PCR-SSCP and sequencing (Brief communication). Tissue Antigens 55: 564-567, 2000.
370. Mielcarek, M., Leisenring, W., Torok-Storb, B., Storb, R. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood 96: 1150-1156, 2000.
371. Storek, J., Storb, R. T-cell reconstitution after stem-cell transplantation – by which organ? (Commentary). Lancet 355: 1843-1844, 2000.
372. Zang, D.Y., Deeg, H.J., Gooley, T., Anderson, J.E., Anasetti, C., Sanders, J., Myerson, D., Storb, R., Appelbaum, F. Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation. Br. J. Haematol. 110: 217-222, 2000.
373. Georges, G.E., Storb, R., Thompson, J.D., Yu, C., Gooley, T., Bruno, B., Nash, R.A.: Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation. Blood 95: 3262-3269, 2000.
374. Storb, R. Allogeneic hematopoietic stem cell transplantation from the nuclear age to the 21ST century: lessons learned from dogs. In: Proceedings of the 18th Annual Veterinary Medical Forum, Lakewood, CO: American College of Veterinary Internal Medicine, Session #191: 479-480, 2000.
375. Feinstein, L.C., Seidel, K., Jocum, J., Bowden, R.A., Anasetti, C., Deeg, H.J., Flowers, M.E.D., Kansu, E., Martin, P.J., Nash, R.A., Storek, J., Etzioni, R., Appelbaum, F.R., Hansen, J.A., Storb, R., Sullivan, K.M.: Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts. Biol. Blood and Marrow Transplantation 5: 369-378, 1999.
376. Georges, G.E., Storb, R.F. Overview of allogeneic procedures: immune modulation and non-myeloablative allogeneic hematopoietic stem cell transplantation. In: High Dose Chemotherapy Principles and Practice, Lorigan, P. and Vandenberghe, E. (eds.). London: Martin Dunitz Ltd, Chapter 20: 267-286, 2002.
377. Molina, A.J., Storb, R.F.: Hematopoietic stem cell transplantation in older adults. In: Handbook of Bone Marrow Transplantation, 1st Edition, Rowe, J.M., Lazarus, H.M., and Carella, A.M. (eds.). London, UK: Martin Dunitz Ltd, Chapter 6: 111-137, 2000.
378. Walters, M.C., Storb, R., Patience, M., Leisenring, W., Taylor, T., Sanders, J.E., Buchanan, G.E., Rogers, Z.R., Dinndorf, P., Davies, S.C., Roberts, I.A.G., Dickerhoff, R., Yeager, A.M., Hsu, L., Kurtzberg, J., Ohene-Frempong, K., Bunin, N., Bernaudin, F., Wong, W.-Y., Scott, J.P., Margolis, D., Vichinsky, E., Wall, D.A., Wayne, A.S., Pegelow, C., Redding-Lallinger, R., Wiley, J., Klemperer, M., Mentzer, W.C., Smith, F.O., Sullivan, K.M.: Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood 95: 1918-1924, 2000.
379. Yu, C., Linsley, P., Seidel, K., Sale, G., Deeg, H.J., Nash, R.A., Storb, R.: Cytotoxic T lymphocyte antigen 4-immunoglobulin fusion protein combined with methotrexate/cyclosporine as graft-versus-host disease prevention in a canine dog leukocyte antigen-nonidentical marrow transplant model. Transplantation 69: 450-454, 2000.
380. Storb, R., McSweeney, P.A., Sandmaier, B.M., Nash, R.A., Georges, G., Maloney, D.G., Molina, A., Chauncey, T., Yu, C., Zaucha, J.M., Blume, K.G., Shizuru, J., Niederwieser, D. Allogeneic hematopoietic stem cell transplantation: from the nuclear age into the 21st century. Transplant. Proc. 32: 2548-2549, 2000.
381. Clift, R.A., Radich, J., Appelbaum, F.R., Martin, P., Flowers, M.E.D., Deeg, H.J., Storb, R., Thomas, E.D.: Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogeneic marrow transplants during chronic phase of chronic myeloid leukemia (Letter to Editor). Blood 94: 3960-3962, 1999.
382. Carella, A.M., Champlin, R., Slavin, S., McSweeney, P., Storb, R.: Mini-allografts: ongoing trials in humans (Editorial). Bone Marrow Transplant. 25: 345-350, 2000.
383. Deeg, H.J., Shulman, H.M., Anderson, J.E., Bryant, E.M., Gooley, T.A., Slattery, J.T., Anasetti, C., Fefer, A., Storb, R., Appelbaum, F.R.: Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age. Blood 95: 1188-1194, 2000.
384. Bhattacharya, V., McSweeney, P.A., Shi, Q., Bruno, B., Ishida, A., Nash, R., Storb, R.F., Sauvage, L.R., Hammond, W.P., Wu, M.H.-D.: Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34+ bone marrow cells. Blood 95: 581-585, 2000.
385. McSweeney, P., Storb, R.: Establishing mixed chimerism with immunosuppressive, minimally myelosuppressive conditioning: preclinical and clinical studies. In: Hematology 1999, The American Society of Hematology Education Program Book, Schechter, G.P., Hoffman, R., Schrier, S.L., and Bajus, J.L. (eds.). Washington, DC: American Society of Hematology, 396-405, 1999.
386. Xun, C.Q., McSweeney, P.A., Boeckh, M., Storb, R.F., Broudy, V.C., Thompson, J.A.: Successful nonmyeloablative allogeneic hematopoietic stem cell transplant in an acute leukemia patient with chemotherapy-induced marrow aplasia and progressive pulmonary aspergillosis (Letter to Editor). Blood 94: 3273-3276, 1999.
387. Martin, P.J., Rowley, S.D., Anasetti, C., Chauncey, T.R., Gooley, T., Petersdorf, E.W., van Burik, J.-A., Flowers, M.E.D., Storb, R., Appelbaum, F.R., Hansen, J.A.: A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients. Blood 94 : 2192-2199, 1999.
388. Cavallaro, A.M., Lilleby, K., Majolino, I., Storb, R., Appelbaum, F.R., Rowley, S.D., Bensinger, W.I.: Three to six year follow-up of normal donors who received recombinant human granulocyte colony stimulating factor. Bone Marrow Transplant. 25: 85-89, 2000.
389. Goerner, M., Bruno, B., McSweeney, P.A., Buron, G., Storb, R., Kiem, H.-P.: The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs. Blood 94: 2287-2292, 1999.
390. Matthews, D.C., Appelbaum, F.R., Eary, J.F., Fisher, D.R., Durack, L.D., Hui, T.E., Martin, P.J., Mitchell, D., Press, O.W., Storb, R., Bernstein, I.D.: Phase I study of 131I-Anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome. Blood 94: 1237-1247, 1999.
391. Storb, R., McSweeney, P.A., Sandmaier, B.M., Nash, R.A., Georges, G., Maloney, D.G., Molina, A., Chauncey, T., Yu, C., Zaucha, M.: Nonmyeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation. Turkish Journal of Haematolgy, Supplement to Volume 16, No.3, 3rd National Bone Marrow and Peripheral Stem Cell Transplantation Congress, 3-5 June, Mersin, Turkey, pp. 3-7, 1999.
392. Storb, R.: Prevention of graft-versus-host disease. Turkish Journal of Haematolgy 16: 107-111, 1999.
393. Storb, R., McSweeney, P.A., Sandmaier, B.M., Nash, R.A., Georges, G., Maloney, D., Yu, C., Zaucha, M., Blume, K., Shizuru, J., Niederwieser, D. Non-myeloablative haematopoietic stem cell transplants. In: Proceedings of the 4th Stem Cell Workshop: High-dose Therapy and Transplantation of Haematopoietic Stem Cells, Schultze, W. (ed.). Vienna: Blackwell Wissenschafts-Verlag Berlin, Chapter 5.2: 170-174, 2000.
394. McSweeney, P.A., Storb, R.: Mixed chimerism: preclinical studies and clinical applications (Review). Biol. Blood. Marrow. Transplant. 5: 192-203, 1999.
395. Storb, R., Yu, C., Zaucha, J.M., Deeg, H.J., Georges, G., Kiem, H.-P., Nash, R.A., McSweeney, P.A., Wagner, J.L.: Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 94: 2523-2529, 1999.
396. Deeg, H.J., Schuler, U.S., Shulman, H., Ehrsam, M., Renner, U., Yu, C., Storb, R., Ehninger, G.: Myeloablation by intravenous busulfan and hematopoietic reconstitution with autologous marrow in a canine model. Biol. Blood. Marrow. Transplant. 5: 316-321, 1999.
397. Sandmaier, B.M., McSweeney, P., Yu, C., Storb, R. Non-myeloablative transplants: preclinical and clinical results. Semin. Oncol. 27 (Suppl. 5): 78-81, 2000.
398. Storb, R., Yu, C., Barnett, T., Wagner, J.L., Deeg, H.J., Nash, R.A., Kiem, H.-P., McSweeney, P., Seidel, K., Georges, G., Zaucha, J.M.: Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation. Blood 94: 1131-1136, 1999.
399. Yamaguchi, M., McSweeney, P.A., Kimball, L., Gersuk, G., Hong, D.S., Kwok, W., Storb, R., Beckham, C., Deeg, H.J.: Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis. Transplantation 68: 1161-1171, 1999.
400. Witherspoon, R.P., Deeg, H.J., Storb, R., Appelbaum, F.R. Secondary leukemia or myelodysplasia treated by bone marrow transplantation. In: Acute Leukemias VIII: Prognostic Factors and Treatment Strategies, Büchner, T., Hiddemann, W., Wörmann, B., Schellong, G., Ritter, J., and Creutzig, U. (eds.). Berlin: Springer-Verlag, 655-659, 2001.
401. Molina, A.J., Sandmaier, B.M., Storb, R. Nonmyeloablative hematopoietic stem cell allografting. Current Opinion in Organ Transplantation 5: 366-371, 2000.
402. Kiem, H.-P., McSweeney, P.A., Bruno, B., Goerner, M., Buron, G., Morris, J., Storb, R., Miller, A.D.: Improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells in combination with a gibbon ape leukemia virus–pseudotype retroviral vector. Gene Ther. 6: 966-972, 1999.
403. Storb, R., Raff, R.F., Graham, T., Appelbaum, F.R., Deeg, H.J., Schuening, F.G., Sale, G., Seidel, K.: Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation. Biol. Blood. Marrow. Transplant. 5: 155-161, 1999.
404. Mielcarek, M., Bryant, E., Loken, M., Torok-Storb, B., Storb, R.: Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation [Report]. Br. J. Haematol. 105: 361-365, 1999.
405. Bruno, B., Nash, R.A., Wallace, P.M., Gass, M.J., Thompson, J., Storb, R., McSweeney, P.A.: CD34+ selected bone marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation. Transplantation 68: 338-344, 1999.
406. Storb, R.: Nonmyeloablative preparative regimens: experimental data and clinical practice. In: ASCO Education Book , Perry, M.C. (ed.). 241-249, 1999.
407. Barsoukov, A.A., Moore, P.F., Storb, R., Santos, E.B., Sandmaier, B.M.: The use of an anti-TCRαβ monoclonal antibody to control host-versus-graft reactions in canine marrow allograft recipients conditioned with low dose total body irradiation. Transplantation 67: 1329-1335, 1999.
408. Witherspoon, R.P., Deeg, H.J., Fisher, L., Schoch, G., Storb, R. Secondary malignancies after allogeneic or autologous marrow transplantation. In: Secondary Neoplasias following Chemotherapy, Radiotherapy, and Immunosuppression, Volume 55, Rüther, U., Nunnensiek, C., and Schmoll, H.-J. (eds.). Basel: Karger, 203-224, 2000.
409. Wagner, J.L., Burnett, R.C., Storb, R.: Organization of the canine major histocompatibility complex: current perspectives. J. Hered. 90: 35-38, 1999.
410. Storb, R., Yu, C., Sandmaier, B., McSweeney, P., Georges, G., Nash, R., Woolfrey, A.: Mixed hematopoietic chimerism after hematopoietic stem cell allografts. Transplant. Proc. 31: 677-678, 1999.
411. McCann, S.R., Passweg, J.R., Storb, R., Deeg, H.J. HLA-identical sibling bone marrow transplantation to treat severe aplastic anemia. In: Aplastic Anemia Pathophysiology and Treatment, Schrezenmeier, H. and Bacigalupo, A. (eds.). Cambridge: Cambridge University Press, Chapter 12: 230-257, 2000.
412. Clift, R.A., Buckner, C.D., Appelbaum, F.R., Sullivan, K.M., Storb, R., Thomas, E.D.: Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia (Letter). Blood 92: 1455-1456, 1998.
413. Martin, P.J., Schoch, G., Gooley, T., Anasetti, C., Deeg, H.J., Nash, R., Sanders, J., Storb, R., Appelbaum, F.: Methods for assessment of graft-versus-host-disease (Letter). Blood 92: 3479-3480, 1998.
414. Sandmaier, B.M., Yu, C., Barsoukov, A., Storb, R.: Canine hematopoietic stem allografts using nonmyeloablative therapy. In: Autologous Blood and Marrow Transplantation, Proceedings of the Ninth International Symposium, Arlington, Texas. Dicke, K.A. and Keating, A. (eds.). Charlottesville: Carden Jennings Publishing, 601-611, 1999.
415. Storb, R., Yu, C., Sandmaier, B.M., McSweeney, P.A., Georges, G., Nash, R.A., Woolfrey, A. Mixed hematopoietic chimerism after marrow allografts: transplantation in the ambulatory care setting. Ann. NY Acad. Sci. 872: 372-376, 1999.
416. Negrin, R., Storb, R., Forman, S.: Bone marrow transplantation in malignant disease. In: Hematology 1998, The American Society of Hematology Education Program Book, McArthur, J.R., Schechter, G.P., Schrier, S.L., and Bajus, J.L. (eds.). Washington, DC: American Society of Hematology, 342-370, 1998.
417. Wagner, J.L., Works, J.D., Storb, R.: DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing (Brief Communication). Tissue Antigens 52: 397-401, 1998.
418. Storb, R., Yu, C., McSweeney, P., Nash, R., Sandmaier, B., Wagner, J., Woolfrey, A.: New strategies for hematopoietic stem cell transplantation. In: Transplantation in Hematology and Oncology, Büchner, Th., Jürgens, H., Berdel, W.E., van de Loo, J., Ritter, J., Kienast, J., and Vormoor, J. (eds.). Berlin, Germany: Springer-Verlag, 97-111, 2000.
419. Stucki, A., Leisenring, W., Sandmaier, B., Sanders, J., Anasetti, C., Storb, R.: Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis). Blood 92: 2742-2749, 1998.
420. Ratanatharathorn, V., Nash, R.A., Przepiorka, D., Devine, S.M., Klein, J.L., Weisdorf, D., Fay, J.W., Nademanee, A., Antin, J.H., Christiansen, N.P., van der Jagt, R., Herzig, R.H., Litzow, M.R., Wolff, S.N., Longo, W.L., Petersen, F.B., Karanes, C., Avalos, B., Storb, R., Buell, D.N., Maher, R.M., Fitzsimmons, W.E., Wingard, J.R.: Phase III study comparing methotrexate and tacrolimus (Prograf, FK506) with methotrexate and cyclosporine for graft-versus-host-disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 92: 2303-2314, 1998.
421. Shi, Q., Rafii, S., Wu, M.H.-D., Wijelath, E.S., Yu, C., Ishida, A., Fujita, Y., Kothari, S., Mohle, R., Sauvage, L.R., Moore, M.A.S., Storb, R.F., Hammond, W.P.: Evidence for circulating bone marrow-derived endothelial cells. Blood 92: 362-367, 1998.
422. Morton, A.J., Gooley, T., Hansen, J.A., Appelbaum, F.R., Bruemmer, B., Bjerke, J.W., Clift, R., Martin, P.J., Petersdorf, E.W., Sanders, J.E., Storb, R., Sullivan, K.M., Woolfrey, A., Anasetti, C.: Association between pretransplant interferon-α and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase. Blood 92: 394-401, 1998.
423. Sullivan, K.M., Kansu, E., Storer, B., Jocom, J., Emerson, G., Reagan, T., Emerson, V., Siadak, M.F., Davis, C., Appelbaum, F.R., Buckner, C.D., Hansen, J.A., Shulman, H.M., Storb, R., McDonald, G.B.: Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation. Biol. Blood and Marrow Transplantation 4: 20-26, 1998.
424. Storb, R., Yu, C., McSweeney, P.: Mixed chimerism after transplantation of allogeneic hematopoietic cells. In: Hematopoietic Cell Transplantation, 2nd Edition, Thomas, E.D., Blume, K.G., and Forman, S.J. (eds.). Boston: Blackwell Science, Chapter 26: 287-295, 1999.
425. Wagner, J.L., Hayes-Lattin, B., Works, J.D., Storb, R.: Molecular analysis and polymorphism of the DLA-DQB genes. Tissue Antigens 52: 242-250, 1998.
426. Georges, G.E., Storb, R., Brunvand, M.W., Kiem, H.-P., Moore, P.F., Malik, P., Ennist, D., Nash, R.A.: Canine T cells transduced with a herpes simplex virus thymidine kinase gene: a model to study effects on engraftment and control of graft-versus-host disease. Transplantation 66: 540-544, 1998.
427. Georges, G., Storb, R.: Failure of sustained engraftment: clinical manifestations and treatment. In: Clinical Bone Marrow and Blood Stem Cell Transplantation, Second Edition, Atkinson, K. (ed.). Cambridge, UK: Cambridge University Press, Chapter 52: 662-680, 2000.
428. Hansen, J.A., Gooley, T.A., Martin, P.J., Appelbaum, F., Chauncey, T.R., Clift, R.A., Petersdorf, E.W., Radich, J., Sanders, J.E., Storb, R.F., Sullivan, K.M., Anasetti, C. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. New England Journal of Medicine 338: 962-968, 1998.
429. Shi, Q., Wu, H.-D., Fujita, Y., Ishida, A., Wijelath, E.S., Hammond, W.P., Wechezak, A.R., Yu, C., Storb, R.F., Sauvage, L.R.: Genetic tracing of arterial graft flow surface endothelialization in allogeneic marrow transplanted dogs. Cardiovasc. Surg. 7: 98-105, 1999.
430. Thomas, E.D., Storb, R.: The development of the scientific foundation of hematopoietic cell transplantation based on animal and human studies. In: Hematopoietic Cell Transplantation, 2nd Edition, Thomas, E.D., Blume, K.G., and Forman, S.J. (eds.). Boston: Blackwell Science, Chapter 1: 1-11, 1999.
431. Wagner, J.L., Flowers, M.E.D., Longton, G., Storb, R., Schubert, M., Sullivan, K.M.: The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation. Bone Marrow Transplant. 22: 139-146, 1998.
432. McSweeney, P.A., Storb, R. Marrow and peripheral blood stem cell transplantation. In: Advances in Tissue Banking, Vol. 2, Phillips, G.O., Strong, D.M., von Versen, R., and Nather, A. (eds.). Singapore: World Scientific Publishing Co. Pte. Ltd., Chapter 2.3: 69-116, 1998.
433. Anderson, J.E., Sale, G., Appelbaum, F.R., Chauncey, T.R., Storb, R.: Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis. Br. J. Haematol. 98: 1010-1016, 1998.
434. Deeg, H.J., Leisenring, W., Storb, R., Nims, J., Flowers, M.E.D., Witherspoon, R.P., Sanders, J., Sullivan, K.M.: Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 91: 3637-3645, 1998.
435. Glimm, H., Kiem, H.-P., Darovsky, B., Storb, R., Wolf, J., Diehl, V., Mertelsmann, R., von Kalle, C.: Efficient gene transfer in primitive CD34+/CD38lo human bone marrow cells reselected after long-term exposure to GALV-pseudotyped retroviral vector. Hum. Gene Ther. 8: 2079-2086, 1997.
436. Sandmaier, B.M., Storb, R., Bennett, K.L., Appelbaum, F.R., Santos, E.B.: Epitope specificity of CD44 for monoclonal antibody dependent facilitation of marrow engraftment in a canine model. Blood 91: 3494-3502, 1998.
437. McSweeney, P.A., Rouleau, K.A., Wallace, P.M., Bruno, B., Andrews, R.G., Krizanac-Bengez, L., Sandmaier, B.M., Storb, R., Wayner, E., Nash, R.A.: Characterization of monoclonal antibodies that recognize canine CD34. Blood 91: 1977-1986, 1998.
438. Yu, C., Seidel, K., Nash, R.A., Deeg, H.J., Sandmaier, B.M., Barsoukov, A., Santos, E., Storb, R.: Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts. Blood 91: 2581-2587, 1998.
439. Storb, R., Raff, R., Deeg, H.J., Graham, T., Appelbaum, F.R., Schuening, F.G., Shulman, H., Seidel, K., Leisenring, W.: Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts. Int. J. Radiat. Oncol. Biol. Phys. 40: 961-966, 1998.
440. Wagner, J.L., Storb, R.: Allogeneic transplantation for aplastic anemia. In: Hematopoietic Cell Transplantation, 2nd Edition, Thomas, E.D., Blume, K.G., and Forman, S.J. (eds.). Boston: Blackwell Science, Chapter 67: 791-806, 1999.
441. Storek, J., Gooley, T., Siadak, M., Bensinger, W.I., Maloney, D.G., Chauncey, T.R., Flowers, M., Sullivan, K.M., Witherspoon, R.P., Rowley, S.D., Hansen, J.A., Storb, R., Appelbaum, F.R.: Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 90: 4705-4709, 1997.
442. Martin, P., Nash, R., Sanders, J., Leisenring, W., Anasetti, C., Deeg, H.J., Storb, R., Appelbaum, F.: Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation. Bone Marrow Transplantation 21: 273-279, 1998.
443. Storb, R., Leisenring, W., Anasetti, C., Appelbaum, F.R., Deeg, H.J., Doney, K., Martin, P., Sullivan, K.M., Witherspoon, R., Pettinger, M., Bensinger, W., Buckner, C.D., Clift, R., Flowers, M.E.D., Hansen, J.A., Pepe, M., Chauncey, T., Sanders, J., Thomas, E.D.: Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine? Biol. Blood and Marrow Transplantation 3: 194-201, 1997.
444. Storb, R.: Aplastic anemia. Journal of Intravenous Nursing 20: 317-322, 1997.
445. Storb, R., Yu, C., Deeg, H.J., Georges, G., Kiem, H.-P., McSweeney, P.A., Nash, R.A., Sandmaier, B.M., Sullivan, K.M., Wagner, J.L., Walters, M.C.: Current and future preparative regimens for bone marrow transplantation in thalassemia. Ann. NY Acad. Sci. 885: 276-287, 1998.
446. Sullivan, K.M., Anasetti, C., Horowitz, M., Rowlings, P.A., Petersdorf, E.W., Martin, P.J., Clift, R.A., Walters, M.C., Gooley, T., Sierra, J., Anderson, J.E., Bjerke, J., Siadak, M., Flowers, M.E.D., Nash, R.A., Sanders, J.E., Appelbaum, F.R., Storb, R., Hansen, J.A.: Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia: a combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry. Ann. NY Acad. Sci. 885: 312-324, 1998.
447. Kiem, H.-P., Myerson, D., Storb, R., McDonald, G.B., Spurgeon, C.L., Leisenring, W.: Prevalence of hepatitis G virus in patients with aplastic anemia (Letter). Blood 90: 1335-1336, 1997.
448. Kiem, H.-P., Storb, R., McDonald, G.B.: Hepatitis-associated aplastic anemia (Response Letter). N. Engl. J. Med. 337: 424-425, 1997.
449. Sierra, J., Radich, J., Hansen, J.A., Martin, P.J., Petersdorf, E.W., Bjerke, J., Bryant, E., Nash, R.A., Sanders, J.E., Storb, R., Sullivan, K.M., Appelbaum, F.R., Anasetti, C.: Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 90: 1410-1414, 1997.
450. Yu, C., Seidel, K., Fitzsimmons, W.E., Sale, G., Storb, R.: Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation. Bone Marrow Transplantation 20: 137-141, 1997.
451. Storek, J., Mendelman, P.M., Witherspoon, R.P., McGregor, B.A., Storb, R.: IgG response to pneumococcal polysaccharide-protein conjugate appears similar to IgG response to polysaccharide in bone marrow transplant recipients and healthy adults. Clin. Infect. Dis. 25: 1253-1255, 1997.
452. Storb, R., Leisenring, W., Anasetti, C., Appelbaum, F.R., Buckner, C.D., Bensinger, W.I., Chauncey, T., Clift, R.A., Deeg, H.J., Doney, K.C., Flowers, M.E.D., Hansen, J.A., Martin, P.J., Sanders, J.E., Sullivan, K.M., Witherspoon, R.P.: Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin (Letter to the Editor). Blood 89: 3890-3891, 1997.
453. Storek, J., Witherspoon, R.P., Maloney, D.G., Chauncey, T.R., Storb, R.: Improved reconstitution of CD4 T cells and B cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow. Blood 89: 3891-3893, 1997.
454. Kiem, H.-P., Storb, R. Canine models for transplantation and gene therapy. In: Hematopoietic Stem Cell Transplantation, Ho, A.D., Haas, R., and Champlin, R.E. (eds.). New York: Marcel Dekker, Inc., Chapter 11: 171-194, 2000.
455. Graumann, M.B., DeRose, S.A., Ostrander, E.A., Storb, R.: Polymorphism analysis of four canine MHC class I genes. Tissue Antigens 51: 374-381, 1998.
456. Theobald, M., Storb, R.: Transplantation von knochenmark und peripheren stammzellen. In: Immunologie, Grundlagen-Klinik-Praxis, 4th Edition, Gemsa, D., Kalden, J.R., and Resch, K. (eds.). Stuttgart: Georg Thieme Verlag, Chapter 34: 661-674, 1997.
457. Sierra, J., Storer, B., Hansen, J.A., Bjerke, J.W., Martin, P.J., Petersdorf, E.W., Appelbaum, F.R., Bryant, E., Chauncey, T.R., Sale, G., Sanders, J.E., Storb, R., Sullivan, K.M., Anasetti, C.: Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching and marrow cell dose. Blood 89: 4226-4235, 1997.
458. Thurston, G.M., Hayden, D.L., Burrows, P., Clark, J.I., Taret, V.G., Kandel, J., Courogen, M., Peetermans, J.A., Bowen, M.S., Miller, D., Sullivan, K.M., Storb, R., Stern, H., Benedek, G.B.: Quasielastic light scattering study of the living human lens as a function of age. Curr. Eye Res. 16: 197-207, 1997.
459. Storb, R., Leisenring, W., Anasetti, C., Appelbaum, F.R., Buckner, C.D., Bensinger, W.I., Chauncey, T., Clift, R.A., Deeg, H.J., Doney, K.C., Flowers, M.E.D., Hansen, J.A., Martin, P.J., Sanders, J.E., Sullivan, K.M., Witherspoon, R.P.: Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin (Letter to the Editor). Blood 89: 3890-3891, 1997.
460. Schuening, F., Longo, W.L., Atkinson, M.E., Zaboikin, M., Kiem, H.P., Sanders, J., Scott, C.R., Storb, R., Miller, A.D., Reynolds, T., Bensinger, W., Rowley, S., Gooley, T., Darovsky, B., Appelbaum, F. Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with Gaucher’s disease. Hum. Gene Ther. 8: 2143-2160, 1997.
461. Curtis, R.E., Rowlings, P.A., Deeg, H.J., Shriner, D.A., Socié, G., Travis, L.B., Horowitz, M.M., Witherspoon, R.P., Hoover, R.N., Sobocinski, K.A., Fraumeni, J.F., Jr., Boice, J.D., Jr., Schoch, H.G., Sale, G.E., Storb, R., Travis, W.D., Kolb, H.-J., Gale, R.P., Passweg, J.R.: Solid cancers after bone marrow transplantation. N. Engl. J. Med. 336: 897-904, 1997.
462. Storb, R., Yu, C., Wagner, J.L., Deeg, H.J., Nash, R.A., Kiem, H.-P., Leisenring, W., Shulman, H.: Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89: 3048-3054, 1997.
463. Georges, G., Storb, R.: HLA-identical sibling hematopoietic stem cell transplantation for severe aplastic anemia. In: Clinical Bone Marrow and Blood Stem Cell Transplantation, Second Edition, Atkinson, K. (ed.). Cambridge, UK: Cambridge University Press, Chapter 40: 515-527, 2000.
464. Burnett, R.C., DeRose, S.A., Wagner, J.L., Storb, R.: Molecular analysis of six dog leukocyte antigen class I sequences including three complete genes, two truncated genes, and one full-length processed gene. Tissue Antigens 49: 484-495, 1997.
465. Deeg, H.J., Seidel, K., Hong, D.-S., Yu, C., Huss, R., Schuening, F.G., Ewel, C.H., Storb, R.: In vivo radioprotective effect of AcSDKP on canine myelopoiesis. Ann. Hematol. 74: 117-122, 1997.
466. Slattery, J.T., Clift, R.A., Buckner, C.D., Radich, J., Storer, B., Bensinger, W.I., Soll, E., Anasetti, C., Bowden, R., Bryant, E., Chauncey, T., Deeg, H.J., Doney, K.C., Flowers, M., Gooley, T., Hansen, J.A., Martin, P.J., McDonald, G.B., Nash, R., Petersdorf, E.W., Sanders, J.E., Schoch, G., Stewart, P., Storb, R., Sullivan, K.M., Thomas, E.D., Witherspoon, R.P., Appelbaum, F.R.: Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood 89: 3055-3060, 1997.
467. Sullivan, K.M., Walters, M.C., Patience, M., Leisenring, W., Buchanan, G.R., Castro, O., Davies, S.C., Dickerhoff, R., Eckman, J.R., Graham, M.L., Ohene-Frempong, K., Powars, D., Rogers, Z.R., Scott, J.P., Styles, L., Vichinsky, E., Wall, D.A., Wayne, A.S., Wiley, J., Wingard, J., Bunin, N., Camitta, B., Darbyshire, P.J., Dinndorf, P., Klingebiel, T., McMahon, L., Mentzer, W.C., Olivieri, N., Orringer, E., Parkman, R., Roberts, I.A.G., Sanders, J.E., Smith, F.O., and Storb, R.: Collaborative study of marrow transplantation for sickle cell disease: aspects specific for transplantation of hemoglobin disorders. Bone Marrow Transplantation 19(Suppl. 2):102-105, 1997.
468. Storek, J., Gooley, T., Witherspoon, R.P., Sullivan, K.M., Storb, R.: Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am. J. Hematol. 54: 131-138, 1997.
469. Storek, J., Witherspoon, R.P., Storb, R.: Reconstitution of membrane IgD- (mIgD-) B cells after marrow transplantation lags behind the reconstitution of mIgD+B cells (Letter to the Editor). Blood 89: 350-351, 1997.
470. Anderson, J.E., Gooley, T.A., Schoch, G., Anasetti, C., Bensinger, W.I., Clift, R.A., Hansen, J.A., Sanders, J.E., Storb, R., Appelbaum, F.R.: Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy. Blood 89: 2578-2585, 1997.
471. Demirer, T., Buckner, C.D., Storer, B., Lilleby, K., Rowley, S., Clift, R., Appelbaum, F.R., Storb, R., Bensinger, W.I.: Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor. J. Clin. Oncol. 15: 684-690, 1997.
472. Schuening, F., Miller, A.D., Torok-Storb, B., Bensinger, W., Storb, R., Reynolds, T., Fisher, L., Buckner, C.D., Appelbaum, F.R.: Study on contribution of genetically marked peripheral blood repopulating cells to hematopoietic reconstitution after transplantation. Human Gene Therapy 5: 1523-1534, 1994.
473. Bensinger, W.I., Demirer, T., Buckner, C.D., Appelbaum, F.R., Storb, R., Lilleby, K., Weiden, P., Bluming, A.Z., Fefer, A.: Syngeneic marrow transplantation in patients with multiple myeloma. Bone Marrow Transplantation 18: 527-531, 1996.
474. Schuening, F.G., Graham, T.C., Hackman, R., Deeg, H.J., Storb, R.: DLA-nonidentical unrelated marrow grafts after high-dose total body irradiation: Granulocyte colony-stimulating factor treatment after transplant does not enhance engraftment (letter to editor). Blood 88: 1900-1901, 1996.
475. Bensinger, W.I., Buckner, C.D., Shannon-Dorcy, K., Rowley, S., Appelbaum, F.R., Benyunes, M., Clift, R., Martin, P., Demirer, T., Storb, R., Lee, M., Schiller, G.: Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 88: 4132-4138, 1996.
476. Walters, M.C., Patience, M., Leisenring, W., Eckman, J.R., Buchanan, G.R., Rogers, Z.R., Olivieri, N.F., Vichinsky, E., Davies, S.C., Mentzer, W.C., Powars, D., Scott, J.P., Bernaudin, F., Ohene-Frempong, K., Darbyshire, P.J., Wayne, A., Roberts, I.A.G., Dinndorf, P., Brandalise, S., Sanders, J.E., Matthews, D.C., Appelbaum, F.R., Storb, R., Sullivan, K.M.: Barriers to bone marrow transplantation for sickle cell anemia. Biol. Blood and Marrow Transplantation 2: 100-104, 1996.
477. Walters, M.C., Patience, M., Leisenring, W., Eckman, J.R., Scott, J.P., Mentzer, W.C., Davies, S.C., Ohene-Frempong, K., Bernaudin, F., Matthews, D.C., Storb, R., Sullivan, K.M.: Bone marrow transplantation for sickle cell disease. N. Engl. J. Med. 335: 369-376, 1996.
478. Bensinger, W.I., Clift, R., Martin, P., Appelbaum, F.R., Demirer, T., Gooley, T., Lilleby, K., Rowley, S., Sanders, J., Storb, R., Buckner, C.D.: Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation. Blood 88: 2794-2800, 1996.
479. Wagner, J.L., Burnett, R.C., Works, J.D., Storb, R.: Molecular analysis of DLA-DRBB1 polymorphism. Tissue Antigens 48: 554-561, 1996.
480. Wagner, J.L., Burnett, R.C., Storb, R.: Molecular analysis of the DLA DR region. Tissue Antigens 48: 549-553, 1996.
481. Georges, G.E., Sandmaier, B.M., Storb, R.: Animal models. In: Blood Stem Cell Transplantation, Reiffers, J., Goldman, J. and Armitage, J. (eds.). London: Martin Dunitz Publishers, 1-17, 1998.
482. Doney, K., Leisenring, W., Storb, R., Appelbaum, F.R., for the Seattle Bone Marrow Transplant Team: Primary treatment of acquired aplastic anemia: Outcomes with bone marrow transplantation and immunosuppressive therapy. Ann. Intern. Med. 126: 107-115, 1997.
483. Wagner, J.L., Burnett, R.C., DeRose, S.A., Storb, R.: Molecular analysis and polymorphism of the DLA-DQA gene. Tissue Antigens 48: 199-204, 1996.
484. Wagner, J.L., Storb, R.: Preclinical large animal models for hematopoietic stem cell transplantation. Curr. Opin. Hematol. 3: 410-415, 1996.
485. Nash, R.A., Storb, R.: Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL. Current Opinion in Immunology, Alt, F. and Marrack, P. (eds.): Current Biology Ltd. London, 674-680, 1996.
486. McSweeney, P.A., Rouleau, K.A., Storb, R., Bolles, L., Wallace, P.M., Beauchamp, M., Krizanac-Bengez, L., Moore, P., Sale, G., Sandmaier, B., de Revel, T., Appelbaum, F.R., Nash, R.A.: Canine CD34: Cloning of the cDNA and evaluation of an antiserum to recombinant protein. Blood 88: 1992-2003, 1996.
487. Kiem, H.-P., Leisenring, W., Raff, R., Deeg, H.J., Schuening, F.G., Appelbaum, F.R., Storb, R.: Failure of recombinant stem cell factor to enhance engraftment of L-leucyl-L-leucine methyl ester treated canine marrow after irradiation (Letter to Editor). Blood 88: 1896-1897, 1996.
488. Storek, J., Witherspoon, R.P., Webb, D., Storb, R.: Lack of B cell precursors in marrow transplant recipients with chronic graft-versus-host disease. Am. J. Hematol. 52: 82-89, 1996.
489. Nash, R.A., Pineiro, L.A., Storb, R., Deeg, H.J., Fitzsimmons, W.E., Furlong, T., Hansen, J.A., Gooley, T., Maher, R.M., Martin, P., McSweeney, P.A., Sullivan, K.M., Anasetti, C., Fay, J.W.: FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. Blood 88: 3634-3641, 1996.
490. McSweeney, P.A., Storb, R.: Hematopoietic stem cell transplantation. In: Encyclopedia of Immunology, Second Edition, Delves, P.J. and Roitt, I.M. (eds.). London: Academic Press Ltd, 1062-1070, 1998.
491. Brunvand, M.W., Bensinger, W.I., Soll, E., Weaver, C.H., Rowley, S.D., Appelbaum, F.R., Lilleby, K., Clift, R.A., Gooley, T.A., Press, O.W., Fefer, A., Storb, R., Sanders, J.E., Martin, P.L., Chauncey, T., Maziarz, R.T., Zuckerman, N., Montgomery, P., Dorn, R., Weiden, P.L., Demirer, T., Holmberg, L.A., Schiffman, K., McSweeney, P.A., Maloney, D.G., Buckner, C.D.: High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells. Bone Marrow Transplantation 18: 131-141, 1996.
492. Huss, R., Deeg, H.J., Gooley, T., Bryant, E., Leisenring, W., Clift, R., Buckner, C.D., Martin, P., Storb, R., Appelbaum, F.R.: Effect of mixed chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Bone Marrow Transplantation 18: 767-776, 1996.
493. Bensinger, W.I., Appelbaum, F.R., Demirer, T., Torok-Storb, B., Storb, R., Buckner, C.D.: Transplantation of Allogeneic Peripheral Blood Stem Cells. Stem Cells 13: 63-70, 1995.
494. Wagner, J.L., Burnett, R.C., DeRose, S.A., Francisco, L.V., Storb, R., Ostrander, E.A.: Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation 62: 876-877, 1996.
495. Sandmaier, B.M., Storb, R., Liu, Y., Santos, E.B., Bryant, E., Schuening, F.G., Deeg, H.J., Seidel, K., Graham, T.: An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiation. Transplant Immunology 4: 271-274, 1996.
496. Nelson, J.L., Torrez, R., Louie, F.M., Choe, O.S., Storb, R., Sullivan, K.M.: Pre-existing autoimmune disease in patients with longterm survival after allogeneic bone marrow transplantation. J. Rheumatol. 24: 23-29, 1997.
497. Deeg, H.J., Seidel, K., Yu, C., Nash, R., Huss, R., Schuening, F., Storb, R.: Delay of radiation-induced decline and recovery of hematopoiesis following treatment with anti-HLA-DR antibody. Biol. Blood and Marrow Transplantation 2: 105-111, 1996.
498. Martin, P.J., Nelson, B.J., Appelbaum, F.R., Anasetti, C., Deeg, H.J., Hansen, J.A., McDonald, G.B., Nash, R.A., Sullivan, K.M., Witherspoon, R.P., Scannon, P.J., Friedmann, N., Storb, R.: Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 88: 824-830, 1996.
499. Kiem, H.-P., McDonald, G.B., Myerson, D., Spurgeon, C.L., Deeg, H.J., Sanders, J.E., Doney, K., Appelbaum, F.R., Sullivan, K.M., Witherspoon, R.P., Storb, R.: Marrow transplantation for hepatitis-associated aplastic anemia: A follow-up of long-term survivors. Biol. Blood and Marrow Transplantation 2: 93-99, 1996.
500. Demirer, T., Buckner, C.D., Gooley, T., Appelbaum, F.R., Rowley, S., Chauncey, T., Lilleby, K., Storb, R., Bensinger, W.I.: Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplantation 17: 937-941, 1996.
501. Bensinger, W.I., Rowley, S.D., Demirer, T., Lilleby, K., Schiffman, K., Clift, R.A., Appelbaum, F.R., Fefer, A., Barnett, T., Storb, R., Chauncey, T., Maziarz, R.T., Klarnet, J., McSweeney, P., Holmberg, L., Maloney, D.G., Weaver, C.H., Buckner, C.D.: High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma. J. Clin. Oncol. 14: 1447-1456, 1996.
502. Clift, R.A., Storb, R.: Marrow transplantation for CML: the Seattle experience. Bone Marrow Transplantation 17: S1-S3, 1996.
503. Demirer, T., Petersen, F.B., Bensinger, W.I., Appelbaum, F.R., Fefer, A., Rowley, S., Sanders, J., Chauncey, T., Storb, R., Lilleby, K., Buckner, C.D.: Autologous transplantation with peripheral blood stem cells collected after granulocyte-colony stimulating factor in patients with acute myelogenous leukemia. Bone Marrow Transplantation 18: 29-34, 1996.
504. Huss, R., Hong, D.-S., Beckham, C., Storb, R., Broudy, V.C., Deeg, H.J.: Neutralization of stem cell factor in vitro and in vivo: dose-dependent inhibition of stromal cells and induction of granulocyte/monocyte differentiation. Ann. Hematol. 72: 253-259, 1996.
505. Anderson, J.E., Anasetti, C., Appelbaum, F.R., Schoch, G., Gooley, T.A., Hansen, J.A., Buckner, C.D., Sanders, J.E., Sullivan, K.M., Storb, R.: Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia. Br. J. Haematol. 93: 59-67, 1996.
506. Nash, R.A., McSweeney, P.A., Storb, R., Nelson, J.L., Gauthier, J., Furst, D.E., Sullivan, K.M.: Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease. J. Rheumatol. 24: 72-78, 1997.
507. McSweeney, P.A., Nash, R.A., Storb, R., Furst, D.E., Gauthier, J., Sullivan, K.M.: Autologous stem cell transplantation for autoimmune diseases: issues in protocol development. J. Rheumatol. 24: 79-84, 1997.
508. Storb, R.: Hematopoietic stem cell transplantation in nonmalignant diseases. J. Rheumatol. 24: 30-35, 1997.
509. Storb, R.: Preparative regimens for patients with leukemias and severe aplastic anemia – Biological basis, experimental animal studies and clinical trials at the Fred Hutchinson Cancer Research Center. Radiation Research: 1895-1995, Congress Proceedings, Hagen, U., Harder, D., Jung, H., and Streffer, C. (eds.): 10th ICRR Society, Würzburg, Germany, 948-952, 1995.
510. Langston, A.A., Sanders, J.E., Deeg, H.J., Crawford, S.W., Anasetti, C., Sullivan, K.M., Flowers, M.E.D., Storb, R.: Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita. Br. J. Haematol. 92: 758-765, 1996.
511. Sandmaier, B.M., Storb, R., Santos, E.B., Krizanac-Bengez, L., Lian, T., McSweeney, P.A., Yu, C., Schuening, F.G., Deeg, H.J., Graham, T.: Allogeneic transplants of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors. Blood 87: 3508-3513, 1996.
512. Schiffman, K.S., Bensinger, W.I., Appelbaum, F.R., Rowley, S., Lilleby, K., Clift, R.A., Weaver, C.H., Demirer, T., Sanders, J.E., Petersdorf, S., Gooley, T., Weiden, P., Zuckerman, N., Montgomery, P., Maziarz, R., Klarnet, J.P., Rivkin, S., Trueblood, K., Storb, R., Holmberg, L., Buckner, C.D.: Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease. Bone Marrow Transplantation 17: 943-950, 1996.
513. Sanders, J.E., Hawley, J., Levy, W., Gooley, T., Buckner, C.D., Deeg, H.J., Doney, K., Storb, R., Sullivan, K., Witherspoon, R., Appelbaum, F.R.: Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87: 3045-3052, 1996.
514. Demirer, T., Buckner, C.D., Appelbaum, F.R., Bensinger, W.I., Sanders, J., Lambert, K., Clift, R., Fefer, A., Storb, R., Slattery, J.T.: Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels. Bone Marrow Transplantation 17: 491-495, 1996.
515. Bensinger, W.I., Buckner, C.D., Anasetti, C., Clift, R., Storb, R., Barnett, T., Chauncey, T., Shulman, H., Appelbaum, F.R.: Allogeneic marrow transplantation for multiple myeloma: An analysis of risk factors on outcome. Blood 88: 2787-2793, 1996.
516. Yu, C., Storb, R., Deeg, H.J., Graham, T.C., Schuening, F.G., Huss, R., Seidel, K., Fitzsimmons, W.E.: Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation. Bone Marrow Transplantation 17: 649-653, 1996.
517. Schuening, F.G., von Kalle, C., Kiem, H.-P., Appelbaum, F.R., Deeg, H.J., Pepe, M., Gooley, T., Graham, T.C., Hackman, R., Storb, R.: Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs. Exp. Hematol. 25: 1240-1245, 1997.
518. Deeg, H.J., Pierpaoli, W., Arrighi, S., Seidel, K., Graham, T., Huss, R., Yu, C., Myerson, D., Schuening, F., Storb, R.: Facilitation of DLA-incompatible marrow grafts by donor-specific serum transferrin? Transplant Immunology 4: 113-116, 1996.
519. Thurston, G.M., Hayden, D.L., Burrows, P., Clark, J.I., Taret, V.G., Kandel, J., Courogen, M., Peetermans, J.A., Bowen, M.S., Miller, D., Sullivan, K.M., Storb, R., Stern, H., Benedek, G.B.: Quasielastic light scattering from the aging human lens in vivo. Vision Science and its Applications, 1995 Technical Digest Series. Optical Society of America and American Academy of Optometry (eds.): The Society, Washington, 57-60, 1995.
520. Demirer, T., Buckner, C.D., Appelbaum, F.R., Clift, R., Storb, R., Myerson, D., Lilleby, K., Rowley, S., Bensinger, W.I.: High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer. Bone Marrow Transplantation 17: 769-774, 1996.
521. Doney, K., Storb, R., Lilleby, K., Appelbaum, F.R.: Recombinant interleukin-1 followed by immunosuppressive therapy for aplastic anemia (Letter). Am. J. Hematol. 52: 61-62, 1996.
522. Demirer, T., Buckner, C.D., Appelbaum, F.R., Lambert, K., Bensinger, W.I., Clift, R., Storb, R., Slattery, J.T.: Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels. Bone Marrow Transplantation 17: 341-346, 1996.
523. Schuening, F.G., Von.Kalle, C., Kiem, H.-P., To, R.Y., Goehle, S., Darovsky, B., Storb, R.: Gene transfer into canine and human hematopoietic cells. Biology of Hematopoiesis and Stem Cell Gene Transfer, Stamatoyannopoulos, G. (ed.): Intercept, Andover, Hants, U.K. 17:247-260, 1995.
524. Sullivan, K.M., Walters, M.C., Bernaudin, F., Souillet, G., Camitta, B., Davies, S., Eckman, J., Mentzer, W., Powars, D., Vichinsky, E., Wonke, B., Dickerhoff, R., Kurtzberg, J., Ohene-Frempong, K., Orringer, J., Parkman, R., Patience, M., Scott, P., Storb, R., and the Collaborative Sickle Cell Marrow Transplant Group.: Collaborative study of marrow transplantation for symptomatic sickle cell anemia. Sickle Cell Disease and Thalassaemias: New Trends in Therapy, Beuzard, Y., Lubin, B., and Rosa, J. (eds.): John Libbey Eurotext Ldt. 571, 1995.
525. Lynch, M.H.E., Petersen, F.B., Appelbaum, F.R., Bensinger, W.I., Clift, R.A., Storb, R., Sanders, J.E., Hansen, J.A., Buckner, C.D.: Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies. Bone Marrow Transplantation 15: 59-64, 1995.
526. Anderson, J.E., Appelbaum, F.R., Schoch, G., Gooley, T., Anasetti, C., Bensinger, W.I., Bryant, E., Buckner, C.D., Chauncey, T.R., Clift, R.A., Doney, K., Flowers, M., Hansen, J.A., Martin, P.J., Matthews, D.C., Sanders, J.E., Shulman, H., Sullivan, K.M., Witherspoon, R.P., Storb, R.: Allogeneic marrow transplantation for refractory anemia: A comparison of two preparative regimens and analysis of prognostic factors. Blood 87: 51-58, 1996.
527. Anderson, J.E., Appelbaum, F.R., Schoch, G., Gooley, T., Anasetti, C., Bensinger, W.I., Bryant, E., Buckner, C.D., Chauncey, T., Clift, R.A., Deeg, H.J., Doney, K., Flowers, M., Hansen, J.A., Martin, P.J., Matthews, D.C., Nash, R.A., Sanders, J.E., Shulman, H., Sullivan, K.M., Witherspoon, R.P., Storb, R.: Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: A phase II study of busulfan, cyclophosphamide and total-body irradiation and analysis of prognostic factors. J. Clin. Oncol. 14: 220-226, 1996.
528. Soll, E., Massumoto, C., Clift, R.A., Buckner, C.D., Appelbaum, F.R., Storb, R., Sale, G., Hackman, R., Martin, P.: Relevance of marrow fibrosis in bone marrow transplantation: A retrospective analysis of engraftment. Blood 86: 4667-4673, 1995.
529. Sullivan, K.M., Storek, J., Kopecky, K.J., Jocom, J., Longton, G., Flowers, M., Siadak, M., Nims, J., Witherspoon, R.P., Anasetti, C., Appelbaum, F.R., Bowden, R.A., Buckner, C.D., Crawford, S.W., Deeg, H.J., Hansen, J.A., McDonald, G.B., Sanders, J.E., Storb, R.: A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: Clinical outcome and effect on subsequent immune recovery. Biol. Blood and Marrow Transplantation 2: 44-53, 1996.
530. Wagner, L.A., Kiem, H.-P., McSweeney, P., Schuening, F.G., Storb, R., Ostrander, E.A.: Development of a clonality assay for canine hematopoietic stem cells. Blood 86: 3265-3267, 1995.
531. Bean, M.A., Graham, T., Appelbaum, F.R., Deeg, H.J., Schuening, F., Sale, G.E., Leisenring, W., Pepe, M., Storb, R.: Gamma radiation of blood products prevents rejection of subsequent DLA-identical marrow grafts: Tolerance vs. abrogation of sensitization to non-DLA antigens. Transplantation 61: 334-335, 1996.
532. Kiem, H.-P., Darovsky, B., von Kalle, C., Goehle, S., Graham, T., Miller, A.D., Storb, R., Schuening, F.G.: Long-term persistence of canine hematopoietic cells genetically marked by retrovirus vectors. Human Gene Therapy 7: 89-96, 1996.
533. Balduzzi, A., Gooley, T., Anasetti, C., Sanders, J.E., Martin, P.J., Petersdorf, E.W., Appelbaum, F.R., Buckner, C.D., Matthews, D., Storb, R., Sullivan, K.M., Hansen, J.A.: Unrelated donor marrow transplantation in children. Blood 86: 3247-3256, 1995.
534. Deeg, H.J., Socié, G., Schoch, G., Henry-Amar, M., Witherspoon, R.P., Devergie, A., Sullivan, K.M., Gluckman, E., Storb, R.: Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients. Blood 87: 386-392, 1996.
535. Flowers, M.E.D., Zanis, J., Pasquini, R., Deeg, H.J., Ribeiro, R., Longton, G., Medeiros, C.R., Doney, K., Sanders, J., Bryant, E., Hansen, J., Sullivan, K.M., Appelbaum, F., Thomas, E.D., Storb, R.: Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation. Br. J. Haematol. 92: 699-706, 1996.
536. Yu, C., Storb, R., Mathey, B., Deeg, H.J., Schuening, F.G., Graham, T.C., Seidel, K., Burnett, R., Wagner, J.L., Shulman, H., Sandmaier, B.M.: DLA-identical bone marrow grafts after low-dose total body irradiation: Effects of high-dose corticosteroids and cyclosporine on engraftment. Blood 86: 4376-4381, 1995.
537. Nash, R.A., Storb, R.: Transplantation of hematopoietic stem cells (Review). Proc. Assoc. Am. Phys. 107: 288-295, 1995.
538. Wagner, J.L., Deeg, H.J., Seidel, K., Anasetti, C., Doney, K., Sanders, J., Sullivan, K.M., Storb, R.: Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives: An update of the Seattle experience. Transplantation 61: 54-61, 1996.
539. McSweeney, P., Storb, R.: Bone marrow transplantation for hematologic malignancies and cancer. Immunology and Allergy Clinics of North America. Organ and Bone Marrow Transplantation, Shearer, W.T. and Fleisher, T.A. (eds.): W.B. Saunders Co. Philadelphia, 393-427, 1996.
540. Storek, J., Witherspoon, R.P., Storb, R.: T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplantation 16: 413-425, 1995.
541. Burnett, R.C., Francisco, L.V., DeRose, S.A., Storb, R., Ostrander, E.A.: Identification and characterization of a highly polymorphic microsatellite marker within the canine MHC class I region. Mammalian Genome 6: 684-685, 1995.
542. Bensinger, W.I., Clift, R.A., Anasetti, C., Appelbaum, F.R., Demirer, T., Rowley, S., Sandmaier, B.M., Torok-Storb, B., Storb, R., Buckner, C.D.: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Stem Cells 14: 90-105, 1996.
543. Bensinger, W., Appelbaum, F., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffman, K., Weaver, C., Clift, R., Chauncey, T., Klarnet, J., Montgomery, P., Petersdorf, S., Weiden, P., Witherspoon, R., Buckner, C.D.: Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J. Clin. Oncol. 13: 2547-2555, 1995.
544. Mathey, B., Yu, C., Sandmaier, B.M., Deeg, H.J., Graham, T., Schuening, F.G., Nash, R.A., Storb, R.: Failure of interleukin-1 and granulocyte-macrophage colony-stimulating factor to enhance allogeneic marrow engraftment and survival in irradiated dogs (letter). Blood 86: 833-834, 1995.
545. Storb, R., Deeg, H.J., Raff, R., Schuening, F., Yu, C., Sandmaier, B.M., Graham, T. Prevention of graft-versus-host disease: Studies in a canine model (Review). Ann. NY Acad. Sci. 770: 149-164, 1995.
546. Barquinero, J., Witherspoon, R., Sanders, J., Horowitz, M.M., Montuoro, A., Patton, D.F., Bacigalupo, A., Abecasis, M.M., Miale, T., Rozman, C., Bryant, E., Storb, R.: Allogeneic marrow grafts from donors with congenital chromosomal abnormalities in marrow cells. Br. J. Haematol. 90: 595-601, 1995.
547. Nash, R.A., Burstein, S.A., Storb, R., Yang, W., Abrams, K., Appelbaum, F.R., Boone, T., Deeg, H.J., Durack, L.D., Schuening, F.G., McDonough, S., Moore, P., Nelp, W.B., Slichter, S.: Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: Increased destruction of circulating platelets. Blood 86: 1765-1775, 1995.
548. Langenmayer, I., Weaver, C., Buckner, C.D., Lilleby, K., Appelbaum, F.R., Longin, K., Rowley, S., Storb, R., Singer, J., Bensinger, W.I.: Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both. Bone Marrow Transplantation 15: 241-246, 1995.
549. Deeg, H.J., Doney, K., Anasetti, C., Storb, R.: Transplant and nontransplant therapy for patients with severe aplastic anemia: an update of the Seattle experience. Ontogeny of hematopoiesis Aplastic anemia, Gluckman, E. and Coulombel, L. (eds.): John Libbey Eurotext, Montrouge, France, 307-312, 1995.
550. Demirer, T., Rowley, S., Buckner, C.D., Appelbaum, F.R., Lilleby, K., Storb, R., Schiffman, K., Bensinger, W.I.: Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer. J. Clin. Oncol. 13: 1714-1719, 1995.
551. Yu, C., Storb, R., Braude, I., Deeg, H.J., Schuening, F.G., Huss, R., Graham, T.C.: Corticotropin releasing factor with or without methotrexate for prevention of graft-versus-host disease in DLA-nonidentical unrelated canine marrow grafts. Transplantation 60: 384-404, 1995.
552. Storek, J., Witherspoon, R.P., Luthy, D., Storb, R.: Low IgG production by mononuclear cells from marrow transplant survivors and from normal neonates is due to a defect of B cells. Bone Marrow Transplantation 15: 679-684, 1995.
553. Demirer, T., Gooley, T., Buckner, C.D., Petersen, F.B., Lilleby, K., Rowley, S., Sanders, J., Storb, R., Appelbaum, F.R., Bensinger, W.I.: Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation. Bone Marrow Transplantation 15: 907-913, 1995.
554. Demirer, T., Petersen, F.B., Appelbaum, F.R., Barnett, T.A., Sanders, J., Deeg, H.J., Storb, R., Doney, K., Bensinger, W.I., Shannon-Dorcy, K., Buckner, C.D.: Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: A phase I/II trial. Int. J. Radiat. Oncol. Biol. Phys. 32: 1103-1109, 1995.
555. Demirer, T., Weaver, C.H., Buckner, C.D., Petersen, F.B., Bensinger, W.I., Sanders, J., Clift, R.A., Lilleby, K., Anasetti, C., Martin, P., Storb, R., Chauncey, T., Doney, K., Sullivan, K., Appelbaum, F.R.: High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy. J. Clin. Oncol. 13: 596-602, 1995.
556. Doney, K.C., Storb, R., Beach, K., Anasetti, C., Deeg, H.J., Hansen, J.A., Martin, P.J., Nash, R.A., Schubert, M.M., Sullivan, K.M., Witherspoon, R.P., Appelbaum, F.R.: A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants. Transplantation 60: 55-58, 1995.
557. Nash, R.A., Etzioni, R., Storb, R., Furlong, T., Gooley, T., Anasetti, C., Appelbaum, F.R., Doney, K., Martin, P., Slattery, J., Sullivan, K., Van Der Jagt, R., Witherspoon, R., Jusko, W.J., Zager, R.A., Deeg, H.J.: Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: A single-center study. Blood 85: 3746-3753, 1995.
558. Demirer, T., Buckner, C.D., Appelbaum, F.R., Petersen, F.B., Rowley, S., Weaver, C.H., Lilleby, K., Sanders, J., Chauncey, T., Storb, R., Schiffman, K., Benyunes, M.C., Fefer, A., Montgomery, P., Bensinger, W.I.: Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte-colony stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Bone Marrow Transplantation 15: 915-922, 1995.
559. Kiem, H.-P., Barquinero, J., von Kalle, C., Darovsky, B., Goehle, S., Storb, R., Schuening, F.G.: Influence of different conditioning regimens on engraftment of genetically marked hematopoietic stem cells. Autologous Marrow and Blood Transplantation – Proceedings of the Seventh International Symposium, Dicke, K.A. and Keating, A. (eds.): The Cancer Treatment Research and Educational Institute, Arlington, Texas, 261-269, 1995.
560. Ehninger, G., Schuler, U., Renner, U., Ehrsam, M., Zeller, K.P., Blanz, J., Storb, R., Deeg, H.J.: Use of a water-soluble busulfan formulation – Pharmacokinetic studies in a canine model. Blood 85: 3247-3249, 1995.
561. Storb, R.: Prevention of graft-versus-host disease after marrow transplantation. Transplant. Proc. 27: 2653-2656, 1995.
562. Storb, R.: Bone marrow transplantation. Transplant. Proc. 27: 2649-2652, 1995.
563. Mathey, B., Storb, R.: Allogeneic bone marrow transplantation: Current problems and possible solutions. Principles of Transfusion Medicine, 2nd: Ross, E.C., Simon, T.L., Moss, G.S., and Gould, S.A. (eds.): Williams and Wilkins, Baltimore, 45:493-508, 1995.
564. Storb, R., Thomas, E.D.: Transplantation of bone marrow. Samter’s Immunologic Diseases, Fifth edition, Frank, M.M., Austen, K.F., Claman, H.N., and Unanue, E.R. (eds.): Little, Brown and Company, Boston, 1471-1493, 1995.
565. Bensinger, W.I., Weaver, C.H., Appelbaum, F.R., Rowley, S., Demirer, T., Sanders, J., Storb, R., Buckner, C.D.: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85: 1655-1658, 1995.
566. Mathey, B., Storb, R.: Allogeneic bone marrow transplantation: General principles and current practice. Principles of Transfusion Medicine, 2nd: Ross, E.C., Simon, T.L., Moss, G.S., and Gould, S.A. (eds.): Williams and Wilkins, Baltimore, 44:475-491, 1995.
567. Weaver, C.H., Petersen, F.B., Appelbaum, F.R., Bensinger, W.I., Press, O., Martin, P., Sandmaier, B., Deeg, H.J., Hansen, J.A., Brunvand, M., Rowley, S., Benyunes, K., Chauncey, T., Fefer, A., Hackman, R., Gooley, T., Schiffman, K., Storb, R., Sullivan, K.M., Weiden, P., Witherspoon, R., Buckner, C.D.: High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma. J. Clin. Oncol. 12: 2559-2566, 1994.
568. Kiem, H.-P., von Kalle, C., Schuening, F., Storb, R.: Gene therapy and bone marrow transplantation. Current Opinion In Oncology 7: 107-114, 1995.
569. Storb, R., Raff, R.F., Deeg, H.J., Graham, T.C., Schuening, F.G., Shulman, H., Bryant, E.: DLA-identical marrow grafts after low-dose total-body irradiation: Addition of viable donor peripheral blood mononuclear cells does not enhance engraftment. Transplantation 59: 1481-1503, 1995.
570. Barquinero, J., Kiem, H.-P., von Kalle, C., Darovsky, B., Goehle, S., Graham, T., Seidel, K., Storb, R., Schuening, F.G.: Myelosuppressive conditioning improves autologous engraftment of genetically marked hematopoietic repopulating cells in dogs. Blood 85: 1195-1201, 1995.
571. Wagner, J.L., DeRose, S.A., Burnett, R.C., Storb, R.: Brief Communication: Nucleotide sequence and polymorphism analysis of canine DRA cDNA clones. Tissue Antigens 45: 284-287, 1995.
572. Walters, M.C., Sullivan, K.M., Bernaudin, F., Souillet, G., Vannier, J.-P., Johnson, F.L., Lenarsky, C., Powars, D., Bunin, N., Ohene-Frempong, K., Wall, D., Michel, G., Plouvier, E., Bodigoni, P., Lutz, P., Sanders, J.E., Matthews, D.C., Patience, M., Appelbaum, F.R., Storb, R.: Rapid Communication: Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood 85: 879-884, 1995.
573. Matthews, D.C., Appelbaum, F.R., Eary, J.F., Fisher, D.R., Durack, L.D., Bush, S.A., Hui, E., Martin, P.J., Mitchell, D., Press, O.W., Badger, C.C., Storb, R., Nelp, W.B., Bernstein, I.D.: Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation. Blood 85: 1122-1131, 1995.
574. Fay, J.W., Nash, R.A., Winegard, J., Prezepiorka, D., Collins, R.H., Anasetti, C., Devine, S., Piñeiro, L.A., Storb, R.F., Aro, R.M., Fitzsimmons, W.E.: FK506-based immunosuppression for prevention of graft-versus-host disease (GVHD) after unrelated marrow donor (UMD) transplantation. Transplant. Proc. 27: 1374, 1995.
575. Kalhs, P., Schwarzinger, I., Anderson, G., Mori, M., Clift, R.A., Storb, R., Buckner, C.D., Appelbaum, F.R., Hansen, J.A., Sullivan, K.M.: A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia. Blood 86: 2028-2032, 1995.
576. Stockschläder, M.A.R., Schuening, F.G., Graham, T.C., Storb, R.: Transplantation of retrovirus-transduced canine keratinocytes expressing the b-galactosidase gene. Gene Therapy 1: 317-322, 1994.
577. Clift, R.A., Buckner, C.D., Thomas, E.D., Bryant, E., Anasetti, C., Bensinger, W.I., Bowden, R., Deeg, H.J., Doney, K.C., Fisher, L.D., Hansen, J.A., Martin, P., McDonald, G.B., Sanders, J.E., Schoch, G., Singer, J., Storb, R., Sullivan, K.M., Witherspoon, R.P., Appelbaum, F.R.: Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia. Blood 84: 4368-4373, 1994.
578. Bensinger, W.I., Longin, K., Appelbaum, F., Rowley, S., Weaver, C., Lilleby, K., Gooley, T., Lynch, M., Higano, T., Klarnet, J., Chauncey, T., Storb, R., Buckner, C.D.: Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br. J. Haematol. 87: 825-831, 1994.
579. von Kalle, C., Kiem, H.-P., Goehle, S., Darovsky, B., Heimfeld, S., Torok-Storb, B., Storb, R., Schuening, F.G.: Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector. Blood 84: 2890-2897, 1994.
580. Jakic-Razumovic, J., Sale, G.E., Beauchamp, M.D., Storb, R., Sandmaier, B.M.: CD8+ activated T lymphocytes produce an in vitro skin graft-versus-host reaction in an organotypic skin culture model. Transplantation 59: 69-78, 1995.
581. Kalhs, P., White, J.S., Gervassi, A., Storb, R., Bean, M.A.: In vitro recall of proliferative and cytolytic responses to minor histocompatibility antigens by dendritic cell enriched canine peripheral blood mononuclear cells. Transplantation 59: 112-118, 1995.
582. Huss, R., Beckham, C., Storb, R., Deeg, H.J.: Major histocompatibility complex class II expression is required for posttransplant immunological but not for hemopoietic reconstitution in mice. Transplantation 58: 1366-1371, 1994.
583. Nash, R.A., Seidel, K., Storb, R., Slichter, S., Schuening, F.G., Appelbaum, F.R., Becker, A.B., Bolles, L., Deeg, H.J., Graham, T., Hackman, R., Burstein, S.A.: Effects of rhIL-11 on normal dogs and after sublethal radiation. Exp. Hematol. 23: 389-396, 1995.
584. Hong, D.-S., Huss, R., Beckham, C., Hoy, C.A., Storb, R., Deeg, H.J.: Major histocompatibility complex class II-mediated inhibition of hemopoiesis in vitro and in vivo is abrogated by C-kit ligand. Transplant. Proc. 27: 642-643, 1995.
585. Storb, R., Raff, R.F., Appelbaum, F.R., Deeg, H.J., Graham, T.C., Schuening, F.G., Shulman, H., Yu, C., Bryant, E., Burnett, R., Seidel, K.: DLA-identical bone marrow grafts after low-dose total body irradiation: The effect of canine recombinant hematopoietic growth factors. Blood 84: 3558-3566, 1994.
586. Sale, G.E., Raff, R.F., Storb, R.: Stem cell regions in filiform papillae of tongue as targets of graft-versus-host disease. Transplantation 58: 1273-1287, 1994.
587. Deeg, H.J., Storb, R.: Canine marrow transplantation models. Current Topics in Vet. Res. 1: 103-114, 1994.
588. Benyunes, M.C., Sullivan, K.M., Deeg, H.J., Mori, M., Meyer, W., Fisher, L., Bensinger, R., Jack, M.K., Hicks, J., Witherspoon, R., Buckner, C.D., Hansen, J.A., Appelbaum, F.R., Storb, R.: Cataracts after bone marrow transplantation: Long-term follow-up of adults treated with fractionated total body irradiation. Int. J. Radiat. Oncol. Biol. Phys. 32: 661-670, 1995.
589. Clift, R.A., Buckner, C.D., Thomas, E.D., Bensinger, W.I., Bowden, R., Bryant, E., Deeg, H.J., Doney, K.C., Fisher, L.D., Hansen, J.A., Martin, P., McDonald, G.B., Sanders, J.E., Schoch, G., Singer, J., Storb, R., Sullivan, K.M., Witherspoon, R.P., Appelbaum, F.R.: Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 84: 2036-2043, 1994.
590. Sayer, H.G., Longton, G., Bowden, R., Pepe, M., Storb, R.: Increased risk of infection in marrow transplant patients given methylprednisolone for graft-versus-host disease prevention. Blood 84: 1328-1332, 1994.
591. Nash, R.A., Storb, R.: Tacrolimus-based immunosuppression for the prevention of acute GVHD after marrow transplantation. Principles of Drug Development in Transplantation and Autoimmunity, Lieberman, R. and Mukherjee, A. (eds.): R.G. Landes Co. Austin, 10.7:205-210, 1996.
592. Nash, R.A., Storb, R.: Graft-versus-host disease after bone marrow transplantation. Principles of Drug Development in Transplantation and Autoimmunity, Lieberman, R. and Mukherjee, A. (eds.): R.G. Landes Co. Austin, 4:47-58, 1996.
593. Huss, R., Hong, D.-S., Beckham, C., Kimball, L., Myerson, D., Storb, R., Deeg, H.J.: Ultrastructural localization of stem cell factor in canine marrow-derived stromal cells. Exp. Hematol. 23: 33-40, 1995.
594. Hong, D.-S., Graham, T., Ewel, C., Storb, R., Deeg, H.J.: Inhibition of hematopoiesis in long-term marrow cultures established on adherent layers from AcSDKP-treated dogs. Exp. Hematol. 23: 639-644, 1995.
595. Anasetti, C., Hansen, J.A., Waldmann, T.A., Appelbaum, F.R., Davis, J., Deeg, H.J., Doney, K., Martin, P.J., Nash, R., Storb, R., Sullivan, K.M., Witherspoon, R.P., Binger, M.-H., Chizzonite, R., Hakimi, J., Mould, D., Satoh, H., Light, S.E.: Treatment of acute graft-versus-host disease with humanized anti-Tac: An antibody that binds to the interleukin-2 receptor. Blood 84: 1320-1327, 1994.
596. Yu, C., Ostrander, E., Bryant, E., Burnett, R., Storb, R.: Use of (CA)n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting. Transplantation 58: 701-706, 1994.
597. Anderson, J.E., Appelbaum, F.R., Storb, R.: An update on allogeneic marrow transplantation for myelodysplastic syndrome. Leukemia and Lymphoma 17: 95-99, 1995.
598. Appelbaum, F.R., Clift, R., Buckner, C.D., Anasetti, C., Radich, J., Higano, T., Storb, R., Hansen, J., Thomas, E.D.: Allogeneic marrow transplantation for chronic myeloid leukemia. Med. Oncol. 11: 69-74, 1994.
599. Raff, R.F., Sandmaier, B.M., Graham, T., Loughran, T.P., Jr., Pettinger, M., Storb, R.: “Resistance” to DLA-nonidentical canine unrelated marrow grafts is unrestricted by the major histocompatibility complex. Exp. Hematol. 22: 893-897, 1994.
600. Storb, R., Etzioni, R., Anasetti, C., Appelbaum, F.R., Buckner, C.D., Bensinger, W., Bryant, E., Clift, R., Deeg, H.J., Doney, K., Flowers, M., Hansen, J., Martin, P., Pepe, M., Sale, G., Sanders, J., Singer, J., Sullivan, K.M., Thomas, E.D., Witherspoon, R.P.: Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 84: 941-949, 1994.
601. Deeg, H.J., Anasetti, C., Petersdorf, E., Storb, R., Doney, K., Hansen, J.A., Sanders, J., Sullivan, K.M., Appelbaum, F.R.: Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors (Letter). Blood 83: 3417-3418, 1994.
602. Storb, R., Anasetti, C., Appelbaum, F.R., Deeg, H.J., Doney, K., Martin, P., Nash, R., Sullivan, K., Witherspoon, R.: Immunosuppressive agents for prevention of graft-versus-host disease. Bone Marrow Transplantation 15: S98-S103, 1995.
603. Storb, R., Leisenring, W., Deeg, H.J., Anasetti, C., Appelbaum, F., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Hansen, J., Martin, P., Sanders, J., Stewart, P., Sullivan, K., Thomas, E.D., Witherspoon, R.: Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia (Letter). Blood 83: 2749-2750, 1994.
604. Witherspoon, R.P., Deeg, H.J., Storb, R.: Secondary malignancies after marrow transplantation for leukemia or aplastic anemia. Transplant. Sci. 4: 33-41, 1994.
605. de Revel, T., Appelbaum, F.R., Storb, R., Schuening, F., Nash, R., Deeg, J., McNiece, I., Andrews, R., Graham, T.: Effects of granulocyte colony stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 83: 3795-3799, 1994.
606. Kiem, H.-P., Darovsky, B., von Kalle, C., Goehle, S., Stewart, D., Graham, T., Hackman, R., Appelbaum, F.R., Deeg, H.J., Miller, A.D., Storb, R., Schuening, F.G.: Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells. Blood 83: 1467-1473, 1994.
607. Storb, R., Raff, R.F., Appelbaum, F.R., Deeg, H.J., Graham, T.C., Schuening, F.G., Sale, G., Bryant, E., Seidel, K.: Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts. Blood 83: 3384-3389, 1994.
608. Nash, R.A., Schuening, F.G., Seidel, K., Appelbaum, F.R., Boone, T., Deeg, H.J., Graham, T.C., Hackman, R., Sullivan-Pepe, M., Storb, R.: Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation. Blood 83: 1963-1970, 1994.
609. Deeg, H.J., Beckham, C., Huss, R., Myerson, D., Greinix, H., Appelbaum, F.R., Graham, T., Schuening, F., Storb, R.: Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-Kit ligand. Blood 83: 2352-2359, 1994.
610. Weaver, C.H., Buckner, C.D., Longin, K., Appelbaum, F.R., Rowley, S., Lilleby, K., Miser, J., Storb, R., Hansen, J.A., Bensinger, W.: Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 82: 1981-1984, 1993.
611. Schwarzinger, I., Raff, R.F., Flowers, M., Niederwieser, D., Graham, T., Shulman, H., Appelbaum, F.R., Schuening, F., Storb, R.: Recipient-specific donor cytotoxic T-lymphocytes enhance engraftment of unrelated, DLA-nonidentical canine marrow. Bone Marrow Transplantation 13: 303-309, 1994.
612. Weaver, C.H., Clift, R.A., Deeg, H.J., Storb, R., Appelbaum, F.R., Bensinger, W., Doney, K., Hansen, J.A., Martin, P.J., Sanders, J., Sullivan, K.M., Thomas, E.D., Singer, J., Witherspoon, R., Buckner, C.D.: Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia. Bone Marrow Transplantation 14: 885-893, 1994.
613. Schuening, F.G., Nemunaitis, J., Appelbaum, F.R., Storb, R.: Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trials. Bone Marrow Transplantation 14: S74-S77, 1994.
614. McSweeney, P., Storb, R.: Bone marrow transplantation for malignant disease. Clinical Immunology: Principles and Practice, Chapter 118, Fleisher, T.A., Schwartz, B.D., Shearer, W.T., and Strober, W. (eds.): Mosby, St. Louis, 1831-1864, 1996.
615. Witherspoon, R.P., Deeg, H.J., Storb, R.: Secondary malignancies after marrow transplantation for leukemia or aplastic anemia. Transplantation 57: 1413-1418, 1994.
616. Huss, R., Hong, D.S., Storb, R., Deeg, H.J.: Modification of growth factor expression in marrow-derived stromal cells by anti-MHC class II antibodies. Molecular Biology of Haematopoiesis, Volume 3, Abraham, N., Shadduck, R.K., Levine, A.S., and Takaku, F. (eds.): Intercept Ltd, Andover, UK, 719-725, 1994.
617. Storb, R.: Preparative regimens for patients with leukemias and severe aplastic anemia (overview) -biological basis, experimental animal studies and clinical trials at the Fred Hutchinson Cancer Research Center (Review). Bone Marrow Transplantation 14: S1-S3, 1994.
618. Nash, R.A., Pepe, M.S., Storb, R., Anasetti, C., Appelbaum, F.R., Deeg, H.J., Doney, K., Martin, P.J., Sullivan, K.M., Witherspoon, R.P.: Risk factors for acute graft-versus-host disease associated with cyclosporine and methotrexate prophylaxis (Response to Letter to the Editor). Blood 81: 1973-1974, 1993.
619. Bean, M.A., Graham, T., Appelbaum, F.R., Deeg, H.J., Schuening, F., Sale, G.E., Storb, R.: Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts. Transplantation 57: 423-426, 1994.
620. Anderson, J.E., Litzow, M.R., Appelbaum, F.R., Schoch, G., Fisher, L.D., Buckner, C.D., Petersen, F.B., Crawford, S.W., Press, O.W., Sanders, J.E., Bensinger, W.I., Martin, P.J., Storb, R., Sullivan, K.M., Hansen, J.A., Thomas, E.D.: Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin’s disease: The 21 year Seattle experience. J. Clin. Oncol. 11: 2342-2350, 1993.
621. Schuening, F., Bean, M.A., Deeg, H.J., Storb, R.: Prevention of graft failure in patients with aplastic anemia. Bone Marrow Transplantation 12: S48-S49, 1993.
622. Jakic-Razumovic, J., Storb, R., Sandmaier, B.M., Sale, G.E.: Brief Communications: Organotypic skin culture model in dogs: A model for transplantation immunopathology in canine systems. Transplantation 57: 285-287, 1994.
623. Storb, R.: Allogeneic marrow transplantation in patients with severe aplastic anemia. Marrow Transplantation Reviews 3: 33-48, 1993.
624. Clift, R.A., Bianco, J.A., Appelbaum, F.R., Buckner, C.D., Singer, J.W., Bakke, L., Bensinger, W.I., Bowden, R.A., McDonald, G.B., Schubert, M., Shields, A.F., Slattery, J.T., Storb, R., Fisher, L.D., Mori, M., Thomas, E.D., Hansen, J.A.: A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation. Blood 82: 2025-2030, 1993.
625. Burnett, R.C., DeRose, S.A., Storb, R.: A simple restriction fragment length polymorphism assay for MHC class II gene testing of dog families. Transplantation 57: 280-282, 1994.
626. Doney, K., Storb, R., Appelbaum, F.R., Buckner, C.D., Sanders, J., Singer, J., Hansen, J.A.: Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia. Br. J. Haematol. 85: 182-184, 1993.
627. Doney, K., Buckner, C.D., Fisher, L., Petersen, F.B., Sanders, J., Appelbaum, F.R., Anasetti, C., Badger, C., Bensinger, W., Deeg, H.J., Fefer, A., Martin, P., Petersdorf, E., Schuening, F., Singer, J., Stewart, P., Storb, R., Sullivan, K.M., Witherspoon, R., Hansen, J.A.: Autologous bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplantation 12: 315-321, 1993.
628. Storb, R.: Marrow grafting for aplastic anemia. Progresos Recientes En Hematologia, Pizzuto, J., Fairbanks, V.F., and Morales, M.R. (eds.): Instituto Mexicano Del Seguro Social Clinica Mayo, Rochester,MN, 204-216, 1993.
629. Storb, R.: Marrow transplantation in the treatment of non-Hodgkin’s lymphoma. Progresos Recientes En Hematologia, Pizzuto, J., Fairbanks, V.F., and Morales, M.R. (eds.): Instituto Mexicano Del Seguro Social Clinica Mayo, Rochester,MN, 109-115, 1993.
630. Sanders, J.E., Hill, R., Appelbaum, F.R., Petersen, F.B., Singer, J., Bensinger, W., Doney, K., Storb, R., Sullivan, K.M., Buckner, C.D.: Autologous marrow transplantation for patients with acute myelogenous leukemia beyond first remission. Autologous Bone Marrow Transplantation. Proceedings of the Fifth International Symposium, Dicke, K.A., Armitage, J.O., and Dicke-Evinger, M.J. (eds.): 55-64, 1991.
631. Weaver, C.H., Appelbaum, F.R., Petersen, F.B., Clift, R., Singer, J., Press, O., Bensinger, W., Bianco, J., Martin, P., Anasetti, C., Badger, C., Deeg, J., Doney, K., Hansen, J.A., Petersdorf, E., Rowley, S., Storb, R., Sullivan, K., Witherspoon, R., Weiden, P., Buckner, C.D.: High-dose cyclophosphamide, carmustine and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy. J. Clin. Oncol. 11: 1329-1335, 1993.
632. Crawford, S.W., Longton, G., Storb, R.: Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplantation 12: 225-231, 1993.
633. Petersen, F.B., Lynch, M.H.E., Clift, R.A., Appelbaum, F.R., Sanders, J.E., Bensinger, W.I., Benyunes, M.C., Doney, K., Fefer, A., Martin, P., Storb, R., Rowley, S., Sullivan, K.M., Witherspoon, R., Weiden, P., Thomas, E.D., Fisher, L., Hansen, J.A., Buckner, C.D.: Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission. J. Clin. Oncol. 11: 1353-1360, 1993.
634. Anderson, J.E., Appelbaum, F.R., Fisher, L.D., Schoch, G., Shulman, H., Anasetti, C., Bensinger, W.I., Bryant, E., Buckner, C.D., Doney, K., Martin, P.J., Sanders, J.E., Sullivan, K.M., Thomas, E.D., Witherspoon, R.P., Hansen, J.A., Storb, R.: Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 82: 677-681, 1993.
635. Schuening, F., Longo, W.L., Atkinson, M.E., Zaboikin, M., Kiem, H.P., Sanders, J., Scott, C.R., Storb, R., Miller, A.D., Reynolds, T., Bensinger, W., Rowley, S., Gooley, T., Darovsky, B., Appelbaum, F. Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with Gaucher’s disease. Hum. Gene Ther. 8: 2143-2160, 1997.
636. Storb, R.: Chronic myelocytic leukemia: Development of conditioning regimens for marrow transplantation. Leukemia 7: 5135-5137, 1993.
637. Storb, R.: Stem cell regulation and engraftment. Leukemia 7: 5148-5150, 1993.
638. Storb, R.: Conditioning regimens for bone marrow transplantation. Bone Marrow Transplantation 12: S16-S18, 1993.
639. Pepe, M.S., Longton, G., Pettinger, M., Mori, M., Fisher, L.D., Storb, R.: Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: Motivation for and description of new methods. Br. J. Haematol. 83: 602-607, 1993.
640. Storb, R., Raff, R.F., Appelbaum, F.R., Deeg, H.J., Fitzsimmons, W., Graham, T.C., Pepe, M., Pettinger, M., Sale, G., Van Der Jagt, R., Schuening, F.G.: FK506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated DLA-nonidentical donors. Transplantation 56: 800-807, 1993.
641. Greinix, H.T., Storb, R., Sanders, J.E., Deeg, H.J., Doney, K.C., Sullivan, K.M., Witherspoon, R.P.: Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan Syndrome). Br. J. Haematol. 84: 515-520, 1993.
642. Storb, R.: Bone marrow transplantation for aplastic anemia. Cell Transplant. 2: 365-379, 1993.
643. Bensinger, W., Singer, J., Appelbaum, F., Lilleby, K., Longin, K., Rowley, S., Clarke, E., Clift, R., Hansen, J., Shields, T., Storb, R., Weaver, C., Weiden, P., Buckner, C.D.: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81: 3158-3163, 1993.
644. Dennis, M.B., Jr., Graham, T.C., Raff, R.F., Schuening, F., Storb, R.: Implanted right atrial catheters for continuous infusion of solutions into dogs. J. Invest. Surg. 6: 461-467, 1993.
645. Storb, R., Raff, R.F., Graham, T., Appelbaum, F.R., Deeg, H.J., Schuening, F.G., Shulman, H., Pepe, M.: Marrow toxicity of fractionated versus single dose total body irradiation is identical in a canine model. Int. J. Radiat. Oncol. Biol. Phys. 26: 275-283, 1993.
646. Ramesh, N., Lau, S., Palmer, T.D., Storb, R., Osborne, W.R.A.: High-level human adenosine deaminase expression in dog skin fibroblasts is not sustained following transplantation. Human Gene Therapy 4: 3-7, 1993.
647. Storb, R., Thomas, E.D.: The scientific foundation of marrow transplantation based on animal studies. Bone Marrow Transplantation, Forman, S.J., Blume, K.G., and Thomas, E.D. (eds.): Blackwell Scientific Publications, Boston, MA, 3-11, 1994.
648. Pene, R., Appelbaum, F.R., Fisher, L., Lilleby, K., Nemunaitis, J., Storb, R., Buckner, C.D.: Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation. Bone Marrow Transplantation 11: 219-222, 1993.
649. Bensinger, W.I., Price, T.H., Dale, D.C., Appelbaum, F.R., Clift, R., Lilleby, K., Williams, B., Storb, R., Thomas, E.D., Buckner, C.D.: The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 81: 1883-1888, 1993.
650. Schiffman, K., Clift, R., Appelbaum, F.R., Sanders, J., Bensinger, W., Petersen, F.B., Rowley, S., Hill, R., Martin, P., Storb, R., Weiden, P., Thomas, E.D., Hansen, J.A., Buckner, C.D.: Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia. Bone Marrow Transplantation 11: 227-232, 1993.
651. Beatty, P.G., Anasetti, C., Hansen, J.A., Longton, G.M., Sanders, J.E., Martin, P.J., Mickelson, E.M., Choo, S.Y., Petersdorf, E.W., Pepe, M.S., Appelbaum, F.R., Bearman, S.I., Buckner, C.D., Clift, R.A., Petersen, F.B., Singer, J., Stewart, P.S., Storb, R.F., Sullivan, K.M., Tesler, M.C., Witherspoon, R.P., Thomas, E.D.: Marrow transplantation from unrelated donors for treatment of hematologic malignancies: Effect of mismatching for one HLA locus. Blood 81: 249-253, 1993.
652. Schuening, F.G., Appelbaum, F.R., Deeg, H.J., Sullivan-Pepe, M., Graham, T.C., Hackman, R., Zsebo, K.M., Storb, R.: Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation. Blood 81: 20-26, 1993.
653. Loughran, T.P., Jr., Deeg, H.J., Storb, R.: Inhibition of canine NK activity by anti-CD18 monoclonal antibody, UV irradiation, and cyclosporine. Exp. Hematol. 21: 411-413, 1993.
654. Raff, R.F., Severns, E.M., Storb, R., Graham, T.C., Sale, G., Schuening, F.G., Appelbaum, F.R.: Studies of the use of L-leucyl-L-leucine methyl ester in canine allogeneic marrow transplantation. Transplantation 55: 1244-1249, 1993.
655. Raff, R.F., Storb, R., Graham, T., Deeg, H.J., Pepe, M., Schaffer, R., Sale, G.E., Schuening, F., Appelbaum, F.R.: What role for 15-deoxyspergualin in enhancing engraftment of unrelated, histoincompatible canine marrow grafts and preventing graft-versus-host disease? Transplantation 55: 684-688, 1993.
656. Sanders, J.E., Storb, R., Anasetti, C., Deeg, H.J., Doney, K., Sullivan, K.M., Witherspoon, R.P., Hansen, J.: Marrow transplant experience for children with severe aplastic anemia. Am. J. Ped. Hematol. Oncol. 16: 43-49, 1994.
657. Walters, M.C., Thomas, E.D., Sullivan, K.M., Appelbaum, F.R., Hansen, J.A., Sanders, J.E., Storb, R., O’Reilly, R.J., Boulad, F., Brochstein, J., Blume, K., Amylon, M., Johnson, F.L., Klemperer, M., Graham-Pole, J.: Bone marrow transplantation for thalassemia: The USA experience. Am. J. Ped. Hematol. Oncol. 16: 11-17, 1994.
658. Petersen, F.B., Buckner, C.D., Appelbaum, F.R., Sanders, J.E., Bensinger, W.I., Storb, R., Deeg, H.J., Witherspoon, R.P., Sullivan, K.M., Clift, R.A., Hansen, J.A., Thomas, E.D.: Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. Bone Marrow Transplantation 10: 83-88, 1992.
659. Clift, R.A., Buckner, C.D., Appelbaum, F.R., Schoch, G., Petersen, F.B., Bensinger, W.I., Sanders, J., Sullivan, K.M., Storb, R., Singer, J., Hansen, J.A., Thomas, E.D.: Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. J. Clin. Oncol. 10: 1723-1729, 1992.
660. Bensinger, W.I., Buckner, C.D., Clift, R.A., Petersen, F.B., Bianco, J.A., Singer, J.W., Appelbaum, F.R., Dalton, W., Beatty, P., Fefer, A., Storb, R., Thomas, E.D., Hansen, J.A.: Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma. J. Clin. Oncol. 10: 1492-1497, 1992.
661. Storb, R., Pepe, M., Deeg, H.J., Anasetti, C., Appelbaum, F.R., Bensinger, W., Buckner, C.D., Clift, R.A., Doney, K., Hansen, J., Martin, P., Pettinger, M., Sanders, J.E., Singer, J., Stewart, P., Sullivan, K.M., Thomas, E.D., Witherspoon, R.P.: Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia. (Letter to the Editor). Blood 80: 560-561, 1992.
662. Raff, R.F., Loughran, T.P., Jr., Graham, T., Pepe, M., Johnston, B., Sale, G.E., Storb, R.: Splenectomy does not enhance engraftment of DLA-nonidentical marrow transplants. Exp. Hematol. 21: 385-387, 1993.
663. Greinix, H.T., Storb, R., Bartelmez, S.H.: Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II molecules. Blood 80: 1950-1956, 1992.
664. Raff, R.F., Storb, R., Graham, T., Sale, G., Shulman, H., Pepe, M., Deeg, H.J., Schuening, F., Appelbaum, F.R., Fidler, J.M., Ando, D.G.: Succinyl acetone plus methotrexate as GVHD prophylaxis in DLA-haploidentical canine littermate marrow grafts (Letter). Transplantation 54: 947-948, 1992.
665. Müller-Sieburg, C., Torok-Storb, B., Visser, J., and Storb, R. (eds.): Hematopoietic Stem Cells: Animal Models and Human Transplantation. Springer-Verlag, Berlin-Heidelberg, 1992.
666. Nash, R.A., Pepe, M.S., Storb, R., Longton, G., Pettinger, M., Anasetti, C., Appelbaum, F.R., Bowden, R., Deeg, H.J., Doney, K., Martin, P.J., Sullivan, K.M., Sanders, J., Witherspoon, R.P.: Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 80: 1838-1845, 1992.
667. Appelbaum, F.R., Brown, P.A., Sandmaier, B.M., Storb, R., Fisher, D.R., Shulman, H.M., Graham, T.C., Schuening, F.G., Deeg, H.J., Bianco, J.A., Ketring, A.R., Kaplan, D.: Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMP. Blood 80: 1608-1613, 1992.
668. Sarmiento, U.M., DeRose, S., Sarmiento, J.I., Storb, R.: Allelic variation in the DQ subregion of the canine major histocompatibility complex: 2. DQB. Immunogenetics 37: 148-152, 1993.
669. Storb, R.: Bone marrow transplantation for aplastic anemia. Bone Marrow Transplantation, Forman, S.J., Blume, K.G., and Thomas, E.D. (eds.): Blackwell Scientific Publications, Boston, MA, 43:583-594, 1994.
670. Storb, R.: Retroviral gene transfer. Biol. Clin. Hematol. 14: 111-112, 1992.
671. Appelbaum, F.R., Badger, C.C., Bernstein, I.D., Buckner, C.D., Deeg, H.J., Eary, J.F., Matthews, D.C., Press, O.W., Storb, R., Thomas, E.D.: Is there a better way to deliver total body irradiation? Bone Marrow Transplantation 10: 77-81, 1992.
672. Sullivan, K.M., Mori, M., Sanders, J., Siadak, M., Witherspoon, R.P., Anasetti, C., Appelbaum, F.R., Bensinger, W., Bowden, R., Buckner, C.D., Clark, J., Crawford, S., Deeg, H.J., Doney, K., Flowers, M., Hansen, J., Loughran, T., Martin, P., McDonald, G., Pepe, M., Petersen, F.B., Schuening, F., Stewart, P., Storb, R.: Late complications of allogeneic and autologous marrow transplantation (Review). Bone Marrow Transplantation 10: 127-134, 1992.
673. Greinix, H.T., Storb, R., Sanders, J.E., Petersen, F.B.: Marrow transplantation for treatment of multisystem progressive Langerhans cell histiocytosis. Bone Marrow Transplantation 10: 39-44, 1992.
674. Storb, R.: HLA-identical marrow transplantation for severe aplastic anemia. Clinical Bone Marrow Transplantation: A Reference Textbook, Atkinson, K. (ed.): Cambridge University Press, Cambridge, 31:230-237, 1994.
675. Storb, R., Deeg, H.J., Pepe, M., Anasetti, C., Appelbaum, F.R., Bensinger, W., Buckner, C.D., Clift, R.A., Doney, K., Hansen, J., Longton, G., Martin, P., Sanders, J.E., Singer, J., Stewart, P., Sullivan, K.M., Thomas, E.D., Witherspoon, R.P.: Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia (Letter). Blood 79: 3091-3092, 1992.
676. Anasetti, C., Martin, P.J., Storb, R., Appelbaum, F.R., Beatty, P.G., Davis, J., Doney, K., Hill, H.F., Stewart, P., Sullivan, K.M., Witherspoon, R.P., Thomas, E.D., Hansen, J.A.: Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody. Transplantation 54: 844-851, 1992.
677. Storb, R., Longton, G., Anasetti, C., Appelbaum, F.R., Beatty, P., Bensinger, W., Crawford, S., Deeg, H.J., Doney, K., Fefer, A., Hansen, J., Loughran, T., Martin, P., Pepe, M., Petersen, F.B., Sanders, J.E., Singer, J., Stewart, P., Sullivan, K.M., Thomas, E.D., Witherspoon, R.P.: Changing trends in marrow transplantation for aplastic anemia (Review). Bone Marrow Transplantation 10: 45-52, 1992.
678. Doney, K., Pepe, M., Storb, R., Bryant, E., Anasetti, C., Appelbaum, F.R., Buckner, C.D., Sanders, J., Singer, J., Sullivan, K., Weiden, P., Hansen, J.A.: Immunosuppressive therapy of aplastic anemia: Results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone and oxymetholone to ATG, very high-dose methylprednisolone and oxymetholone. Blood 79: 2566-2571, 1992.
679. Nemunaitis, J., Anasetti, C., Storb, R., Bianco, J.A., Buckner, C.D., Onetto, N., Martin, P., Sanders, J., Sullivan, K., Mori, M., Shannon-Dorcy, K., Bowden, R., Appelbaum, F.R., Hansen, J., Singer, J.W.: Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors. Blood 79: 2572-2577, 1992.
680. Raff, R.F., Storb, R., Graham, T., Fidler, J.M., Sale, G.E., Johnston, B., Deeg, H.J., Pepe, M., Schuening, F., Appelbaum, F.R., Bauer, R.J., Young, J.D., Marafino, B.J., Ando, D.G., Braude, I.A.: Pharmacologic, toxicologic and marrow transplantation studies in dogs given succinyl acetone. Transplantation 54: 813-820, 1992.
681. Flowers, M.E.D., Doney, K.C., Storb, R., Deeg, H.J., Sanders, J.E., Sullivan, K.M., Bryant, E., Witherspoon, R.P., Appelbaum, F.R., Buckner, C.D., Hansen, J.A., Thomas, E.D.: Marrow transplantation for Fanconi anemia with or without leukemic transformation: An update of the Seattle experience. Bone Marrow Transplantation 9: 167-173, 1992.
682. Witherspoon, R.P., Storb, R., Pepe, M., Longton, G., Sullivan, K.M.: Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone (Letter). Blood 79: 289-292, 1992.
683. Kawahara, K., Witherspoon, R.P., Storb, R.: Marrow transplantation for paroxysmal nocturnal hemoglobinuria. Am. J. Hematol. 39: 283-288, 1992.
684. Petersen, F.B., Deeg, H.J., Buckner, C.D., Appelbaum, F.R., Storb, R., Clift, R.A., Sanders, J.E., Bensinger, W.I., Witherspoon, R.P., Sullivan, K.M., Doney, K., Hansen, J.A.: Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide – A phase I trial. Int. J. Radiat. Oncol. Biol. Phys. 23: 1027-1032, 1992.
685. Sarmiento, U.M., DeRose, S., Sarmiento, J.I., Storb, R.: Allelic variation in the DQ subregion of the canine major histocompatibility complex: I. DQA. Immunogenetics 35: 416-420, 1992.
686. Stockschlaeder, M., Storb, R., Pepe, M., Longton, G., McDonald, G., Anasetti, C., Appelbaum, F., Doney, K., Martin, P., Sullivan, K., Witherspoon, R.: A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation. Br. J. Haematol. 80: 49-54, 1992.
687. Buckner, C.D., Clift, R.A., Appelbaum, F.R., Storb, R., Fefer, A., Petersen, F.B., Sanders, J.E., Sullivan, K., Thomas, E.D., Hansen, J.A.: Effects of treatment regimens on post marrow transplant relapse (Review). Semin. Hematol. 28: 32-34, 1991.
688. Schuening, F.G., Kawahara, K., Miller, D.A., To, R., Goehle, S., Stewart, D., Mullally, K., Fisher, L., Graham, T.C., Appelbaum, F.R., Hackman, R., Osborne, W.R.A., Storb, R.: Retrovirus-mediated gene transduction into long-term repopulating marrow cells of dogs. Blood 78: 2568-2576, 1991.
689. Deeg, H.J., Erickson, K., Storb, R., Sullivan, K.M.: Photoinactivation of lymphohemopoietic cells: Studies in transfusion medicine and bone marrow transplantation. Blood Cells 18: 151-162, 1992.
690. Greinix, H.T., Ladiges, W.C., Graham, T.C., Maslan, S., Raff, R.F., Sandmaier, B.M., Appelbaum, F.R., Schuening, F.G., Deeg, H.J., Storb, R.: Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class-II monoclonal antibody. Blood 78: 2131-2138, 1991.
691. Sullivan, K.M., Agura, E., Anasetti, C., Appelbaum, F.R., Badger, C., Bearman, S., Erickson, K., Flowers, M., Hansen, J.A., Loughran, T., Martin, P., Matthews, D., Petersdorf, E., Radich, J., Riddell, S., Rovira, D., Sanders, J., Schuening, F., Siadak, M., Storb, R., Witherspoon, R.P.: Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin. Hematol. 28: 250-259, 1991.
692. Buckner, C.D., Clift, R.A., Appelbaum, F.R., Storb, R., Petersen, F.B., Sanders, J.E., Thomas, E.D., Hansen, J.A.: Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia. Bone Marrow Transplantation 7: 6-8, 1991.
693. Storb, R., Sanders, J.E., Pepe, M., Anasetti, C., Appelbaum, F.R., Buckner, C.D., Deeg, H.J., Doney, K., Hansen, J., Martin, P., Stewart, P., Sullivan, K.M., Thomas, E.D., Witherspoon, R.P.: Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts (letter). Blood 78: 1144-1145, 1991.
694. Nemunaitis, J., Meyers, J.D., Buckner, C.D., Shannon-Dorcy, K., Mori, M., Shulman, H., Bianco, J.A., Higano, C.S., Groves, E., Storb, R., Hansen, J., Appelbaum, F.R., Singer, J.W.: Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood 78: 907-913, 1991.
695. Bean, M.A., Storb, R., Graham, T., Raff, R., Sale, G.E., Schuening, F., Appelbaum, F.R.: Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood. Transplantation 52: 956-960, 1991.
696. Kawahara, K., Storb, R., Sanders, J., Petersen, F.B.: Successful allogeneic bone marrow transplantation in a 6.5-year-old male for severe aplastic anemia complicating orthotopic liver transplantation for fulminant non-A-non-B hepatitis. Blood 78: 1140-1143, 1991.
697. Storb, R., Santos, G.W.: Indications for bone marrow transplantation. Dateline, DiBenedetto, F.E. (ed.): AM Medica Communications, Ltd. New York, N.Y. 3-20, 1992.
698. Deeg, H.J., Storb, R.: Bone marrow transplantation in dogs. Handbook of Animal Models in Transplantation Research, Makowka, L., Cramer, D.V., and Podesta, L.G. (eds.): CRC Press, Inc. Boca Raton, Florida, 255-285, 1994.
699. van der Jagt, R.H.C., Appelbaum, F.R., Petersen, F.B., Bigelow, C.L., Fisher, L.D., Schoch, G.H., Buckner, C.D., Sanders, J., Storb, R., Sullivan, K.M., Thomas, E.D.: Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy. Bone Marrow Transplantation 8: 211-215, 1991.
700. Doney, K., Fisher, L.D., Appelbaum, F.R., Buckner, C.D., Storb, R., Singer, J., Fefer, A., Anasetti, C., Beatty, P., Bensinger, W., Clift, R., Hansen, J., Hill, R., Loughran, T.P., Jr., Martin, P., Petersen, F.B., Sanders, J., Sullivan, K.M., Stewart, P., Weiden, P., Witherspoon, R., Thomas, E.D.: Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. Bone Marrow Transplantation 7: 453-459, 1991.
701. Sullivan, K.M., Kopecky, K.J., Buckner, C.D., Storb, R.: Intravenous IgG to prevent graft-versus-host disease after bone marrow transplantation. (letter). N. Engl. J. Med. 324: 631-633, 1991.
702. Storb, R., Champlin, R.E.: Bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplantation 8: 69-72, 1991.
703. Nash, R., Scherf, U., Storb, R.: Molecular cloning of the CD3epsilon subunit of the T-cell receptor/CD3 complex in dog. Immunogenetics 33: 396-398, 1991.
704. Anasetti, C., Martin, P.J., Storb, R., Appelbaum, F.R., Beatty, P.G., Calori, E., Davis, J., Doney, K., Reichert, T., Stewart, P., Sullivan, K.M., Thomas, E.D., Witherspoon, R.P., Hansen, J.A.: Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody-2A3. Bone Marrow Transplantation 7: 375-381, 1991.
705. Nash, R.A., Schuening, F., Appelbaum, F., Hammond, W.P., Boone, T., Morris, C.F., Slichter, S.J., Storb, R.: Molecular cloning and in vivo evaluation of canine granulocyte-macrophage colony-stimulating factor. Blood 78: 930-937, 1991.
706. Storb, R.: Marrow transplantation. Hematopoietic Stem Cells: Animal Models and Human Transplantation, Müller-Sieburg, C., Torok-Storb, B., Visser, J., and Storb, R. (eds.): Springer-Verlag, Berlin Heidelberg, 169-186, 1992.
707. Martin, P.J., Schoch, G., Fisher, L., Byers, V., Appelbaum, F.R., McDonald, G.B., Storb, R., Hansen, J.A.: A retrospective analysis of therapy for acute graft-versus-host disease: Secondary treatment. Blood 77: 1821-1828, 1991.
708. Stockschlaeder, M.A.R., Storb, R., Osborne, W.R.A., Miller, A.D.: L-histidinol provides effective selection of retrovirus-vector-transduced keratinocytes without impairing their proliferative potential. Human Gene Therapy 2: 33-39, 1991.
709. Schuening, F.G., Storb, R.: Hematopoietic growth factors in bone marrow transplantation. Topics on Supportive Care in Oncology 1: 9-12, 1991.
710. Clift, R.A., Buckner, C.D., Appelbaum, F.R., Bryant, E., Bearman, S.I., Petersen, F.B., Fisher, L.D., Anasetti, C., Beatty, P., Bensinger, W.I., Doney, K., Hill, R.S., McDonald, G.B., Martin, P., Meyers, J., Sanders, J., Singer, J., Stewart, P., Sullivan, K.M., Witherspoon, R., Storb, R., Hansen, J.A., Thomas, E.D.: Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: A randomized trial of two irradiation regimens. Blood 77: 1660-1665, 1991.
711. Nemunaitis, J., Buckner, C.D., Appelbaum, F.R., Higano, C.S., Mori, M., Bianco, J., Epstein, C., Lipani, J., Hansen, J., Storb, R., Thomas, E.D., Singer, J.W.: Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation. Blood 77: 2065-2071, 1991.
712. Storb, R., Anasetti, C., Appelbaum, F., Bensinger, W., Buckner, C.D., Clift, R., Deeg, H.J., Doney, K., Hansen, J., Loughran, T., Martin, P., Pepe, M., Petersen, F., Sanders, J., Singer, J., Stewart, P., Sullivan, K.M., Witherspoon, R., Thomas, E.D.: Marrow transplantation for severe aplastic anemia and thalassemia major. Semin. Hematol. 28: 235-239, 1991.
713. de Gast, G.C., Beatty, P.G., Amos, D., Mickelson, E.M., Sullivan, K.M., Anderson, J.E., Giblett, E.R., Appelbaum, F., Storb, R., Deeg, H.J., Hansen, J.A.: Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease. Bone Marrow Transplantation 7: 293-295, 1991.
714. Sandmaier, B.M., Schuening, F.G., Bianco, J.A., Rosenman, S.J., Bernstein, I., Goehle, S., Storb, R., Appelbaum, F.R.: Biochemical characterization of a unique canine myeloid antigen. Leukemia 5: 125-130, 1991.
715. Schmid, I., Anasetti, C., Petersen, F.B., Storb, R.: Marrow transplantation for severe aplastic anemia associated with exposure to quinacrine. Blut 61: 1-3, 1990.
716. Sullivan, K.M., Kopecky, K.J., Jocom, J., Fisher, L., Buckner, C.D., Meyers, J.D., Counts, G.W., Bowden, R.A., Petersen, F.B., Witherspoon, R.P., Budinger, M.D., Schwartz, R.S., Appelbaum, F.R., Clift, R.A., Hansen, J.A., Sanders, J.E., Thomas, E.D., Storb, R.: Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N. Engl. J. Med. 323: 705-712, 1990.
717. Klingemann, H.-G., Storb, R., Deeg, H.J.: Inhibition of cluster formation and lymphocyte proliferation by anti-fibronectin antiserum. J. Leukocyte Biol. 49: 152-157, 1991.
718. Martin, P.J., Schoch, G., Fisher, L., Byers, V., Anasetti, C., Appelbaum, F.R., Beatty, P.G., Doney, K., McDonald, G.B., Sanders, J.E., Sullivan, K.M., Storb, R., Thomas, E.D., Witherspoon, R.P., Lomen, P., Hannigan, J., Hansen, J.A.: A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment. Blood 76: 1464-1472, 1990.
719. Clift, R.A., Buckner, C.D., Appelbaum, F.R., Bearman, S.I., Petersen, F.B., Fisher, L.D., Anasetti, C., Beatty, P., Bensinger, W.I., Doney, K., Hill, R., McDonald, G., Martin, P., Sanders, J., Singer, J., Stewart, P., Sullivan, K.M., Witherspoon, R., Storb, R., Hansen, J., Thomas, E.D.: Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: A randomized trial of two irradiation regimens. Blood 76: 1867-1871, 1990.
720. Storb, R., Bean, M., Appelbaum, F., Schuening, F., Graham, T., Raff, R.: Treatment of marrow donor blood products with gamma-irradiation prevents transfusion-induced sensitization to DLA-identical marrow grafts. Transplant. Proc. 23: 1697-1698, 1991.
721. Beatty, P.G., Hansen, J.A., Longton, G.M., Thomas, E.D., Sanders, J.E., Martin, P.J., Bearman, S.I., Anasetti, C., Petersdorf, E.W., Mickelson, E.M., Pepe, M.S., Appelbaum, F.R., Buckner, C.D., Clift, R.A., Petersen, F.B., Stewart, P.S., Storb, R.F., Sullivan, K.M., Tesler, M.C., Witherspoon, R.P.: Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 51: 443-447, 1991.
722. Sarmiento, U.M., Sarmiento, J.I., Storb, R.: Allelic variation in the DR subregion of the canine major histocompatibility complex. Immunogenetics 32: 13-19, 1990.
723. Sarmiento, U.M., Storb, R.: Nucleotide sequence of a dog DRB cDNA clone. Immunogenetics 31: 396-399, 1990.
724. Ljungman, P., Niederwieser, D., Pepe, M.S., Longton, G., Storb, R., Meyers, J.D.: Cytomegalovirus infection after marrow transplantation for aplastic anemia. Bone Marrow Transplantation 6: 295-300, 1990.
725. Loughran, T.P., Jr., Raff, R.F., Graham, T.C., Appelbaum, F.R., Schuening, F.G., Sale, G.E., Storb, R.: Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow grafts. Exp. Hematol. 18: 1126-1131, 1990.
726. O’Brien, J.S., Storb, R., Raff, R.F., Harding, J., Appelbaum, F., Morimoto, S., Kishimoto, Y., Graham, T., Ahern-Rindell, A., O’Brien, S.L.: Bone marrow transplantation in canine GM1 gangliosidosis. Clin. Genet. 38: 274-280, 1990.
727. Storb, R., for the Seattle Marrow Transplant Team: Conditioning regimens: Experimental approaches and clinical applications. Irradiazione Corporea Totale e Subtotale. Problematische Fisiche, Radiobiologiche e Cliniche, Vitale, V. and Santi, L. (eds.): Scuola Superiore Oncologia, Genova, Italy, 99-106, 1990.
728. Storb, R., Bianco, J., Sandmaier, B., Schuening, F., Kaplan, D., Appelbaum, F.R.: Whole marrow irradiation with isotopes. Irradiazione Corporea Totale e Subtotale: Problematiche Fisiche, Radiobiologiche e Cliniche, Vitale, V. (ed.): Scuola Superiore di Oncologia, Genova, Italy, 185-193, 1990.
729. Sullivan, K.M., Weiden, P.L., Fefer, A., Appelbaum, F.R., Anasetti, C., Buckner, C.D., Clift, R., Doney, K., Fisher, L., Martin, P., Petersen, F., Sanders, J., Singer, J., Stewart, P., Witherspoon, R.P., Hansen, J.A., Thomas, E.D., Storb, R.: Graft-versus-leukemia effect of allogeneic bone marrow transplantation in patients with acute nonlymphocytic leukemia. Acute Myelogenous Leukemia: Progress and Controversies, Gale, R.P. (ed.): Wiley-Liss, Inc. New York, NY, 391-401, 1990.
730. Storb, R., Appelbaum, F., Buckner, C.D., Clift, R., Anasetti, C., Beatty, P., Bianco, J., Doney, K., Hansen, J., Martin, P., Sanders, J., Sandmaier, B., Schuening, F., Sullivan, K., Witherspoon, R., Thomas, E.D.: HLA-identical marrow transplantation in the leukemias without T-cell depletion. Bone Marrow Transplantation 6: 80-84, 1990.
731. Storb, R., Appelbaum, F., Nemunaitis, J., Schuening, F., Singer, J., Epstein, C., Buckner, C.D., Souza, L.M., Thomas, E.D.: Hematopoietic growth factors in marrow transplantation and radiation injury. Bone Marrow Transplantation 6: 116-120, 1990.
732. Storb, R., Pepe, M., Anasetti, C., Appelbaum, F.R., Beatty, P., Doney, K., Martin, P., Stewart, P., Sullivan, K.M., Witherspoon, R., Bensinger, W., Buckner, C.D., Clift, R., Hansen, J., Longton, G., Loughran, T., Petersen, F.B., Singer, J., Sanders, J., Thomas, E.D.: What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? Blood 76: 1037-1045, 1990.
733. Storb, R., Appelbaum, F., Badger, C., Bernstein, I., Buckner, C.D., Petersen, F.B., Martin, P., Hansen, J., Anasetti, C., Sandmaier, B., Bianco, J., Schuening, F., Thomas, E.D.: Conditioning regimens in bone marrow transplantation. Organ Transplantation 1990, Abouna, G.M., Kumar, M.S.A., and White, A.G. (eds.): Kluwer Academic Publishers, Dordrecht, The Netherlands, 437-442, 1991.
734. Storb, R.: Current status of bone marrow transplantation. Organ Transplantation 1990, Abouna, G.M., Kumar, M.S.A., and White, A.G. (eds.): Kluwer Academic Publishers, Dordrecht, The Netherlands, 415-424, 1991.
735. Bianco, J.A., Brown, P.A., Durack, L., Badger, C., Bernstein, I., Eary, J., Durham, J., Fisher, D., Sandmaier, B., Schuening, F., Storb, R., Appelbaum, F.: Effects of propylthiouracil on the biodistribution of an iodine-131-labeled anti-myeloid antibody in normal dogs: Dosimetry and clinical implications. J. Nucl. Med. 31: 1384-1389, 1990.
736. Sandmaier, B.M., Storb, R., Appelbaum, F.R., Gallatin, W.M.: An antibody that facilitates hematopoietic engraftment recognizes CD44. Blood 76: 630-635, 1990.
737. Nemunaitis, J., Singer, J.W., Buckner, C.D., Durnam, D., Epstein, C., Hill, R., Storb, R., Thomas, E.D., Appelbaum, F.R.: Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation. Blood 76: 245-253, 1990.
738. Storb, R.: Pathogenesis and recent therapeutic approaches to graft-versus-host disease. J. Pediatr. 118: S10-S13, 1991.
739. Schuening, F.G., Storb, R., Goehle, S., Graham, T.C., Hackman, R., Mori, M., Sousa, L.M., Appelbaum, F.R.: Recombinant human granulocyte colony-stimulating factor accelerates hematopoietic recovery after DLA-identical littermate marrow transplants in dogs. Blood 76: 636-640, 1990.
740. Hansen, J.A., Anasetti, C., Beatty, P.G., Martin, P.J., Sanders, J.E., Storb, R., Thomas, E.D.: Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival. Bone Marrow Transplantation 6: 108-111, 1990.
741. Appelbaum, F.R., Buckner, C.D., Clift, R.A., Petersen, F.B., Sullivan, K.M., Storb, R., Thomas, E.D.: Allogeneic marrow transplantation for acute myelogenous leukemia: Major issues concerning its clinical application. New Strategies in Bone Marrow Transplantation, UCLA Symposia on Molecular and Cellular Biology, New Series Vol. 137, Champlin, R.E. and Gale, R.P. (eds.): Wiley-Liss, Inc. New York, NY, 131-144, 1991.
742. Schubert, M.A., Sullivan, K.M., Schubert, M.M., Nims, J., Hansen, M., Sanders, J.E., O’Quigley, J., Witherspoon, R.P., Buckner, C.D., Storb, R., Thomas, E.D.: Gynecological abnormalities following allogeneic bone marrow transplantation. Bone Marrow Transplantation 5: 425-430, 1990.
743. Witherspoon, R.P., Fisher, L.D., Sullivan, K.M., Storb, R., Thomas, E.D.: Secondary cancers after bone marrow transplantation (Letter). N. Engl. J. Med. 322: 853, 1990.
744. Storb, R.: Allogeneic marrow transplants in the acute leukemias. Acute Leukemias IV – Prognostic Factors and Treatment Strategies, Büchner, T. (ed.): Springer-Verlag, Berlin Heidelberg, 783-793, 1994.
745. Nemunaitis, J., Singer, J.W., Buckner, C.D., Mori, T., Laponi, J., Hill, R., Storb, R., Sullivan, K.M., Hansen, J.A., Appelbaum, F.R.: Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy. Bone Marrow Transplantation 7: 49-52, 1991.
746. Storb, R.: Allogeneic marrow transplantation in the acute leukemias. Current Opinion In Oncology 2: 250-257, 1990.
747. Storb, R., Anasetti, C., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Hansen, J., Loughran, T., Martin, P., Pepe, M., Petersen, F., Sanders, J., Singer, J., Stewart, P., Sullivan, K., Witherspoon, R., Thomas, E.D.: Allogeneic marrow transplantation for aplastic anemia: Major issues. New Strategies in Bone Marrow Transplantation, UCLA Symposia on Molecular and Cellular Biology, New Series Vol. 137, Champlin, R.E. and Gale, R.P. (eds.): Wiley-Liss, Inc. New York, 73-85, 1991.
748. Loughran, T.P., Jr., Sullivan, K., Morton, T., Beckham, C., Schubert, M., Witherspoon, R., Sale, G., Sanders, J., Fisher, L., Shulman, H., Thomas, E.D., Storb, R.: Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Blood 76: 228-234, 1990.
749. Nash, R., Storb, R., Torok-Storb, B., Neiman, P.: Clonal hematopoiesis after bone marrow transplantation (Letter). N. Engl. J. Med. 321: 1758-1759, 1989.
750. Anasetti, C., Beatty, P.G., Storb, R., Martin, P.J., Mori, M., Sanders, J.E., Thomas, E.D., Hansen, J.A.: Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum. Immunol. 29: 79-91, 1990.
751. Flowers, M.E.D., Pepe, M.S., Longton, G., Doney, K.C., Monroe, D., Witherspoon, R.P., Sullivan, K.M., Storb, R.: Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation. Br. J. Haematol. 74: 492-496, 1990.
752. Flowers, M.E.D., Stockschlaeder, M.A.R., Schuening, F.G., Niederwieser, D., Hackman, R., Miller, A.D., Storb, R.: Long-term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 87: 2349-2353, 1990.
753. Appelbaum, F.R., Barrall, J., Storb, R., Fisher, L.D., Schoch, G., Ramberg, R.E., Shulman, H., Anasetti, C., Bearman, S.I., Beatty, P., Bensinger, W.I., Buckner, C.D., Clift, R.A., Hansen, J.A., Martin, P., Petersen, F.B., Sanders, J.E., Singer, J., Stewart, P., Sullivan, K.M., Witherspoon, R.P., Thomas, E.D.: Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome. Ann. Intern. Med. 112: 590-597, 1990.
754. Sarmiento, U.M., Storb, R.: Nucleotide sequence of a dog class-1 cDNA clone. Immunogenetics 31: 400-404, 1990.
755. Anasetti, C., Martin, P.J., Hansen, J.A., Appelbaum, F.R., Beatty, P.G., Doney, K., Harkonen, S., Jackson, A., Reichert, T., Stewart, P., Storb, R., Sullivan, K.M., Thomas, E.D., Warner, N., Witherspoon, R.P.: A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease. Transplantation 50: 49-54, 1990.
756. Petersen, F.B., Appelbaum, F.R., Hill, R., Fisher, L.D., Bigelow, C.L., Sanders, J.E., Sullivan, K.M., Bensinger, W.I., Witherspoon, R.P., Storb, R., Clift, R.A., Fefer, A., Press, O.W., Weiden, P.L., Singer, J., Thomas, E.D., Buckner, C.D.: Autologous marrow transplantation for malignant lymphoma: A report of 101 cases from Seattle. J. Clin. Oncol. 8: 638-647, 1990.
757. Storb, R., Buckner, C.D.: Human bone marrow transplantation. Eur. J. Clin. Invest. 20: 119-132, 1990.
758. Deeg, H.J., Graham, T.C., Gerhard-Miller, L., Appelbaum, F.R., Schuening, F., Storb, R.: Prevention of transfusion-induced graft-versus-host disease in dogs by ultraviolet irradiation. Blood 74: 2592-2595, 1989.
759. Deeg, H.J., Shulman, H.M., Albrechtsen, D., Graham, T.C., Storb, R., Koppang, N.: Batten’s disease: Failure of allogeneic bone marrow transplantation to arrest disease progression in a canine model. Clin. Genet. 37: 264-270, 1990.
760. Loughran, T.P., Jr., Storb, R.: Treatment of aplastic anemia. Hematology/Oncology Clinics of North America, Forman, S.J. (ed.): W.B. Saunders Co. Philadelphia, 559-575, 1990.
761. Marmont, A.M., Gale, R.P., Butturini, A., Goldman, J.M., Martelli, M.F., Prentice, H.G., Slavin, S., Storb, R., Truitt, R.L., van Bekkum, D.W.: T-cell depletion in allogeneic bone marrow transplantation: Progress and Problems. Haematologica 74: 235-248, 1989.
762. Storb, R.: Bone marrow transplantation. Encyclopedia of Immunology, Roitt, I.M. and Delves, P.J. (eds.): Academic Press, UK, 250-253, 1992.
763. Ladiges, W.C., Storb, R., Raff, R.F., Appelbaum, F.R., Sandmaier, B., Schuening, F., Graham, T.: Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipients. Bone Marrow Transplantation 5: 43-46, 1990.
764. Storb, R.: Pathology and immunopathology of rejection and graft-versus-host disease in bone marrow transplantation. Progress in Immunology, Vol. VII, Melchers, F., Albert, E.D., von Boehmer, H., Dierich, M.P., Du Pasquier, L., Eichmann, K., Gemsa, D., Götze, O., Kalden, J.R., Kaufmann, S.H.E., Kirchner, H., Resch, K., Riethmüller, G., Schimpl, A., Sorg, C., Steinmetz, M., Wagner, H., and Zachau, H.G. (eds.): Springer-Verlag, Heidelberg, 1177-1184, 1989.
765. Witherspoon, R.P., Fisher, L.D., Schoch, G., Martin, P., Sullivan, K.M., Sanders, J., Deeg, H.J., Doney, K., Thomas, D., Storb, R., Thomas, E.D.: Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N. Engl. J. Med. 321: 784-789, 1989.
766. Storb, R.: Acute and chronic graft-vs-host disease in bone marrow transplantation. Transplantation & Immunology 6: 13-15, 1990.
767. Shields, A.F., Appelbaum, F.R., Graham, T., Deeg, H.J., Allalunis-Turner, J., Chapman, J.D., Storb, R.: Bone marrow toxicity of total-body irradiation combined with radiosensitizers. Radiat. Res. 120: 364-369, 1989.
768. Sarmiento, U.M., Storb, R.F.: RFLP analysis of DLA class I genes in the dog. Tissue Antigens 34: 158-163, 1989.
769. Petersen, F.B., Buckner, C.D., Appelbaum, F.R., Clift, R.A., Sanders, J.E., Bensinger, W.I., Storb, R., Witherspoon, R.P., Sullivan, K.M., Bearman, S.I., Flournoy, N., Thomas, E.D.: Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: A phase I study. Bone Marrow Transplantation 4: 617-623, 1989.
770. Petersen, F.B., Appelbaum, F.R., Bigelow, C.L., Buckner, C.D., Clift, R.A., Sanders, J.E., Storb, R., Sullivan, K.M., Weiden, P.L., Fefer, A., Thomas, E.D.: High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma. Bone Marrow Transplantation 4: 483-488, 1989.
771. Symington, F.W., Storb, R.: Mechanisms of tissue damage in human acute graft-versus-host disease. EOS-J. Immunol. Immunopharmacol. 9: 214-219, 1989.
772. Storb, R., Deeg, H.J., Appelbaum, F.R., Schuening, F.G., Raff, R., Graham, T.: Total body irradiation in bone marrow transplantation. Treatment of Radiation Injuries, Browne, D., Weiss, J.F., MacVittie, T.J., and Pillai, M.V. (eds.): Plenum Press, New York, 29-33, 1990.
773. Storb, R., for the Seattle Bone Marrow Transplant Team.: Allogeneic marrow transplantation for acute leukemia. Leukemias, Fleischer, J. (ed.): Springer-Verlag, Berlin Heidelberg, 175-179, 1993.
774. Buckner, C.D., Fefer, A., Bensinger, W.I., Storb, R., Durie, B.G., Appelbaum, F.R., Petersen, C.B., Weiden, P., Clift, R.A., Sanders, J.E., Sullivan, K.M., Witherspoon, R.P., Hill, R., Martin, P., Thomas, E.D.: Marrow transplantation for malignant plasma cell disorders: Summary of the Seattle Experience. Eur. J. Haematol. 43: 186-190, 1989.
775. Bensinger, W., Petersen, F.B., Banaji, M., Buckner, C.D., Clift, R., Slichter, S.J., Storb, R., Thomas, E.D.: Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission. Bone Marrow Transplantation 4: 409-414, 1989.
776. Schuening, F.G., Storb, R., Goehle, S., Graham, T.C., Appelbaum, F.R., Hackman, R., Souza, L.M.: Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood 74: 1308-1313, 1989.
777. Storb, R., Raff, R.F., Appelbaum, F.R., Graham, T.C., Schuening, F.G., Sale, G., Pepe, M.: Comparison of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts. Blood 74: 1139-1143, 1989.
778. Storb, R., Deeg, H.J., Pepe, M., Doney, K., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Hansen, J., Hill, R., Longton, G., Anasetti, C., Martin, P., Loughran, T.P., Sanders, J., Singer, J., Stewart, P., Sullivan, K.M., Witherspoon, R., Thomas, E.D.: Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: Long-term follow-up of a controlled trial. Br. J. Haematol. 72: 567-572, 1989.
779. Ladiges, W.C., Storb, R., Thomas, E.D.: Canine models of bone marrow transplantation. Lab. Anim. Sci. 40: 11-15, 1990.
780. Appelbaum, F.R., Nemunaitis, J., Singer, J., Epstein, C., Buckner, C.D., Storb, R., Thomas, E.D.: Acceleration of engraftment and treatment of graft failure with recombinant human granulocyte-macrophage colony stimulating factor. Hematopoiesis. UCLA Symposia on Molecular and Cellular Biology, New Series, Vol. 120, Golde, D.W. and Clark, S.C. (eds.): Alan R. Liss, Inc. New York, 207-216, 1990.
781. Beatty, P.G., Hansen, J.A., Anasetti, C., Sanders, J., Buckner, C.D., Storb, R., Thomas, E.D.: Marrow transplantation from unrelated HLA-matched volunteer donors. Transplant. Proc. 21: 2993-2994, 1989.
782. Schuening, F.G., Storb, R., Stead, R.B., Goehle, S., Nash, R., Miller, A.D.: Improved retroviral transfer of genes into canine hematopoietic progenitor cells kept in long-term marrow culture. Blood 74: 152-155, 1989.
783. Storb, R., Buckner, C.D., Clift, R.A., Appelbaum, F.R., Doney, K.C., Martin, P., Anasetti, C., Hansen, J., Sanders, J.E., Petersen, F.B., Sullivan, K.M., Witherspoon, R.P., Thomas, E.D.: Marrow grafting for acute leukemia: Results and future treatment strategies. Haematology and Blood Transfusion, Vol. 33. Acute Leukemias II, Büchner, T., Schellong, G., Hiddemann, W., and Ritter, J. (eds.): Springer-Verlag, Berlin, Heidelberg, 629-635, 1990.
784. Schuening, F.G., Storb, R., Goehle, S., Nash, R., Graham, T.C., Appelbaum, F.R., Hackman, R., Sandmaier, B.M., Urdal, D.L.: Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor. Exp. Hematol. 17: 889-894, 1989.
785. Appelbaum, F.R., Nemunaitis, J., Singer, J.W., Buckner, C.D., Storb, R., Thomas, E.D.: Use of recombinant human granulocyte macrophage colony stimulating factor to speed engraftment and treat graft failure following marrow transplantation in man. Haematology and Blood Transfusion, Vol. 33, Acute Leukemias II, Büchner, T., Schellong, G., Hiddemann, W., and Ritter, J. (eds.): Springer-Verlag, New York, 736-740, 1990.
786. Sullivan, K.M., Storb, R.: Bone marrow transplantation. U. W. Med. 15: 6-9, 1989.
787. Bianco, J.A., Sandmaier, B., Brown, P., Badger, C., Bernstein, I., Eary, J., Durak, L., Schuening, F., Storb, R., Appelbaum, F.: Specific marrow localization of an 131I-labeled anti-myeloid antibody in normal dogs: Effects of a “cold” antibody pretreatment dose on marrow localization. Exp. Hematol. 17: 929-934, 1989.
788. Storb, R., Appelbaum, F.R., Badger, C., Bernstein, I., Buckner, C.D., Petersen, F.B., Martin, P., Hansen, J., Anasetti, C., Sandmaier, B., Bianco, J., Schuening, F., Thomas, E.D., for the Seattle Bone Marrow Transplant Team: New conditioning regimens. Bone Marrow Transplantation 4: 15, 1989.
789. Appelbaum, F.R., Nemunaitis, J., Storb, R., Singer, J., Buckner, C.D., Epstein, C., Thomas, E.D.: Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) following bone marrow transplantation (BMT) in man. Bone Marrow Transplantation 4: 82, 1989.
790. Sullivan, K.M., Shulman, H.M., Storb, R., Anasetti, C., Appelbaum, F.R., Beatty, P., Doney, K., Loughran, T., Sanders, J., Witherspoon, R.P., Thomas, E.D.: New strategies in the management of chronic graft-versus-host disease. Bone Marrow Transplantation 4: 47, 1989.
791. Sullivan, K.M., Meyers, J., Petersen, F.B., Bowden, R., Counts, G.C., Banaji, M., Schubert, M., Clark, J., Clift, R.A., Appelbaum, F.R., Bensinger, W.I., Stewart, P., Storb, R., Thomas, E.D., Buckner, C.D.: Supportive care of the marrow transplant recipient: The Seattle experience. Hematology and Blood Transfusion Acute Leukemias II, Büchner, T., Schellong, G., Hiddemann, W., and Ritter, J. (eds.): Springer-Verlag, Berlin Heidelberg, 539-545, 1990.
792. Appelbaum, F.R., Brown, P., Sandmaier, B., Badger, C., Schuening, F., Graham, T.C., Storb, R.: Antibody-radionuclide conjugates as part of a myeloblative preparative regimen for marrow transplantation. Blood 73: 2202-2208, 1989.
793. Mortimer, J., Blinder, M.A., Schulman, S., Appelbaum, F.R., Buckner, C.D., Clift, R.A., Sanders, J.E., Storb, R., Thomas, E.D.: Relapse of acute leukemia after marrow transplantation: Natural history and results of subsequent therapy. J. Clin. Oncol. 7: 50-57, 1989.
794. Storb, R.: Transfusions in marrow transplantation: Rationale for limiting patient exposure to donors. Limiting Homologous Exposure: Alternative Strategies, Carlson, K.B. and Goleb, A.H. (eds.): Association of Blood Banks, Arlington, 9-24, 1989.
795. Witherspoon, R.P., Storb, R.S.: Bone marrow transplantation. Clinical Aspects of Immunology, 5th: Lachmann, P.J., Peters, D.K., Rosen, F.S., and Walport, M.J. (eds.): Blackwell Scientific Publications, Cambridge, Mass. 1711-1724, 1993.
796. Sullivan, K.M., Storb, R., Buckner, C.D., Fefer, A., Fisher, L., Weiden, P.L., Witherspoon, R.P., Appelbaum, F.R., Banaji, M., Hansen, J., Martin, P., Sanders, J.E., Singer, J., Thomas, E.D.: Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. N. Engl. J. Med. 320: 828-834, 1989.
797. Appelbaum, F.R., Raff, R.F., Storb, R., Deeg, H.J., Graham, T.C., Sandmaier, B., Schuening, F.: Use of trimetrexate for the prevention of graft-versus-host disease. Bone Marrow Transplantation 4: 421-424, 1989.
798. Storb, R., Deeg, H.J., Pepe, M., Appelbaum, F.R., Anasetti, C., Beatty, P., Bensinger, W., Berenson, R., Buckner, C.D., Clift, R., Doney, K., Longton, G., Hansen, J., Hill, R., Loughran, T., Jr., Martin, P., Singer, J., Sanders, J., Stewart, P., Sullivan, K., Witherspoon, R., Thomas, E.D.: Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial. Blood 73: 1729-1734, 1989.
799. Sullivan, K.M., Weiden, P.L., Storb, R., Witherspoon, R.P., Fefer, A., Fisher, L., Buckner, C.D., Anasetti, C., Appelbaum, F.R., Badger, C., Beatty, P., Bensinger, W., Berenson, R., Bigelow, C., Cheever, M.A., Clift, R., Deeg, H.J., Doney, K., Greenberg, P., Hansen, J.A., Hill, R., Loughran, T., Martin, P., Neiman, P., Petersen, F.B., Sanders, J., Singer, J., Stewart, P., Thomas, E.D.: Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73: 1720-1728, 1989.
800. Appelbaum, F.R., Brown, P., Sandmaier, B., Shields, A., Bianco, J., Graham, T., Schuening, F., Ketring, A., Kaplan, D., Storb, R.: Development of improved marrow transplant preparative regimens. Use of aminophosphonic acid-radionuclide conjugates. Biology of Radionuclide Therapy, DeNardo, G.L. (ed.): American College of Nuclear Physicians, Washington DC, 94-101, 1989.
801. Appelbaum, F.R., Badger, C., Bernstein, I., Bianco, J., Brown, P., Eary, J., Press, O., Sandmaier, B., Schuening, F., Storb, R.: Development of improved marrow transplant preparative regimens. Use of antibody-radionuclide conjugates. Technical Proceedings of the ACNP-SNM Joint Symposium on Biology of Radionuclide Therapy, DeNardo, G.L. (ed.): American College of Nuclear Physicians, Washington DC, 102-109, 1989.
802. Sanders, J.E., Buckner, C.D., Sullivan, K.M., Doney, K., Appelbaum, F., Witherspoon, R., Storb, R., Thomas, E.D.: Growth and development in children after bone marrow transplantation. Horm. Res. 30: 92-97, 1988.
803. Anasetti, C., Amos, D., Beatty, P.G., Appelbaum, F.R., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Martin, P.J., Mickelson, E., Nisperos, B., O’Quigley, J., Ramberg, R., Sanders, J.E., Stewart, P., Storb, R., Sullivan, K.M., Witherspoon, R.P., Thomas, E.D., Hansen, J.A.: Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N. Engl. J. Med. 320: 197-204, 1989.
804. Agosti, J.M., Sprenger, J.D., Lum, L.G., Witherspoon, R.P., Fisher, L.D., Storb, R., Henderson, W.R., Jr.: Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N. Engl. J. Med. 319: 1623-1628, 1988.
805. Doney, K., Kopecky, K., Storb, R., Buckner, C.D., Singer, J., Anasetti, C., Appelbaum, F., Beatty, P., Bensinger, W., Berenson, R., Clift, R., Deeg, H.J., Hansen, J., Hill, R., Loughran, T., Martin, P., Petersen, F.B., Sale, G., Sanders, J., Sullivan, K., Stewart, P., Weiden, P., Witherspoon, R., Thomas, E.D.: Long-term comparison of immunosuppressive therapy with antithymocyte globulin to bone marrow transplantation in aplastic anemia. Aplastic Anemia and Other Bone Marrow Failure Syndromes, Shahidi, N.T. (ed.): Springer-Verlag, New York, 9:104-114, 1990.
806. Appelbaum, F.R., Sandmaier, B., Brown, P.A., Kaplan, D., Ketring, A.R., Geockeler, W.F., Graham, T., Schuening, F., Storb, R.: Myelosuppression and mechanism of recovery following administration of 153 Samarium-EDTMP. Antibody, Immunoconjugates, and Radiopharmaceuticals 1: 263-270, 1988.
807. Schuening, F.G., Storb, R., Meyer, J., Goehle, S.: Long-term culture of canine bone marrow cells. Exp. Hematol. 17: 411-417, 1989.
808. Buckner, C.D., Sanders, J.E., Storb, R.: Bone marrow transplantation. Advances and Controversies in Thalassemia Therapy: Bone Marrow Transplantation and Other Approaches, Buckner, C.D., Gale, R.P., and Lucarelli, G. (eds.): A.R. Liss, Inc. New York, 317-323, 1989.
809. Niederwieser, D., Pepe, M., Storb, R., Witherspoon, R., Longton, G., Sullivan, K.: Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia. Bone Marrow Transplantation 4: 151-156, 1989.
810. Storb, R., Appelbaum, F., Schuening, F., Raff, R., Graham, T., Deeg, H.J.: Bone marrow transplantation and massive total body irradiation. The Medical Basis for Radiation Accident Preparedness: II. Clinical Experience and Follow-Up Since 1979, Ricks, R.C. and Fry, S.A. (eds.): Elsevier, New York, 109-120, 1990.
811. Sullivan, K.M., Buckner, C.D., Sanders, J.E., Anasetti, C., Appelbaum, F.R., Clark, J., Doney, K., Meyers, J., Sale, G., Storb, R., Thomas, E.D., Witherspoon, R.P.: Long-term complications of bone marrow transplantation. Advances and Controversies in Thalassemia Therapy: Bone Marrow Transplantation and Other Approaches, Buckner, C.D., Gale, R.P., and Lucarelli, G. (eds.): Alan R. Liss, Inc. New York, 367-374, 1989.
812. Storb, R.: Current issues and future directions in marrow transplantation. Modern Trends in Human Leukemia VIII, Neth, R., Gallo, R.C., Greaves, M.F., Gaedicke, G., Gohla, S., Mannweiler, K., and Ritter, J. (eds.): Springer-Verlag, Heidelberg, 37-45, 1989.
813. Sanders, J.E., Buckner, C.D., Sullivan, K.M., Doney, K., Appelbaum, F., Witherspoon, R., Anasetti, C., Storb, R., Thomas, E.D.: Growth and development after bone marrow transplantation. Advances and Controversies in Thalassemia Therapy: Bone Marrow Transplantation and Other Approaches, Buckner, C.D., Gale, R.P., and Lucarelli, G. (eds.): Alan R. Liss, Inc. New York, 375-382, 1989.
814. Buckner, C.D., Sanders, J.E., Anasetti, C., Beatty, P., Hansen, J.A., Storb, R., Clift, R.A., Thomas, E.D.: Donors other than HLA-identical siblings. Advances and Controversies in Thalassemia Therapy: Bone Marrow Transplantation and Other Approaches, Buckner, C.D., Gale, R.P., and Lucarelli, G. (eds.): Alan R. Liss, Inc. New York, 383-390, 1989.
815. Storb, R.: Allogeneic marrow transplantation. Experimental Hematology Today – 1988, Baum, S.J., Dicke, K., Lotzova, E., and Pluznik, D.H. (eds.): Springer-Verlag, New York, 155-161, 1989.
816. Sullivan, K.M., Storb, R., Witherspoon, R.P., Weiden, P.L., Anasetti, C., Appelbaum, F.R., Beatty, P., Buckner, C.D., Deeg, H.J., Doney, K., Fisher, L., Loughran, T.P., Martin, P., Meyers, J., McDonald, G.B., Sanders, J., Shulman, H., Stewart, P., Thomas, E.D.: Deletion of immunosuppressive prophylaxis after marrow transplantation increases hyperacute graft-versus-host disease but does not influence chronic graft-versus-host disease or relapse in patients with advanced leukemia. Clin. Transplant. 3: 5-11, 1989.
817. Mitchell, R.B., Wagner, J.E., Karp, J.E., Watson, A.J., Brusilow, S.W., Przepiorka, D., Storb, R., Santos, G.W., Burke, P.J., Saral, R.: Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: Review of nine cases. Am. J. Med. 85: 662-667, 1988.
818. Sanders, J.E., Doney, K.C., Hill, R., Martin, P., Buckner, C.D., Appelbaum, F.R., Bensinger, W.I., Petersen, F.B., Berenson, R., Sullivan, K.M., Storb, R., Thomas, E.D.: Autologous marrow transplant experience for acute lymphoblastic leukemia. Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium, Dicke, K.A., Spitzer, G., Jagannath, S., and Evinger-Hodges, M.J. (eds.): University of Texas MD Anderson Hospital, Houston, 155-160, 1989.
819. Buckner, C.D., Sanders, J.E., Hill, R., Martin, P., Doney, K., Clift, R., Appelbaum, F., Petersen, F.B., Storb, R., Bensinger, W.I., Berenson, R., Sullivan, K.M., Thomas, E.D.: Allogeneic versus autologous marrow transplantation for patients with acute lymphoblastic leukemia in first or second marrow remission. Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium, Dicke, K.A., Spitzer, G., Jagannath, S., and Evinger-Hodges, M.J. (eds.): University of Texas M.D. Hospital, Houston, 145-149, 1989.
820. Appelbaum, F.R., Buckner, C.D., Beatty, P.G., Hill, R., Petersen, F., Martin, P., Sanders, J., Stewart, P., Storb, R., Sullivan, K., Thomas, E.D.: Timing of bone marrow transplantation for adults with acute nonlymphocytic leukemia. Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium, Dicke, K.A., Spitzer, G., Jagannath, S., and Evinger-Hodges, M.J. (eds.): University of Texas M.D. Anderson Hospital, Houston, 21-26, 1989.
821. Nemunaitis, J., Singer, J.W., Buckner, C.D., Hill, R., Storb, R., Thomas, E.D., Appelbaum, F.R.: Use of recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) in autologous marrow transplantation for lymphoid malignancies. Autologous Bone Marrow Transplantation: Proceedings of the Third International Symposium, Dicke, K.A., Spitzer, G., Jagannath, S., and Evinger-Hodges, M.J. (eds.): University of Texas M.D. Anderson Hospital, Houston, 631-636, 1989.
822. Schuening, F.G., Storb, R., Stead, R.B., Kwok, W.W., Nash, R., Miller, A.D.: Improved retroviral transfer of genes into canine hematopoietic progenitor cells. Experimental Hematology Today, 1988, Baum, S.J., Dicke, K.A., Lotzova, E., and Pluznik, D.H. (eds.): Springer Verlag, New York, 75-80, 1989.
823. Storb, R.: Graft rejection and graft-versus-host disease in marrow transplantation. Transplant. Proc. 21: 2915-2918, 1989.
824. Storb, R.: Allogeneic bone marrow transplantation: General principles and current practice, Chapter 54. Principles of Transfusion Medicine, Rossi, E.C., Simon, T.L., and Moss, G.S. (eds.): Williams & Wilkins, Baltimore, 477-485, 1991.
825. Storb, R.: Allogeneic bone marrow transplantation: Current problems and possible solutions, Chapter 55. Principles of Transfusion Medicine, Rossi, E.C., Simon, T.L., and Moss, G.S. (eds.): Williams & Wilkins, Baltimore, 487-497, 1991.
826. Martin, P.J., Clift, R.A., Fisher, L.D., Buckner, C.D., Hansen, J.A., Appelbaum, F.R., Doney, K.C., Sullivan, K.M., Witherspoon, R.P., Storb, R., Thomas, E.D.: HLA-identical marrow transplantation during accelerated phase chronic myelogenous leukemia: Analysis of survival and remission duration. Blood 72: 1978-1984, 1988.
827. Ladiges, W.C., Keast, M., Appelbaum, F., Storb, R.: Phenotypic characterization of canine lymphoma, using monoclonal antibodies and a microlymphocytotoxicity assay. Am. J. Vet. Res. 49: 870-872, 1988.
828. Sullivan, K.M., Storb, R.: Bone marrow transplantation and graft-versus-host disease. Organ Transplantation: Current Clinical and Immunological Concepts, Brent, L. and Sells, R.A. (eds.): Bailliere Tindall Ltd. London, 91-118, 1989.
829. Deeg, H.J., Koppang, N., Shulman, H.M., Albrechtsen, D., Graham, T.C., Storb, R.: Allogeneic bone marrow transplantation for canine ceroid lipofuscinosis. Transplant. Proc. 21: 3082-3083, 1989.
830. Sullivan, K.M., Witherspoon, R.P., Storb, R., Buckner, C.D., Sanders, J., Thomas, E.D.: Long-term results of allogeneic bone marrow transplantation. Transplant. Proc. 21: 2926-2928, 1989.
831. Nash, R., Storb, R., Neiman, P.: Polyclonal reconstitution of human marrow after allogeneic bone marrow transplantation. Blood 72: 2031-2037, 1988.
832. Sarmiento, U.M., Storb, R.F.: Characterization of class II alpha genes and DLA-D region allelic associations in the dog. Tissue Antigens 32: 224-234, 1988.
833. Martin, P.J., Hansen, J.A., Torok-Storb, B., Moretti, L., Press, O., Storb, R., Thomas, E.D., Weiden, P.L., Vitetta, E.S.: Effects of treating marrow with a CD3-specific immunotoxin for prevention of acute graft-versus-host disease. Bone Marrow Transplantation 3: 437-444, 1988.
834. Martin, P.J., Hansen, J.A., Torok-Storb, B., Durnam, D., Przepiorka, D., O’Quigley, J., Sanders, J., Sullivan, K.M., Witherspoon, R.P., Deeg, H.J., Appelbaum, F.R., Stewart, P., Weiden, P., Doney, K., Buckner, C.D., Clift, R., Storb, R., Thomas, E.D.: Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplantation 3: 445-456, 1988.
835. Witherspoon, R.P., Storb, R.: Immunologic aspects of marrow transplantation. Immunology and Allergy Clinics of North America, Halloran, P.F. (ed.): W.B. Saunders & Co. Philadelphia, 187-208, 1989.
836. Witherspoon, R.P., Sullivan, K.M., Lum, L.G., Goehle, S., Atkinson, M.K., Ochs, H.D., Doney, K.C., Hansen, J.A., Sanders, J.E., Storb, R.: Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: brief report with 2 to 12 years’ follow-up. Bone Marrow Transplantation 3: 425-435, 1988.
837. Anasetti, C., Storb, R., Longton, G., Witherspoon, R., Doney, K., Sullivan, K.M., Thomas, E.D.: Donor buffy coat cell infusion after marrow transplantation for aplastic anemia. Letter to the Editor. Blood 72: 1099-1100, 1988.
838. Lum, L.G., Noges, J.E., Beatty, P., Martin, P.J., Deeg, J., Doney, K.C., Loughran, T., Sullivan, K.M., Witherspoon, R.P., Thomas, E.D., Storb, R.: Transfer of specific immunity in marrow recipients given HLA-mismatched, T cell-depleted, or HLA-identical marrow grafts. Bone Marrow Transplantation 3: 399-406, 1988.
839. Storb, R., Raff, R.F., Appelbaum, F.R., Schuening, F.W., Sandmaier, B.M., Graham, T.C., Thomas, E.D.: What radiation dose for DLA-identical canine marrow grafts? Blood 72: 1300-1304, 1988.
840. Storb, R., Deeg, H.J., Anasetti, C., Appelbaum, F., Beatty, P., Doney, K., Hansen, J., Schuening, F., Simmons, P., Sullivan, K., Witherspoon, R., Thomas, E.D., Torok-Storb, B.: Pathophysiology of marrow graft failure: A review of the Seattle data. Bone Marrow Transplantation: Current Controversies, UCLA Symposia on Molecular and Cellular Biology, New Series, Vol. 91, Gale, R.P. and Champlin, R. (eds.): Alan R. Liss, Inc. New York, 19-30, 1989.
841. Hill, R.S., Mazza, P., Amos, D., Buckner, C.D., Appelbaum, F.R., Martin, P., Still, B.J., Sica, S., Berenson, R., Bensinger, W., Clift, R.A., Stewart, P., Doney, K., Sanders, J., Singer, J., Sullivan, K.M., Witherspoon, R.P., Storb, R., Livingston, R., Chard, R., Thomas, E.D.: Engraftment in 86 patients with lymphoid malignancy after autologous marrow transplantation. Bone Marrow Transplantation 4: 69-74, 1989.
842. Raff, R.F., Severns, E., Storb, R., Martin, P., Graham, T., Sandmaier, B., Schuening, F., Sale, G., Appelbaum, F.R.: L-Leucyl-L-Leucine methyl ester treatment of canine marrow and peripheral blood cells: Inhibition of proliferative responses with maintenance of the capacity for autologous marrow engraftment. Transplantation 46: 655-660, 1988.
843. Appelbaum, F.R., Buckner, C.D., Storb, R., Thomas, E.D.: Marrow transplantation as treatment for hereditary hemoglobinopathies. Mechanisms of Action and Therapeutic Applications of Biologicals in Cancer and Immune Deficiency Disorders. UCLA Symposia on Molecular and Cellular Biology, New series, Vol. 100, Groopman, J., Evans, C., and Golde, D. (eds.): Alan R. Liss, Inc. New York, NY, 145-151, 1989.
844. Sullivan, K.M., Witherspoon, R.P., Storb, R., Anasetti, C., Appelbaum, F.R., Bigelow, C., Clark, J., Doney, K., Hill, R., Loughran, T., Matthews, D.D., Nims, J., Petersen, F., Sanders, J., Schüning, F., Shields, A., Strom, S., Thomas, E.D.: Chronic graft-versus-host disease: Recent advances in diagnosis and treatment. Bone Marrow Transplantation: Current Controversies. UCLA Symposia on Molecular and Cellular Biology, New Series, Vol. 91, Gale, R.P. and Champlin, R. (eds.): Alan R. Liss, Inc. New York, 511-522, 1989.
845. Nemunaitis, J., Singer, J.W., Buckner, C.D., Hill, R., Storb, R., Thomas, E.D., Appelbaum, F.R.: Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Concise Report. Blood 72: 834-836, 1988.
846. Storb, R., Anasetti, C., Appelbaum, F.R., Beatty, P., Deeg, H.J., Doney, K., Martin, P., Sullivan, K., Witherspoon, R., Thomas, E.D., for the Seattle Marrow Transplant Team: Predictive factors and prevention of acute graft-versus-host disease, the Seattle experience. Bone Marrow Transplantation 3: 7-10, 1988.
847. Sarmiento, U.M., Storb, R.F.: Restriction fragment length polymorphism of the major histocompatibility complex of the dog. Immunogenetics 28: 117-124, 1988.
848. Appelbaum, F.R., Petersen, F.B., Buckner, C.D., Badger, C., Sandmaier, B., Storb, R., Thomas, E.D.: New preparative regimens prior to marrow transplantation for acute nonlymphoblastic leukemia. Bone Marrow Transplantation: Current Controversies. UCLA Symposia on Molecular and Cellular Biology, New Series, Vol. 91, Gale, R.P. and Champlin, R. (eds.): Alan R. Liss, Inc. New York, NY, 107-116, 1989.
849. Witherspoon, R.P., Storb, R., Sullivan, K.M.: Enhancement of immunologic recovery after bone marrow transplantation: Is there a role for interleukins? Bone Marrow Transplantation: Current Controversies. UCLA Symposia on Molecular and Cellular Biology, New Series, Vol.91, Gale, R.P. and Champlin, R. (eds.): Alan R. Liss, Inc. New York, 585-594, 1989.
850. Storb, R.: Bone marrow transplantation for the treatment of chronic myelogenous leukemia. Am. J. Med. Sci. 31: 87-94, 1988.
851. Beatty, P.G., Witherspoon, R.P., Sullivan, K.M., Martin, P.J., Sanders, J.E., Appelbaum, F.R., Buckner, C.D., Storb, R., Thomas, E.D.: Long term results of bone marrow transplantation: The Seattle experience. Transplantation and Clinical Immunology, Touraine, J.L., Traeger, J., Betuel, H., Dubernard, J.M., Revillard, J.P., and Triau, R. (eds.): Elsevier Science Publishers B.B. Amsterdam, 203-216, 1987.
852. Deeg, H.J., Storb, R., Longton, G., Graham, T.C., Shulman, H.M., Appelbaum, F., Thomas, E.D.: Single dose or fractionated total body irradiation and autologous marrow transplantation in dogs: Effects of exposure rate, fraction size and fractionation interval on acute and delayed toxicity. Int. J. Radiat. Oncol. Biol. Phys. 15: 647-653, 1988.
853. Schuening, F., Storb, R., Nash, R., Stead, R.B., Kwok, W.W., Miller, A.D. Retroviral transfer of genes into canine hematopoietic progenitor cells. Advances in Experimental Medicine & Biology 241: 9-18, 1988.
854. Storb, R., Raff, R.F., Appelbaum, F.R., Schuening, F.W., Sandmaier, B.M., Graham, T.C.: The influence of transfusions from unrelated DLA-matched or mismatched donors upon marrow grafts between DLA-identical canine littermates. (Brief Communications). Transplantation 46: 334-336, 1988.
855. Sanders, J.E., Buckner, C.D., Thomas, E.D., Fleischer, R., Sullivan, K.M., Appelbaum, F.R., Storb, R.: Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. Concise Report. Blood 71: 1144-1146, 1988.
856. Deeg, H.J., Aprile, J., Storb, R., Graham, T.C., Hackman, R., Appelbaum, F.R., Schuening, F.: Functional dendritic cells are required for transfusion-induced sensitization in canine marrow graft recipients. Concise Report. Blood 71: 1138-1140, 1988.
857. Sanders, J.E., Buckner, C.D., Amos, D., Levy, W., Appelbaum, F.R., Doney, K., Storb, R., Sullivan, K.M., Witherspoon, R.P., Thomas, E.D.: Ovarian function following marrow transplantation for aplastic anemia or leukemia. J. Clin. Oncol. 6: 813-818, 1988.
858. Appelbaum, F.R., Meyers, J.D., Deeg, H.J., Graham, T., Schuening, F., Storb, R.: Toxicity trial of prophylactic 9-[2-Hydroxy-1-Hydroxymethyl)Ethoxymethyl] Guanine (Ganciclovir) after marrow transplantation in dogs. Antimicrob. Agents Chemother. 32: 271-273, 1988.
859. Riddell, S., Appelbaum, F.R., Buckner, C.D., Stewart, P., Clift, R., Sanders, J., Storb, R., Sullivan, K., Thomas, E.D.: High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia. J. Clin. Oncol. 6: 576-582, 1988.
860. Niederwieser, D., Pepe, M., Storb, R., Loughran, T.P., Jr., Longton, G., for the Seattle Marrow Transplant Team: Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anemia. Br. J. Haematol. 69: 23-28, 1988.
861. Storb, R.: Bone marrow transplantation. Cancer: Principles and Practice of Oncology, 1989, 3rd: DeVita, V.T., Jr., Hellman, S., and Rosenberg, S.A. (eds.): J.B.Lippincott Co. Philadelphia, 2474-2489, 1989.
862. Doney, K., Storb, R., Buckner, C.D., Thomas, E.D.: Treatment of gold-induced aplastic anaemia with immunosuppressive therapy. Br. J. Haematol. 68: 469-472, 1988.
863. Sullivan, K.M., Witherspoon, R.P., Storb, R., Weiden, P., Flournoy, N., Dahlberg, S., Deeg, H.J., Sanders, J.E., Doney, K.C., Appelbaum, F.R., McGuffin, R., McDonald, G.B., Meyers, J., Schubert, M.M., Gauvreau, J., Shulman, H.M., Sale, G.E., Anasetti, C., Loughran, T.P., Strom, S., Nims, J., Thomas, E.D.: Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: Prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 72: 546-554, 1988.
864. Storb, R.: Knochenmarktransplantation. Immunologie, 3rd: Gemsa, D., Kalden, J.R., and Resch, K. (eds.): Georg Thieme Verlag, Stuttgart, 606-619, 1991.
865. Stead, R.B., Kwok, W.W., Storb, R., Miller, A.D.: Canine model for gene therapy: Inefficient gene expression in dogs reconstituted with autologous marrow infected with retroviral vectors. Blood 71: 742-747, 1988.
866. Sullivan, K.M., Witherspoon, R.P., Storb, R., Deeg, H.J., Dahlberg, S., Sanders, J.E., Appelbaum, F.R., Doney, K.C., Weiden, P., Anasetti, C., Loughran, T.P., Hill, R., Shields, A., Yee, G., Shulman, H., Nims, J., Strom, S., Thomas, E.D.: Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-versus-host disease. Blood 72: 555-561, 1988.
867. Petersen, F.B., Sanders, J.E., Storb, R., Bensinger, W.I., Clift, R.A., Buckner, C.D.: Inadvertent administration of a greater-than-usual pre-marrow transplant dose of busulfan – Report of a case (Brief Communication). Transplantation 45: 821-822, 1988.
868. Sanders, J.E., Buckner, C.D., Clift, R.A., Fefer, A., McGuffin, R., Storb, R., Appelbaum, F., Bensinger, W., Beatty, P., Doney, K., Durnam, D., Martin, P., Sullivan, K., Stewart, P., Witherspoon, R.P., Thomas, E.D.: Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation. Bone Marrow Transplantation 3: 11-19, 1988.
869. Appelbaum, F.R., Graham, T., Sandmaier, B., Schuening, F., Storb, R.: Sensitivity of newly transplanted marrow to further irradiation. Transplantation 45: 813-814, 1988.
870. Storb, R., Deeg, H.J., Fisher, L.D., Appelbaum, F., Buckner, C.D., Bensinger, W., Clift, R., Doney, K., Irle, C., McGuffin, R., Martin, P., Sanders, J., Schoch, G., Singer, J., Stewart, P., Sullivan, K., Witherspoon, R., Thomas, E.D.: Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: Long-term follow-up of three controlled trials. Blood 71: 293-298, 1988.
871. Doney, K., Buckner, C.D., Kopecky, K.J., Sanders, J.E., Appelbaum, F.R., Clift, R.A., Sullivan, K., Witherspoon, R., Storb, R., Thomas, E.D.: Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission. Bone Marrow Transplantation 2: 355-363, 1987.
872. Sullivan, K.M., Storb, R.: Long-term results of marrow transplantation using cyclosporine. (Letter). Transplantation & Immunology 4: 9-11, 1988.
873. Deeg, H.J., Raff, R.F., Severns, E., Szer, J., Storb, R.: Two monoclonal antibodies recognizing subpopulations of canine T lymphocytes with or without suppressor/cytotoxic functions. Meth. Find. Exptl. Clin. Pharmacol. 9(11): 755-759, 1987.
874. Deeg, H.J., Slichter, S.J., Storb, R.: Transfusion-induced allosensitization in marrow transplant recipients: Mechanisms and preventive measures. Recent Advances and Future Directions in Bone Marrow Transplantation, (Experimental Hematology Today–1987), Baum, S.J., Santos, G.W., and Takaku, F. (eds.): Springer Verlag, New York, 18-23, 1988.
875. Appelbaum, F.R., Brown, P.A., Graham, T.C., Sandmaier, B.M., Schuening, F.W., Storb, R.: Characterization of malignant lymphoma in dogs and use as a model for the development of treatment strategies. Recent Advances and Future Directions in Bone Marrow Transplantation, (Experimental Hematology Today–1987), Baum, S.J., Santos, G.W., and Takaku, F. (eds.): Springer Verlag, New York, 31-35, 1988.
876. Martin, P.J., Hansen, J.A., Anasetti, C., Zutter, M., Durnam, D., Storb, R., Thomas, E.D.: Treatment of acute graft-versus-host disease with anti-CD3 monoclonal antibodies. Am. J. Kidney Dis. 11: 149-152, 1988.
877. Deeg, H.J., Atkinson, K., Weiden, P.L., Storb, R.: Mechanisms of tolerance in canine radiation chimeras. Transplant. Proc. Suppl.7, 19: 75-81, 1987.
878. Meyers, J.D., Flournoy, N., Sanders, J.E., McGuffin, R.W., Newton, B.A., Fisher, L.D., Lum, L.G., Appelbaum, F.R., Doney, K., Sullivan, K.M., Storb, R., Buckner, C.D., Thomas, E.D.: Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation. Ann. Intern. Med. 107: 809-816, 1987.
879. Storb, R., Doney, K., Thomas, E.D., Anasetti, C., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Fefer, A., Hansen, J., Hill, R., Martin, P., McGuffin, R., Sanders, J., Singer, J., Stewart, P., Sullivan, K., Witherspoon, R.: Allogeneic and syngeneic marrow transplantation for aplastic anemia: Overview of Seattle results. Recent Advances and Future Directions in Bone Marrow Transplantation, (Experimental Hematology Today–1987), Baum, S.J., Santos, G.W., and Takaku, F. (eds.): Springer-Verlag, New York, 119-124, 1988.
880. Slichter, S.J., Weiden, P., Kane, P., Storb, R.: Approaches to preventing or reversing platelet alloimmunization using animal models. Transfusion 28: 103-108, 1988.
881. Storb, R., Deeg, H.J., Appelbaum, F.R., Schuening, F.W., Raff, R.F., Graham, T.C.: The biology of graft rejection in a canine model of marrow transplantation. Transplant. Proc. Suppl.7, 19: 18-22, 1987.
882. Muller-Hermelink, H.K., Sale, G.E., Borisch, B., Storb, R.: Pathology of the thymus after allogeneic bone marrow transplantation in man: A histological and immunohistochemical study of 36 patients. Am. J. Pathol. 129: 242-256, 1987.
883. Deeg, H.J., Ladiges, W.C., Aprile, J., Schuening, F., Raff, R.F., Storb, R.: Monoclonal antibodies to canine differentiation antigens. Meth. Find. Exptl. Clin. Pharmacol. 9: 749-753, 1987.
884. Lum, L.G., Seigneuret, M.C., Doney, K.C., Storb, R.: In vitro immunoglobulin production, proliferation, and cell markers before and after antithymocyte globulin therapy in patients with aplastic anemia. Am. J. Hematol. 26: 1-15, 1987.
885. Appelbaum, F.R., Barrall, J., Storb, R., Ramberg, R., Doney, K., Sale, G.E., Thomas, E.D.: Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp. Hematol. 15: 1134-1139, 1987.
886. Storb, R., Deeg, H.J., Appelbaum, F.R., Schuening, F., Sandmaier, B., Raff, R.F., Graham, T.: Failure of anti-Ia monoclonal antibody to abrogate transfusion-induced sensitization and prevent marrow graft rejection in DLA-identical canine littermates. (Brief Communications). Transplantation 45: 505-506, 1988.
887. Sale, G.E., Rajantie, J., Doney, K., Appelbaum, F.R., Storb, R., Thomas, E.D.: Does histologic grading of inflammation in bone marrow predict the response of aplastic anemia patients to antithymocyte globulin therapy? Br. J. Haematol. 67: 261-266, 1987.
888. Clift, R.A., Buckner, C.D., Thomas, E.D., Kopecky, K.J., Appelbaum, F.R., Tallman, M., Storb, R., Sanders, J., Sullivan, K., Banaji, M., Beatty, P.S., Bensinger, W., Cheever, M., Deeg, J., Doney, K., Fefer, A., Greenberg, P., Hansen, J.A., Hackman, R., Hill, R., Martin, P., Meyers, J., McGuffin, R., Neiman, P., Sale, G., Shulman, H., Singer, J., Stewart, P., Weiden, P., Witherspoon, R.: The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation. Bone Marrow Transplantation 2: 243-258, 1987.
889. Ladiges, W.C., Pesando, J.M., Severns, E., Longton, G., Deeg, H.J., Storb, R.: Selective inhibition of the canine mixed lymphocyte response by HLA-DR and DP-reactive monoclonal antibodies. Transplantation 45: 484-488, 1988.
890. Storb, R., Raff, R.F., Appelbaum, F.R., Schuening, F., Sandmaier, B., Shulman, H., Deeg, H.J., Graham, T.: Failure of antithymocyte serum postgrafting to overcome “resistance” to DLA-nonidentical canine marrow grafts. (Brief Communications). Transplantation 45: 236-239, 1988.
891. Appelbaum, F.R., Sullivan, K.M., Buckner, C.D., Clift, R.A., Deeg, H.J., Fefer, A., Hill, R., Mortimer, J., Neiman, P.E., Sanders, J.E., Singer, J., Stewart, P., Storb, R., Thomas, E.D.: Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. J. Clin. Oncol. 5: 1340-1347, 1987.
892. Ladiges, W., Deeg, H.J., Pesando, J., Storb, R.: Effect of anti-Ia monoclonal antibodies on in vitro immune responses of canine cells. Am. J. Vet. Res. 49: 147-151, 1988.
893. Schuening, F., Storb, R., Goehle, S., Meyer, J., Graham, T.C., Deeg, H.J., Appelbaum, F.R., Sale, G.E., Graf, L., Loughran, T.P., Jr.: Facilitation of engraftment of DLA-nonidentical marrow by treatment of recipients with monoclonal antibody directed against marrow cells surviving radiation. Transplantation 44: 607-613, 1987.
894. Witherspoon, R.P., Buckner, C.D., Sullivan, K.M., Fisher, L., Clark, J., Storb, R., Thomas, E.D.: Causes of late failure in patients transplanted for acute leukemia. Bone Marrow Transplantation 2: 92-93, 1987.
895. Storb, R.: Prevention of human graft-versus-host disease by immunosuppression. T-Cell Depletion in Allogneic Bone-Marrow Transplantation. Serono Symposia Review No.13. Martelli, M.F., Grignani, F., and Reisner, Y. (eds.): Raven Press, New York, 105-110, 1988.
896. Storb, R.: Graft-versus-host and host-versus-graft reactions in a preclinical canine model. T-Cell Depletion in Allogeneic Bone-Marrow Transplantation. Serono Symposia Review No.13, Martelli, M.F., Grignani, F., and Reisner, Y. (eds.): Raven Press, New York, 31-36, 1988.
897. Beatty, P.G., Di Bartolomeo, P., Storb, R., Clift, R.A., Buckner, C.D., Sullivan, K.M., Doney, K., Appelbaum, F.R., Anasetti, C., Witherspoon, R., Sanders, J., Stewart, P., Martin, P.J., Ciancarelli, M., Hansen, J.A., Thomas, E.D.: Treatment of aplastic anemia with marrow grafts from related donors other than HLA genotypically-matched siblings. Clin. Transplant. 1: 117-124, 1987.
898. Deeg, H.J., Severns, E., Raff, R.F., Sale, G.E., Storb, R.: Specific tolerance and immunocompetence in haploidentical but not in completely allogeneic canine chimeras treated with methotrexate and cyclosporine. Transplantation 44: 621-632, 1987.
899. Ladiges, W.C., Raff, R.F., Storb, R.: A DLA-associated polymorphic cell surface determinant defined by the murine monoclonal antibody W3G10. Animal Genetics 18: 149-158, 1987.
900. Storb, R., Weiden, P.L., Sullivan, K.M., Appelbaum, F.R., Beatty, P., Buckner, C.D., Clift, R.A., Doney, K.C., Hansen, J., Martin, P.J., Sanders, J.E., Stewart, P., Witherspoon, R.P., Thomas, E.D.: Second marrow transplants in patients with aplastic anemia rejecting the first graft: Use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. Blood 70: 116-121, 1987.
901. Sullivan, K.M., Fefer, A., Witherspoon, R., Storb, R., Buckner, C.D., Weiden, P., Schoch, G., Thomas, E.D.: Graft-versus-leukemia in man: Relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation. Cellular Immunotherapy of Cancer, Truitt, R.L., Gale, R.P., and Bortin, M.M. (eds.): Alan R. Liss, Inc. New York, 391-399, 1987.
902. Lum, L.G., Seigneuret, M.C., Shiobara, S., Noges, J., Munn, N., Shough, N., Jin, N.-R., Beatty, P., Martin, P., Sullivan, K., Storb, R., Thomas, E.D.: Adoptively transferred immunity persists in human marrow graft recipients. Cellular Immunotherapy of Cancer, Truitt, R.L., Gale, R.P., and Bortin, M.M. (eds.): Alan R. Liss, Inc. New York, 449-460, 1987.
903. Fefer, A., Sullivan, K.M., Weiden, P., Buckner, C.D., Schoch, G., Storb, R., Thomas, E.D.: Graft versus leukemia effect in man: The relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. Cellular Immunotherapy of Cancer, Truitt, R.L., Gale, R.P., and Bortin, M.M. (eds.): Alan R. Liss, Inc. New York, 401-408, 1987.
904. Ladiges, W.C., Storb, R., Graham, T., Thomas, E.D.: Experimental techniques used to study the immune system of dogs and other large animals. Methods of Animal Experimentation, Vol.7, Part C, Gay, W.I. and Heavener, J.E. (eds.): Academic Press, New York, NY, 103-133, 1989.
905. Klingemann, H.-G., Tsoi, M.-S., Storb, R.: Fibronectin restores defective in vitro proliferation of lymphocytes from patients after marrow grafting. Transplant. Proc. 19: 2646-2647, 1987.
906. Deeg, H.J., Sale, G.E., Storb, R., Graham, T.C., Schuening, F., Appelbaum, F.R., Thomas, E.D.: Engraftment of DLA-nonidentical bone marrow facilitated by recipient treatment with anti-class II monoclonal antibody and methotrexate. Transplantation 44: 340-345, 1987.
907. Klingemann, H.-G., Self, S., Banaji, M., Deeg, H.J., Doney, K., Slichter, S.J., Thomas, E.D., Storb, R.: Refractoriness to random donor platelet transfusions in patients with aplastic anemia: A multivariate analysis of data from 264 cases. Br. J. Haematol. 66: 115-121, 1987.
908. Klingemann, H.-G., Lum, L.G., Storb, R.: Phenotypical and functional studies on a subtype of suppressor cells (CD8+CD11+) in patients after bone marrow transplantation. Transplantation 44: 381-386, 1987.
909. Appelbaum, F.R., Sullivan, K., Buckner, C.D., Clift, R., Hill, R., Sanders, J.E., Storb, R., Thomas, E.D.: Treatment of malignant lymphoma at first relapse or second remission with marrow transplantation. Autologous Bone Marrow Transplantation, Proceedings of the Third International Symposium on Autologous Transplantation, Houston, TX, Dicke, K.A., Spitzer, G., and Jagannath, S. (eds.): The University of Texas, Houston, 275-277, 1987.
910. Berenson, R.J., Bensinger, W.I., Kalamasz, D., Schuening, F., Deeg, H.J., Graham, T., Storb, R.: Engraftment of dogs with Ia-positive marrow cells isolated by avidin-biotin immunoadsorption. Blood 69: 1363-1367, 1987.
911. Witherspoon, R.P., Navari, R., Storb, R., Sullivan, K.M., Doney, K., Beatty, P., Lum, L.G., Thomas, E.D.: Treatment of marrow graft recipients with thymopentin. Bone Marrow Transplantation 1: 365-371, 1987.
912. Storb, R., Witherspoon, R.: Marrow transplantation: What determines success or failure of hematologic reconstitution? Onkologie 10: 166-171, 1987.
913. Shulman, H.M., Luk, K., Deeg, H.J., Shuman, W.B., Storb, R.: Induction of hepatic veno-occlusive disease in dogs. Am. J. Pathol. 126: 114-125, 1987.
914. Elkins, W., Pierson, G.R., Storb, R.: Study of a human minor alloantigen in relation to clinical graft-versus-host disease. Bone Marrow Transplantation 1: 397-403, 1987.
915. Yee, G.C., Kennedy, M.S., Self, S.G., Storb, R., Deeg, H.J.: Pharmacodynamics of cyclosporine in patients undergoing bone marrow transplantation. Transplant. Proc. 18: 774-776, 1986.
916. Storb, R., Kolb, H.J., Deeg, H.J., Weiden, P.L., Appelbaum, F., Graham, T.C., Thomas, E.D.: Prevention of graft-versus-host disease by immunosuppressive agents after transplantation of DLA-nonidentical canine marrow. Bone Marrow Transplantation 1: 167-177, 1986.
917. Doney, K., Storb, R., Buckner, C.D., McGuffin, R., Witherspoon, R., Deeg, H.J., Appelbaum, F., Sullivan, K., Thomas, E.D.: Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens. Exp. Hematol. 15: 239-242, 1987.
918. Storb, R.: The role of T cells in engraftment: Experimental models, clinical trials. Progress in Bone Marrow Transplantation, UCLA Symposia on Molecular and Cellular Biology, New Series, Vol. 53, Gale, R.P. and Champlin, R. (eds.): Alan R. Liss, Inc. New York, 23-35, 1987.
919. Matsue, K., Lum, L.G., Witherspoon, R.P., Storb, R.: Proliferative and differentiative responses of B cells from human marrow graft recipients to T cell-derived factors. Blood 69: 308-315, 1987.
920. Torok-Storb, B., Johnson, G.G., Bowden, R., Storb, R.: Gamma-interferon in aplastic anemia: Inability to detect significant levels in sera or demonstrate hematopoietic suppressing activity. Blood 69: 629-633, 1987.
921. Kanfer, E.J., Buckner, C.D., Fefer, A., Storb, R., Appelbaum, F.R., Hill, R.S., Amos, D., Doney, K.C., Clift, R.A., Shulman, H.M., McDonald, G.B., Thomas, E.D.: Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation. Bone Marrow Transplantation 1: 339-346, 1987.
922. Deeg, H.J., Aprile, J., Severns, E., Rajantie, J., Schmidt, E., Raff, R.F., Green, K.E., Storb, R.: Phenotypic and functional alterations of recipient lymphocytes after transfusion of UV-irradiated and normal blood -implications for marrow transplantation. Transplant. Proc. 19: 2709-2714, 1987.
923. Schuening, F., Storb, R., Goehle, S., Meyer, J., Graham, T., Deeg, H.J., Pesando, J.: Canine pluripotent hemopoietic stem cells and CFU-GM express Ia-like antigens as recognized by two different class-II specific monoclonal antibodies. Blood 69: 165-172, 1987.
924. Storb, R.: Critical issues in bone marrow transplantation. Transplant. Proc. 19: 2774-2781, 1987.
925. Kanfer, E.J., Petersen, F.B., Buckner, C.D., Stewart, P., Storb, R., Hill, R.S., Appelbaum, F.R., Clift, R.A., Doney, K.C., Shulman, H.M., Thomas, E.D.: Phase I study of high-dose dimethylbusulfan followed by autologous bone marrow transplantation in patients with advanced malignancy. Cancer Treat. Rep. 71: 101-102, 1987.
926. Raff, R.F., Loughran, T.P., Jr., Deeg, H.J., Aprile, J.A., Graham, T.C., Sale, G.E., Storb, R.: Role of radiation-resistant large granular lymphocytes in the rejection of unrelated DLA-nonidentical marrow grafts in dogs. Transplant. Proc. 19: 2718-2720, 1987.
927. Storb, R., Deeg, H.J., Whitehead, J., Farewell, V., Appelbaum, F.R., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Hansen, J., Hill, R., Lum, L.G., Martin, P., McGuffin, R., Sanders, J.E., Singer, J., Stewart, P., Sullivan, K.M., Witherspoon, R.P., Thomas, E.D.: Marrow transplantation for leukemia and aplastic anemia: Two controlled trials of a combination of methotrexate and cyclosporine versus cyclosporine alone or methotrexate alone for prophylaxis of acute graft-versus-host disease. Transplant. Proc. 19: 2608-2613, 1987.
928. Storb, R., Deeg, H.J.: Failure of allogeneic canine marrow grafts after total body irradiation: Allogeneic “resistance” vs transfusion induced sensitization. Transplantation 42: 571-580, 1986.
929. Clift, R.A., Storb, R.: Histoincompatible bone marrow transplants in humans. Annual Review of Immunology, Vol.5, Paul, W.E., Fathman, C.G., and Metzger, H. (eds.): Annual Reviews, Inc. Palo Alto, 43-64, 1987.
930. Appelbaum, F.R., Storb, R., Ramberg, R.E., Shulman, H.M., Buckner, C.D., Clift, R.A., Deeg, H.J., Fefer, A., Sanders, J., Self, S., Singer, J., Stewart, P., Sullivan, K., Witherspoon, R., Thomas, E.D.: Treatment of preleukemic syndromes with marrow transplantation. Blood 69: 92-96, 1987.
931. Martin, P.J., Hansen, J., Storb, R., Thomas, E.D.: Human marrow transplantation: An immunological perspective. Advances in Immunology, Vol.40, Dixon, F.J., Austen, K.F., Hood, L.E., and Uhr, J.W. (eds.): Academic Press, Orlando, Florida, 379-438, 1987.
932. Klingemann, H.-G., Maunder, R.J., Storb, R.: Reduced monocyte-associated fibronectin in patients after allogeneic marrow transplantation. Transplantation 43: 454-457, 1987.
933. Klingemann, H.-G., Tsoi, M.-S., Storb, R.: Inhibition of prostaglandin E2 restores defective lymphocyte proliferation and cell-mediated lympholysis in recipients after allogeneic marrow grafting. Blood 68: 102-107, 1986.
934. Deeg, H.J., Self, S., Storb, R., Doney, K., Appelbaum, F.R., Witherspoon, R.P., Sullivan, K.M., Sheehan, K., Sanders, J., Mickelson, E., Thomas, E.D.: Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: Changing impact of risk factors. Blood 68: 1363-1368, 1986.
935. Sanders, J.E., Pritchard, S., Mahoney, P., Amos, D., Buckner, C.D., Witherspoon, R.P., Deeg, H.J., Doney, K.C., Sullivan, K.M., Appelbaum, F.R., Storb, R., Thomas, E.D.: Growth and development following marrow transplantation for leukemia. Blood 68: 1129-1135, 1986.
936. Ladiges, W., Deeg, H.J., Aprile, J., Raff, R., Schuening, F., Storb, R.: Differentiation and function of lymphohemopoietic cells in the dog. Differentiation Antigens in Lymphohemopoietic Tissues, Trnka, Z. and Miyasaka, M. (eds.): Marcel-Dekker, Inc. New York, 307-335, 1988.
937. Raff, R.F., Deeg, H.J., Loughran, T.P., Jr., Graham, T.C., Aprile, J.A., Sale, G.E., Storb, R.: Characterization of host cells involved in resistance to marrow grafts in dogs transplanted from unrelated DLA-nonidentical donors. Blood 68: 861-868, 1986.
938. Hansen, J.A., Beatty, P.G., Anasetti, C., Clift, R.A., Martin, P.J., Sanders, J., Sullivan, K., Buckner, C.D., Storb, R., Thomas, E.D.: Treatment of leukemia by marrow transplantation from donors other than HLA genotypically identical siblings. Progress in Bone Marrow Transplantation, UCLA Symposia on Molecular and Cellular Biology, New Series, Vol. 53, Gale, R.P. and Champlin, R. (eds.): Alan R. Liss, Inc. New York, N.Y. 667-675, 1987.
939. Lum, L.G., Seigneuret, M.C., Storb, R.: The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients. J. Clin. Immunol. 6: 389-396, 1986.
940. Storb, R.: Graft-versus-host disease after marrow transplantation. Transplantation: Approaches to Graft Rejection, Meryman, H.T. (ed.): Alan R. Liss, Inc. New York, 139-157, 1986.
941. Lum, L.G., Seigneuret, M.C., Jin, N.-R., Noges, J.E., Munn, N.A., Culbertson, N.J., Storb, R.: Transfer of antigen-specific memory cells from marrow donors to marrow recipients. Progress in Bone Marrow Transplantation, UCLA Symposia on Molecular and Cellular Biology, New Series, Vol. 53, Gale, R.P. and Champlin, R. (eds.): Alan R. Liss, Inc. 635-639, 1987.
942. Sullivan, K.M., Witherspoon, R., Deeg, H.J., Doney, K., Appelbaum, F., Sanders, J., Lum, L., Loughran, T., Hill, R., Anasetti, C., Shields, A., Nims, J., Shulman, H., Storb, R., Thomas, E.D.: Chronic graft-versus-host disease in man. Progress in Bone Marrow Transplantation, UCLA Symposia on Molecular and Cellular Biology, New Series, Vol.53, Gale, R.P. and Champlin, R. (eds.): Alan R. Liss, Inc. New York, 473-487, 1987.
943. Klingemann, H.-G., Deeg, H.J., Self, S., Thomas, E.D., Storb, R.: Is race a risk factor for allogeneic marrow transplantation? Bone Marrow Transplantation 1: 87-94, 1986.
944. Deeg, H.J., Sullivan, K.M., Buckner, C.D., Storb, R., Appelbaum, F.R., Clift, R.A., Doney, K., Sanders, J.E., Witherspoon, R.P., Thomas, E.D.: Marrow transplantation for acute nonlymphoblastic leukemia in first remission: Toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplantation 1: 151-157, 1986.
945. Berenson, R.J., Bensinger, W.I., Kalamasz, D., Schuening, F., Deeg, H.J., Storb, R.: Avidin-Biotin immunoadsorption: A technique to purify cells and its potential applications. Progress in Marrow Transplantation, UCLA Symposia on Molecular and Cellular Biology, New Series, Vol. 53, Gale, R.P. and Champlin, R. (eds.): Alan R. Liss, Inc. New York, 423-428, 1987.
946. Appelbaum, F.R., Storb, R., Buckner, C.D., Ramberg, R.E., Shulman, H.M., Sargur, M., Clift, R.A., Deeg, H.J., Fefer, A., Sanders, J., Singer, J., Stewart, P., Sullivan, K., Witherspoon, R., Thomas, E.D.: The role of marrow transplantation in the treatment of preleukemia, therapy-related preleukemia, and acute leukemia evolving from preleukemia. Progress in Bone Marrow Transplantation, UCLA Symposia on Molecular and Cellular Biology, New Series, Vol.53, Gale, R.P. and Champlin, R. (eds.): Alan R. Liss, Inc. New York, 103-111, 1987.
947. Deeg, H.J., Shulman, H.M., Schmidt, E., Yee, G.C., Thomas, E.D., Storb, R.: Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine. Transplantation 42: 497-501, 1986.
948. Banaji, M., Bearman, S.I., Buckner, C.D., Clift, R.A., Bensinger, W.I., Petersen, F.B., Slichter, S.J., McGuffin, R.W., Sanders, J.E., Stewart, P.S., Hill, R.S., Deeg, H.J., Storb, R., Thomas, E.D.: The effects of splenectomy on engraftment and platelet transfusion requirements in patients with chronic myelogenous leukemia undergoing marrow transplantation. Am. J. Hematol. 22: 275-283, 1986.
949. Deeg, H.J., Storb, R.: Immunobiology of marrow transplantation. EOS 6: 202-209, 1986.
950. Rajantie, J., Sale, G.E., Deeg, H.J., Amos, D., Appelbaum, F., Storb, R., Clift, R.A., Buckner, C.D.: Adverse effect of severe marrow fibrosis on hematological recovery after chemoradiotherapy and allogeneic bone marrow transplantation. Blood 67: 1693-1697, 1986.
951. Deeg, H.J., Doney, K., Sullivan, K.M., Witherspoon, R.P., Appelbaum, F.R., Storb, R.: Prevention and treatment of graft-versus-host disease (GVHD) with drugs. Progress in Bone Marrow Transplantation, UCLA Symposia on Molecular and Cellular Biology, New Series, Vol.53, Gale, R.P. and Champlin, R. (eds.): Alan R. Liss, Inc. New York, 265-276, 1987.
952. Slichter, S.J., O’Donnell, M.R., Weiden, P.L., Storb, R., Schroeder, M.-L.: Canine platelet alloimmunization; The role of donor selection. Br. J. Haematol. 63: 713-727, 1986.
953. Sullivan, K.M., Deeg, H.J., Sanders, J., Klosterman, A., Amos, D., Shulman, H., Sale, G., Martin, P., Witherspoon, R., Appelbaum, F.R., Doney, K., Stewart, P., Meyers, J., McDonald, G.B., Weiden, P., Fefer, A., Buckner, C.D., Storb, R., Thomas, E.D.: Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation (concise report). Blood 67: 1172-1175, 1986.
954. Bolger, G.B., Sullivan, K.M., Storb, R., Witherspoon, R.P., Weiden, P.L., Stewart, P., Sanders, J., Meyers, J.D., Martin, P.J., Doney, K.C., Deeg, H.J., Clift, R.A., Buckner, C.D., Appelbaum, F.R., Thomas, E.D.: Second marrow infusion for poor graft function after allogeneic marrow transplantation. Bone Marrow Transplantation 1: 21-30, 1986.
955. Anasetti, C., Doney, K.C., Storb, R., Meyers, J.D., Farewell, V.T., Buckner, C.D., Appelbaum, F.R., Sullivan, K.M., Clift, R.A., Deeg, H.J., Fefer, A., Martin, P.J., Singer, J.W., Sanders, J.E., Stewart, P.S., Witherspoon, R.P., Thomas, E.D.: Marrow transplantation for severe aplastic anemia: Long term outcome in fifty “untransfused” patients. Ann. Intern. Med. 104: 461-466, 1986.
956. Klingemann, H.-G., Tsoi, M.-S., Storb, R.: Fibronectin restores defective in vitro proliferation of patients’ lymphocytes after marrow grafting. Transplantation 42: 412-417, 1986.
957. Klingemann, H.-G., Storb, R., Fefer, A., Deeg, H.J., Appelbaum, F.R., Buckner, C.D., Cheever, M.A., Greenberg, P.D., Stewart, P.S., Sullivan, K.M., Witherspoon, R.P., Thomas, E.D.: Bone marrow transplantation in patients aged 45 years and older. Blood 67: 770-776, 1986.
958. Storb, R., Deeg, H.J., Farewell, V., Doney, K., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Hansen, J., Hill, R., Longton, G., Lum, L., Martin, P., McGuffin, R., Sanders, J., Singer, J., Stewart, P., Sullivan, K., Witherspoon, R., Thomas, E.D.: Marrow transplantation for severe aplastic anemia: Methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 68: 119-125, 1986.
959. Storb, R., Deeg, H.J., Whitehead, J., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Farewell, V., Hansen, J., Hill, R., Lum, L., Martin, P., McGuffin, R., Sanders, J., Stewart, P., Sullivan, K., Witherspoon, R., Yee, G., Thomas, E.D.: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N. Engl. J. Med. 314: 729-735, 1986.
960. Bolger, G.B., Sullivan, K.M., Spencer, A.M., Appelbaum, F.R., Johnston, R., Sanders, J.E., Deeg, H.J., Witherspoon, R.P., Doney, K.C., Nims, J., Thomas, E.D., Storb, R.: Myasthenia gravis after allogeneic bone marrow transplantation: Relationship to chronic graft-versus-host disease. Neurology 36: 1087-1091, 1986.
961. Tilney, N.L., Bach, J.F., Bell, P., Groth, C., Hardy, M., Jonasson, A., Monaco, A., Najarian, J., Rapaport, F., Salvatierra, O., Sells, R., Kincaid Smith, P., Stiller, C., Storb, R., Svejgaard, A., Terasaki, P., Ting, A., Wood, M., Veith, F., Morris, P.: Commercialization in transplantation: The problems and some guidelines for practice. Lancet ii: 715-716, 1985.
962. Appelbaum, F.R., Deeg, H.J., Storb, R., Graham, T.C., Charrier, K., Bensinger, W.: Cure of malignant lymphoma in dogs with peripheral blood stem cell transplantation. Transplantation 42: 19-22, 1986.
963. Appelbaum, F.R., Sullivan, K.M., Thomas, E.D., Buckner, C.D., Clift, R.A., Deeg, H.J., Fefer, A., Flournoy, N., Hill, R., Sanders, J.E., Stewart, P., Storb, R.: Autologous marrow transplantation for malignant lymphoma. Experimental Hematology Today 1985, Baum, S.J., Pluznik, D.H., and Rozenszajn, L.A. (eds.): Springer-Verlag, New York, 122-127, 1986.
964. Hill, R.S., Petersen, F.B., Storb, R., Appelbaum, F.R., Doney, K., Dahlberg, S., Ramberg, R., Thomas, E.D.: Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood 67: 811-816, 1986.
965. Witherspoon, R.P., Buckner, C.D., Thomas, E.D., Deeg, H.J., Sullivan, K., Clift, R., Doney, K., Flournoy, N., Appelbaum, F., Clark, J., Sanders, J., Storb, R.: Results of allogeneic marrow transplantation in patients transplanted for acute leukemia: A long-term follow-up. Minimal Residual Disease in Acute Leukemia, Hagenbeek, A. and Lowenberg, B. (eds.): Martinus Nijhoff, Dodrecht, 318-322, 1986.
966. Appelbaum, F.R., Badger, C., Deeg, H.J., Nelp, W.B., Storb, R.: Use of iodine-131-labeled anti-immune response-associated monoclonal antibody as preparative regimen prior to bone marrow transplantation: Initial dosimetry. NCI Monogr. 3: 67-71, 1987.
967. Deeg, H.J., Aprile, J., Graham, T.C., Appelbaum, F.R., Storb, R.: Ultraviolet irradiation of blood prevents transfusion-induced sensitization and marrow graft rejection in dogs. Concise Report. Blood 67: 537-539, 1986.
968. Deeg, H.J., Lum, L.G., Sanders, J., Levy, G.J., Sullivan, K.M., Beatty, P., Thomas, E.D., Storb, R.: Severe aplastic anemia associated with chronic mucocutaneous candidiasis: Immunologic and hematologic reconstitution after allogeneic bone marrow transplantation. Transplantation 41: 583-586, 1986.
969. Shiobara, S., Lum, L.G., Witherspoon, R.P., Storb, R.: Antigen specific antibody responses of lymphocytes to tetanus toxoid after human marrow transplantation. Transplantation 41: 587-592, 1986.
970. Irle, C., Deeg, H.J., Buckner, C.D., Kennedy, M., Storb, R., Clift, R.A., Thomas, E.D.: Marrow transplantation for advanced leukemia in patients over 30 years with fractionated TBI: A randomized trial of MTX and Cyclosporine. Exp. Hematol. 13: 154, 1985.
971. Witherspoon, R., Flournoy, N., Thomas, E.D., Ramberg, R., Buckner, C.D., Storb, R.: Recurrence of acute leukemia more than two years after allogeneic marrow grafting. Exp. Hematol. 14: 178-181, 1986.
972. Sullivan, K.M., Witherspoon, R., Storb, R., Appelbaum, F., Beatty, P., Bensinger, W., Bigelow, C., Buckner, C.D., Cheever, M., Clift, R., Doney, K., Fefer, A., Greenberg, P., Hansen, J., Martin, P., Matthews, D., McDonald, G., Meyers, J., Petersen, F.B., Sanders, J., Shulman, H., Singer, J., Stewart, P., Thomas, E.D.: Chronic graft-versus-host disease: Pathogenesis, diagnosis, treatment and prognostic factors. Recent Advances and Future Directions in Bone Marrow Transplantation, (Experimental Hematology Today–1987), Baum, S.J., Santos, G.W., and Takaku, F. (eds.): Springer Verlag, New York, 150-157, 1988.
973. Thomas, E.D., Clift, R.A., Fefer, A., Appelbaum, F.R., Beatty, P., Bensinger, W.I., Buckner, C.D., Cheever, M.A., Deeg, H.J., Doney, K., Flournoy, N., Greenberg, P., Hansen, J.A., Martin, P., McGuffin, R., Ramberg, R., Sanders, J.E., Singer, J., Stewart, P., Storb, R., Sullivan, K., Weiden, P.L., Witherspoon, R.: Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann. Intern. Med. 104: 155-163, 1986.
974. Lum, L.G., Munn, N.A., Schanfield, M.S., Storb, R.: The detection of specific antibody formation to recall antigens after human bone marrow transplantation. Blood 67: 582-587, 1986.
975. Storb, R., Thomas, E.D.: Graft-versus-host disease in dog and man: The Seattle Experience. Immunological Reviews No.88, Möller, G. (ed.): Munksgaard, Copenhagen, 215-238, 1985.
976. Deeg, H.J., Doney, K., Sullivan, K.M., Loughran, T.P., Appelbaum, F., Kennedy, M., Witherspoon, R.P., Storb, R.: Antithymocyte globulin followed by cyclosporine for the treatment of acute GVHD in patients given HLA-identical or -nonidentical marrow grafts. Transplant. Proc. 18: 791-793, 1986.
977. Appelbaum, F.R., Sullivan, K.M., Thomas, E.D., Buckner, C.D., Clift, R.A., Deeg, H.J., Neiman, P.E., Sanders, J.E., Stewart, P., Storb, R.: Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin’s disease. J. Clin. Oncol. 3: 1490-1494, 1985.
978. Huebers, H.A., Eng, M., Graham, T.C., Deeg, H.J., Storb, R., Finch, C.A.: Erythropoietic reserve in marrow-transplanted dogs. Exp. Hematol. 14: 97-100, 1986.
979. Bull, R.W., Vriesendorp, H.M., Cech, R., Grosse-Wilde, H., Bijma, A.M., Ladiges, W.L., Krumbacher, K., Doxiadis, I., Ejima, H., Templeton, J., Albert, E.D., Storb, R., Deeg, H.J.: Joint Report of the Third International Workshop on Canine Immunogenetics. II. Analysis of the serological typing of cells. Transplantation 43: 154-161, 1987.
980. Deeg, H.J., Raff, R.F., Grosse-Wilde, H., Bijma, A.M., Buurman, W., Doxiadis, I., Kolb, H.J., Krumbacher, K., Ladiges, W., Losslein, K.L., Schoch, G., Westbroek, D.L., Bull, R.W., Storb, R.: Joint Report of the Third International Workshop on Canine Immunogenetics: I. Analysis of homozygous typing cells. Transplantation 41: 111-117, 1986.
981. Doney, K., Storb, R., Buckner, C.D., Sanders, J., Witherspoon, R., Thomas, E.D.: Marrow transplantation for treatment of pregnancy-associated aplastic anemia. Exp. Hematol. 13: 1080-1083, 1985.
982. Witherspoon, R.P., Goehle, S., Kretschmer, M., Storb, R.: Regulation of immunoglobulin production after human marrow grafting: The role of helper and suppressor T cells in acute graft-versus-host disease. Transplantation 41: 328-335, 1986.
983. Doney, K.C., Storb, R.: Immunosuppressive therapy for aplastic anemia. Cancer Bull. 37: 235-237, 1985.
984. Loughran, T.P., Jr., Deeg, H.J., Storb, R.: Morphologic and phenotypic analysis of canine natural killer cells: Evidence for T-cell lineage. Cell. Immunol. 95: 207-217, 1985.
985. Sanders, J.E., Thomas, E.D., Buckner, C.D., Flournoy, N., Stewart, P.S., Clift, R.A., Lum, L., Bensinger, W.I., Storb, R., Appelbaum, F.R., Sullivan, K.M.: Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: An update. Blood 66: 460-462, 1985.
986. Klingemann, H.-G., Storb, R., Sanders, J., Deeg, H.J., Appelbaum, F.R., Thomas, E.D.: Acute lymphoblastic leukaemia after bone marrow transplantation for aplastic anaemia. Br. J. Haematol. 63: 47-50, 1986.
987. Beatty, P.G., Clift, R.A., Mickelson, E.M., Nisperos, B., Flournoy, N., Martin, P.J., Sanders, J.E., Stewart, P., Buckner, C.D., Storb, R., Thomas, E.D., Hansen, J.A.: Marrow transplantation from related donors other than HLA-identical siblings. N. Engl. J. Med. 313: 765-771, 1985.
988. Jin, N.R., Hill, R.S., Petersen, F.B., Buckner, C.D., Stewart, P.S., Amos, D., Appelbaum, F.R., Clift, R.A., Bensinger, W.I., Sanders, J.E., Doney, K.C., Sullivan, K.M., Witherspoon, R.P., Deeg, H.J., Storb, R., Livingston, R., Chard, R., Thomas, E.D.: Marrow harvesting for autologous marrow transplantation. Exp. Hematol. 13: 879-884, 1985.
989. Klingemann, H.-G., Storb, R.: Cyclosporin in der allogenen knochenmark – transplantation. Internist 26: 569-574, 1985.
990. Sullivan, K.M., Meyers, J.D., Flournoy, N., Storb, R., Thomas, E.D.: Early and late interstitial pneumonia following human bone marrow transplantation. Int. J. Cell Cloning 4: 107-121, 1986.
991. Sanders, J.E., Whitehead, J., Storb, R., Buckner, C.D., Clift, R.A., Mickelson, E., Appelbaum, F.R., Bensinger, W.I., Stewart, P.S., Doney, K., Sullivan, K., Deeg, H.J., Witherspoon, R.P., Thomas, E.D.: Bone marrow transplantation experience for children with aplastic anemia. Pediatrics 77: 179-186, 1986.
992. Martin, P.J., Hansen, J.A., Buckner, C.D., Sanders, J.E., Deeg, H.J., Stewart, P., Appelbaum, F.R., Clift, R., Fefer, A., Witherspoon, R.P., Kennedy, M.S., Sullivan, K.M., Flournoy, N., Storb, R., Thomas, E.D.: Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66: 664-672, 1985.
993. Yee, G.C., Kennedy, M.S., Deeg, H.J., Leonard, T.M., Thomas, E.D., Storb, R.: Cyclosporine-associated renal dysfunction in marrow transplant recipients. Transplant. Proc. 17: 196-201, 1985.
994. Raff, R.F., Storb, R., Ladiges, W.C., Deeg, H.J.: Recognition of target cell determinants associated with DLA-D-locus-encoded antigens by canine cytotoxic lymphocytes. Transplantation 40: 323-328, 1985.
995. Torok-Storb, B., Doney, K., Sale, G., Thomas, E.D., Storb, R.: Subsets of patients with aplastic anemia identified by flow microfluorometry. N. Engl. J. Med. 312: 1015-1022, 1985.
996. Storb, R., Doney, K., for the Seattle Bone Marrow Transplant Team: Therapy of severe aplastic anemia. Exp. Hematol. 13: 58-60, 1985.
997. Storb, R.: Marrow grafting for leukemia. Exp. Hematol. 13: 6-8, 1985.
998. Klingemann, H.-G., Deeg, H.J., Storb, R.: Knochenmark-transplantation bei chronisch myeloischer leukamie. Dtsch. Med. Wochenschr. 109: 37-38, 1985.
999. Storb, R., Deeg, H.J., Thomas, E.D., Appelbaum, F.R., Buckner, C.D., Cheever, M.A., Clift, R.A., Doney, K.C., Flournoy, N., Kennedy, M.S., Loughran, T.P., McGuffin, R.W., Sale, G.E., Sanders, J.E., Singer, J.W., Stewart, P.S., Sullivan, K.M., Witherspoon, R.P.: Marrow transplantation for chronic myelocytic leukemia: A controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease. Blood 66: 698-702, 1985.
1000. Irle, C., Deeg, H.J., Buckner, C.D., Kennedy, M., Clift, R., Storb, R., Appelbaum, F.R., Beatty, P., Bensinger, W., Doney, K., Cheever, M., Fefer, A., Greenberg, P., Hill, R., Martin, P., McGuffin, R., Sanders, J., Stewart, P., Sullivan, K., Witherspoon, R., Thomas, E.D.: Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine. Leuk. Res. 9: 1255-1261, 1985.
1001. Szer, J., Deeg, H.J., Rieber, P., Storb, R.: Monoclonal antibody to human cytotoxic-suppressor T-Lymphocytes cross-reacts with canine lymphocytes and inhibits cell-mediated lympholysis of canine cells. Exp. Hematol. 13: 641-646, 1985.
1002. Deeg, H.J., Loughran, T.P., Jr., Storb, R., Kennedy, M.S., Sullivan, K.M., Doney, K., Appelbaum, F.R., Thomas, E.D.: Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. Transplantation 40: 162-166, 1985.
1003. Storb, R., Deeg, H.J.: Contributions of the dog model in marrow transplantation. Plasma Ther. Transfus. Technol. 6: 303-312, 1985.
1004. Deeg, H.J., Appelbaum, F.R., Weiden, P.L., Hackman, R.C., Graham, T.C., Storb, R.: Autologous marrow transplantation as consolidation therapy for canine lymphoma: Efficacy and toxicity of various regimens of total body irradiation. Am. J. Vet. Res. 46: 2016-2018, 1985.
1005. Deeg, H.J., Storb, R.: Immunosuppression for marrow transplantation. Plasma Ther. Transfus. Technol. 6: 163-180, 1985.
1006. Lum, L.G., Storb, R.: Bone marrow transplantation, Chapter 19. Principles of Organ Transplantation, Flye, M.W. (ed.): WB Saunders and Company, Philadelphia, 19:478-499, 1989.
1007. Lum, L.G., Seigneuret, M.C., Orcutt-Thordarson, N., Noges, J.E., Storb, R.: The regulation of immunoglobulin synthesis after HLA-identical bone marrow transplantation: VI. Differential rates of maturation of distinct functional groups within lymphoid subpopulations in patients after human marrow grafting. Blood 65: 1422-1433, 1985.
1008. Deeg, H.J., Storb, R.: Acute and chronic graft-versus-host-disease: Clinical manifestations, prophylaxis and treatment. J. Natl. Cancer Inst. 76: 1325-1328, 1986.
1009. Warren, R.P., Lum, L.G., Storb, R.: Is the leukocyte group-5a antigen associated with reduced NK cell function? Tissue Antigens 25: 107-110, 1985.
1010. Appelbaum, F.R., Deeg, H.J., Storb, R., Self, S., Graham, T.C., Sale, G.E., Weiden, P.L.: Marrow transplant studies in dogs with malignant lymphoma. Transplantation 39: 499-504, 1985.
1011. Kennedy, M.S., Deeg, H.J., Storb, R., Doney, K., Sullivan, K.M., Witherspoon, R.P., Appelbaum, F.R., Stewart, P., Sanders, J., Buckner, C.D., Martin, P., Weiden, P., Thomas, E.D.: Treatment of acute graft-versus-host disease after allogeneic marrow transplantation: Randomized study comparing corticosteroids and cyclosporine. Am. J. Med. 78: 978-983, 1985.
1012. Doney, K., Martin, P., Storb, R., Whitehead, J., Smith, A., Hansen, J.A., Appelbaum, F., Buckner, C.D., Thomas, E.D.: A randomized trial of antihuman thymocyte globulin versus murine monoclonal antihuman T-cell antibodies as immunosuppressive therapy for aplastic anemia. Exp. Hematol. 13: 520-524, 1985.
1013. Deeg, H.J., Storb, R., Thomas, E.D., Flournoy, N., Kennedy, M.S., Banaji, M., Appelbaum, F.R., Bensinger, W.I., Buckner, C.D., Clift, R.A., Doney, K., Fefer, A., McGuffin, R., Sanders, J.E., Singer, J., Stewart, P., Sullivan, K.M., Witherspoon, R.P.: Cyclosporine as prophylaxis for graft-versus-host disease: A randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood 65: 1325-1334, 1985.
1014. Klingemann, H.-G., Storb, R.: Allogene knochenmark – transplantation. Deutsches Aerzteblatt 82: 1852-1861, 1985.
1015. Storb, R., for the Seattle Marrow Transplant Team: Treatment of Leukemia: Marrow transplantation versus chemotherapy. Internal Medicine Today and Tomorrow, Oda, T., Hamaguchi, K., Homma, M., and Kawai, C. (eds.): Elsevier Science Publishers B.V. Amsterdam, 233-236, 1986.
1016. Buckner, C.D., Meyers, J.D., Springmeyer, S.C., Sullivan, K.M., Hackman, R.C., Flournoy, N., Clift, R., Storb, R., Witherspoon, R.P., Petersen, F.B., Thomas, E.D.: Pulmonary complications of marrow transplantation. Review of the Seattle experience. Exp. Hematol. 12: 1-5, 1984.
1017. Appelbaum, F.R., Cheever, M.A., Fefer, A., Storb, R., Thomas, E.D.: Recurrence of aplastic anemia following cyclophosphamide and syngeneic bone marrow transplantation: Evidence for two mechanisms of graft failure. Blood 65: 553-556, 1985.
1018. Storb, R., for the Seattle Marrow Transplant Team: Marrow transplantation: The Seattle experience. Tokai J. Exp. Clin. Med. 10: 75-83, 1985.
1019. Yee, G.C., Kennedy, M.S., Storb, R., Thomas, E.D.: Effect of hepatic dysfunction on oral cyclosporine pharmacokinetics in marrow transplant patients. Blood 64: 1277-1279, 1984.
1020. Storb, R.: Marrow transplantation in the treatment of malignant diseases. Directions in Oncology. Vol.1, No.4, Mitchell, M.S. (ed.): Nassau Publications, Inc. New Canaan, CT, 2-8, 1984.
1021. Ladiges, W.C., Durkopp, N., Urban, C., Wulff, J.C., Storb, R.: Monoclonal antibodies to canine cell surface antigens: A comparison of screening assays. Hybridoma 3(4): 387-390, 1984.
1022. Brkic, S., Tsoi, M.-S., Mori, T., Lachman, L., Gillis, S., Thomas, E.D., Storb, R.: Cellular interactions in marrow-grafted patients. III. Normal interleukin 1 and defective interleukin 2 production in short-term patients and in those with chronic graft-versus-host disease. Transplantation 39: 30-35, 1985.
1023. Martin, P.J., Hansen, J.A., Storb, R., Thomas, E.D.: T cell depletion of donor marrow for prevention of acute graft-versus-host disease. Haematology and Blood Transfusion, Modern Trends in Human Leukemia VI, Neth, R., Gallo, R.C., Greaves, M.F., and Janka, G.E. (eds.): Springer-Verlag, Berlin, 42-43, 1985.
1024. Szer, J., Deeg, H.J., Appelbaum, F.R., Storb, R.: Failure of autologous marrow reconstitution after cytolytic treatment of marrow with anti-Ia monoclonal antibody. Blood 65: 819-822, 1985.
1025. Martin, P.J., Hansen, J.A., Storb, R., Thomas, E.D.: A clinical trial of in vitro depletion of T cells in donor marrow for prevention of acute graft-versus-host disease. Transplant. Proc. 17: 486-487, 1985.
1026. Deeg, H.J., Storb, R., Szer, J., Appelbaum, F.R., Hackman, R.C., Thomas, E.D.: Facilitation of engraftment of DLA-nonidentical marrow by treatment of the recipient with monoclonal anti-Ia antibody. Transplant. Proc. 17: 493-494, 1985.
1027. Szer, J., Deeg, H.J., Severns, E., Storb, R.: DLA-D-specific suppressor cells characterized by monoclonal antibodies. Transplantation 39: 187-192, 1985.
1028. Ladiges, W.C., Deeg, H.J., Raff, R.F., Storb, R.: Immunogenetic aspects of a canine breeding colony. Lab. Anim. Sci. 35: 58-62, 1985.
1029. Loughran, T.P., Jr., Deeg, H.J., Dahlberg, S., Kennedy, M.S., Storb, R., Thomas, E.D.: Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graft-versus-host disease prophylaxis. Br. J. Haematol. 59: 547-553, 1985.
1030. Appelbaum, F.R., Dahlberg, S., Thomas, E.D., Buckner, C.D., Cheever, M.A., Clift, R.A., Crowley, J., Deeg, H.J., Fefer, A., Greenberg, P., Kadin, M., Smith, W., Stewart, P., Sullivan, K., Storb, R., Weiden, P.: Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia – A prospective comparison. Ann. Intern. Med. 101: 581-588, 1984.
1031. Thomas, E.D., Sanders, J.E., Buckner, C.D., Papayannopoulou, T., Borgna-Pignatti, C., De Stefano, P., Sullivan, K.M., Deeg, H.J., Witherspoon, R.P., Appelbaum, F.R., Clift, R.A., Storb, R.: Marrow transplantation for thalassemia. Ann. NY Acad. Sci. 445: 417-427, 1985.
1032. Yee, G.C., Kennedy, M.S., Storb, R., Thomas, E.D.: Pharmacokinetics of intravenous cyclosporine in bone marrow transplant patients. Comparison of two assay methods. Transplantation 38: 511-513, 1984.
1033. Martin, P.J., Hansen, J.A., Storb, R., Thomas, E.D.: Applications of monoclonal antibodies for prevention of graft-versus-host disease. Monoclonal Antibodies in Haematopathology, Grignani, F., Mantelli, M.F., and Mason, D.Y. (eds.): Raven Press, New York, 139-148, 1986.
1034. Springmeyer, S.C., Silvestri, R.C., Flournoy, N., Kosanke, C.W., Peterson, D.L., Huseby, J.S., Hudson, L.D., Storb, R., Thomas, E.D.: Pulmonary function of marrow transplant patients. I. Effects of marrow infusion, acute graft-versus-host disease, and interstitial pneumonitis. Exp. Hematol. 12: 805-810, 1984.
1035. Buckner, C.D., Clift, R.A., Sanders, J.E., Stewart, P., Bensinger, W.I., Doney, K.C., Sullivan, K.M., Witherspoon, R.P., Deeg, H.J., Appelbaum, F.R., Storb, R., Thomas, E.D.: Marrow harvesting from normal donors. Blood 64: 630-634, 1984.
1036. Storb, R.: Bone marrow transplantation: Progress and problems. Editorial Comment. J. Pediatr. 105: 414-418, 1984.
1037. Sanders, J.E., Flournoy, N., Thomas, E.D., Buckner, C.D., Lum, L.G., Clift, R.A., Appelbaum, F.R., Sullivan, K.M., Stewart, P., Deeg, H.J., Doney, K., Storb, R.: Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse and graft-versus-host disease. Med. Pediatr. Oncol. 13: 165-172, 1985.
1038. Deeg, H.J., Sanders, J., Martin, P., Fefer, A., Neiman, P., Singer, J., Storb, R., Thomas, E.D.: Secondary malignancies after marrow transplantation. Exp. Hematol. 12: 660-666, 1984.
1039. Shiobara, S., Witherspoon, R.P., Lum, L.G., Storb, R.: Immunoglobulin synthesis after HLA-identical marrow grafting: V. The role of peripheral blood monocytes in the regulation of in vitro immunoglobulin secretion stimulated by PW mitogen. J. Immunol. 132: 2850-2856, 1984.
1040. Storb, R.: Prevention and treatment of graft-versus-host disease. Newsletter. Clin. Immunol. 6: 132-135, 1985.
1041. Mickelson, E.M., Beatty, P.G., Storb, R., Hansen, J.A.: Immune responses in an untransfused patient with aplastic anemia: Analysis of cytolytic and proliferative T cell clones. Hum. Immunol. 10: 189-201, 1984.
1042. Szer, J., Deeg, H.J., Witherspoon, R.P., Fefer, A., Buckner, C.D., Thomas, E.D., Storb, R.: Long-term survival after marrow transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia. Ann. Intern. Med. 101: 193-195, 1984.
1043. Witherspoon, R.P., Storb, R., Shulman, H., Buckner, C.D., Deeg, H.J., Clift, R.A., Sanders, J.E., Doney, K., McDonald, G., Sullivan, K.M., Appelbaum, F.R., Thomas, E.D.: Marrow transplantation in hepatitis-associated aplastic anemia. Am. J. Hematol. 17: 269-278, 1984.
1044. Stewart, P., Buckner, C.D., Bensinger, W., Appelbaum, F., Fefer, A., Clift, R., Storb, R., Sanders, J., Meyers, J., Hill, R., Thomas, E.D.: Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remission. Exp. Hematol. 13: 267-272, 1985.
1045. Thomas, E.D., Storb, R.: Acquired severe aplastic anemia: Progress and perplexity. Blood 64: 325-328, 1984.
1046. Deeg, H.J., Flournoy, N., Sullivan, K.M., Sheehan, K., Buckner, C.D., Sanders, J.E., Storb, R., Witherspoon, R.P., Thomas, E.D.: Cataracts after total body irradiation and marrow transplantation: A sparing effect of dose fractionation. Int. J. Radiat. Oncol. Biol. Phys. 10: 957-964, 1984.
1047. Schubert, M.M., Sullivan, K.M., Morton, T.H., Izutsu, K.T., Peterson, D.E., Flournoy, N., Truelove, E.L., Sale, G.E., Buckner, C.D., Storb, R., Thomas, E.D.: Oral manifestations of chronic graft-v-host disease. Arch. Intern. Med. 144: 1591-1595, 1984.
1048. Appelbaum, F.R., Storb, R., Ramberg, R.E., Shulman, H.M., Buckner, C.D., Clift, R.A., Deeg, H.J., Fefer, A., Sanders, J., Stewart, P., Sullivan, K., Witherspoon, R., Thomas, E.D.: Allogeneic marrow transplantation in the treatment of preleukemia. Ann. Intern. Med. 100: 689-693, 1984.
1049. Storb, R.: Anticancer agents in bone marrow transplantation. Biological Responses in Cancer Immunomodulation by Anticancer Drugs. Chapter 7, Vol.3, Mihich, E. and Sakurai, Y. (eds.): Plenum Publishing Co. New York, 7:181-206, 1985.
1050. Ladiges, W.C., Raff, R.F., Brown, S., Deeg, H.J., Storb, R.: The canine major histocompatibility complex. Supertypic specificities defined by the primed lymphocyte test (PLT). Immunogenetics 19: 359-365, 1984.
1051. Tsoi, M.-S., Dobbs, S., Brkic, S., Ramberg, R., Thomas, E.D., Storb, R.: Cellular interactions in marrow-grafted patients. II. Normal monocyte antigen-presenting and defective T-cell-proliferative functions early after grafting and during chronic graft-versus-host disease. Transplantation 37: 556-561, 1984.
1052. Storb, R., Thomas, E.D.: Transplantation of bone marrow. Immunological Diseases, Vol 1, 4th: Samter, M. (ed.): Little, Brown & Co. Boston, 19:467-495, 1988.
1053. Witherspoon, R.P., Deeg, H.J., Lum, L.G., Ochs, H.D., Hansen, J.A., Thomas, E.D., Storb, R.: Immunologic recovery in human marrow graft recipients given cyclosporine or methotrexate for the prevention of graft-versus-host disease. Transplantation 37: 456-461, 1984.
1054. Cheever, M.A., Fefer, A., Greenberg, P.D., Appelbaum, F.R., Armitage, J.O., Buckner, C.D., Sale, G.E., Storb, R., Witherspoon, R.P., Thomas, E.D.: Identical twin bone marrow transplantation for hairy cell leukemia. Semin. Oncol. 11: 511-513, 1984.
1055. Schmidt, E., Deeg, H.J., Storb, R.: Regression of androgen-related hepatic tumors in patients with Fanconi’s anemia following marrow transplantation. Transplantation 37: 452-455, 1984.
1056. Storb, R.: Marrow transplantation for the treatment of malignant diseases. Progress in Transplantation, Vol.1, Morris, P.J. and Tilney, N. (eds.): Churchill Livingstone, London, 46-70, 1984.
1057. Martin, P.J., Remlinger, K., Hansen, J.A., Storb, R., Thomas, E.D., Seattle Marrow Transplant Team: Murine monoclonal anti-T cell antibodies for treatment of refractory acute graft-versus-host disease (GVHD). Transplant. Proc. 16: 1494-1495, 1984.
1058. Tsoi, M.-S., Mori, T., Brkic, S., Dobbs, S., Gillis, S., Santos, E., Thomas, E.D., Storb, R.: Ineffective cellular interaction and interleukin 2 deficiency causing T cell defects in human allogeneic marrow recipients early after grafting and in those with chronic graft-versus-host disease. Transplant. Proc. 16: 1470-1472, 1984.
1059. Ralph, D.D., Springmeyer, S.C., Sullivan, K.M., Hackman, R.C., Storb, R., Thomas, E.D.: Rapidly progressive air-flow obstruction in marrow transplant recipients: Possible association between obliterative bronchiolitis and chronic graft-versus-host disease. Am. Rev. Respir. Dis. 129: 641-644, 1984.
1060. Ramsay, N.K.C., Storb, R.: Bone marrow transplantation for aplastic anemia. Aplastic Anemia: Stem Cell Biology and Advances in Treatment, Young, N.S., Levine, A.S., and Humphries, R.K. (eds.): Alan R. Liss, Inc. New York, 291-295, 1984.
1061. Deeg, H.J., Storb, R., Thomas, E.D.: Bone marrow transplantation: A review of delayed complications. (Review). Br. J. Haematol. 57: 185-208, 1984.
1062. Springmeyer, S.C., Kopecky, K.J., Deeg, H.J., Whitehead, J., Altman, L.C., Storb, R.: Pulmonary bronchoalveolar cell and protein kinetics in dogs given total body irradiation, autologous marrow grafts and methotrexate. Transplantation 37: 336-339, 1984.
1063. Navari, R.M., Buckner, C.D., Clift, R.A., Storb, R., Sanders, J.E., Stewart, P., Sullivan, K.M., Williams, B., Counts, G.W., Meyers, J.D., Thomas, E.D.: Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants. Am. J. Med. 76: 564-572, 1984.
1064. Remlinger, K., Martin, P.J., Hansen, J.A., Doney, K.C., Smith, A., Deeg, H.J., Sullivan, K., Storb, R., Thomas, E.D.: Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host disease. Hum. Immunol. 9: 21-35, 1984.
1065. Appelbaum, F.R., Sale, G.E., Storb, R., Charrier, K., Deeg, H.J., Graham, T., Wulff, J.C.: Phenotyping of canine lymphoma with monoclonal antibodies directed at cell surface antigens: Classification, morphology, clinical presentation, and response to chemotherapy. Hematol. Oncol. 2: 151-168, 1984.
1066. Storb, R.: Marrow transplantation in cancer. International Medicine 4: 9-13, 1984.
1067. Doney, K.C., Torok-Storb, B., Dahlberg, S., Buckner, C.D., Martin, P., Hansen, J.A., Thomas, E.D., Storb, R.: Immunosuppressive therapy of severe aplastic anemia. Aplastic Anemia: Stem Cell Biology and Advances in Treatment, Young, N.S., Levine, A.S., and Humphries, R.K. (eds.): Alan R. Liss Inc. New York, 259-270, 1984.
1068. O’Brien, K.D., Hackman, R.C., Sale, G.E., Prentice, R., Deeg, J., Thomas, E.D., Storb, R.: Lymphocytic bronchitis unrelated to acute graft-versus-host disease in canine marrow graft recipients. Transplantation 37: 233-238, 1984.
1069. Doney, K., Dahlberg, S.J., Monroe, D., Storb, R., Buckner, C.D., Thomas, E.D.: Therapy of severe aplastic anemia with anti-human thymocyte globulin and androgens: The effect of HLA-haploidentical marrow infusion. Blood 63: 342-348, 1984.
1070. Prentice, R.L., Storb, R., Brown, K.S., Mason, M.W.: HLA and disease: Relative risk regression methods and multiple testing considerations. Biometrics 40: 653-661, 1984.
1071. Sullivan, K.M., Deeg, H.J., Sanders, J.E., Shulman, H.M., Witherspoon, R.P., Doney, K., Appelbaum, F.R., Schubert, M.M., Stewart, P., Springmeyer, S., McDonald, G.B., Storb, R., Thomas, E.D.: Late complications after marrow transplantation. Semin. Hematol. 21: 53-63, 1984.
1072. Thomas, E.D., Storb, R.: Hematopoietic cell transplantation. Hematol. Transfusiol. 4: 38-44, 1984.
1073. Storb, R., Thomas, E.D., Buckner, C.D., Appelbaum, F.R., Clift, R.A., Deeg, H.J., Doney, K., Hansen, J.A., Prentice, R.L., Sanders, J.E., Stewart, P., Sullivan, K.M., Witherspoon, R.P.: Marrow transplantation for aplastic anemia. Semin. Hematol. 21: 27-35, 1984.
1074. Witherspoon, R.P., Lum, L.G., Storb, R.: Immunologic reconstitution after human marrow grafting. Semin. Hematol. 21: 2-10, 1984.
1075. Storb, R., Thomas, E.D., Santos, G.: Marrow transplantation. Hematology 1985. American Society of Hematology, AnonymousCharles B. Slack, Inc. Thorofare, NJ, 69-75, 1985.
1076. Thomas, E.D., Sanders, J.E., Flournoy, N., Johnson, F.L., Buckner, C.D., Clift, R.A., Fefer, A., Goodell, B.W., Storb, R., Weiden, P.L.: Marrow transplantation for patients with acute lymphoblastic leukemia: A long-term follow-up. Blood 62: 1139-1141, 1983.
1077. Storb, R., Prentice, R.L., Hansen, J.A., Thomas, E.D.: Association between HLA-B antigens and acute graft-versus-host disease. Lancet ii: 816-819, 1983.
1078. Deeg, H.J., Storb, R.: Graft-versus-host disease: Pathophysiological and clinical aspects. Annu. Rev. Med. 35: 11-24, 1984.
1079. Fefer, A., Cheever, M.A., Greenberg, P.D., Buckner, C.D., Storb, R., Thomas, E.D.: Bone marrow transplantation for neoplasia in man. Biological Responses in Cancer: Progress Toward Potential Application, Mihich, E. (ed.): Plenum Press, New York, 207-237, 1984.
1080. Thomas, E.D., Clift, R.A., Storb, R.: Indications for marrow transplantation. Annu. Rev. Med. 35: 1-9, 1984.
1081. Witherspoon, R.P., Matthews, D., Storb, R., Atkinson, K., Cheever, M., Deeg, H.J., Doney, K., Kalbfleisch, J., Noel, D., Prentice, R., Sullivan, K.M., Thomas, E.D.: Recovery of in vivo cellular immunity after human marrow grafting: Influence of time postgrafting and acute graft-versus-host disease. Transplantation 37: 145-150, 1984.
1082. Storb, R., Thomas, E.D., Appelbaum, F.R., Clift, R.A., Deeg, H.J., Doney, K., Hansen, J.A., Prentice, R.L., Sanders, J.E., Singer, J.W., Shulman, H., Stewart, P.S., Sullivan, K.M., Dahlberg, S.J., Buckner, C.D., Witherspoon, R.P.: Marrow transplantation for severe aplastic anemia: The Seattle experience. Aplastic Anemia: Stem Cell Biology and Advances in Treatment, Young, N.S., Levine, A.S., and Humphries, R.K. (eds.): Alan R. Liss Inc. New York, 297-313, 1984.
1083. Deeg, H.J., Storb, R., Appelbaum, F.R., Kennedy, M.S., Graham, T.C., Thomas, E.D.: Combined immunosuppression with cyclosporine and methotrexate in dogs given bone marrow grafts from DLA-haploidentical littermates. Transplantation 37: 62-65, 1984.
1084. Sale, G.E., Storb, R.: Bilateral diffuse pulmonary ectopic ossification after marrow allograft in a dog. Evidence for allotransplantation of hemopoietic and mesenchymal stem cells. Exp. Hematol. 11: 961-966, 1983.
1085. Wulff, J.C., Springmeyer, S.C., Deeg, H.J., Storb, R.: Canine bronchoalveolar cells: Antigen-presenting macrophages are Ia-positive, lymphocytes are of non-B lineage. Blut 47: 263-270, 1983.
1086. Kennedy, M.S., Yee, G.C., Deeg, H.J., Storb, R., Thomas, E.D.: Pharmacokinetics and toxicity of cyclosporine in marrow transplant patients. Transplant. Proc. 15: 2416-2418, 1983.
1087. Camitta, B., O’Reilly, R.J., Sensenbrenner, L., Rappeport, J., Champlin, R., Doney, K., August, C., Hoffmann, R.G., Kirkpatrick, D., Stuart, R., Santos, G., Parkman, R., Gale, R.P., Storb, R., Nathan, D.: Anti-thoracic duct lymphocyte globulin therapy of severe aplastic anemia. Blood 62: 883-888, 1983.
1088. Storb, R., Deeg, H.J., Thomas, E.D., Buckner, C.D., Clift, R.A., Flournoy, N., Kennedy, M.S., Doney, K., Appelbaum, F.R., Sanders, J.E., Stewart, P., Shulman, H., Sullivan, K.M., Witherspoon, R.P.: Preliminary results of prospective randomized trials comparing methotrexate and cyclosporine for prophylaxis of graft-vs.-host-disease after HLA-identical marrow transplantation. Transplant. Proc. 15: 2620-2623, 1983.
1089. Deeg, H.J., Raff, R.F., Severns, E., Appelbaum, F.R., Thomas, E.D., Storb, R.: Suppressor and cytotoxic cells in DLA nonidentical canine radiation chimeras given cyclosporine and methotrexate as prophylaxis for graft-versus-host disease. Transplant. Proc. 15: 3042-3045, 1983.
1090. Navari, R.M., Sullivan, K.M., Springmeyer, S.C., Siegel, M.S., Meyers, J.D., Buckner, C.D., Sanders, J.E., Stewart, P.S., Clift, R.A., Fefer, A., Storb, R., Thomas, E.D.: Mycobacterial infections in marrow transplant patients. Transplantation 36: 509-513, 1983.
1091. Deeg, H.J., Prentice, R., Fritz, T.E., Sale, G.E., Lombard, L.S., Thomas, E.D., Storb, R.: Increased incidence of malignant tumors in dogs after total body irradiation and marrow transplantation. Int. J. Radiat. Oncol. Biol. Phys. 9: 1505-1511, 1983.
1092. Storb, R.: Pathophysiology and prevention of graft-versus-host disease. Advances in Immunobiology: Blood Cell Antigens and Bone Marrow Transplantation, McCullough, J. and Sandler, S.G. (eds.): Alan R. Liss, Inc. New York, 337-366, 1984.
1093. Deeg, H.J., Tsoi, M.-S., Storb, R.: Mechanisms of tolerance in marrow transplantation. Transplant. Proc. 16: 933-937, 1984.
1094. Storb, R.: Advances in bone marrow transplantation. Transplantation in the 1980s: Recent Advances, Jamison, R.L. (ed.): Praeger, New York, 37-59, 1984.
1095. Deeg, H.J., Kennedy, M.S., Sanders, J.E., Thomas, E.D., Storb, R.: Successful pregnancy after marrow transplantation for severe aplastic anemia and immunosuppression with cyclosporine. JAMA 250: 647, 1983.
1096. Sullivan, K.M., Storb, R.: Allogeneic marrow transplantation. Cancer Invest. 2: 27-38, 1984.
1097. Witherspoon, R.P., Hersman, J., Storb, R., Ochs, H., Goldstein, A.L., McClure, J., Noel, D., Weiden, P.L., Thomas, E.D.: Thymosin fraction 5 does not accelerate reconstitution of immunologic reactivity after human marrow grafting. Br. J. Haematol. 55: 595-608, 1983.
1098. Martin, P.J., Hansen, J.A., Remlinger, K., Torok-Storb, B., Storb, R., Thomas, E.D.: Murine monoclonal anti-human T cell antibodies for the prevention and treatment of graft-versus-host disease. Recent Advances in Bone Marrow Transplantation, Gale, R.P. (ed.): Alan R. Liss Inc. New York, 313-329, 1983.
1099. Sullivan, K.M., Storb, R., Witherspoon, R., Shulman, H., Deeg, H.J., Schubert, M., Doney, K., Appelbaum, F., Tsoi, M.-S., Sale, G., Sanders, J., McDonald, G., Thomas, E.D.: Biology and treatment of chronic graft-versus-host disease. Recent Advances in Bone Marrow Transplantation, Gale, R.P. (ed.): Alan R. Liss Inc. New York, 331-342, 1983.
1100. Thomas, E.D., Appelbaum, F.R., Buckner, C.D., Clift, R.A., Deeg, H.J., Fefer, A., Sanders, J.E., Singer, J., Stewart, P., Sullivan, K.M., Storb, R., Witherspoon, R.P.: Marrow transplantation for acute nonlymphocytic leukemia. Recent Advances in Bone Marrow Transplantation, Gale, R.P. (ed.): Alan R. Liss Inc. New York, 61-70, 1983.
1101. Springmeyer, S.C., Flournoy, N., Sullivan, K.M., Storb, R., Thomas, E.D.: Pulmonary function changes in long-term survivors of allogeneic marrow transplantation. Recent Advances in Bone Marrow Transplantation, Gale, R.P. (ed.): Alan R. Liss Inc. NY, 343-353, 1983.
1102. Deeg, H.J., Storb, R., Thomas, E.D.: The dog as a preclinical model of marrow transplantation. Recent advances in bone marrow transplantation, Gale, R.P. (ed.): Alan R. Liss Inc. New York, 527-546, 1983.
1103. Storb, R., Witherspoon, R.P., Sullivan, K.M., Stewart, P., Sanders, J.E., Sale, G.E., Prentice, R.L., Hansen, J.A., Doney, K., Deeg, H.J., Clift, R.A., Buckner, C.D., Appelbaum, F.R., Thomas, E.D.: Allogeneic marrow transplants for treatment of severe aplastic anemia. Recent Advances in Bone Marrow Transplantation, Gale, R.P. (ed.): Alan R. Liss Inc. New York, 3-10, 1983.
1104. Witherspoon, R., Lum, L., Storb, R., Thomas, E.D.: Transplant-related immune deficiency in man. Recent Advances in Bone Marrow Transplantation, Gale, R.P. (ed.): Alan R. Liss Inc. New York, 473-482, 1983.
1105. Tsoi, M.-S., Storb, R., Thomas, E.D.: Immunological basis of graft-versus-host disease in humans. Recent Advances in Bone Marrow Transplantation, Gale, R.P. (ed.): Alan R. Liss Inc. New York, 291-312, 1983.
1106. Buckner, C.D., Stewart, P.S., Bensinger, W., Clift, R., Appelbaum, F., Martin, P., Sanders, J., Fefer, A., Lum, L., Storb, R., Hill, R., Thomas, E.D.: Critical issues in autologous marrow transplantation for hematologic malignancies. Recent advances in bone marrow transplantation, Gale, R.P. (ed.): Alan R. Liss Inc. New York, 599-613, 1983.
1107. Storb, R., Santos, G.W.: Application of marrow transplantation in leukemia and aplastic anemia, Chapter 5. Clinics in Haematology, Vol.12, Nathan, D.G. (ed.): W.B. Saunders & Co. Ltd. London, 5:721-737, 1983.
1108. Sanders, J.E., Buckner, C.D., Leonard, J.M., Sullivan, K.M., Witherspoon, R.P., Deeg, H.J., Storb, R., Thomas, E.D.: Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 36: 252-255, 1983.
1109. Storb, R., Prentice, R.L., Thomas, E.D., Appelbaum, F.R., Deeg, H.J., Doney, K., Fefer, A., Goodell, B.W., Mickelson, E., Stewart, P., Sullivan, K.M., Witherspoon, R.P.: Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. Br. J. Haematol. 55: 573-585, 1983.
1110. Hansen, J.A., Atkinson, K., Martin, P.J., Storb, R., Longton, G., Thomas, E.D.: Human T lymphocyte phenotypes after bone marrow transplantation. T cells expressing “la-like” antigen. Transplantation 36: 277-281, 1983.
1111. Lum, L.G., Seigneuret, M.C., Orcutt-Thordarson, N., Froelich, T.L., Storb, R.: Functional diversity in OKT4 and OKT8 subsets from long-term survivors after HLA-identical marrow grafting. Diagn. Immunol. 1: 179-187, 1983.
1112. Appelbaum, F.R., Thomas, E.D., Buckner, C.D., Clift, R.A., Deeg, H.J., Fefer, A., Neiman, P.E., Sanders, J., Stewart, P., Storb, R., Sullivan, K.: Treatment of non-Hodgkin’s lymphoma with chemoradiotherapy and allogeneic marrow transplantation. Hematol. Oncol. 1: 149-157, 1983.
1113. Storb, R.: Marrow transplantation in aplastic anemia and acute leukemia: Experience of the Seattle team. J. Exp. Clin. Cancer Res. 2: 249-258, 1983.
1114. Raff, R.F., Deeg, H.J., Farewell, V.T., DeRose, S., Storb, R.: The canine major histocompatibility complex. Population study of DLA-D alleles using a panel of homozygous typing cells. Tissue Antigens 21: 360-373, 1983.
1115. Mori, T., Tsoi, M.-S., Dobbs, S., Thomas, E.D., Storb, R.: Impaired autologous and allogeneic mixed lymphocyte reaction in human marrow transplant recipients. Exp. Hematol. 11: 425-434, 1983.
1116. Storb, R., Prentice, R.L., Buckner, C.D., Clift, R.A., Appelbaum, F., Deeg, J., Doney, K., Hansen, J.A., Mason, M., Sanders, J.E., Singer, J., Sullivan, K.M., Witherspoon, R.P., Thomas, E.D.: Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N. Engl. J. Med. 308: 302-307, 1983.
1117. Appelbaum, F.R., Clift, R.A., Buckner, C.D., Stewart, P., Storb, R., Sullivan, K.M., Thomas, E.D.: Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. Blood 61: 949-953, 1983.
1118. Schmidt, E., Deeg, H.J., Lum, L.G., Kopecky, K.J., Storb, R.: Identification of immunoglobulin-secreting cells among canine peripheral blood mononuclear cells by the protein A hemolytic plaque assay. Exp. Hematol. 11: 193-201, 1983.
1119. Wulff, J.C., Santner, T.J., Storb, R., Banaji, M., Buckner, C.D., Clift, R., Stewart, P., Sanders, J., Slichter, S., Thomas, E.D.: Transfusion requirements after HLA-identical marrow transplantation in 82 patients with aplastic anemia. Vox Sang. 44: 366-374, 1983.
1120. Storb, R., Thomas, E.D.: Current state of marrow transplantation. Contemporary Hematology/Oncology, Vol. 3, Silber, R., Gordon, A.S., and Lobue, J. (eds.): Plenum Medical, New York, 235-266, 1984.
1121. Storb, R., Prentice, R.L., Banaji, M., Witherspoon, R.P., Sullivan, K.M., Stewart, P., Sanders, J.E., Mason, M., Doney, K., Deeg, J., Clift, R.A., Buckner, C.D., Appelbaum, F.R., Thomas, E.D.: Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: Is exposure to marrow donor blood products 24 hours before high-dose cyclosphosphamide needed for successful engraftment? Blood 61: 672-675, 1983.
1122. Storb, R., Thomas, E.D.: Allogeneic bone-marrow transplantation. Immunol. Rev. 71: 77-102, 1983.
1123. Storb, R., Prentice, R.L., Sullivan, K.M., Shulman, H.M., Deeg, H.J., Doney, K.C., Buckner, C.D., Clift, R.A., Witherspoon, R.P., Appelbaum, F.R., Sanders, J.E., Stewart, P.S., Thomas, E.D.: Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann. Intern. Med. 98: 461-466, 1983.
1124. Mori, T., Tsoi, M.-S., Gillis, S., Santos, E., Thomas, E.D., Storb, R.: Cellular interactions in marrow-grafted patients. I. Impairment of cell-mediated lympholysis associated with graft-vs-host disease and the effect of interleukin 2. J. Immunol. 130: 712-716, 1983.
1125. Storb, R., Thomas, E.D.: Transplantation. Practice of Pediatrics, Chapter 12, Vol. 3, Kelley, V.C. (ed.): Harper & Row, Philadelphia, 12:126-151, 1983.
1126. Tsoi, M.-S., Warren, R.P., Storb, R., Witherspoon, R.P., Mickelson, E., Giblett, E.R., Schanfield, M.S., Weiden, P., Thomas, E.D.: Autologous marrow recovery and sensitization to non-HLA antigens after HLA-identical marrow transplantation for aplastic anemia. Exp. Hematol. 11: 73-81, 1983.
1127. Urban, C., Wulff, J.C., Deeg, H.J., Raff, R.F., Durkopp, N., Storb, R.: Analysis of alloreactive and cytotoxic canine lymphocytes and their precursors with murine monoclonal antibodies. Transplantation 35: 469-473, 1983.
1128. zutsu, K.T., Sullivan, K.M., Schubert, M.M., Truelove, E.L., Shulman, H.M., Sale, G.E., Morton, T.H., Rice, J.C., Witherspoon, R.P., Storb, R., Thomas, E.D.: Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease. Transplantation 35: 441-446, 1983.
1129. Deeg, H.J., Wulff, J.C., DeRose, S., Sale, G.E., Braun, M., Brown, M.A., Springmeyer, S.C., Martin, P.J., Storb, R.: Unusual distribution of Ia-like antigens on canine lymphocytes. Immunogenetics 16: 445-457, 1982.
1130. Storb, R., for the Seattle Marrow Transplant Team: Human bone marrow transplantation. Transplant. Proc. 15: 1379-1384, 1983.
1131. Deeg, H.J., Storb, R., Thomas, E.D., Appelbaum, F., Buckner, C.D., Clift, R.A., Doney, K., Johnson, L., Sanders, J.E., Stewart, P., Sullivan, K.M., Witherspoon, R.P.: Fanconi’s anemia treated by allogeneic marrow transplantation. Blood 61: 954-959, 1983.
1132. Kennedy, M.S., Deeg, H.J., Storb, R., Thomas, E.D.: Cyclosporine in marrow transplantation: Concentration-dependent toxicity and immunosuppression in vivo. Transplant. Proc. 15: 471-473, 1983.
1133. Warren, R.P., Storb, R., Thomas, E.D.: Immunologic characterization of marrow graft rejection after transplantation from an HLA-identical sibling. Transplant. Proc. 15: 1417-1419, 1983.
1134. Anderson, J.E., Ladiges, W.C., Giblett, E.R., Weiden, P., Storb, R.: Polymorphism of the sixth component of complement (C6) in the dog. Biochem. Genet. 21: 155-160, 1983.
1135. Tsoi, M.-S., Storb, R., Santos, E., Thomas, E.D.: Anti-host cytotoxic cells in patients with acute graft-versus-host disease after HLA-identical marrow grafting. Transplant. Proc. 15: 1484-1486, 1983.
1136. Deeg, H.J., Storb, R., Thomas, E.D., Kennedy, M.S., Flournoy, N., Buckner, C.D., Clift, R., Doney, K., Sale, G., Sanders, J., Witherspoon, R.: Marrow transplantation for acute nonlymphoblastic leukemia in first remission: Preliminary results of a randomized trial comparing cyclosporine and methotrexate for the prophylaxis of graft-versus-host disease. Transplant. Proc. 15: 1385-1388, 1983.
1137. Storb, R.: Aktuelle beitrage zur modernen diagnose und therapie. Die behandlung der akuten leukamie durch knochenmarkstransplantation. Wien. Klin. Wochenschr. 94: 520-523, 1982.
1138. Clift, R.A., Buckner, C.D., Thomas, E.D., Doney, K., Fefer, A., Neiman, P.E., Singer, J., Sanders, J., Stewart, P., Sullivan, K.M., Deeg, J., Storb, R.: Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation. Lancet ii: 621-623, 1982.
1139. Thomas, E.D., Buckner, C.D., Sanders, J.E., Papayannopoulou, T., Borgna-Pignatti, C., De Stefano, P., Sullivan, K.M., Clift, R.A., Storb, R.: Marrow transplantation for thalassaemia. Lancet ii: 227-229, 1982.
1140. Kennedy, M.S., Deeg, H.J., Siegel, M., Crowley, J.J., Storb, R., Thomas, E.D.: Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation. Transplantation 35: 211-215, 1983.
1141. Wulff, J.C., Tsoi, M.-S., Aprile, J., Deeg, H.J., Durkopp, N., Storb, R.: Stimulation of canine lymphocyte subpopulations separated nonlytically by monoclonal anti-T and polyclonal anti-B cell antibodies. Blut 45: 309-316, 1982.
1142. Wulff, J.C., Durkopp, N., Aprile, J., Tsoi, M.-S., Springmeyer, S.C., Deeg, H.J., Storb, R.: Two monoclonal antibodies (DLy-1 and DLy-6) directed against canine lymphocytes. Exp. Hematol. 10: 609-619, 1982.
1143. Warren, R., Kalamasz, D., Storb, R.: Enhancement of human ADCC with interferon. Clin. Exp. Immunol. 50: 183-188, 1982.
1144. Cheever, M.A., Fefer, A., Greenberg, P.D., Appelbaum, F., Armitage, J.O., Buckner, C.D., Sale, G.E., Storb, R., Witherspoon, R.P., Thomas, E.D.: Treatment of hairy-cell leukemia with chemoradiotherapy and identical twin bone-marrow transplantation. N. Engl. J. Med. 307: 479-481, 1982.
1145. Corson, S.L., Sullivan, K., Batzer, F., August, C., Storb, R., Thomas, E.D.: Gynecologic manifestations of chronic graft-versus-host disease. Obstet. Gynecol. 60: 488-492, 1982.
1146. Sullivan, K.M., Storb, R., Shulman, H.M., Shaw, C.-M., Spence, A., Beckham, C., Clift, R.A., Buckner, C.D., Stewart, P., Thomas, E.D.: Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantation. Ann. Intern. Med. 97: 182-189, 1982.
1147. Storb, R., Deeg, H.J., Atkinson, K., Weiden, P.L., Sale, G., Colby, R., Thomas, E.D.: Cyclosporin-A abrogates transfusion-induced sensitization and prevents marrow graft rejection in DLA-identical canine littermates. Blood 60: 524-526, 1982.
1148. Storb, R., for the Seattle Marrow Transplant Team: Marrow transplantation for the treatment of leukemia. B and T Cell Tumors. UCLA Symposia on Molecular and Cellular Biology, Vol. XXIV, Vitetta, E.S. (ed.): Academic Press, New York, 451-458, 1982.
1149. Lum, L.G., Orcutt-Thordarson, N., Seigneuret, M.C., Storb, R.: The regulation of Ig synthesis after marrow transplantation: IV. T4 and T8 subset function in patients with chronic graft-versus-host disease. J. Immunol. 129: 113-119, 1982.
1150. Atkinson, K., Shulman, H.M., Deeg, H.J., Weiden, P.L., Graham, T.C., Thomas, E.D., Storb, R.: Acute and chronic graft-versus-host disease in dogs given hemopoietic grafts from DLA-nonidentical littermates: Two distinct syndromes. Am. J. Pathol. 108: 196-205, 1982.
1151. Buckner, C.D., Clift, R.A., Thomas, E.D., Sanders, J.E., Hackman, R., Stewart, P.S., Storb, R., Sullivan, K.M.: Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission. Leuk. Res. 6: 395-399, 1982.
1152. Buckner, C.D., Clift, R.A., Thomas, E.D., Sanders, J.E., Stewart, P.S., Storb, R., Sullivan, K.M., Hackman, R.: Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiation. Leuk. Res. 6: 389-394, 1982.
1153. Badger, C., Buckner, C.D., Thomas, E.D., Clift, R.A., Sanders, J.E., Stewart, P.S., Storb, R., Sullivan, K.M., Shulman, H., Flournoy, N.: Allogeneic marrow transplantation for acute leukemia in relapse. Leuk. Res. 6: 383-387, 1982.
1154. Clift, R.A., Buckner, C.D., Thomas, E.D., Sanders, J.E., Stewart, P.S., Sullivan, K.M., McGuffin, R., Hersman, J., Sale, G.E., Storb, R.: Allogeneic marrow transplantation using fractionated total body irradiation in patients with acute lymphoblastic leukemia in relapse. Leuk. Res. 6: 401-407, 1982.
1155. Clift, R.A., Buckner, C.D., Thomas, E.D., Sanders, J.E., Stewart, P.S., McGuffin, R., Hersman, J., Sullivan, K.M., Sale, G.E., Storb, R.: Allogeneic marrow transplantation for acute lymphoblastic leukemia in remission using fractionated total body irradiation. Leuk. Res. 6: 409-412, 1982.
1156. Ochs, H.D., Lum, L.G., Johnson, F.L., Schiffman, G., Wedgwood, R.J., Storb, R.: Bone marrow transplantation in the Wiskott-Aldrich syndrome. Complete hematological and immunological reconstitution. Transplantation 34: 284-288, 1982.
1157. Warren, R.P., Storb, R., Thomas, E.D.: Immunological studies in patients with aplastic anemia who rejected marrow grafts from HLA-identical sibling donors. Transplantation 34: 280-283, 1982.
1158. Atkinson, K., Hansen, J.A., Storb, R., Goehle, S., Goldstein, G., Thomas, E.D.: T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets. Blood 59: 1292-1298, 1982.
1159. Storb, R.: What role for autologous marrow transplantation in cancer therapy? Nature 295: 555, 1982.
1160. Osserman, E.F., Dire, L.B., Dire, J., Sherman, W.H., Hersman, J.A., Storb, R.: Identical twin marrow transplantation in multiple myeloma. Acta Haematol. 68: 215-223, 1982.
1161. Tsoi, M.-S., Aprile, J., Dobbs, S., Goehle, S., Storb, R.: Enrichment (and depletion) of human suppressor cells with monoclonal antibodies and immunoglobulin-coated plates. J. Immunol. Methods 53: 293-305, 1982.
1162. Deeg, H.J., Storb, R., Weiden, P.L., Raff, R.F., Sale, G.E., Atkinson, K., Graham, T.C., Thomas, E.D.: Cyclosporin A and methotrexate in canine marrow transplantation: Engraftment, graft-versus-host disease, and induction of tolerance. Transplantation 34: 30-35, 1982.
1163. Deeg, H.J., Storb, R., Thomas, E.D.: Marrow graft studies in dogs: Factors influencing resistance to engraftment and graft-versus-host disease. Surv. Immunol. Res. 1: 148-154, 1982.
1164. Atkinson, K., Farewell, V., Storb, R., Tsoi, M.-S., Sullivan, K.M., Witherspoon, R.P., Fefer, A., Clift, R., Goodell, B., Thomas, E.D.: Analysis of late infections after human bone marrow transplantation: Role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 60: 714-720, 1982.
1165. Deeg, H.J., Storb, R., Shulman, H.M., Weiden, P.L., Graham, T.C., Thomas, E.D.: Engraftment of DLA-nonidentical unrelated canine marrow after high-dose fractionated total body irradiation. Transplantation 33: 443-446, 1982.
1166. Wulff, J.C., Deeg, H.-J., Storb, R.: A monoclonal antibody (DT-2) recognizing canine T lymphocytes. Transplantation 33: 616-620, 1982.
1167. Lum, L.G., Seigneuret, M.C., Orcutt-Thordarson, N., Ostenson, R.C., Storb, R.: Immunoglobulin production after marrow transplantation: III. The functional heterogeneity of FC-IgG receptor positive and negative T cell subpopulations. Clin. Exp. Immunol. 48: 675-684, 1982.
1168. Camitta, B.M., Storb, R., Thomas, E.D.: Aplastic anemia. Pathogenesis, diagnosis, treatment, and prognosis. N. Engl. J. Med. 306: 645-652 &-712-718, 1982.
1169. Slichter, S.J., Weiden, P.L., O’Donnell, M.R., Storb, R.: Interruption of tumor-associated platelet consumption with platelet enzyme inhibitors. Blood 59: 1252-1258, 1982.
1170. Storb, R.: Clonal nature of leukemia. Leukaemia. UICC Technical Reports Series – Vol. 61, Warner, N.L. and Metcalf, D. (eds.): International Union Against Cancer, Geneva, 94-100, 1981.
1171. Storb, R.: Marrow transplantation. Leukaemia. UICC Technical Reports Series – Vol. 61, Warner, N.L. and Metcalf, D. (eds.): International Union Against Cancer, Geneva, 181-188, 1981.
1172. Storb, R., fur die Seattle Knochenmarktransplantationsgruppe.: Allogene knochenmarktransplantation bei aplasticher anamie. Beitr Onkol 13: 14-23, 1982.
1173. Storb, R.: Bone marrow transplantation in patients with malignant and nonmalignant hematologic diseases. Jpn. J. Clin. Hematol. 23: 597-603, 1982.
1174. Deeg, H.J., Storb, R.: Experimental marrow transplantation. Cyclosporin A. Proceedings of an International Conference on Cyclosporin A, White, D.J.G. (ed.): Elsevier Biomedical Press, Amsterdam, 10:121-134, 1982.
1175. Storb, R.: Marrow grafting in leukaemia, Chapter 47. Cyclosporin A. Proceedings of an International Conference on Cyclosporin A, White, D.J.G. (ed.): Elsevier Biomedical Press, Amsterdam, 47:501-509, 1982.
1176. Atkinson, K., Incefy, G.S., Storb, R., Sullivan, K.M., Iwata, T., Dardenne, M., Ochs, H.D., Good, R.A., Thomas, E.D.: Low serum thymic hormone levels in patients with chronic graft-versus-host disease. Blood 59: 1073-1077, 1982.
1177. Witherspoon, R.P., Kopecky, K., Storb, R.F., Flournoy, N., Sullivan, K.M., Sosa, R., Deeg, H.J., Ochs, H.D., Cheever, M.A., Fefer, A., Thomas, E.D.: Immunological recovery in 48 patients following syngeneic marrow transplantation for hematological malignancy. Transplantation 33: 143-149, 1982.
1178. Johnson, F.L., Thomas, E.D., Clark, B.S., Chard, R.L., Hartmann, J.R., Storb, R.: A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. N. Engl. J. Med. 305: 846-851, 1981.
1179. Witherspoon, R.P., Lum, L.G., Storb, R., Thomas, E.D.: In vitro regulation of immunoglobulin synthesis after human marrow transplantation. II. Deficient T and non-T lymphocyte function within 3-4 months of allogeneic, syngeneic, or autologous marrow grafting for hematologic malignancy. Blood 59: 844-850, 1982.
1180. Shulman, H., Striker, G., Deeg, H.J., Kennedy, M., Storb, R., Thomas, E.D.: Nephrotoxicity of Cyclosporin A after allogeneic marrow transplantation: Glomerular thromboses and tubular injury. N. Engl. J. Med. 305: 1392-1395, 1981.
1181. Tsoi, M.-S., Storb, R., Weiden, P., Santos, E., Kopecky, K.J., Thomas, E.D.: Sequential studies of cell inhibition of host fibroblasts in 51 patients given HLA-identical marrow grafts. J. Immunol. 128: 239-242, 1982.
1182. Deeg, H.J., Hackman, R.C., Weiden, P.L., Storb, R.: Growth of canine tumors transplanted into normal adult dogs immunosuppressed by Cyclosporin A. Cancer Immunol. Immunother. 12: 147-152, 1982.
1183. Springmeyer, S.C., Altman, L.C., Kopecky, K.J., Deeg, H.J., Storb, R.: Alveolar macrophage kinetics and function after interruption of canine marrow function. Am. Rev. Respir. Dis. 125: 347-351, 1982.
1184. Storb, R., Doney, K.C., Thomas, E.D., Appelbaum, F., Buckner, C.D., Clift, R.A., Deeg, H.J., Goodell, B.W., Hackman, R., Hansen, J.A., Sanders, J., Sullivan, K., Weiden, P.L., Witherspoon, R.P.: Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 59: 236-246, 1982.
1185. Atkinson, K., Storb, R., Ochs, H.D., Goehle, S., Sullivan, K.M., Witherspoon, R.P., Lum, L.G., Tsoi, M.-S., Sanders, J.E., Parr, M., Stewart, P., Thomas, E.D.: Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans. Transplantation 33: 168-173, 1982.
1186. Lum, L.G., Witherspoon, R.P., Storb, R.: The role of T cells and T cell subsets in immune reconstitution after marrow grafting in humans. J. Behring Institute Mitteilungen 70: 188-195, 1982.
1187. Mickelson, E.M., Clift, R.A., Fefer, A., Storb, R., Thomas, E.D., Warren, R.P., Hansen, J.A.: Studies of the response in mixed leukocyte culture of cells from patients with aplastic anemia to cells from HLA-identical siblings. Transplantation 32: 90-95, 1981.
1188. Deeg, H.J., Storb, R., Raff, R.F., Weiden, P.L., Atkinson, K., Thomas, E.D.: Long-term survival of dogs given marrow grafts from unrelated DLA-nonidentical donors and treated with Cyclosporin A and Methotrexate — Is tolerance mediated by suppressor cells? Experimental Hematology Today, Baum, S.J., Ledney, G.D., and Thierfelder, S. (eds.): S.Karger, Basel, 127-133, 1982.
1189. Fefer, A., Cheever, M.A., Greenberg, P.D., Appelbaum, F.R., Boyd, C.N., Buckner, C.D., Kaplan, H.G., Ramberg, R., Sanders, J.E., Storb, R., Thomas, E.D.: Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins. N. Engl. J. Med. 306: 63-68, 1982.
1190. Thomas, E.D., Clift, R.A., Hersman, J., Sanders, J.E., Stewart, P., Buckner, C.D., Fefer, A., McGuffin, R., Smith, J.W., Storb, R.: Marrow transplantation for acute nonlymphoblastic leukemia in first remission using fractionated or single-dose irradiation. Int. J. Radiat. Oncol. Biol. Phys. 8: 817-821, 1982.
1191. Deeg, H.J., Storb, R., Raff, R.F., Weiden, P.L., DeRose, S., Thomas, E.D.: Marrow grafts between phenotypically DLA-identical and haploidentical unrelated dogs: Additional antigens controlling engraftment are not detected by cell-mediated lympholysis. Transplantation 33: 17-21, 1982.
1192. Appelbaum, F.R., Fefer, A., Cheever, M.A., Buckner, C.D., Greenberg, P.D., Kaplan, H.G., Storb, R., Thomas, E.D.: Treatment of non-Hodgkin’s lymphoma with marrow transplantation in identical twins. Blood 58: 509-513, 1981.
1193. Deeg, H.J., Storb, R., Weiden, P.L., Schumacher, D., Shulman, H., Graham, T., Thomas, E.D.: High-dose total-body irradiation and autologous marrow reconstitution in dogs: Dose-rate-related acute toxicity and fractionation-dependent long-term survival. Radiat. Res. 88: 385-391, 1981.
1194. Doney, K.C., Buckner, C.D., Thomas, E.D., Sanders, J., Clift, R.A., Hansen, J.A., Sale, G.E., Singer, J., Storb, R.: Allogeneic bone marrow transplantation for chronic granulocytic leukemia. Exp. Hematol. 9: 966-971, 1981.
1195. Doney, K.C., Weiden, P.L., Buckner, C.D., Storb, R., Thomas, E.D.: Treatment of severe aplastic anemia using antithymocyte globulin with or without an infusion of HLA haploidentical marrow. Exp. Hematol. 9: 829-834, 1981.
1196. Weiden, P.L., Sullivan, K.M., Flournoy, N., Storb, R., Thomas, E.D., and the Seattle Marrow Transplant Team: Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation. N. Engl. J. Med. 304: 1529-1533, 1981.
1197. Wulff, J.C., Sale, G.E., Deeg, H.J., Storb, R.: Nonspecific acid esterase activity as a marker for canine T lymphocytes. Exp. Hematol. 9: 865-870, 1981.
1198. Witherspoon, R.P., Storb, R., Ochs, H.D., Flournoy, N., Kopecky, K.J., Sullivan, K.M., Deeg, H.J., Sosa, R., Noel, D.R., Atkinson, K., Thomas, E.D.: Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood 58: 360-368, 1981.
1199. Lum, L.G., Seigneuret, M.C., Storb, R.F., Witherspoon, R.P., Thomas, E.D.: In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease. Blood 58: 431-439, 1981.
1200. Sale, G.E., Shulman, H.M., Schubert, M.M., Sullivan, K.M., Kopecky, K.J., Hackman, R.C., Morton, T.H., Storb, R., Thomas, E.D.: Oral and ophthalmic pathology of graft versus host disease in man: Predictive value of the lip biopsy. Hum. Pathol. 12: 1022-1030, 1981.
1201. Warren, R.P., Storb, R., Nelson, N.J., Sale, G.E., Thomas, E.D.: Increased frequency of the group 5a antigen in patients with hematologic malignancies. Tissue Antigens 18: 85-91, 1981.
1202. Storb, R., for the Seattle Marrow Transplant Team: Recent developments in allogeneic marrow transplantation for the treatment of severe aplastic anemia. Blut 43: 339-344, 1981.
1203. Doney, K.C., Weiden, P.L., Storb, R., Thomas, E.D.: Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids. Am. J. Hematol. 11: 1-8, 1981.
1204. Tsoi, M.-S., Storb, R., Dobbs, S., Thomas, E.D.: Specific suppressor cells in graft-host tolerance of HLA-identical marrow transplantation. Nature 292: 355-357, 1981.
1205. Weiden, P.L., Deeg, H.J., Graham, T.C., Storb, R.: Canine osteosarcoma: Failure of intravenous or intralesional BCG as adjuvant immunotherapy. Cancer Immunol. Immunother. 11: 69-72, 1981.
1206. Deeg, H.J., Storb, R.: Functional dichotomy of canine thoracic duct lymphocytes: Proliferation in mixed leukocyte culture and unresponsiveness to plant lectins. J. Reticuloendothel. Soc. 29: 395-405, 1981.
1207. Lopez, C., Kirkpatrick, D., Livnat, S., Storb, R.: Natural killer cells in bone marrow transplantation. (Letter). Lancet ii: 1025, 1980.
1208. Storb, R., for the Seattle Marrow Transplant Team: Bone marrow transplantation. Il Trapianto Oggi, Sirchia, G. and Notari, D. (eds.): Centro Transfusionale Ospedale Policlinico de Milano Editore, Milano, 369-374, 1982.
1209. Storb, R., Tsoi, M.S., Witherspoon, R.P., Sullivan, K., Lum, L., Deeg, H.J., Atkinson, K.: Unique immunologic problems in human bone marrow transplant recipients. Transplant. Proc. 13: 1624-1627, 1981.
1210. Storb, R., Weiden, P.L.: Transfusion problems associated with transplantation. Semin. Hematol. 18: 163-176, 1981.
1211. Fefer, A., Cheever, M.A., Thomas, E.D., Appelbaum, F.R., Buckner, C.D., Clift, R.A., Glucksberg, H., Greenberg, P.D., Johnson, F.L., Kaplan, H.G., Sanders, J.E., Storb, R., Weiden, P.L.: Bone marrow transplantation for refractory acute leukemia in 34 patients with identical twins. Blood 57: 421-430, 1981.
1212. Storb, R., Atkinson, K., Lum, L.G., Sullivan, K.M., Tsoi, M.-S., Weiden, P.L., Witherspoon, R.P.: Graft-versus-host disease, immunologic reconstitution and graft-host tolerance in marrow graft recipients. Cancer: Achievements, Challenges, and Prospects for the 1980s, Vol.2. Burchenal, J.H. and Oettgen, H.F. (eds.): Grune & Stratton, New York, 639-648, 1981.
1213. Sullivan, K.M., Shulman, H.M., Storb, R., Weiden, P.L., Witherspoon, R.P., McDonald, G.B., Schubert, M.M., Atkinson, K., Thomas, E.D.: Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 57: 267-276, 1981.
1214. Weiden, P.L., Hackman, R.C., Deeg, H.J., Graham, T.C., Thomas, E.D., Storb, R.: Long-term survival and reversal of iron overload after marrow transplantation in dogs with congenital hemolytic anemia. Blood 57: 66-70, 1981.
1215. Doney, K.C., Weiden, P.L., Storb, R., Thomas, E.D.: Failure of early administration of antithymocyte globulin to lessen graft-versus-host disease in human allogeneic marrow transplant recipients. Transplantation 31: 141-143, 1981.
1216. Deeg, H.J., Torok-Storb, B., Storb, R., Weiden, P.L., DeRose, S., Graham, T.C., Atkinson, K., Thomas, E.D.: Rejection of DLA-identical canine littermate marrow after transfusion-induced sensitization: Antigens involved are expressed on cotton-wool adherent but not on nonadherent mononuclear cells, granulocytes or thoracic duct lymphocytes. Experimental Hematology Today, Baum, S.J., Ledney, G.D., and Khan, A. (eds.): S.Karger, Basel, 31-37, 1981.
1217. Sosa, R., Weiden, P.L., Storb, R., Syrotuck, J., Thomas, E.D.: Granulocyte function in human allogeneic marrow graft recipients. Exp. Hematol. 8: 1183-1189, 1980.
1218. Storb, R.: Bone marrow transplantation. Cecil Textbook of Medicine. 16th Edition, 1982, 977-979; 17th Edition 1985, 1025-1028; 18th Edition, 1988. 19th: Wyngaarden, J.B., Smith, L.H., Jr., and Bennett, J.C. (eds.): W.B.Saunders & Co. Philadelphia, 153:985-987, 1992.
1219. Tsoi, M.-S., Storb, R., Dobbs, S., Medill, L., Thomas, E.D.: Cell-mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-vs-host disease. J. Immunol. 125: 2258-2262, 1980.
1220. Storb, R.: Clinical bone marrow transplantation: Results and immunological aspects. Immunobiology of the Major Histocompatibility Complex, 7th International Convocation on Immunology, Abeyounis, C.J., Kano, K., and Zaleski, M.B. (eds.): Karger, Basel, 277-285, 1981.
1221. Hansen, J.A., Clift, R.A., Thomas, E.D., Buckner, C.D., Storb, R., Giblett, E.R.: Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N. Engl. J. Med. 303: 565-567, 1980.
1222. Storb, R., for the Seattle Marrow Transplant Team: Bone marrow transplantation for the treatment of hematologic malignancy and of aplastic anemia. Transplant. Proc. 13: 221-226, 1981.
1223. Warren, R.P., Storb, R., Thomas, E.D.: Detection of the leukocyte group-5 antigens on normal and leukemic lymphocytes with the antibody-dependent cell-mediated cytotoxicity assay. Tissue Antigens 17: 174-178, 1981.
1224. Warren, R.P., Storb, R., Weiden, P.L., Su, P.J., Thomas, E.D.: Lymphocyte-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity in patients with aplastic anemia: Distinguishing transfusion-induced sensitization from possible immune-mediated aplastic anemia. Transplant. Proc. 13: 245-247, 1981.
1225. Tsoi, M.-S., Storb, R., Dobbs, S., Santos, E., Thomas, E.D.: Specific suppressor cells and immune response to host antigens in long-term human allogeneic marrow recipients: Implications for the mechanisms of graft-host tolerance and chronic graft-versus-host disease. Transplant. Proc. 13: 237-240, 1981.
1226. Lum, L.G., Seigneuret, M.C., Storb, R., Witherspoon, R.P., Thomas, E.D.: T and B cell deficiencies in patients with chronic graft-versus-host disease after HLA-identical marrow transplantation. Transplant. Proc. 13: 1231-1232, 1981.
1227. Storb, R.: Bone marrow transplantation for the treatment of leukemia. Modern Trends in Human Leukemia IV: Haematology and Blood Transfusion, Vol.26, Neth, R., Gallo, R.C., Graf, T., Mannweiler, K., and Winkler, K. (eds.): Springer-Verlag, New York, 136-138, 1981.
1228. Storb, R.: Treatment of acute leukemia in remission by bone marrow transplantation. Recent Results in Cancer Res. 80: 73-77, 1982.
1229. Deeg, H.J., Storb, R., Weiden, P.L., Graham, T., Atkinson, K., Thomas, E.D.: Cyclosporin-A: Effect on marrow engraftment and graft-versus-host disease in dogs. Transplant. Proc. 13: 402-409, 1981.
1230. Warren, R.P., Storb, R., Thomas, E.D., Su, P.J., Mickelson, E.M., Weiden, P.L.: Autoimmune and alloimmune phenomena in patients with aplastic anemia: Cytotoxicity against autologous lymphocytes and lymphocytes from HLA identical siblings. Blood 56: 683-689, 1980.
1231. O’Donnell, M.R., Slichter, S.J., Weiden, P.L., Storb, R.: Platelet and fibrinogen kinetics in canine tumors. Cancer Res. 41: 1379-1383, 1981.
1232. Storb, R., for the Seattle Marrow Transplant Team: Current status of marrow transplantation for the treatment of aplastic anemia. Biology of Bone Marrow Transplantation. ICN-UCLA Symposia on Molecular and Cellular Biology, Vol. XVII, Gale, R.P. and Fox, C.F. (eds.): Academic Press, New York, 1-9, 1980.
1233. Weiden, P.L., Giblett, E.R., Anderson, J.E., Storb, R.: Esterase D: Polymorphic red blood cell enzyme in the dog. (Brief Communication). Transplantation 30: 230-231, 1980.
1234. Ringden, O., Witherspoon, R.P., Storb, R., Thomas, E.D.: The use of hemolysis-in-gel assays to study polyclonal antibody secretion in bone marrow transplant recipients. Blut 42: 221-226, 1981.
1235. Buckner, C.D., Clift, R.A., Fefer, A., Meyers, J.D., Sullivan, K.M., Storb, R., Weiden, P., Witherspoon, R.P., Thomas, E.D.: Bone marrow transplantation. Recent Advances in Haematology, 3rd: Hoffbrand, A.V. (ed.): Churchill Livingstone, Edinburgh, 143-159, 1982.
1236. Torok-Storb, B., Deeg, H.J., Storb, R.: Functional subsets of peripheral blood mononuclear cells in transfused dogs separated by size with the fluorescence activated cell sorter. Exp. Hematol. 8: 906-910, 1980.
1237. Claas, F.H.J., van Rood, J.J., Warren, R.P., Storb, R., Weiden, P.L., Su, P.J.: The detection of non-HLA antibodies and their significance in bone marrow graft rejection. Bone Marrow Transplantation in Europe. Proceedings of the Second European Symposium on Bone Marrow Transplantation, France, Touraine, J.-L. (ed.): Excerpta Medica, Amsterdam, 57-62, 1980.
1238. Atkinson, K., Storb, R., Weiden, P.L., Deeg, H.J., Kopecky, K.J., Graham, T.C., Thomas, E.D.: Studies on transplantation tolerance in canine radiation chimeras. Biology of Bone Marrow Transplantation, Gale, R.P. and Fox, C.F. (eds.): Academic Press, New York, 271-280, 1980.
1239. Tsoi, M.-S., Storb, R., Dobbs, S., Sullivan, K.M., Thomas, E.D.: Suppressor cells in patients with HLA identical marrow grafts. Biology of Bone Marrow Transplantation, Gale, R.P. and Fox, C.F. (eds.): Academic Press, New York, 119-125, 1980.
1240. Thomas, E.D., Fefer, A., Storb, R.: Bone marrow transplantation in the treatment of neoplastic diseases, Chapter 10. Immunological Approaches to Cancer Therapeutics, Mihich, E. (ed.): John Wiley & Sons, New York, 10:299-332, 1982.
1241. Warren, R.P., Storb, R., Weiden, P.L., Su, P.J., Thomas, E.D.: Prediction of marrow graft rejection by the lymphocyte-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity assays. Transplantation 30: 118-121, 1980.
1242. Atkinson, K., Deeg, H.J., Storb, R., Weiden, P.L., Gerhard-Miller, L., Torok-Storb, B.J., Seigneuret, M., Thomas, E.D.: Canine lymphocyte subpopulations. Exp. Hematol. 8: 821-829, 1980.
1243. Deeg, H.J., Storb, R., Weiden, P.L., Graham, T., Thomas, E.D.: Cyclosporin A in marrow transplantation in the dog. Biology of Bone Marrow Transplantation, Gale, R.P. and Fox, C.F. (eds.): Academic Press, New York, 281-284, 1980.
1244. Sullivan, K.M., Shulman, H.M., Weiden, P.L., Storb, R., Tsoi, M.-S., Thomas, E.D.: The spectrum of chronic graft-vs-host disease in man. Biology of Bone Marrow Transplantation, Gale, R.P. and Fox, C.F. (eds.): Academic Press, New York, 69-73, 1980.
1245. Atkinson, K., Storb, R., Weiden, P.L., Deeg, H.J., Gerhard-Miller, L., Thomas, E.D.: In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: Evidence that clonal abortion maintains stable graft-host tolerance. J. Immunol. 124: 1808-1814, 1980.
1246. Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M.S., Storb, R., Thomas, E.D.: Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am. J. Med. 69: 204-217, 1980.
1247. Ochs, H.D., Witherspoon, R.P., Storb, R., Wedgwood, R.J.: Immune recovery after marrow transplantation. Immunoglobulins: Characteristics and Uses of Intravenous Preparations. DHHS Publication No. (FDA)-80-9005. Alving, B.M. and Finlayson, J.S. (eds.): U.S. Government Printing Office, Washington, D.C. 99-106, 1980.
1248. Deeg, H.J., Storb, R., Prentice, R., Fritz, T.E., Weiden, P.L., Sale, G.E., Graham, T.C., Thomas, E.D.: Increased cancer risk in canine radiation chimeras. Blood 55: 233-239, 1980.
1249. Livnat, S., Seigneuret, M., Storb, R., Prentice, R.L.: Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation. J. Immunol. 124: 481-490, 1980.
1250. Deeg, H.J., Storb, R., Gerhard-Miller, L., Shulman, H.M., Weiden, P.L., Thomas, E.D.: Cyclosporin A, a powerful immunosuppressant in vivo and in vitro in the dog, fails to induce tolerance. Transplantation 29: 230-235, 1980.
1251. Torok-Storb, B.J., Sieff, C., Storb, R., Adamson, J., Thomas, E.D.: In vitro tests for distinguishing possible immune-mediated aplastic anemia from transfusion-induced sensitization. Blood 55: 211-215, 1980.
1252. Ringden, O., Witherspoon, R., Storb, R., Thomas, E.D.: B cell function in human marrow transplant recipients assessed by direct and indirect hemolysis-in-gel assays. J. Immunol. 123: 2729-2734, 1979.
1253. Ringden, O., Witherspoon, R.P., Storb, R., Ekelund, E., Thomas, E.D.: Increased in vitro B-cell IgG secretion during acute graft-versus-host disease and infection. Observations in 50 human marrow transplant recipients. Blood 55: 179-186, 1980.
1254. Storb, R., for the Seattle Marrow Transplant Team: Severe aplastic anemia–a stem cell disease treated by marrow transplantation. Proceedings of the Conference on Aplastic Anemia: A Stem Cell Disease, Levine, A.S. (ed.): U.S. Department of Health and Human Services, Washington, 37-43, 1981.
1255. Weiden, P.L., Flournoy, N., Thomas, E.D., Fefer, A., Storb, R.: Antitumor effect of marrow transplantation in human recipients of syngeneic or allogeneic grafts. Graft-Versus-Leukemia in Man and Animal Models, Okunewick, J. and Meredith, R. (eds.): CRC Press Inc. Boca Raton, Florida, 11-23, 1981.
1256. Storb, R., Weiden, P.L.: Transfusion in transplantation with emphasis on bone marrow transplantation, Chapter 28. Clinical Practice of Blood Transfusion, Petz, L.D. and Swisher, S.N. (eds.): Churchill Livingstone, New York, 28:573-589, 1981.
1257. Torok-Storb, B., Deeg, H.J., Atkinson, K., Weiden, P.L., Adamson, J.W., Storb, R.: Erythroid colony stimulating and inhibiting cells in peripheral blood of transfused dogs: Separation of function by velocity sedimentation. Blood 54: 955-958, 1979.
1258. Weiden, P.L., Storb, R., Deeg, H.J., Graham, T.C., Thomas, E.D.: Prolonged disease-free survival in dogs with lymphoma after total-body irradiation and autologous marrow transplantation consolidation of combination-chemotherapy-induced remissions. Blood 54: 1039-1049, 1979.
1259. Storb, R., Thomas, E.D., Buckner, C.D., Clift, R.A., Deeg, H.J., Fefer, A., Goodell, B.W., Sale, G.E., Sanders, J.E., Singer, J., Stewart, P., Weiden, P.L.: Marrow transplantation in thirty “untransfused” patients with severe aplastic anemia. Ann. Intern. Med. 92: 30-36, 1980.
1260. Atkinson, K., Meyers, J.D., Storb, R., Prentice, R.L., Thomas, E.D.: Varicella-zoster virus infection after marrow transplantation for aplastic anemia or leukemia. Transplantation 29: 47-50, 1980.
1261. Tsoi, M.-S., Storb, R., Dobbs, S., Kopecky, K.J., Santos, E., Weiden, P.L., Thomas, E.D.: Nonspecific suppressor cells in patients with chronic graft-vs-host disease after marrow grafting. J. Immunol. 123: 1970-1976, 1979.
1262. Witherspoon, R.P., Storb, R., Mickelson, E.M., Weiden, P.L., Thomas, E.D.: Association of interstitial pneumonia and diminished in vitro lymphocyte blastogenesis in human marrow graft recipients. Transplantation 28: 412-414, 1979.
1263. Thomas, E.D., Buckner, C.D., Clift, R.A., Fefer, A., Johnson, F.L., Neiman, P.E., Sale, G.E., Sanders, J.E., Singer, J.W., Shulman, H., Storb, R., Weiden, P.L.: Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N. Engl. J. Med. 301: 597-599, 1979.
1264. Hansen, J.A., Clift, R.A., Thomas, E.D., Buckner, C.D., Mickelson, E.M., Storb, R.: Histocompatibility and marrow transplantation. Transplant. Proc. 11: 1924-1929, 1979.
1265. Card, R.T., Holmes, I.H., Sugarman, R.G., Storb, R., Thomas, E.D.: Successful pregnancy after high dose chemotherapy and marrow transplantation for treatment of aplastic anemia. Exp. Hematol. 8: 57-60, 1980.
1266. Boranic, M., Storb, R., Graham, T.C., Weiden, P.L.: “Transient” grafts of bone marrow in dogs. Acta Med. Iugosl. 33: 243-254, 1979.
1267. Storb, R., for the Seattle Marrow Transplant Team: Immunologic and hematologic concepts in marrow transplantation as they relate to aplastic anemia. Transplant. Proc. 11: 1916-1919, 1979.
1268. Deeg, H.J., Meyers, J.D., Storb, R., Graham, T.C., Weiden, P.L.: Effect of trimethoprim-sulfamethoxazole on hematological recovery after total body irradiation and autologous marrow infusion in dogs. Transplantation 28: 243-246, 1979.
1269. Thomas, E.D., Sanders, J.E., Flournoy, N., Johnson, F.L., Buckner, C.D., Clift, R.A., Fefer, A., Goodell, B.W., Storb, R., Weiden, P.L.: Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 54: 468-476, 1979.
1270. Clift, R.A., Hansen, J.A., Thomas, E.D., Buckner, C.D., Sanders, J.E., Mickelson, E.M., Storb, R., Johnson, F.L., Singer, J.W., Goodell, B.W.: Marrow transplantation from donors other than HLA-identical siblings. Transplantation 28: 235-242, 1979.
1271. Storb, R., Thomas, E.D.: Human marrow transplantation – an overview. Transplantation 28: 1-3, 1979.
1272. Kolb, H., Sale, G.E., Lerner, K.G., Storb, R., Thomas, E.D.: Pathology of acute graft-versus-host disease in the dog. An autopsy study of ninety-five dogs. Am. J. Pathol. 96: 581-594, 1979.
1273. Storb, R., Weiden, P.L., Deeg, H.J., Graham, T.C., Atkinson, K., Slichter, S.J., Thomas, E.D.: Rejection of marrow from DLA-identical canine littermates given transfusions before grafting: Antigens involved are expressed on leukocytes and skin epithelial cells but not on platelets and red blood cells. Blood 54: 477-484, 1979.
1274. Weiden, P.L., Flournoy, N., Thomas, E.D., Prentice, R., Fefer, A., Buckner, C.D., Storb, R.: Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med. 300: 1068-1073, 1979.
1275. Weiden, P.L., Gochoel, K., Deeg, H.J., Storb, R.: Primed lymphocyte test in dogs: Restimulation by non-DLA-D determinants and failure to detect lymphoma associated antigens. Immunogenetics 8: 529-538, 1979.
1276. Weiden, P.L., Storb, R., Deeg, H.J.: Antitumor effect of marrow transplantation in randomly bred species: Studies in dogs with spontaneous lymphoma. Graft-Versus-Leukemia in Man and Animal Models, Okunewick, J. and Meredith, R. (eds.): CRC Press Inc., Boca Raton, Florida, 127-138, 1981.
1277. Weiden, P.L., Storb, R., Deeg, H.J., Graham, T.C.: Total body irradiation and autologous marrow transplantation as consolidation therapy for spontaneous canine lymphoma in remission. Exp. Hematol. (Suppl.5) 7: 160-163, 1979.
1278. Storb, R., Weiden, P.L., Deeg, H.J., Torok-Storb, B., Atkinson, K., Graham, T.C., Thomas, E.D.: Marrow graft studies in dogs. Immunobiology of Bone Marrow Transplantation, Thierfelder, S., Rodt, H., and Kolb, H.J. (eds.): Springer-Verlag, Heidelberg/Berlin, 43-52, 1980.
1279. Storb, R., for the Seattle Marrow Transplant Team: Recent results in marrow transplantation for the treatment of aplastic anemia and acute leukemia in Seattle. Immunobiology of Bone Marrow Transplantation, Thierfelder, S., Rodt, H., and Kolb, H.J. (eds.): Springer-Verlag, Heidelberg, 367-374, 1980.
1280. Storb, R., for the Seattle Marrow Transplant Team: Bone marrow transplantation for the treatment of aplastic anemia and acute leukemia. Verh. Dtsch. Ges. Inn. Med. 84: 503-512, 1978.
1281. Stewart, P.S., Buckner, C.D., Clift, R.A., Sanders, J.E., Storb, R., Leonard, J.M., Thomas, E.D.: Allogeneic marrow grafting for acute leukemia: A follow-up of long-term survivors. Exp. Hematol. 7: 509-518, 1979.
1282. Atkinson, K., Storb, R., Prentice, R.L., Weiden, P.L., Witherspoon, R.P., Sullivan, K., Noel, D., Thomas, E.D.: Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 53: 720-731, 1979.
1283. Camitta, B.M., Thomas, E.D., Nathan, D.G., Gale, R.P., Kopecky, K.J., Rappeport, J.M., Santos, G., Gordon-Smith, E.C., Storb, R.: A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53: 504-514, 1979.
1284. Weiden, P.L., Doney, K., Storb, R., Thomas, E.D.: Antihuman thymocyte globulin for prophylaxis of graft-versus-host disease. A randomized trial in patients with leukemia treated with HLA-identical sibling marrow grafts. Transplantation 27: 227-230, 1979.
1285. Fefer, A., Cheever, M.A., Thomas, E.D., Boyd, C., Ramberg, R., Glucksberg, H., Buckner, C.D., Storb, R.: Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin. N. Engl. J. Med. 300: 333-337, 1979.
1286. Deeg, H.J., Storb, R., Weiden, P.L., Shulman, H.M., Graham, T.C., Torok-Storb, B.J., Thomas, E.D.: Abrogation of resistance to and enhancement of DLA-nonidentical unrelated marrow grafts in lethally irradiated dogs by thoracic duct lymphocytes. Blood 53: 552-557, 1979.
1287. Claas, F.H.J., van Rood, J.J., Warren, R.P., Weiden, P.L., Su, P.J., Storb, R.: The detection of non-HLA antibodies and their possible role in bone marrow graft rejection. Transplant. Proc. 11: 423-426, 1979.
1288. Torok-Storb, B.J., Storb, R., Deeg, H.J., Graham, T.C., Wise, C.M., Weiden, P.L., Adamson, J.W.: Lymphocyte/marrow co-cultures as a tool to detect transfusion-induced sensitization and predict marrow graft rejection in dogs. Experimental Hematology Today, Baum, S.J. and Ledney, G.D. (eds.): Springer-Verlag,New York, 33:257-261, 1979.
1289. Harrison, D.T., Flournoy, N., Ramberg, R., Boyd, C., Erne, K., Buckner, C.D., Fefer, A., Sanders, J.E., Storb, R., Thomas, E.D.: Relapse following marrow transplantation for acute leukemia. Am. J. Hematol. 5: 191-202, 1978.
1290. Weiden, P.L., Storb, R., Tsoi, M.-S., Deeg, H.J., Graham, T.C.: Canine osteosarcoma: Results of amputation with and without adjuvant immunotherapy. Cancer Immunol. Immunother. 5: 181-186, 1978.
1291. Storb, R.: Critical issues in clinical bone marrow transplantation. Natural Resistance Systems Against Foreign Cells, Tumors and Microbes, Cudkowicz, G., Landy, M., and Shearer, G.M. (eds.): Academic Press, New York, 49-71, 1978.
1292. Storb, R., Santos, G.W.: Bone marrow transplantation. Transplant. Proc. 11: 1163-1166, 1979.
1293. Storb, R., for the Seattle Marrow Transplant Team: Decrease in the graft rejection rate and improvement in survival after marrow transplantation for severe aplastic anemia. Transplant. Proc. 11: 196-198, 1979.
1294. Storb, R., Deeg, H.J., Weiden, P.L., Graham, T.C., Atkinson, K.A., Slichter, S.J., Thomas, E.D.: Marrow graft rejection in DLA-identical canine littermates: Antigens involved are expressed on leukocytes and skin epithelial cells but probably not on platelets and red blood cells. Transplant. Proc. 11: 504-506, 1979.
1295. Deeg, H.J., Storb, R., Weiden, P.L., Torok-Storb, B.J., Graham, T.C., Thomas, E.D.: Resistance to marrow grafts in dogs mediated by antigens close to but not identical with DLA-A, B, and D and overcome by infusion of thoracic-duct lymphocytes. Transplant. Proc. 11: 1495-1496, 1979.
1296. Torok-Storb, B.J., Storb, R., Deeg, H.J., Graham, T.C., Wise, C., Weiden, P.L., Adamson, J.W.: Growth in vitro of donor marrow cultured with recipient lymphocytes predicts the fate of marrow grafts in transfused DLA-identical dogs. Blood 53: 104-108, 1979.
1297. Torok-Storb, B.J., Storb, R., Graham, T.C., Prentice, R.L., Weiden, P.L., Adamson, J.W.: Erythropoiesis in vitro: Effect of normal versus “transfusion-sensitized” mononuclear cells. Blood 52: 706-711, 1978.
1298. Storb, R., Hansen, J.A., Weiden, P.L., Clift, R.A., Thomas, E.D.: Pretransplant lymphocytotoxins do not predict bone marrow graft rejection. Transplantation 26: 423-425, 1978.
1299. Witherspoon, R.P., Schanfield, M.S., Storb, R., Thomas, E.D., Giblett, E.R.: Immunoglobulin production of donor origin after marrow transplantation for acute leukemia or aplastic anemia. Transplantation 26: 407-408, 1978.
1300. Buckner, C.D., Clift, R.A., Sanders, J.E., Williams, B., Gray, M., Storb, R., Thomas, E.D.: ABO-incompatible marrow transplants. Transplantation 26: 233-238, 1978.
1301. Storb, R., Thomas, E.D., for the Seattle Marrow Transplant Team: Marrow transplantation for treatment of aplastic anaemia. Clinics in Haematology, Chapter 11, Vol. 7, Thomas, E.D. (ed.): W.B.Saunders Company Ltd. London, 11:597-609, 1978.
1302. Sale, G.E., Storb, R., Kolb, H.: Histopathology of hepatic acute graft-versus-host disease in the dog. A double blind study confirms the specificity of small bile duct lesions. Transplantation 26: 103-106, 1978.
1303. Shulman, H.M., Sale, G.E., Lerner, K.G., Barker, E.A., Weiden, P.L., Sullivan, K., Gallucci, B., Thomas, E.D., Storb, R.: Chronic cutaneous graft-versus-host disease in man. Am. J. Pathol. 91: 545-570, 1978.
1304. Tsoi, M.-S., Storb, R., Jones, E., Weiden, P.L., Shulman, H., Witherspoon, R., Atkinson, K., Thomas, E.D.: Deposition of IgM and complement at the dermo-epidermal junction in acute and chronic cutaneous graft-vs-host disease in man. J. Immunol. 120: 1485-1492, 1978.
1305. Noel, D.R., Witherspoon, R.P., Storb, R., Atkinson, K., Doney, K., Mickelson, E.M., Ochs, H.D., Warren, R.P., Weiden, P.L., Thomas, E.D.: Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors. Blood 51: 1087-1105, 1978.
1306. Singer, J.W., Brown, J.E., James, M.C., Doney, K., Warren, R.P., Storb, R., Thomas, E.D.: Effect of peripheral blood lymphocytes from patients with aplastic anemia on granulocytic colony growth from HLA-matched and -mismatched marrows: Effect of transfusion sensitization. Blood 52: 37-46, 1978.
1307. Buckner, C.D., Clift, R.A., Fefer, A., Neiman, P.E., Sanders, J.E., Storb, R., Weiden, P.L., Thomas, E.D., and the Seattle Marrow Transplant Team: Marrow transplantation for acute leukemia. Experimental Hematology Today, Chapter 23, Baum, S.J. and Ledney, G.D. (eds.): Springer-Verlag, New York, 23:191-194, 1978.
1308. Storb, R., Thomas, E.D., Weiden, P.L., Buckner, C.D., Clift, R.A., Fefer, A., Goodell, B.W., Johnson, F.L., Neiman, P.E., Sanders, J.E., Singer, J.: Engraftment of HLA identical marrow in treatment of severe aplastic anemia: Results of 110 consecutive transplants. Experimental Hematology Today, Baum, S.J. and Ledney, G.D. (eds.): Springer-Verlag, New York, 17:151-156, 1978.
1309. Storb, R., Weiden, P.L., Graham, T.C., Lerner, K.G., Nelson, N., Thomas, E.D.: Hemopoietic grafts between DLA-identical canine littermates following dimethyl myleran. Evidence for resistance to grafts not associated with DLA and abrogated by antithymocyte serum. Transplantation 24: 349-357, 1977.
1310. Warren, R.P., Storb, R., Weiden, P.L., Su, P.J., Thomas, E.D.: Cytotoxicity against HLA-identical sibling lymphocytes: Genetic determination and independent segregation of the antigenic system involved. Transplant. Proc. 10: 67-69, 1978.
1311. Storb, R., Thomas, E.D., Weiden, P.L., Buckner, C.D., Clift, R.A., Fefer, A., Goodell, B.W., Johnson, F.L., Neiman, P.E., Sanders, J.E., Singer, J.: One-hundred-ten patients with aplastic anemia (AA) treated by marrow transplantation in Seattle. Transplant. Proc. 10: 135-140, 1978.
1312. Storb, R., Weiden, P.L., Graham, T.C., Thomas, E.D.: Failure of engraftment and graft-versus-host disease after canine marrow transplantation. Two phenomena linked to but not exclusively determined by known antigens of the major histocompatibility complex. Transplant. Proc. 10: 113-118, 1978.
1313. Thomas, E.D., Buckner, C.D., Fefer, A., Neiman, P.E., Storb, R.: Marrow transplantation in the treatment of acute leukemia. Advances in Cancer Research, Vol.27, Klein, G. and Weinhouse, S. (eds.): Academic Press, Inc. New York, 269-279, 1978.
1314. Witherspoon, R., Noel, D., Storb, R., Ochs, H.D., Thomas, E.D.: The effect of graft-versus-host disease on reconstitution of the immune system following marrow transplantation for aplastic anemia or leukemia. Transplant. Proc. 10: 233-235, 1978.
1315. Weiden, P.L., Doney, K., Storb, R., Thomas, E.D.: Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts. Transplant. Proc. 10: 213-216, 1978.
1316. Thomas, E.D., Buckner, C.D., Fefer, A., Sanders, J.E., Storb, R.: Efforts to prevent recurrence of leukemia in marrow graft recipients. Transplant. Proc. 10: 163-165, 1978.
1317. Buckner, C.D., Stewart, P., Clift, R.A., Fefer, A., Neiman, P.E., Singer, J., Storb, R., Thomas, E.D.: Treatment of blastic transformation of chronic granulocytic leukemia by chemotherapy, total body irradiation and infusion of cryopreserved autologous marrow. Exp. Hematol. 6: 96-109, 1978.
1318. Weiden, P.L., Storb, R., Shulman, H., Graham, T.C.: Dimethyl myleran and autologous marrow grafting for the treatment of spontaneous canine lymphoma. Eur. J. Cancer Clin. Oncol. 13: 1411-1415, 1977.
1319. Warren, R.P., Storb, R., Weiden, P.L., Su, P.J., Thomas, E.D.: Immunologic monitoring of marrow graft recipients following transplantation from HLA-identical siblings. Transplant. Proc. 10: 535-536, 1978.
1320. Warren, R.P., Storb, R., Weiden, P.L., Su, P.J., Thomas, E.D.: Association of lymphocyte-mediated cytotoxicity (LMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) with bone-marrow graft rejection in HLA-identical siblings. Transplant. Proc. 10: 433-434, 1978.
1321. Weiden, P.L., Storb, R., Mickelson, E.M., Warren, R.P., Thomas, E.D.: Immune response to transplantation antigens in human marrow graft recipients. Transplant. Proc. 10: 409-413, 1978.
1322. Vriesendorp, H.M., Albert, E.D., Belotsky, S., Bull, R.W., Epstein, R.B., Ferrebee, J.W., Grosse-Wilde, H., Hammer, C., Rapaport, F.T., Saison, R., Schnappauf, H., Storb, R., Swisher, S.N., Templeton, J.W., Westbroek, D.L., Zweibaum, A.: Report of the IUIS committee on nomenclature of DLA determinants. Transplant. Proc. 9: 1909-1910, 1977.
1323. Fefer, A., Buckner, C.D., Thomas, E.D., Cheever, M.A., Clift, R.A., Glucksberg, H., Neiman, P.E., Storb, R.: Cure of hematologic neoplasia with transplantation of marrow from identical twins. N. Engl. J. Med. 297: 146-148, 1977.
1324. Storb, R., Graham, T.C., Epstein, R.B., Sale, G.E., Thomas, E.D.: Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation. Blood 50: 537-542, 1977.
1325. Storb, R., Weiden, P.L., Graham, T.C., Lerner, K.G., Thomas, E.D.: Marrow grafts between DLA-identical and homozygous unrelated dogs. Evidence for an additional locus involved in graft-versus-host disease. Transplantation 24: 165-174, 1977.
1326. Warren, R.P., Storb, R., Nguyen, D.D., Thomas, E.D.: The failure to demonstrate an involvement of human leukocyte group 5 antigens in graft-versus-host disease and marrow graft rejection. Brief Communication. Transplantation 24: 89-91, 1977.
1327. Thomas, E.D., Fefer, A., Buckner, C.D., Storb, R.: Current status of bone marrow transplantation for aplastic anemia and acute leukemia. Blood 49: 671-681, 1977.
1328. Warren, R.P., Nguyen, D.D., Storb, R., Thomas, E.D.: Association between leucocyte group-5a antigen and acute lymphoblastic leukaemia. Lancet i: 509-510, 1977.
1329. Tsoi, M.-S., Storb, R., Weiden, P.L., Thomas, E.D.: Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings. J. Immunol. 118: 1799-1805, 1977.
1330. Weiden, P.L., Storb, R., Sale, G.E., Graham, T.C., Thomas, E.D.: Allogeneic hematopoietic grafts after total-body irradiation in dogs with spontaneous tumors. J. Natl. Cancer Inst. 61: 353-357, 1978.
1331. Baldwin, J.L., Storb, R., Thomas, E.D., Mannik, M.: Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum. 20: 1043-1048, 1977.
1332. Thomas, E.D., Flournoy, N., Buckner, C.D., Clift, R.A., Fefer, A., Neiman, P.E., Storb, R.: Cure of leukemia by marrow transplantation. Leuk. Res. 1: 67-70, 1977.
1333. Storb, R., Prentice, R.L., Thomas, E.D.: Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. J. Clin. Invest. 59: 625-632, 1977.
1334. Thomas, E.D., Buckner, C.D., Banaji, M., Clift, R.A., Fefer, A., Flournoy, N., Goodell, B.W., Hickman, R.O., Lerner, K.G., Neiman, P.E., Sale, G.E., Sanders, J.E., Singer, J., Stevens, M., Storb, R., Weiden, P.L.: One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49: 511-533, 1977.
1335. Storb, R., Prentice, R.L., Thomas, E.D.: Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N. Engl. J. Med. 296: 61-66, 1977.
1336. Storb, R.: Total-body irradiation and marrow transplantation. Transplant. Proc. 9: 1113-1119, 1977.
1337. Weiden, P.L., Storb, R., Graham, T.C., Sale, G.E., Thomas, E.D.: Resistance to DLA-nonidentical marrow grafts in lethally irradiated dogs. Transplant. Proc. 9: 285-288, 1977.
1338. Schroeder, M.L., Storb, R., Goselink, H., Gluckman, E.: Freezing of canine lymphocytes for use in mixed leukocyte culture and cell-mediated lympholysis tests. Transplantation 23: 33-38, 1977.
1339. Storb, R., Weiden, P.L., Graham, T.C., Lerner, K.G., Thomas, E.D.: Marrow grafts between unrelated dogs homozygous and identical for DLA antigens. Transplant. Proc. 9: 281-283, 1977.
1340. Storb, R., Weiden, P.L., Prentice, R., Buckner, C.D., Clift, R.A., Einstein, A.B., Fefer, A., Johnson, F.L., Lerner, K.G., Neiman, P.E., Sanders, J.E., Thomas, E.D.: Aplastic anemia (AA) treated by allogeneic marrow transplantation: The Seattle experience. Transplant. Proc. 9: 181-185, 1977.
1341. Neiman, P.E., Reeves, W., Ray, G., Buckner, C.D., Storb, R., Clift, R.A., Weiden, P.L., Fefer, A., Thomas, E.D.: Interstitial pneumonia and opportunistic viral infection following marrow transplantation for acute leukemia and aplastic anemia. International Society of Blood Transfusion Symposium on Human Bone Marrow Transplantation, Perkins, H.A. and James, L.J. (eds.): American Association of Blood Banks, Washington, 4:29-34, 1976.
1342. Storb, R. , for the Seattle Marrow Transplant Team: Aplastic anemia treated by allogeneic marrow transplantation: The Seattle experience. International Society of Blood Transfusion, Symposium on Human Bone Marrow Transplantation, Perkins, H.A. and James, L.J. (eds.): American Association of Blood Banks, Washington, 5:35-45, 1976.
1343. Camitta, B.M., Thomas, E.D., Nathan, D.G., Santos, G., Gordon-Smith, E.C., Gale, R.P., Rappeport, J.M., Storb, R.: Severe aplastic anemia: A prospective study of the effect of early marrow transplantation on acute mortality. Blood 48: 63-70, 1976.
1344. Storb, R., Thomas, E.D., Weiden, P.L., Buckner, C.D., Clift, R.A., Fefer, A., Fernando, L.P., Giblett, E.R., Goodell, B.W., Johnson, F.L., Lerner, K.G., Neiman, P.E., Sanders, J.E.: Aplastic anemia treated by allogeneic bone marrow transplantation: A report on 49 new cases from Seattle. Blood 48: 817-841, 1976.
1345. Storb, R., Thomas, E.D., Buckner, C.D., Clift, R.A., Fefer, A., Fernando, L.P., Giblett, E.R., Johnson, F.L., Neiman, P.E.: Allogeneic marrow grafting for treatment of aplastic anemia: A follow-up on long-term survivors. Blood 48: 485-490, 1976.
1346. Warren, R.P., Storb, R., Weiden, P.L., Mickelson, E.M., Thomas, E.D.: Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejection. Transplantation 22: 631-635, 1976.
1347. Albert, E., Thomas, E.D., Nisperos, B., Storb, R., Camitta, B.M., Parkman, R.: HLA antigens and haplotypes in 200 patients with aplastic anemia. Transplantation 22: 528-531, 1976.
1348. Johnson, F.L., Hartmann, J.R., Thomas, E.D., Chard, R.L., Hersman, J.A., Buckner, C.D., Clift, R.A., Storb, R.: Marrow transplantation in treatment of children with aplastic anaemia or acute leukaemia. Arch. Dis. Child. 51: 403-410, 1976.
1349. Weiden, P.L., Thomas, E.D., Storb, R., Fefer, A., Neiman, P.E., Clift, R.A., Buckner, C.D., Lerner, K.G.: Marrow transplantation in aplastic anemia and leukemia. Compr. Ther. 2: 57-62, 1976.
1350. Weiden, P.L., Storb, R., Slichter, S., Warren, R.P., Sale, G.E.: Effect of six weekly transfusions on canine marrow grafts: Tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum. J. Immunol. 117: 143-150, 1976.
1351. Storb, R., Thomas, E.D.: Transplantation. Practice of Pediatrics, Vol. II, Chap. 4, Kelley, V.C. (ed.): Harper & Row, Philadelphia, 4:1-26, 1981.
1352. Fefer, A., Freeman, H., Storb, R., Hill, J., Singer, J., Edwards, A., Thomas, E.D.: Paroxysmal nocturnal hemoglobinuria and marrow failure treated by infusion of marrow from an identical twin. Ann. Intern. Med. 84: 692-695, 1976.
1353. Mickelson, E.M., Fefer, A., Storb, R., Thomas, E.D.: Correlation of the relative response index with marrow graft rejection in patients with aplastic anemia. Transplantation 22: 294-300, 1976.
1354. Weiden, P.L., Storb, R., Tsoi, M.-S., Graham, T.C., Lerner, K.G., Thomas, E.D.: Infusion of donor lymphocytes into stable canine radiation chimeras: Implications for mechanism of transplantation tolerance. J. Immunol. 116: 1212-1219, 1976.
1355. Tsoi, M.-S., Weiden, P.L., Storb, R.: Immunologic reactivity to soluble autochthonous tumor extracts in dogs with spontaneous malignancies. J. Immunol. 116: 1134-1139, 1976.
1356. Weiden, P.L., Storb, R., Graham, T.C., Schroeder, M.L.: Severe hereditary haemolytic anaemia in dogs treated by marrow transplantation. Br. J. Haematol. 33: 357-362, 1976.
1357. Storb, R., Ochs, H.D., Weiden, P.L., Thomas, E.D.: Immunologic reactivity in marrow graft recipients. Transplant. Proc. 8: 637-639, 1976.
1358. Storb, R., Tsoi, M.S., Weiden, P.L., Graham, T.C., Thomas, E.D.: Studies on the mechanism of stable graft-host tolerance in canine and human radiation chimeras. Transplant. Proc. 8: 561-564, 1976.
1359. Weiden, P.L., Storb, R., Thomas, E.D., Graham, T.C., Lerner, K.G., Buckner, C.D., Fefer, A., Neiman, P.E., Clift, R.A.: Preceding transfusions and marrow graft rejection in dogs and man. Transplant. Proc. 8: 551-554, 1976.
1360. Storb, R., Weiden, P.L., Graham, T.C., Thomas, E.D.: Studies of marrow transplantation in dogs. Transplant. Proc. 8: 545-549, 1976.
1361. Vriesendorp, H.M., Albert, E.D., Templeton, J.W., Belotsky, S., Taylor, B., Blumenstock, D.A., Bull, R.W., Cannon, F.D., Epstein, R.B., Ferrebee, J.W., Grosse-Wilde, H., Hammer, C., Krumbacher, K., Leon, S., Meera Kahn, P., Mickey, M.R., Motola, M., Rapaport, F.T., Saison, R., Schnappauf, H., Scholz, S., Schroeder, M.L., Storb, R., Wank, R., Westbroek, D.L., Zweibaum, A.: Joint Report of the Second International Workshop on Canine Immunogenetics. Transplant. Proc. 8: 289-311, 1976.
1362. Thomas, E.D., Buckner, C.D., Cheever, M.A., Clift, R.A., Einstein, A.B., Fefer, A., Neiman, P.E., Sanders, J., Storb, R., Weiden, P.L.: Marrow transplantation for leukemia and aplastic anemia. Transplant. Proc. 8: 603-605, 1976.
1363. Thomas, E.D., Storb, R., Buckner, C.D.: Total body irradiation in preparation for marrow engraftment. Transplant. Proc. 8: 591-593, 1976.
1364. Neiman, P.E., Thomas, E.D., Reeves, W.C., Ray, C.G., Sale, G., Lerner, K.G., Buckner, C.D., Clift, R.A., Storb, R., Weiden, P.L., Fefer, A.: Opportunistic infection and interstitial pneumonia following marrow transplantation for aplastic anemia and hematologic malignancy. Transplant. Proc. 8: 663-667, 1976.
1365. Fefer, A., Thomas, E.D., Buckner, C.D., Cheever, M.A., Clift, R.A., Einstein, A.B., Jr., Neiman, P.E., Storb, R., Weiden, P.L.: Marrow transplantation for acute leukemia in man. Ann. NY Acad. Sci. 277: 52-59, 1976.
1366. Wright, S.E., Thomas, E.D., Buckner, C.D., Clift, R.A., Fefer, A., Neiman, P.E., Storb, R.: Experience with second marrow transplants. Exp. Hematol. 4: 221-226, 1976.
1367. Storb, R., Weiden, P.L., Schroeder, M.-L., Graham, T.C., Lerner, K.G., Thomas, E.D.: Marrow grafts between canine littermates homozygous or heterozygous for lymphocyte-defined histocompatibility antigens. Transplantation 21: 299-306, 1976.
1368. Storb, R., Thomas, E.D.: Marrow transplantation for the treatment of aplastic anemia and acute leukemia. Transplant. Proc. 8: 159-163, 1976.
1369. Thomas, E.D., Buckner, C.D., Clift, R.A., Fefer, A., Neiman, P.E., Storb, R.: Current status of marrow transplantation for leukaemia or aplastic anaemia. Recent Advances in Haematology, No.2, Chapter 6, Hoffbrand, A.V., Brain, M.C., and Hirsch, J. (eds.): Churchill Livingstone, New York, 6:111-125, 1977.
1370. Thomas, E.D., Storb, R., Giblett, E.R., Longpre, B., Weiden, P.L., Fefer, A., Witherspoon, R., Clift, R.A., Buckner, C.D.: Recovery from aplastic anemia following attempted marrow transplantation. Exp. Hematol. 4: 97-102, 1976.
1371. Storb, R., Weiden, P.L., Thomas, E.D.: Use of antithymocyte serum in clinical and experimental marrow transplantation. Postgrad. Med. J. 52: 96-103, 1976.
1372. Storb, R., Thomas, E.D.: Bone marrow transplantation for aplastic anaemia. Br. J. Haematol. 31: 83-88, 1975.
1373. Storb, R.: Knochenmark-transplantation bei panmyelopathie. Blut 30: 229-234, 1975.
1374. Weiden, P.L., Storb, R., Tsoi, M.-S.: Marrow origin of canine alveolar macrophages. J. Reticuloendothel. Soc. 17: 342-345, 1975.
1375. Warren, R.P., Tsoi, M.S., Henderson, B.H., Weiden, P.L., Storb, R.: Demonstration of tumor-associated antigens in dogs. Transplant. Proc. 7: 481-484, 1975.
1376. Schroeder, M.L., Warren, R.P., Storb, R., Goselink, H., Johnson, S., Brewer, M.: Cell-mediated lympholysis in the dog. Transplant. Proc. 7: 411-413, 1975.
1377. Schroeder, M.L., Gluckman, E., Storb, R., Thomas, E.D.: One-way nonstimulation of mixed leukocyte culture in canine families. Transplant. Proc. 7: 395-398, 1975.
1378. Storb, R., Weiden, P.L., Schroeder, M.L., Graham, T.C.: Marrow grafts between canine littermates showing one-way nonstimulation in mixed leukocyte culture. Transplant. Proc. 7: 459-460, 1975.
1379. Weiden, P.L., Storb, R., Kolb, H.J., Graham, T.C., Kao, G., Thomas, E.D.: Effect of time on sensitization to hemopoietic grafts by preceding blood transfusions. Transplantation 19: 240-244, 1975.
1380. Thomas, E.D., Storb, R., Clift, R.A., Fefer, A., Johnson, F.L., Neiman, P.E., Lerner, K.G., Glucksberg, H., Buckner, C.D.: Bone-marrow transplantation. N. Engl. J. Med. 292: 832-843, 895-902, 1975.
1381. Thomas, E.D., Fefer, A., Storb, R., Clift, R.A., Johnson, F.L., Neiman, P.E.: Marrow transplantation. Treatment for refractory aplastic anemia or acute leukemia. U. W. Med. 1: 19-24, 1974.
1382. Schroeder, M.L., Storb, R., Graham, T.C., Weiden, P.L.: Canine radiation chimeras: An attempt to demonstrate serum blocking factors by an in vivo approach. J. Immunol. 114: 540-541, 1975.
1383. Tsoi, M.-S., Storb, R., Weiden, P.L., Graham, T.C., Schroeder, M.-L., Thomas, E.D.: Canine marrow transplantation: Are serum blocking factors necessary to maintain the stable chimeric state? J. Immunol. 114: 531-539, 1975.
1384. Weiden, P.L., Storb, R., Lerner, K.G., Kao, G.F., Graham, T.C., Thomas, E.D.: Treatment of canine malignancies by 1200 R total body irradiation and autologous marrow grafts. Exp. Hematol. 3: 124-134, 1975.
1385. Gluckman, E., Schroeder, M.L., Storb, R., Goselink, H., Johnson, S., Graham, T.C., Pretorius, G., Thomas, E.D.: One-way nonstimulation of mixed leukocyte culture in dog families. Transplantation 19: 36-41, 1975.
1386. Tsoi, M.-S., Storb, R., Weiden, P.L., Schroeder, M.L., Thomas, E.D.: Canine marrow transplantation: Do serum blocking factors maintain stable graft-vs.-host tolerance? Transplant. Proc. 7: 841-843, 1975.
1387. Storb, R., Thomas, E.D., Buckner, C.D., Clift, R.A., Johnson, F.L., Fefer, A., Glucksberg, H., Lerner, K.G., Neiman, P.E., Weiden, P.L., Wright, S.E.: Aplastic anemia (AA) treated by allogeneic marrow grafting. Transplant. Proc. 7: 813-816, 1975.
1388. Storb, R.: Role de la transplantation de moelle osseuse dans le traitement de l’anemie aplastique et des leucemies aigues. Med. et Hyg. 32: 1947-1949, 1974.
1389. Storb, R., Thomas, E.D., Buckner, C.D., Clift, R.A., Fefer, A., Johnson, F.L., Neiman, P.E.: Marrow grafting for the treatment of aplastic anemia and acute leukemias. Forschungsergebnisse der Transfusions-medizin & Immunohaematologie, Vol. 2, Matthes, M. and Nagel, V. (eds.): Medicus Verlag, Berlin, 819-834, 1975.
1390. Buckner, C.D., Clift, R.A., Fefer, A., Funk, D.D., Glucksberg, H., Neiman, P.E., Paulsen, A., Storb, R., Thomas, E.D.: High-dose cyclophosphamide (NSC-26271) for the treatment of metastatic testicular neoplasms. Cancer Chemother. Rep. 58: 709-714, 1974.
1391. Weiden, P.L., Storb, R., Kolb, H.-J., Ochs, H.D., Graham, T.C., Tsoi, M.-S., Schroeder, M.-L., Thomas, E.D.: Immune reactivity in dogs with spontaneous malignancy. J. Natl. Cancer Inst. 53: 1049-1056, 1974.
1392. Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G., Thomas, E.D.: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18: 295-304, 1974.
1393. Buckner, C.D., Clift, R.A., Fefer, A., Neiman, P.E., Storb, R., Thomas, E.D.: Treatment of blastic transformation of chronic granulocytic leukemia by high dose cyclophosphamide, total body irradiation and infusion of cryopreserved autologous marrow. Exp. Hematol. 2: 138-146, 1974.
1394. Storb, R., Epstein, R.B., Graham, T.C., Kolb, H.J., Kolb, H., Thomas, E.D.: Rescue from canine graft-versus-host reaction by autologous or DL-A-compatible marrow. Transplantation 18: 357-367, 1974.
1395. Ochs, H.D., Storb, R., Thomas, E.D., Kolb, H.-J., Graham, T.C., Mickelson, E., Parr, M., Rudolph, R.H.: Immunologic reactivity in canine marrow graft recipients. J. Immunol. 113: 1039-1057, 1974.
1396. Buckner, C.D., Briggs, R., Clift, R.A., Fefer, A., Funk, D.D., Glucksberg, H., Neiman, P.E., Storb, R., Thomas, E.D.: Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinoma. Cancer Chemother. Rep. 58: 697-703, 1974.
1397. Kolb, H.J., Storb, R., Weiden, P.L., Ochs, H.D., Kolb, H., Graham, T.C., Floersheim, G.L., Thomas, E.D.: Immunologic, toxicologic and marrow transplantation studies in dogs given dimethyl myleran. Biomedicine 20: 341-351, 1974.
1398. Fefer, A., Einstein, A.B., Thomas, E.D., Buckner, C.D., Clift, R.A., Glucksberg, H., Neiman, P.E., Storb, R.: Bone-marrow transplantation for hematologic neoplasia in 16 patients with identical twins. N. Engl. J. Med. 290: 1389-1393, 1974.
1399. Tsoi, M.-S., Weiden, P.L., Storb, R.: Lymphocyte reactivity to autochthonous tumor cells in dogs with spontaneous malignancies. Cell. Immunol. 13: 431-439, 1974.
1400. Thomas, E.D., Storb, R., Buckner, C.D., Clift, R.A., Fefer, A.: Current status of bone marrow transplantation. News in Hematology, Vorobjev, A.I. and Lorie, Y.I. (eds.): Meditsina, Moscow, 1974.
1401. Johnson, F.L., Thomas, E.D., Buckner, C.D., Clift, R.A., Fefer, A., Storb, R.: The current status of bone marrow transplantation in cancer treatment. Cancer. Treat. Rev. 1: 81-97, 1974.
1402. Weiden, P., Robinett, B., Graham, T.C., Adamson, J.W., Storb, R.: Canine cyclic neutropenia. A stem cell defect. J. Clin. Invest. 53: 950-953, 1974.
1403. Gluckman, E., Storb, R., Thomas, E.D.: Traitement des aplasies medullaires et des leucemies aigues par la greffe de moelle osseuse allogenique. Progres recents. Actual. Hematologiques 8: 195-206, 1974.
1404. Storb, R., Gluckman, E., Thomas, E.D., Buckner, C.D., Clift, R.A., Fefer, A., Glucksberg, H., Graham, T.C., Johnson, F.L., Lerner, K.G., Neiman, P.E., Ochs, H.: Treatment of established human graft-versus-host disease by antithymocyte globulin. Blood 44: 57-75, 1974.
1405. Storb, R., Floersheim, G.L., Weiden, P.L., Graham, T.C., Kolb, H.-J., Lerner, K.G., Schroeder, M.-L., Thomas, E.D.: Effect of prior blood transfusions on marrow grafts: Abrogation of sensitization by procarbazine and antithymocyte serum. J. Immunol. 112: 1508-1516, 1974.
1406. Floersheim, G.L., Storb, R.: Knochenmarktransplantation bei aplastichen anamien und akuten leukamien (bone marrow transplantation in aplastic anemias and acute leukemias). Schweiz. Med. Wochenschr. 104: 3-10, 52-59, 87-94, 1974.
1407. Storb, R., Thomas, E.D., Buckner, C., Clift, R.A., Fefer, A., Glucksberg, H., Neiman, P.E.: Transplantation of bone marrow in refractory marrow failure and neoplastic diseases. Am. J. Clin. Pathol. 62: 212-217, 1974.
1408. Weiden, P., Storb, R., Kolb, H.J., Graham, T., Anderson, J., Giblett, E.: Genetic variation of red blood cell enzymes in the dog: Use of soluble glutamic oxaloacetic transaminase as proof of chimerism. Transplantation 17: 115-120, 1974.
1409. Fefer, A., Thomas, E.D., Buckner, C.D., Storb, R., Neiman, P., Glucksberg, H., Clift, R.A., Lerner, K.G.: Marrow transplants in aplastic anemia and leukemia. Semin. Hematol. 11: 353-367, 1974.
1410. Storb, R., Thomas, E.D., Buckner, C.D., Clift, R.A., Johnson, F.L., Fefer, A., Glucksberg, H., Giblett, E.R., Lerner, K.G., Neiman, P.: Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43: 157-180, 1974.
1411. Neiman, P., Thomas, E.D., Buckner, C.D., Storb, R., Fefer, A., Glucksberg, H., Lerner, K.G.: Marrow transplantation for aplastic anemia and acute leukemia. Annu. Rev. Med. 25: 179-198, 1974.
1412. Storb, R., Thomas, E.D.: Irradiation and marrow transplantation. Recent Advances in Nuclear Medicine, Vol. IV, Lawrence, J.H. (ed.): Grune & Stratton, New York, 161-187, 1974.
1413. Fass, L., Ochs, H.D., Thomas, E.D., Mickelson, E., Storb, R., Fefer, A.: Studies of immunological reactivity following syngeneic or allogeneic marrow grafts in man. Transplantation 16: 630-640, 1973.
1414. Albert, E.D., Erickson, V.M., Graham, T.C., Parr, M., Templeton, J.W., Mickey, M.R., Thomas, E.D., Storb, R.: Serology and genetics of the DL-A system. I. Establishment of specificities. Tissue Antigens 3: 417-430, 1973.
1415. Buckner, C.D., Johnson, F.L., Thomas, E.D., Storb, R., Clift, R.A., Chard, R.L., Funk, D.D., Neiman, P., Fefer, A.: Allogeneic marrow grafting in acute lymphoid leukemia during marrow remission. Biomedicine 18: 295-303, 1973.
1416. Fefer, A., Buckner, C.D., Clift, R.A., Fass, L., Glucksberg, H., Mickelson, E.M., Neiman, P., Storb, R., Thomas, E.D.: Marrow grafting and immunotherapy in identical twins with hematologic malignancies. Trans. Assoc. Am. Physicians. 86: 178-184, 1973.
1417. Clift, R.A., Buckner, C.D., Fefer, A., Lerner, K.G., Neiman, P.E., Storb, R., Murphy, M., Thomas, E.D.: Infectious complications of marrow transplantation. Transplant. Proc. 6: 389-393, 1974.
1418. Buckner, C.D., Clift, R.A., Fefer, A., Lerner, K.G., Neiman, P.E., Storb, R., Thomas, E.D.: Marrow transplantation for the treatment of acute leukemia using HL-A-identical siblings. Transplant. Proc. 6: 365-366, 1974.
1419. Lerner, K.G., Kao, G.F., Storb, R., Buckner, C.D., Clift, R.A., Thomas, E.D.: Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant. Proc. 6: 367-371, 1974.
1420. Storb, R., Buckner, C.D., Fefer, A., Clift, R.A., Neiman, P.E., Glucksberg, H., Lerner, K.G., Thomas, E.D.: Marrow transplantation in aplastic anemia. Transplant. Proc. 6: 355-358, 1974.
1421. Gluckman, E., Parr, M., Mickelson, E., Schroeder, M.L., Storb, R.: Mixed leucocyte cultures in dogs: A microtechnique using gradient-purified cells. Transplantation 15: 642-645, 1973.
1422. Storb, R., Kolb, H.J., Graham, T.C., Kolb, H., Weiden, P.L., Thomas, E.D.: Treatment of established graft-versus-host disease in dogs by antithymocyte serum or prednisone. Blood 42: 601-609, 1973.
1423. Kolb, H.J., Storb, R., Graham, T.C., Kolb, H., Thomas, E.D.: Antithymocyte serum and methotrexate for control of graft-versus-host disease in dogs. Transplantation 16: 17-23, 1973.
1424. Buckner, C.D., Clift, R.A., Fefer, A., Neiman, P., Storb, R., Thomas, E.D.: Human marrow transplantation – Current status. Progress in Hematology, Vol. VIII, Brown, E.B. (ed.): Grune & Stratton Inc. New York, 299-324, 1973.
1425. Neiman, P., Wasserman, P.B., Wentworth, B.B., Kao, G.F., Lerner, K.G., Storb, R., Buckner, C.D., Clift, R.A., Fefer, A., Fass, L., Glucksberg, H., Thomas, E.D.: Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation. Transplantation 15: 478-485, 1973.
1426. Storb, R., Congdon, C.C.: Radiation induced tolerance. Handbuch der Allgemeinen Pathologie, Vol. 8. Masshoff, W. (ed.): Springer-Verlag, Berlin, 655-693, 1977.
1427. Storb, R., Evans, R.S., Thomas, E.D., Buckner, C.D., Clift, R.A., Fefer, A., Neiman, P., Wright, S.E.: Paroxysmal nocturnal haemoglobinuria and refractory marrow failure treated by marrow transplantation. Br. J. Haematol. 24: 743-750, 1973.
1428. Storb, R., Rudolph, R.H., Kolb, H.J., Graham, T.C., Mickelson, E., Erickson, V., Lerner, K.G., Kolb, H., Thomas, E.D.: Marrow grafts between DL-A-matched canine littermates. Transplantation 15: 92-100, 1973.
1429. Fefer, A., Buckner, C.D., Clift, R.A., Fass, L., Lerner, K.G., Mickelson, E.M., Neiman, P., Rudolph, R., Storb, R., Thomas, E.D.: Marrow grafting in identical twins with hematologic malignancies. Transplant. Proc. 5: 927-931, 1973.
1430. Buckner, C.D., Clift, R.A., Fefer, A., Funk, D.D., Glucksberg, H., Ramberg, R.E., Storb, R., Thomas, E.D.: Aplastic anemia treated by marrow transplantation. Transplant. Proc. 5: 913-916, 1973.
1431. Storb, R., Bryant, J.I., Buckner, C.D., Clift, R.A., Fefer, A., Fialkow, P.J., Johnson, F.L., Neiman, P., Thomas, E.D.: Allogeneic marrow grafting for acute lymphoblastic leukemia: Leukemic relapse. Transplant. Proc. 5: 923-926, 1973.
1432. Thomas, E.D., Buckner, C.D., Clift, R.A., Fass, L., Fefer, A., Lerner, K.G., Neiman, P., Rowley, N., Storb, R.: Marrow grafting in patients with acute leukemia. Transplant. Proc. 5: 917-922, 1973.
1433. Storb, R., Kolb, H.J., Graham, T.C., Erickson, V., Thomas, E.D.: The effect of buffy coat-poor blood transfusion on subsequent hemopoietic grafts. Transplantation 15: 129-136, 1973.
1434. Storb, R., Thomas, E.D.: Significance of DL-A typing in tissue transplantation. Liver Transplantation, Lie, T.S. and Gutgemann, A. (eds.): Verlag Gerhard Witzstrock Inc. Baden-Baden, 195-199, 1972.
1435. Thomas, E.D., Fass, L., Ochs, H.D., Mickelson, E.M., Storb, R., Fefer, A.: Immunological reactivity of human recipients of syngeneic and allogeneic marrow grafts. Recent Results in Cancer Res. 47: 12-16, 1974.
1436. Rudolph, R.H., Fefer, A., Thomas, E.D., Buckner, C.D., Clift, R.A., Storb, R.: Isogeneic marrow grafts for hematologic malignancy in man. Arch. Intern. Med. 132: 279-285, 1973.
1437. Adamson, J.W., Storb, R.: The proliferative potential of frozen stored human marrow cells. Transplantation 14: 490-494, 1972.
1438. Thomas, E.D., Bryant, J.I., Buckner, C.D., Clift, R.A., Fefer, A., Neiman, P., Ramberg, R.E., Storb, R.: Leukemic transformation of engrafted human marrow. Transplant. Proc. 4: 567-570, 1972.
1439. Thomas, E.D., Bryant, J.I., Buckner, C.D., Clift, R.A., Fefer, A., Johnson, F.L., Neiman, P., Ramberg, R.E., Storb, R.: Leukaemic transformation of engrafted human marrow cells in vivo. Lancet i: 1310-1313, 1972.
1440. Storb, R., Kolb, H.J., Graham, T.C., LeBlond, R., Kolb, H., Lerner, K.G., Thomas, E.D.: Marrow grafts between histoincompatible canine family members. (Short communication). Eur. J. Clin. Biol. Res. 17: 680-685, 1972.
1441. Storb, R., Kolb, H.J., Graham, T.C., Kane, P.J., Thomas, E.D.: The effect of prior blood transfusions on hemopoietic grafts from histoincompatible canine littermates. Transplantation 14: 248-252, 1972.
1442. Storb, R., Marchioro, T.L., Graham, T.C., Willemin, M., Hougie, C., Thomas, E.D.: Canine hemophilia and hemopoietic grafting. Blood 40: 234-238, 1972.
1443. Thomas, E.D., Buckner, C.D., Clift, R.A., Fass, L., Fefer, A., Glucksberg, H., Johnson, F.L., Kane, P.J., Lerner, K.G., Neiman, P.E., Storb, R.: Marrow grafting for aplastic anemia and for leukemia using HL-A matched donor-recipient sibling pairs. Exp. Hematol. 22: 138-140, 1972.
1444. Storb, R., Kolb, H.J., Graham, T.C., Ochs, H.D., Thomas, E.D.: Principles of marrow grafting derived from canine studies. Exp. Hematol. 22: 126-137, 1972.
1445. Thomas, E.D., Buckner, C.D., Storb, R., Neiman, P.E., Fefer, A., Clift, R.A., Slichter, S.J., Funk, D.D., Bryant, J.I., Lerner, K.G.: Aplastic anaemia treated by marrow transplantation. Lancet i: 284-289, 1972.
1446. Storb, R., Thomas, E.D.: Transplantation. Brennemann’s Practice of Pediatrics, Vol.II, Chapter 4, Kelley, V.C. (ed.): Harper & Row, Hagerstown, Maryland, 4:1-23, 1972.
1447. Storb, R., Thomas, E.D.: Bone marrow transplantation in randomly bred animal species and in man. Proceedings of the Sixth Leukocyte Culture Conference, Schwarz, M.R. (ed.): Academic Press, New York, 805-840, 1972.
1448. Buckner, C.D., Rudolph, R.H., Fefer, A., Clift, R.A., Epstein, R.B., Funk, D.D., Neiman, P.E., Slichter, S.J., Storb, R., Thomas, E.D.: High-dose cyclophosphamide therapy for malignant disease. Toxicity, tumor response, and the effects of stored autologous marrow. Cancer 29: 357-365, 1972.
1449. Thomas, E.D., Bryant, J.I., Buckner, C.D., Clift, R.A., Fefer, A., Fialkow, P.J., Funk, D.D., Neiman, P.E., Rudolph, R.H., Slichter, S.J., Storb, R.: Allogeneic marrow grafting using HL-A matched donor-recipient sibling pairs. Trans. Assoc. Am. Physicians. 84: 248-261, 1971.
1450. Storb, R., Rudolph, R.H., Graham, T.C., Thomas, E.D.: The influence of transfusions from unrelated donors upon marrow grafts between histocompatible canine siblings. J. Immunol. 107: 409-413, 1971.
1451. Thomas, E.D., Buckner, C.D., Rudolph, R.H., Fefer, A., Storb, R., Neiman, P.E., Bryant, J.I., Chard, R.L., Clift, R.A., Epstein, R.B., Fialkow, P.J., Funk, D.D., Giblett, E.R., Lerner, K.G., Reynolds, F.A., Slichter, S.: Allogeneic marrow grafting for hematologic malignancy using HL-A matched donor-recipient sibling pairs. Blood 38: 267-287, 1971.
1452. Storb, R., Rudolph, R.H., Thomas, E.D.: Marrow grafts between canine siblings matched by serotyping and mixed leukocyte culture. J. Clin. Invest. 50: 1272-1275, 1971.
1453. Thomas, E.D., Storb, R.: The effect of amethopterin on the immune response. Ann. NY Acad. Sci. 186: 467-474, 1971.
1454. Thomas, E.D., Rudolph, R.H., Fefer, A., Storb, R., Slichter, S., Buckner, C.D.: Isogeneic marrow grafting in man. Exp. Hematol. 21: 16-18, 1971.
1455. Epstein, R.B., Graham, T.C., Storb, R., Thomas, E.D.: Studies of marrow transplantation, chemotherapy and cross-circulation in canine lymphosarcoma. Blood 37: 349-359, 1971.
1456. Epstein, R.B., Storb, R., Thomas, E.D.: Relation of canine histocompatibility testing to marrow grafting. Transplant. Proc. 3: 161-164, 1971.
1457. Buckner, C.D., Storb, R., Dillingham, L.A., Thomas, E.D.: Low temperature preservation of monkey marrow in dimethyl sulfoxide. Cryobiol. 7: 136-140, 1970.
1458. Thomas, E.D., Storb, R., Epstein, R.B.: Bone marrow chimeras in man and animals. Plenary Sessions Scientific Contributions. XIII. International Congress of Hematology, Munchen. Hamatol. Und. Bluttransfus. 9: 86-95, 1970.
1459. Storb, R., Buckner, C.D., Dillingham, L.A., Thomas, E.D.: Cyclophosphamide regimens in rhesus monkeys with and without marrow infusion. Cancer Res. 30: 2195-2203, 1970.
1460. Storb, R., Epstein, R.B., Rudolph, R.H., Thomas, E.D.: The effect of prior transfusion on marrow grafts between histocompatible canine siblings. J. Immunol. 105: 627-633, 1970.
1461. Storb, R., Graham, T.C., Shiurba, R., Thomas, E.D.: Treatment of canine graft-versus-host disease with methotrexate and cyclophosphamide following bone marrow transplantation from histoincompatible donors. Transplantation 10: 165-172, 1970.
1462. Thomas, E.D., Storb, R.: Technique for human marrow grafting. Blood 36: 507-515, 1970.
1463. Buckner, C.D., Epstein, R.B., Rudolph, R.H., Clift, R.A., Storb, R., Thomas, E.D.: Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia. Blood 35: 741-750, 1970.
1464. Gerdes, A.J., Storb, R.: The repopulation of irradiated bone marrow by the infusion of stored autologous marrow. Radiology 94: 441-445, 1970.
1465. Hellstrom, I., Hellstrom, K.E., Storb, R., Thomas, E.D.: Colony inhibition of fibroblasts from chimeric dogs mediated by the dogs’ own lymphocytes and specifically abrogated by their serum. Proc. Natl. Acad. Sci. USA 66: 65-71, 1970.
1466. Storb, R., Epstein, R.B., Graham, T.C., Thomas, E.D.: Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 9: 240-246, 1970.
1467. Storb, R., Epstein, R.B., Thomas, E.D.: Hemopoietic grafts after irradiation and buffy coat cell transfusion. White Cell Transfusions, AnonymousEditions du Centre National de la Recherche Scientifique, Paris, 61-74, 1970.
1468. Thomas, E.D., LeBlond, R., Graham, T., Storb, R.: Marrow infusions in dogs given midlethal or lethal irradiation. Radiat. Res. 41: 113-124, 1970.
1469. Epstein, R.B., Storb, R., Clift, R.A., Thomas, E.D.: Transplantation of stored allogeneic bone marrow in dogs selected by histocompatibility typing. Transplantation 8: 496-501, 1969.
1470. Storb, U., Bauer, J., Storb, R., Fliedner, T.M., Weiser, R.S.: Ultrastructure of rosette-forming cells in the mouse during the antibody response. J. Immunol. 102: 1474-1485, 1969.
1471. Storb, R., Epstein, R.B., LeBlond, R.F., Rudolph, R.H., Thomas, E.D.: Transplantation of allogeneic canine bone marrow stored at -80OC in dimethyl sulfoxide. (Brief report). Blood 33: 918-923, 1969.
1472. Storb, R., Epstein, R.B., Rudolph, R.H., Thomas, E.D.: Allogeneic canine bone marrow transplantation following cyclophosphamide. Transplantation 7: 378-386, 1969.
1473. Epstein, R.B., Storb, R., Clift, R.A., Thomas, E.D.: Autologous bone marrow grafts in dogs treated with lethal doses of cyclophosphamide. Cancer Res. 29: 1072-1075, 1969.
1474. Storb, R., Ragde, H., Thomas, E.D.: Extracorporeal irradiation of the blood in baboons. Radiat. Res. 38: 43-54, 1969.
1475. Thomas, E.D., Storb, R., Epstein, R.B., Rudolph, R.H.: Symposium on bone marrow transplantation: Experimental aspects in canines. Transplant. Proc. 1: 31-33, 1969.
1476. Storb, R., Buckner, C.D., Epstein, R.B., Graham, T., Thomas, E.D.: Clinical and hematologic effects of cross circulation in baboons. Transfusion 9: 23-31, 1969.
1477. Storb, R., Epstein, R.B., Thomas, E.D.: Marrow repopulating ability of peripheral blood cells compared to thoracic duct cells. Blood 32: 662-667, 1968.
1478. Storb, R., Epstein, R.B., Ragde, H., Thomas, E.D.: Marrow grafts by combined marrow and leukocyte infusions in unrelated dogs selected by histocompatibility typing. Transplantation 6: 587-593, 1968.
1479. Storb, R., Epstein, R.B., Buckner, C.D., Thomas, E.D.: Treatment of chronic lymphocytic leukemia by extracorporeal irradiation. Blood 31: 490-502, 1968.
1480. Epstein, R.B., Storb, R., Ragde, H., Thomas, E.D.: Cytotoxic typing antisera for marrow grafting in littermate dogs. Transplantation 6: 45-58, 1968.
1481. Storb, R., Epstein, R.B., Ragde, H., Thomas, E.D.: Marrow engraftment by allogeneic leukocytes in lethally irradiated dogs. Blood 30: 805-811, 1967.
1482. Storb, R., Amy, R.L., Wertz, R.K., Bessis, M.: Ruby Laser micro-irradiation of single tissue culture cells vitally stained with Janus green B: An electron microscope study. Record of the IEEE 9th. Annual Symposium on Electron, Ion and Laser Beam Technology, Pease, R.F.W. (ed.): San Francisco Press, Inc. San Francisco, California, 391-395, 1967.
1483. Storb, U., Chambers, V., Storb, R., Weiser, R.S.: Antibody-carrying cells in the immune response. II. Ultrastructure of “rosette” forming cells. Res. J. Reticuloendothel. Soc. 4: 69-83, 1967.
1484. Wertz, R.K., Storb, R., Amy, R.L.: Ruby Laser micro-irradiation of single tissue culture cells vitally stained with Janus green B. III. Effects on the incorporation of an RNA pyrimidine precursor. Exp. Cell Res. 45: 61-71, 1967.
1485. Storb, R., Wertz, R.K., Amy, R.L.: Ruby Laser micro-irradiation of single tissue culture cells vitally stained with Janus green B. II. Effects on dehydrogenase activities. Exp. Cell Res. 45: 374-384, 1967.
1486. Amy, R.L., Storb, R., Fauconnier, B., Wertz, R.K.: Ruby Laser micro-irradiation of single tissue culture cells vitally stained with Janus green B. I. Effects observed with a phase-contrast microscope. Exp. Cell Res. 45: 361-373, 1967.
1487. Storb, R., Amy, R.L., Wertz, R.K., Fauconnier, B., Bessis, M.: An electron microscope study of vitally stained single cells irradiated with a Ruby Laser microbeam. J. Cell Biol. 31: 11-29, 1966.
1488. Bessis, M., Storb, R.: Quelques resultates du l’utilisation du laser en cytologie experimentale. Alta Frequenza, 1965.
1489. Amy, R.L., Storb, R.: Selective mitochondrial damage by a ruby laser microbeam: An electron microscope study. Science 150: 756-758, 1965.
1490. Bessis, M., Storb, R.: Sensibilite des leucocytes au Laser a Rubis apres differentes colorations vitales. NRF Hemat. 5: 459-474, 1965.
1491. Storb, R.: La coloration vitale des organelles cellulaires. NRF Hemat. 5: 475-490, 1965.
1492. Storb, R., Najean, Y.: Dosage de l’activite “facteur intrinsique” du sac gastrique. Path. Biol. 13: 339-342, 1965.
1493. Konn, G., Storb, R.: Uber den formwandel der kleinen lungenarterien des menschen nach der gaburt (zugleich ein beitrag zum postnatalen verhalten der kleinen lungenarterien bei angeborenen herz-cefassmissbildungen mit vermehrter lungendurchblutung und zur frage der fruhkindlichen pulmonalen hypertonie). Beitr Pathol Anat 123: 212-250, 1960.